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This thesis investigates the perceptions of electronic cigarettes held by electronic cigarette 
users and stop smoking advisors in South East England between 2014 and 2015. This 
qualitative study draws on two thematically analysed datasets: 15 semi-structured 
interviews with electronic cigarette users and 13 semi-structured interviews with stop 
smoking advisors. 
The theoretical underpinnings of my empirical investigation are the Boundary Objects 
theory and Biomedicalization theory. I discuss how electronic cigarettes as boundary objects 
can function as both translational and facilitative objects between different actors, who 
construct different social meanings of electronic cigarettes. I clarify how the different social 
meanings attached to electronic cigarettes are impacted by the wider political, cultural and 
technological processes of biomedicalization. I also argue that biomedicalization processes 
are the outcome of divergent, but coexisting, perceptions and meanings. Electronic 
cigarettes bring both opportunities and threats, including the ways in which electronic 
cigarettes challenge contemporary social meanings of addiction and how such new 
innovations can prompt wider social and political changes. 
All my data exhibits a high level of ambiguity regarding electronic cigarettes’ status, 
efficacy and potential health and social risks. However, the research also shows different 
representations of electronic cigarettes that are related to a biomedical model of 
understanding and managing nicotine addiction, where individualisation and empowerment 
are at the core. Lastly, the data shows a potential for social change towards a socially 
acceptable recreational use of nicotine that mimics smoking, in spite of some electronic 
cigarette users’ concern about stigma potentially shifting from smokers to electronic 
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Chapter 1. Electronic Cigarettes: Emergent Quandary 
1.1. Introduction 
The main aim of this chapter is to set out the context through which the study will be 
developed. This thesis investigates the perceptions of electronic cigarettes (e-cigarettes) 
held by electronic cigarette users (vapers) and stop smoking advisors in South East England, 
between 2014 and 2015. Although this study focuses on the current use of electronic 
cigarettes, it is difficult to ignore the fact that the arguments of both advocates and 
opponents of electronic cigarette use, have their roots in the era that precedes the 
existence of electronic cigarettes. Hence, this chapter introduces the historical view of harm 
reduction strategy in relation to nicotine use in the United Kingdom (UK) and focuses on the 
social, political and media discourses that influence the discourse of electronic cigarettes. 
This overview is vital to fully understand the ongoing debate about electronic cigarettes and 
to grasp the complex factors that shape the perceptions of electronic cigarettes. It is 
important to point out that, although this is a South East England-based study, the literature 
review presents a holistic overview from the UK. This is because much of the literature that 
is relevant to this thesis does not provide specific information from England only. Whenever 
English-specific data was available, I point it out. 
The aim of this literature review is to map out the relevant empirical literature, 
highlight the gaps, position this thesis in its wider research context and introduce the 
research questions. The literature review is divided into two chapters (Chapter 1 and 2). The 
structure of this chapter is as follows. First, it begins with a brief history of tobacco use and 
nicotine addiction. Second, it reflects on the history of tobacco public health and the 
emergence of harm reduction in the UK. Third, I present an overview of electronic cigarette 
use and its position within harm reduction in the UK and highlight some contextual factors 
that influence the discourse of electronic cigarettes, which include their position within the 
Stop Smoking Services, the tobacco industry, marketing and the media. Fourth, I present my 
reasons for choosing to conduct this sociological study and present the theoretical 
framework. I then introduce the research questions and, finally, I outline the structure of 
the thesis. The second chapter presents the existing literature regarding the risks attributed 




literature review on the sociology of risk by introducing relevant risk theories. It discusses 
the link between risk perceptions and trust between professionals and lay people, and 
explores risk perceptions and stigma. 
1.2. The History of Tobacco Use and Nicotine Addiction 
1.2.1. Tobacco Use in the UK 
This section traces the development of tobacco use in the UK. This overview enables us to 
understand how electronic cigarette perceptions emerged from earlier experiences. 
It is suggested that tobacco smoking in Europe began around 1560 and was used to 
treat some illnesses such as headaches, intestinal worms, coughs and epilepsy (Doll, 2004; 
Milne, 2011). In the 17th century, tobacco cultivation resulted in high tobacco consumption 
in England (Mold, 2011). Pipes were the most popular way to consume tobacco at that time, 
followed by snuff in the 18th century, which was then replaced by cigars. Philip Morris, 
which is currently one of the world’s largest private cigarette companies, was established in 
1847 as a tobacconist in London, selling hand-rolled Turkish cigarettes, which became 
popular among British soldiers during the Crimean War (1853-6). Later, the mass 
manufacturing of cigarettes led to a global growth in the habit of tobacco use and the 
beginning of the smoking epidemic. This was accelerated by the creation of transnational 
tobacco companies, accompanied by mass advertising, promotion and glamorising of 
particular brands (Thun and Henley, 2004; Doll, 2004; RCP, 2007: 2-3). 
In the West, although manufactured cigarettes are the most common way of 
consuming tobacco, there are various methods used around the world, including using 
hand-rolled cigarettes, cigars, pipes, water pipes, chewing tobacco, moist snuff and dry 
snuff (RCP, 2007: 5). In the UK, male smoking increased rapidly during the two world wars 
and, by the late 1940s, an estimated 65% of men were smoking cigarettes. Then, the 
prevalence of male smoking began to fall until the early 1990s. Women began to smoke 
approximately 20 years after males, reaching a peak in about the mid-1970s. Afterwards, 
rates of smoking for both males and females fell substantially (RCP, 2007: 9). Latest smoking 
statistics show that there are about 9.1 million adult smokers in the UK and 8.7 million in 
Great Britain (GB) (ASH, 2017). Official statistics showed that the proportion of adults 




official figures suggesting that the prevalence among the over-18s fell from 19.8% in 2012 to 
18.7% in 2013, and continued to 18.3% in 2014. England had the lowest proportion of 
cigarette smokers in 2014 (18.0%) compared to other parts of the UK (ONS, 2015).  
Throughout the 19th and the 20th centuries, several harmful effects and diseases 
proved to be associated with smoking, most importantly mouth cancer, myocardial 
infarction and lung cancer. It is estimated that more than 35 diseases are partly caused by 
smoking (Doll, 2004: 4-9). However, Sir Richard Doll, a pioneering tobacco epidemiologist, 
remarked that accepting the medical evidence of tobacco harms took more than 200 years. 
Doll attributed the resistance to agreeing that smoking causes cancer, from 1950 to 1964 in 
particular, to the following reasons: the widespread nature of the habit among adult males, 
including scientists and doctors, the newly acquired epidemiological techniques and the 
importance given to bacteriological explanations for diseases (Doll, 1998). This argument is 
relevant to my study because it shows that harm is not the key factor for accepting or 
rejecting an object or a phenomenon. It also conforms to views that suggest the social, 
cultural and historical context of drug use is a key issue for tobacco control policies (Mold, 
2011; Hansen and Roberts, 2012). The influence of these factors is apparent throughout the 
discussion of tobacco and electronic cigarette use in this thesis. 
Over time, more morbidities and mortalities resulted from smoking across the globe. 
It was estimated that, in 2014, there were around 1.1 thousand million smokers worldwide. 
Using tobacco products causes about 4.9 million deaths a year; that figure is expected to 
rise to 10 million deaths per year by the 2020s or early 2030s. Amongst industrialised 
countries, smoking is estimated to cause over 90% of lung cancer in men and around 70% of 
lung cancer in women. In addition, an estimation of 56-80% of chronic respiratory disease 
and 22% of cardiovascular disease is attributed to smoking (WHO, 2014a). In the UK, it is 
estimated that approximately 96,000 smokers die from smoking-related causes (ASH, 
2016c). Consequently, public health policies to combat tobacco use have been a 
fundamental issue for the UK government (ASH, 2015c). However, there is a claim that other 
social, economic and political factors influence these policies (Elam, 2012; Netherland, 
2012). For example, it has been suggested that the revenue from tobacco tax to the 
economy hinders any real efforts to eliminate tobacco use (Mold, 2011). Before discussing 




nicotine. This will help elucidate the prominent position that nicotine has acquired in the 
field of tobacco public health. 
1.2.2. Nicotine Addiction 
To understand the debate about electronic cigarette use, it is important to understand how 
electronic cigarettes link to nicotine. This section provides an overview of the available 
evidence on nicotine, its role in smoking addiction and concludes by presenting the existing 
views of leading health organisations in the UK, which form the basis for current tobacco 
public health measures. 
Nicotine Characteristics 
Historically, world-leading health organisations, such as the Royal College of Physicians in 
the UK (RCP), the Advisory Committee to the US Surgeon General on Smoking and Health 
and the World Health Organization (WHO), viewed smoking as a sign of ‘habituation’, where 
social factors and personal characteristics influence the habit rather than biological 
addiction. It was not until the late 1970s that such organisations began to view smoking as a 
form of addiction. In 1988, cigarettes were declared to be addictive and nicotine as the main 
cause of addiction due to more proven psychological and physiological effects of smoking 
(Parascandola, 2005; Keane, 2013: 190). Nicotine is defined by the Oxford Dictionary (2016) 
as a: 
toxic colourless or yellowish oily liquid which is the chief active constituent of tobacco. It 
acts as a stimulant in small doses, but in larger amounts blocks the action of autonomic 
nerve and skeletal muscle cells. 
Among scholars, there is no consensus with regards to the effects of nicotine use. Studies 
suggest that nicotine can be poisonous at very high dosages, much higher than those 
contained in medications and cigarettes. A 40-60 mg nicotine dose can be lethal for humans; 
however, a dose of 1 mg acts as a stimulant. Several studies have demonstrated that 
nicotine causes a negative effect on animal and human brain development, an influence 
which is believed to continue to adolescence (Dwyer, Broide and Leslie, 2008; Liao et al., 
2012; Longo et al., 2013). Although there are no experimental studies in humans on the 
carcinogenic effects of pure nicotine-containing products, it has been suggested that some 




observational studies on humans indicate that nicotine may contribute to cancer 
development (Sanner and Grimsrud, 2015). However, the RCP (2016: 5) states that nicotine 
is not a highly hazardous drug and ‘is not a carcinogen’. 
Evidence suggests that nicotine is an addictive substance. The 1988 Surgeon General's 
Report on The Health Consequences of Smoking provided evidence to underpin the notion 
that nicotine is addictive like heroin and cocaine. The report states: 
All of these drugs [opioids, amphetamines, barbiturates, certain organic solvents, alcohol, 
cocaine, and nicotine] were found to maintain powerful chains of drug-seeking behavior, 
even when insufficient drug was taken to produce a clinically significant degree of physical 
dependence. Drugs that did not serve as reinforcers in these studies included caffeine. 
(U.S. Department of Health and Human Services, 1988: 281) 
Henningfield and Benowitz (2004: 139) pointed out that: ‘the development of dependence 
to nicotine is far more common than that to cocaine, heroin, or alcohol’, and that the 
intravenous nicotine produced a similar ‘mood altering effect’ as cocaine. Similarly, Foll and 
Goldberg (2009) concluded that evidence obtained from studies in experimental animals 
and humans indicate that nicotine can act like a typical drug of abuse. However, other in 
vivo studies showed that, although drugs of abuse induce changes in the brain, there are 
differences in the reward mechanisms for nicotine and cocaine (Sershen, Hashim and Lajtha, 
2010). Indeed, Molimard (2013) demonstrated that brain stimulation by nicotine is very low 
compared to amphetamine and cocaine. 
Although several definitions and models were proposed to explain addiction (West 
and Brown, 2013; West, 2013), the explanation provided by the biomedical model is widely 
accepted in the West. This model proposes that the addictive nature of nicotine is 
attributed to the activation of the reward pathways in the brain, resulting in increased 
secretion of the neurotransmitter dopamine, which regulates the feelings of pleasure 
experienced by many smokers. When smoking a cigarette, the nicotine reaches the brain 
within 10 seconds of inhalation. The positive effect of acute nicotine administration includes 
mild euphoria and mildly cognitive enhancement. However, this effect of pleasure 
disappears quickly and consequently causes smokers to continue smoking to maintain the 




(Markou, 2008; Benowitz, 2009). Withdrawal symptoms may include: irritability; depressed 
mood; anxiety and sleep disturbances. Although they do not pose a risk to life, they can be 
‘occupationally and socially debilitating’ (Henningfield and Benowitz, 2004: 139; Glover, 
2006; NIDA, 2015). 
Moreover, studies found that materials in tobacco smoke, in addition to nicotine, may 
contribute to the development and maintenance of the habit of smoking (Foll and Goldberg, 
2009). Each cigarette contains nicotine, which is accompanied by carcinogens that are 
responsible for inducing cancer (Cao et al., 2007). Hence, nicotine contained in tobacco is 
more toxic and addictive than pure nicotine (Henningfield and Benowitz, 2004). Scholars 
believe that the physical design of the cigarette can also optimise nicotine delivery (Fowles 
and Shusterman, 2004; WHO FCTC, 2012a: 12). Cultural, social, physical and economic 
factors are also believed to be associated with the maintenance of tobacco use (WHO FCTC, 
2012a: 12). The RCP (2016: 101) states that nicotine addiction is sustained because of the 
‘reward given to stimuli and behaviours associated with nicotine delivery’. 
The Introduction of Pharmaceutical Nicotine 
During the 1970s, Professor Michael Russell explored the role of nicotine in smoking. He 
concluded that: ‘People smoke for nicotine but they die from the tar’ (Russell, 1976: 1431). 
Russell’s findings that ‘nicotine addiction is not harmful’ (1991: 654) led him to promote the 
use of pharmacological ‘clean’ nicotine as a self-administration tool to replace the ‘dirty’ 
tobacco and fight smoking-related diseases. Nicotine chewing gum was the first 
pharmacological nicotine to be approved as a treatment for nicotine addiction and became 
widely available around the world during the 1980s. Other nicotine replacement therapies 
were introduced and sold in pharmacies and gained more support to be used as a strategy 
to stop smoking (Berridge, 1999: 40). Currently, different forms of nicotine replacement 
therapies are available, such as transdermal patches, tablets, oral inhalers, lozenges, nasal 
sprays and mouth mist (NICE, 2016a). The rationale for using these therapies is to produce 
lower plasma nicotine levels than those produced by smoking, yet at the same time to help 
to reduce withdrawal symptoms and craving (Glover, 2006). 
Nevertheless, some scholars challenged the views that nicotine is addictive. For 




of smoking and created ‘the myth of nicotine addiction’. He noted that there are no cases of 
using nicotine ‘alone as a "drug" or addiction to nicotine’, and that the well-accepted notion 
that nicotine is the cause of tobacco dependence was based on ‘simple observations’. 
Similarly, Elam (2012: 56) argued that the acceptance of smoking as a substance-related 
disorder in the 1970s, and the rise of nicotine addiction thereafter as a global drug problem 
is linked to advances in nicotine pharmacotherapy. Elam believed that 
‘psychopharmacological’ and ‘neurobiological’ researches were both triggered by the 
growth of the global nicotine replacement therapies’ market; this, he confirmed, formed the 
basis of the neurobiology of addiction and the foundation for the US Surgeon General’s 
Report in 1988 about nicotine addiction. 
However, in the UK, it is generally believed that: ‘People smoke because they are 
addicted to nicotine, but are harmed by other constituents of tobacco smoke’ (RCP, 2016: 
189), and that: ‘the main driver of tobacco smoking is addiction to nicotine’ (RCP, 2016: 5). 
Therefore, the recognition of nicotine as the addictive, not the harmful, substance that can 
be utilised medically has led to a series of tobacco public health measures where nicotine 
has attained a major role. This is discussed next. 
1.3. Tobacco Public Health and the Emergence of Tobacco Harm Reduction 
It is imperative to highlight the history of tobacco public health in order to understand the 
controversy surrounding electronic cigarettes today. An important account for electronic 
cigarettes stemmed from harm reduction, as this section reveals. 
Tobacco Public Health 
Scholars like Rosen (1993) identified different eras of public health throughout the history in 
the West, including Britain. It was suggested that public health work was mainly managed 
by engineers and politicians, not by doctors. It was not until 1860, when the germ theory 
was discovered, that the door opened for doctors to be part of the public health process. 
Although still focusing on managing the environment and providing services, it was argued 
that a process of increased ‘medicalisation’ of public health had originated (Gorsky, 2011: 
27), and labels such as ‘health promotion’ and ‘new public health’ emerged (Berridge, 2011: 
195). It was argued that, in the post-war era, the changing pattern of disease, where 




cancer and cardiovascular diseases increased (Gorsky, 2011: 27), led to a rise of the concept 
of ‘risk factors’ and ‘the role of psych-social factors in health’ (Berridge, 2011: 199). 
Therefore, modern public health concepts, which started in the nineteenth century with the 
‘hygienist/preventive’ model, were replaced by the ‘biomedical model’, which emphasises 
the responsibility of individuals to change their behaviours and lifestyles (Frenk, 1993: 479). 
It is in this new era that tobacco control and tobacco harm reduction were initiated and 
developed. For example, in 1971, Action on Smoking and Health (ASH), which actively works 
to eliminate the harms caused by tobacco, was established by the RCP in the UK (White, 
2004: 208; Berridge, 2011: 200). Later, the globalisation of the tobacco epidemic led to 
more international health cooperation. For example, international law to combat tobacco 
was introduced via the Framework Convention on Tobacco Control (FCTC), adopted by the 
WHO Assembly in 2003 and embraced by governments around the world. Also, tobacco 
public health campaigns became globally widespread (Berridge, 2011: 209). It is in this 
context that I initially saw the relevance of biomedicalization theory to my thesis. The 
diffusion of the biomedical model in Western society will surely influence the perceptions of 
electronic cigarettes and, at the same time, the diverse perceptions of electronic cigarettes 
will influence biomedicalization. By drawing on my empirical data, I aim to explore this 
mutual link. 
Tobacco Harm Reduction 
The phenomenon of tobacco harm reduction has gained importance since the beginning of 
tobacco public health moves. Historically, the concept of harm reduction was applied to 
some psychoactive drugs before it was embraced by tobacco public health. Harm reduction 
was described as ‘a pragmatic approach to psychoactive drug use’, where ‘Emphasis is on 
attainable short-term results over utopian long-term goals’ (Des Jarlais, Friedman and Ward, 
1993: 425). Harm reduction was defined as: 
a social policy which prioritizes the aim of decreasing the negative effects of drug 
use as an alternative drug policy to abstentionism, which prioritizes the aim of 
decreasing the prevalence or incidence of drug use. (Newcombe, 1992: 1) 
Newcombe (2015) perceives harm reduction as a strategy with a hierarchy of goals. For 




harm reduction strategies include: the termination of sharing of injection equipment; the 
use of oral drug use rather than injectable; a reduction in the amount of consumed drugs; 
and, finally, abstinence. Therefore, targeting drug consumption is one of the goals for harm 
reduction of HIV/AIDS. 
For tobacco control, the tobacco harm reduction strategy has been controversial since 
its initiation. Initiatives against tobacco consumption can be traced back to 1616 when King 
James produced an anti-smoking tract that highlighted the dangers and the ‘loathsome 
custom’ of smoking (Milne, 2011). However, tobacco harm reduction efforts were increased 
in the 1950s, when the scientific evidence proved a causative relation between smoking and 
lung cancer (Doll, 2004: 6). To date, there is no consensus in the literature on the definition 
and approaches to tobacco harm reduction. The National Institute for Clinical Excellence 
(NICE), the body responsible for providing national guidance and advice to improve health 
and social care in England and Wales, defines tobacco harm reduction as ‘measures to 
reduce the illnesses and deaths caused by smoking tobacco among people who smoke and 
those around them’ (NICE, 2012a: 4). The publication of Smoking and Health by the RCP of 
London in 1962 and the US Surgeon General’s Report in 1964 documented the link between 
smoking and lung cancer, as well as several other diseases (Doll, 2004: 8). As a result, the 
medical professions advised smokers to substitute smoking cigarettes with less harmful 
forms of smoking, which at the time included pipes and cigars. Since then, an emphasis on 
developing a ‘safer cigarette’ or ‘less harmful cigarette’ has been at the core of these 
policies (Berridge, 1999: 38). In the late 1960s, tobacco companies, responding to increased 
health concerns, introduced new brands such as ‘light’, ‘filtered’, ‘low tar’ and ‘ultra-low 
tar’, and marketed them as less dangerous than regular cigarettes; thus, millions of smokers 
used them throughout the 1970s (ASH, 2003: 3; Parascandola, 2005). This shift was backed 
by the pioneering researcher Russell, who suggested that altering the ratio of tar to nicotine 
in cigarettes could be the option to safer smoking, specifically a low tar, medium-nicotine 
cigarette (Russell, 1976: 1431). 
Nevertheless, studies found that switching to low tar and nicotine, or light cigarettes, 
did not reduce the harm from smoking; this was due to the ‘compensating behaviour’, 
where smokers take deeper puffs from smoking or smoke more (Djordjevic, 2004: 186; Elam 




industry claiming to reduce harm by reducing the amount of cancer-causing substances. 
Examples of such products include: a modified cigarette containing reduced levels of 
carcinogens; a cigarette made with genetically modified nicotine-free tobacco; technological 
delivery devices that resemble cigarettes and reduce tobacco toxicity due to heating the 
tobacco instead of burning it; and smokeless tobacco products, with reduced or eliminated 
cancer-causing agents (Djordjevic, 2004: 199; Centers for Disease Control and Prevention 
(US), 2010). However, all cigarette substitutes proved to be non-beneficial to smokers, did 
not reduce the harm to health and were considered by some to be a ‘public health disaster’ 
(ASH, 2003: 3; Gartner and Hall, 2010). 
New Tobacco Control Policies 
In 1998, the Department of Health (DOH) in England published the White Paper, ‘Smoking 
Kills’, which set out specific measures to reduce the number of premature deaths caused by 
smoking and to prevent the uptake of smoking. This led to the establishment of the National 
Health Service (NHS) Stop Smoking Services to support smokers who were motivated to quit 
(DOH, 1998, Chapter 4; McNeil et al., 2005; Bauld et al., 2010). Over the years, a variety of 
tobacco-control policies were implemented such as a ban on tobacco advertisements, 
increasing the price of tobacco, and the ‘Smokefree’ Legislation, which was introduced in 
2007 and imposed a ban on smoking in workplaces and all enclosed public places 
throughout the UK (ASH, 2015g). Nicotine replacement therapies became a core part of the 
treatment plan offered to clients, besides the behavioural support, at the Stop Smoking 
Services, with the emphasis on the abrupt quitting as the only effective approach to stop 
smoking, as well as a specified short-term supply of nicotine replacement therapies (DOH, 
1998, Chapter 4; Raw, McNeill and West, 1998; NICE, 2008: 25, 26; Rooke, 2013). Evidence 
from research (Stead and Lancaster, 2012; Kotz, Brown and West, 2014) and Public Health 
England (PHE) argued that the most effective way to stop smoking is a combination of 
behavioural support and medications that are offered across the Stop Smoking Services in 
England. West, McNeill and Raw (2000: 987) stated that these interventions delivered ‘are 
an extremely cost-effective way of preserving life and reducing ill health’. PHE suggested 
that ‘the problem is that few smokers access these services, limiting their impact on 




Although the role of nicotine in causing and treating smoking dependence became 
widely accepted among tobacco public health programmes, evidence of the effectiveness of 
nicotine has been challenged. Some evidence indicates that nicotine replacement therapies 
are an effective intervention in achieving sustained smoking abstinence (Moore et al., 2009; 
Kamerow, 2012). One systematic review concluded that nicotine replacement therapies can 
increase the chance for smokers who make a quit attempt to successfully stop smoking by 
50-70%, regardless of the setting and independent of the counselling support (Stead et al., 
2008). On the contrary, another meta-analysis research found that less than 7% of smokers 
had achieved six months sustained smoking abstinence when using nicotine replacement 
therapies (Moore et al., 2009). Other evidence put into question the effectiveness of these 
therapies to successfully prevent a relapse (Alpert, Connolly and Biener, 2012). It was 
claimed that nearly all population level studies since 2000 concluded that nicotine 
replacement therapies were no more effective than quitting without them (Polito, 2012). 
Nicotine replacement therapies, as some scholars noted, lack high levels of efficacy in real-
life settings and fail to achieve a sustained impact on smoking prevalence (Casella, 
Caponnetto and Polosa, 2010; Chapman and MacKenzie, 2010). Pharmaceutical nicotine, it 
was suggested, proved to only partially relieve tobacco craving. Two reasons for this were 
suggested. First, craving can be prompted by different factors such as the smell of smoke, 
seeing other people smoking and tobacco advertisements. Second, other substances in 
cigarettes might reduce craving (Henningfield and Benowitz, 2004: 133). Other anti-craving 
treatments were introduced later in the Stop Smoking Services such as Bupropion and 
Varenicline (Champix). However, some authors argue that the level of the available evidence 
of the effectiveness of all these medications is low (Molimard, 2013). 
Some studies showed that willpower has a major role in achieving successful quitting. 
For example, lack of willpower was identified in a survey of smokers’ and non-smokers’ 
physicians to be the main barrier to quitting, followed by addiction and, lastly, the social 
environment (Pipe, Sorensen and Reid, 2008). Also, in Bottorff et al.’s study (2009), it was 
noted that willpower, self-reliance and autonomy were mostly prominent in the men’s 
quitting stories. Similarly, a systematic review of qualitative studies on pregnant women 
found lack of willpower to be a major barrier to quitting (Ingall and Cropley, 2010). 




quitting in two disadvantaged areas in Scotland, it was noted that nicotine replacement 
therapies were viewed to be unhelpful without willpower, which was considered to be 
important in maintaining long-term cessation (Wiltshire et al., 2003). Similarly, in Rooke, 
Cunningham-Burley and Amos’s (2015: 61) study, many participants ‘emphasised the role an 
individual’s “mindset” or “willpower” played in quitting smoking’. 
However, the role of pharmaceutical aids in quitting continued to grow. Russell (1991: 
654) promoted the use of pharmacological nicotine on a long-term basis rather than a 
temporary basis and called for the continuing production of nicotine replacement products 
that are as ‘palatable and acceptable [to smokers] as possible’, and to make them readily 
available to users without prescription (Russell, 1991: 656). In 2007, the RCP published a 
report, Harm reduction in Nicotine Addiction, which proposed the application of harm-
reduction strategies to tobacco dependence. The report suggested that marketing 
‘effective, affordable, socially acceptable, low-hazard nicotine products’ to smokers as 
alternatives to tobacco could significantly improve health. Smokers, it was suggested, can 
stop smoking tobacco, ‘without having to stop using the nicotine to which they are addicted’ 
(RCP, 2007; 2016: xi). Elam and Gunnarsson (2012: 151) argue that the anti-tobacco 
movements have played a role in hindering the progression of such harm reduction 
approaches, as their main aim has been to eliminate all kinds of nicotine use. I will now 
explain why, in spite of the declines in smoking rates, it is argued that a harm reduction 
approach should be part of tobacco control in the UK. 
Why is it argued that a harm reduction approach should be part of tobacco control in the 
UK?  
In the UK, it is recognised that smoking is still the largest avoidable cause of premature 
death, disability and social inequalities in health. Currently, there are still nearly nine million 
smokers in the UK, a high proportion of whom are from the most disadvantaged groups in 
society (BMJ, 2016). It has been argued that there is a ‘strong inverse social gradient in 
smoking’ in the UK (Thirlway, 2016: 107). Over the years, inequalities in smoking rates have 
increased as the decline in smoking rates have been slower or non-existent among low 
socioeconomic status (SES) groups (Hiscock et al., 2012; McNeill and Munafò, 2013; BMJ, 
2016). A review conducted by Hiscock et al. (2012) found that smoking prevalence is higher 




whose current or most recent occupation is manual, smoke, compared with 16% of non-
manual groups (Robinson and Lader, 2009). In 2015, 12% of adults in managerial and 
professional occupations smoked compared with 28% in routine and manual occupations 
(ASH, 2017). Similarly, when other socioeconomic measures were used (like income, 
housing tenure, car availability, economic status, lone parenting and neighbourhood 
deprivation), it was found that smoking prevalence differences are significant in England 
(Amos et al., 2011). Evidence also suggests that there is a cumulative effect of disadvantage. 
For example, one study analysed anonymised data for over 2 million patients from The 
Health Improvement Network (THIN) database in the UK. It found that the highest smoking 
prevalence occurred in localities characterized by single-parent households living in public 
rented accommodation with little community support, having no access to a car, with few 
occupational qualifications and a behaviour of high TV-viewing (Sharma, Lewis and 
Szatkowski, 2010). It was also reported that smoking during pregnancy is still common, and 
in some areas in the UK, ‘the gap in smoking prevalence between deprivation areas is larger 
in the pregnant population’, where the reduction in smoking is less in the most deprived 
areas than in the least deprived areas (Shipton et al., 2009: b4347). In addition, there is 
evidence that disadvantaged smokers might face higher exposure to harm inflicted by 
tobacco use. It was found that those from greater economic deprivation groups show higher 
levels of cotinine concentration (the most commonly used objective identifier of smoke 
intake) than those from more affluent groups, even after adjusting for daily cigarette 
consumption (Fidler, Jarvis, Mindell and West, 2008). Furthermore, it was found that people 
with low SES are more likely to take up smoking, but are less likely to succeed in their quit 
attempts, despite being as likely to try to quit as other smokers (Kotz and West, 2009; 
Hiscock et al., 2012).  
 
Scholars argue that while effective tobacco control measures for reducing smoking 
prevalence exist, there is a need to focus on interventions that could reduce socioeconomic 
inequalities in smoking (Hiscock et al., 2012; Hill, Amos, Clifford and Platt, 2014). Over the 
years, several tobacco control measures have been adopted and applied, in the UK and 
around the world, to combat smoking on a population and individual level. On a population 
level, measures include: increasing the price of cigarettes; mass media campaigns; smoke-




free homes interventions and financial incentives. On an individual level, measures include: 
combined behavioural and pharmacological support; brief interventions; behavioural or 
pharmacotherapy only; quit lines; incentives and other types of support. Lorenc, Petticrew, 
Welch and Tugwell (2013) conducted a rapid overview of systematic reviews to identify 
evidence on ‘intervention-generated inequalities’ by socioeconomic status in high-income 
countries. They found that structural workplace interventions, provision of resources and 
fiscal interventions, such as tobacco pricing, show some evidence of reducing health 
inequalities. However, they found that media campaigns and workplace smoking bans show 
some evidence of increasing inequalities. Hiscock et al. (2012) provided evidence that 
among population-level interventions, increasing the price of cigarettes was the policy most 
likely to reduce the high level of smoking among disadvantaged smokers. It was suggested 
that certain types of mass media campaigns that are tailored to low SES smokers have a 
positive equity effect. Other evidence suggested that comprehensive smoke-free legislation 
removes inequalities by protecting from second-hand smoke. Among individual-level 
interventions, strong evidence showed that combined behavioural and pharmacological 
support can have a positive influence on smoking inequalities if they effectively targeted 
smokers from low SES groups (Hiscock et al., 2012). However, an updated and expanded 
review of a previous systematic literature review (Hill, Amos, Clifford and Platt, 2014: e89) 
confirmed that the increased pricing of tobacco is the intervention with ‘the greatest 
potential to reduce socioeconomic inequalities in smoking’. It also showed that non-
targeted smoking cessation programmes have a greater effectiveness among high SES and 
hence seem to have a negative equity impact on socioeconomic status inequalities in 
smoking. However, the study also confirmed that for other interventions, evidence on the 
equity impact is inconclusive.  
 
Some scholars argue that if current trends in smoking prevalence continue, even with 
the implementation of tobacco control measures, millions of smokers will continue to get 
smoking-related diseases and die as a direct result of their smoking habit. That is why 
practices of harm reduction are gaining a deeper support among experts and within the field 
of tobacco control. Some experts advise that, combined with the prevention and cessation 
approaches, ‘harm reduction, under appropriate regulatory oversight, has the capacity to 




caused by tobacco use’ (McNeill and Munafò, 2013: 17). Furthermore, it has been proposed 
that for those smokers who are unable to quit smoking and those who are the most 
addicted to nicotine, harm reduction strategies such as ‘the continuing use of nicotine in the 
form of the e-cigarettes might be a solution’ (Gartner, Hall and Borland, 2012; Benowitz, 
2014; Chapman, 2014; Thirlway, 2016: 107). Given that those who are most addicted to 
nicotine are usually from the most disadvantaged groups in society, it has been suggested 
that harm reduction approaches have the potential to reduce inequalities (Purcell, O'Rourke 
and Rivis, 2015). It is argued that electronic cigarettes seem to ‘have the potential to 
contribute to reducing death and disability caused by Britain’s biggest killer’ (BMJ, 2016). 
This notion has been supported by Public Health England who highlighted e-cigarettes’ 
potential to address the challenge of health inequalities, stating that these devices 
‘potentially offer a wide reach, low-cost intervention to reduce smoking and improve health 
in these more deprived groups in society where smoking is elevated’ (McNeill et al., 2015: 
40). A shift to applying a harm reduction strategy in England has been identified since 2011, 
as I will explain next. 
A Shift to Applying a Harm Reduction Strategy 
In 2011, the new tobacco control strategy for England incorporated ‘New approaches to 
help tobacco users who cannot quit to instead use safer sources of nicotine’ (DOH, 2011: 36; 
NICE, 2013a: 10). Here, a shift towards applying harm reduction strategies is evidenced by 
recognising smokers who are unable to quit and introducing new measures to help them. 
Indeed, NICE guidelines explained that smokers can reduce the harm of smoking for 
themselves and for the people around them in four ways: by stopping smoking altogether, 
cutting down prior to quitting, smoking less, or abstaining from smoking temporarily. NICE 
guidelines further state that: ‘it is safer to use licensed nicotine-containing products than to 
smoke’ and note that ‘there is a reason to believe that lifetime use of licensed nicotine-
containing products will be considerably less harmful than smoking’ (NICE, 2012b: 4; 2013a: 
10). The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved an 
extension to the indication of nicotine replacement therapies to include ‘harm reduction’. 
Particular nicotine replacement therapies were extended ‘for use as a complete or partial 
substitute for smoking’, both for those making an attempt to quit and those not currently 




on its duration of use’ (MHRA, 2010). Such approaches have been described as having ‘the 
potential to lead to one of the greatest public health breakthroughs in human history by 
fundamentally changing the forecast of a billion cigarette-caused deaths this century’ 
(Sweanor, Alcabes and Drucker, 2007: 74; Rodu, 2011). 
However, not all scholars and public health personnel support the harm-reduction 
approach, with some empirical and moral objections documented in the literature opposing 
its implementation. Harm reduction generated criticism of the possible dangers, such as: 
maintaining the use of a drug in society, prolonging, or preventing, quit attempts, and 
encouraging new people to use tobacco products (RCP, 2007: 204). Notions of individual 
choice, as well as calls for reducing smoking rather than quitting, it was argued, serve to 
negate public health interventions and legitimatise the existence of the tobacco industry in 
the marketplace (White, Oliffe and Bottorff, 2013). Also, scholars highlighted the challenges 
in communicating harm-reduction messages without undermining the complete withdrawal 
from nicotine and cessation measures, or diluting the notion that smoking is dangerous. 
Such measures have emphasised that smoking is unsafe and opposed all nicotine or tobacco 
product use, and that indeed has been at the core of tobacco control programmes to date 
(RCP, 2007: 204; de Andrade, Hastings and Angus, 2013). Coxhead and Rhodes (2006) 
argued that contemporary public health risk management of smoking behaviour emphasises 
individual choice and agency as key risk management solutions in relation to smoking, and 
considers those who embrace risk behaviours to be failures of risk management and 
citizenship (Petersen, 1997). Thus, new public health programmes, together with harm-
reduction strategies, it has been argued, are extending the medical model in society 
(Armstrong, 1995; Miller, 2001; Roe, 2005). I will expand on the link between 
biomedicalization and tobacco harm reduction in the relevant theory chapter. 
To summarise, it is well-accepted by policymakers and health regulators in the UK 
that, although nicotine is addictive, it is not a cause of the morbidity and mortality 
associated with smoking. Moreover, the new tobacco control policies are taking into 
consideration the difficulty of quitting smoking abruptly; therefore, they have proposed 
alternative approaches besides quitting and recommended the use of less harmful forms of 
nicotine delivery to reduce the harm of tobacco use (NICE, 2013a, b). The extension of 




cigarettes into the field of tobacco harm reduction (Keane, 2013). Next, I will introduce 
electronic cigarettes, the reasons for their use and their position in harm reduction. 
1.4. The Emergence and Use of Electronic Cigarettes in the UK 
The electronic cigarette is a battery-powered device that does not require tobacco or 
combustion to operate. It mainly vaporises a mixture of water, propylene glycol or glycerin, 
flavourings, with or without nicotine, and is activated when the user inhales through the 
mouthpiece of the device. Invented in 2003 by a Chinese pharmacist, it was initially 
designed to look like a cigarette, and was first marketed in China as an alternative to regular 
smoking and an aid to stop smoking. It received its first international patent in 2007 
(Caponnetto et al., 2012). Most electronic cigarettes include an aerosol generator, a flow 
sensor, a battery and a storage area for a solution (or e-liquid). Some are disposable, while 
others are reusable with a rechargeable battery and refillable e-liquid container or 
replaceable, pre-filled cartridges (Brown and Cheng, 2014). Over the years, more brands 
have become available in the market with different prices, sizes, colours, weights, 
accessories, flavours and with variable levels of nicotine. The term ‘vaping’ is used to 
describe the act of using electronic cigarettes. Currently, there are different electronic 
cigarette designs and ‘generations’ with a range in complexity. People can choose from first, 
second and third-generation electronic cigarettes. The third generation does not resemble 
the traditional cigarette; rather, its shape varies between a screwdriver shape to a box the 
size of a bulky smartphone. A fourth generation was also introduced to the market late in 
2015 (Martin, 2015). This study explores the perceptions of electronic cigarettes without a 
particular focus on a specific design, brand or components. 
The electronic cigarette’s popularity has increased internationally and in the UK (King 
et al., 2013; Adkison et al., 2013; Pepper and Brewer, 2013; ASH, 2016b). In GB, awareness, 
trial, and current use among adult smokers have increased over time. A survey conducted in 
2015 found that 95% of smokers and 93% of non-smokers had heard of electronic cigarettes 
(ASH, 2016b: 2). The number of current smokers who also used electronic cigarettes 
increased from 2.7% in 2010 to 6.7% in 2012 (Dockrell et al., 2013), and then to 17.6% in 
2014. However, between 2014 and 2015, the proportion remained at 17.6%. In 2014, it was 




electronic cigarette (Britton and Bogdanovica, 2014: 8). At the same time, it was suggested 
that the electronic cigarette market, in the UK, increased by 340% in 2013 to reach £193 
million, and it was expected to be worth £340 million by 2015 (Clarke, 2014; Bauld, Angus 
and de Andrade, 2014: 4). In 2015, it was estimated that the number of users of electronic 
cigarettes in GB reached 2.8 million, mostly made up of current and ex-smokers (ASH, 
2016b: 1). 
1.4.1. Reasons for Electronic Cigarettes Use 
A growing body of international and national studies has investigated the reasons for 
electronic cigarette use. The studies’ methods ranged between cross-sectional surveys (e.g. 
Etter, 2010; Etter and Bullen, 2011; Foulds, Veldheer and Berg, 2011; Siegel, Tanwar and 
Wood, 2011; Dawkins et al., 2013; Adkison et al., 2013; Vickerman et al., 2013; Goniewicz, 
Lingas and Hajek, 2013; Farsalinos et al., 2014; Richardson et al., 2014; Hummel, et al., 2015; 
Pepper et al., 2015; Rutten et al., 2015; Berg et al., 2015); qualitative interviews (McQueen, 
Tower and Sumner, 2011; Barbeau, Burda and Siegel, 2013; Sherratt et al., 2015a; Rooke, 
Cunningham-Burley and Amos, 2015; Measham, O’Brien and Turnbull, 2016); longitudinal 
surveys (Etter and Bullen, 2014; Biener and Hargraves, 2014; Brose et al., 2015a,b); case 
reports (Caponnetto et al., 2011a); observational (Polosa et al., 2011) and systematic 
reviews (Pepper and Brewer, 2013; McRobbie et al., 2014; Farsalinos and Polosa, 2014; 
Burstyn, 2014; Pisinger and Døssing, 2014). 
The documented reasons for using electronic cigarettes include: users’ perceptions 
that electronic cigarettes are less harmful than tobacco to users and bystanders; to quit 
smoking; to cut down smoking; to deal with tobacco withdrawal symptoms and avoid 
relapse; an alternative to smoking, where smoking is banned; and because they are found to 
be cheaper than cigarettes. Electronic cigarettes appeal to users because of their tobacco-
free smell, social acceptance, innovative design, varied flavours and the ability to be 
customised. Some people use them as a hobby and one study found that young people used 
electronic cigarettes primarily for flavour combinations and to perform ‘tricks’ (Measham, 
O’Brien and Turnbull, 2016). In general, it was noted that, across different populations, the 
top endorsed reasons for using electronic cigarettes were to help stop smoking and harm 




Several studies addressed the use of electronic cigarettes in the UK. Some data were 
obtained from worldwide surveys (e.g. Etter and Bullen 2011; Farsalinos et al., 2014; 
Adkison et al., 2013). For example, Adkison et al. (2013) collected data from Wave 8 of the 
International Tobacco Control Four-Country Survey between July 2010 and June 2011. There 
were 1,325 participants from the UK. It was found that the main reasons for electronic 
cigarettes use were to help reduce smoking and quit smoking. Also, Dawkins et al. (2013) 
conducted an online survey of 1,347respondents from 33 countries (23% from the UK). It 
was found that electronic cigarettes were used primarily for smoking cessation, but for a 
longer duration than nicotine replacement therapies, and users believed them to be safer 
than smoking. National studies have similar findings; for example, the Smoking Toolkit Study 
(STS) monthly household surveys have shown that the electronic cigarette has become the 
most common aid that smokers, in England, use to help them stop smoking (West, Beard 
and Brown, 2016). Also, in an Internet cohort GB survey, which was carried out in 2012, 
2013 and 2014, it was noted that approximately 80% of current users at all three time 
points mentioned that the main reasons for using electronic cigarettes were: ‘health, to cut 
down and to quit smoking’ (McNeill et al., 2015: 53). Similarly, in the ASH Smokefree GB 
adult 2015 survey, the results showed that ex-smokers stated using electronic cigarettes to 
help them stop smoking completely and to help them keep off tobacco. The main reasons 
given by current vapers who were still smoking were to help them reduce the amount of 
tobacco they smoke and to help them stop smoking entirely. Among those who no longer 
use electronic cigarettes, nearly half said they used an electronic cigarette simply to give it a 
try. Other reasons were to save money as it was cheaper than tobacco and to avoid the risk 
of second-hand tobacco smoke (ASH, 2016b). To conclude, in the UK, electronic cigarettes 
are used ‘primarily as an aid to cutting down or quitting smoking’ (ASH, 2016a). 
However, electronic cigarettes have created a controversy among professionals in 
medicine and public health, and in wider society. It was stated that: ‘Harm reduction, and in 
particular the role of e-cigarettes, has probably split global and, to some extent, national 
opinion on tobacco control more than any other issue’ (RCP, 2016: 3). This thesis addresses 
this controversy. Next, I begin to discuss the controversy of the electronic cigarette’s 




1.4.2. Electronic Cigarettes and Harm Reduction 
This section will introduce the reasons which underlie the controversy that the electronic 
cigarette has created and the debate that surrounds its position in harm reduction. 
In their discussions on the matter of electronic nicotine delivery systems (ENDS), 
including electronic cigarettes, the WHO highlighted that ‘the role of ENDS is not clearly 
established: they are perceived in some quarters as smoking cessation aids, and in others as 
a starter or dual-use (to maintain nicotine addiction) product’ (WHO FCTC, 2012b: 8). The 
electronic cigarette’s advocates view the electronic cigarette as an expansion for the use of 
pharmacological nicotine that is believed to have a pivotal role in eliminating smoking-
related diseases. They consider electronic cigarettes a breakthrough in public health history 
and harm reduction development (Britton and McNeill, 2013; Hajek et al., 2014; Nicotine 
Policy, 2014). However, opponents warn that the electronic cigarette’s safety, quality and 
long-term use has not been established fully and, therefore, oppose its promotion 
(Chapman, 2014; Centre for Tobacco Control Research and Education, 2014). Also, concerns 
were raised that electronic cigarettes might glamorise smoking and provide an entryway 
(gateway) for recruiting more people (the younger generation, in particular) to become 
addicted, by creating a new culture of vaping. This might result in maintaining nicotine 
addiction in society, promoting continued smoking and, thus, preventing smokers from 
quitting or deterring them from using existing, effective cessation aids (Cobb and Abrams, 
2011; de Andrade and Hasting, 2013; Chapman, 2014). I will expand on the risks attributed 
to electronic cigarettes in the second chapter. Next, however, I introduce an important 
concept for this thesis, which is the classification of ‘good’ nicotine and ‘bad’ nicotine. This is 
important because the circulated perceptions of electronic cigarettes mainly stem from this 
categorisation. 
‘Good’ and ‘Bad’ Nicotine 
Scholars Bell and Keane (2012: 245) believe that the controversy of electronic cigarettes 
originates from ‘the ideological challenge they pose to the binary categorisation of nicotine 
into not only remedial and harmful forms, but morally “good” and “bad” ones.’ ‘Good’ 
nicotine, they suggest, represents nicotine that does not connote smoking and is used in a 




recreational habit (Bell and Keane, 2012: 245). They discussed nicotine replacement 
therapies which, since their emergence, were described, perceived and marketed as 
‘medicine’ that ‘cures’ smokers of their nicotine addiction (p: 245). Hence, they are seen as 
‘good (health-promoting)’ products (Keane, 2013: 190), and nicotine in nicotine 
replacement therapies is considered ‘good’ ‘because it weans smokers off the “bad” 
nicotine in cigarettes and ideally nicotine itself’ (Bell and Keane, 2014: 50). However, 
nicotine becomes ‘bad (health-destroying)’ nicotine if smokers shift their nicotine addiction 
from cigarette to nicotine replacement therapies (Bell and Keane, 2014: 50; Keane, 2013: 
190). Therefore, these scholars argued that nicotine replacement therapies only maintain 
their legitimacy as long as they treat nicotine addiction, ‘rather than perpetuating it’ (Bell 
and Keane, 2012: 246). Similarly, Elam argued that the invention of nicotine replacement 
therapies provided evidence of a difference between the ‘‘good’/right nicotine’ and the 
‘‘bad’/wrong nicotine’ and brought ‘alternative paths leading us in and out of injurious 
temptation’ (Elam, 2012: 61). Elam and Gunnarsson (2012: 138) produced a similar 
argument when they discussed the Swedish invention of ‘medicinal nicotine’ – the 
smokeless oral tobacco (snus) – to cure smokers’ addiction. The success of medicinal 
nicotine in Sweden, Elam and Gunnarsson suggested, has opened up the possibility of what 
they have called an advanced liberal response to the problem of smoking; thus, promoting 
advances in the nicotine market, which offer ‘good/clean’ nicotine to consumers as a form 
of harm reduction. The power of consumerism and marketing are important factors in my 
research and I will expand later on their influence on electronic cigarettes. 
Is the Electronic Cigarette Good or Bad Nicotine? 
The questions that arise as a consequence of the above argument are: How is the electronic 
cigarette different to nicotine replacement therapies? And why is it received differently? 
Electronic cigarettes were described as novel devices that ‘deliver nicotine without the 
harmful toxins found in tobacco smoke’ (ASH, 2010; 2013). The nicotine inside them was 
described as ‘pharmaceutical-grade nicotine’ (HL Grand Committee, 17 Dec 2013). Scholars 
argue that the resemblance of the electronic cigarette to a traditional cigarette is the main 
reason for the hostility projected towards electronic cigarettes. Electronic cigarettes have 
several characteristics that are similar to traditional cigarettes, such as: the hand to mouth 




(RCP, 2016: 70). Bell and Keane (2012: 245) pointed at the visual similarity of smoke, in 
particular, as ‘perhaps, the most powerful semiotic referent of the cigarettes’. Smoke, they 
believe, is a ‘signifier of smoking’ and, hence, is seen by mainstream tobacco control as a 
threat to their historical efforts to denormalise tobacco through eliminating the visibility of 
the smoking behaviour. These efforts were culminated by enforcing the Smokefree 
legislation and restricting tobacco marketing and advertising. 
Public health and tobacco control policies have been focusing on separating the two 
worlds of ‘good’/medicinal nicotine and ‘bad’/recreational nicotine. Nicotine replacement 
therapies act as a substitution for the bad nicotine in a cigarette with the good nicotine. 
Hence, nicotine replacement therapies, it has been argued, ‘enabled nicotine to be 
assembled as not only a therapeutic medicine but a safe consumer product’ (Keane, 2013: 
191). Nicotine replacement therapies do not resemble smoking; they are traditionally used 
to temporarily substitute smoking without the intention of maintaining an addiction, and 
they act as a therapeutic agent which functions against, rather than for, the continuation of 
smoking (Keane, 2013: 194). Although extending nicotine replacement therapies to be used 
for harm reduction on a long-term basis can maintain nicotine addiction, their position in 
harm reduction is well-established and is not controversial, like electronic cigarettes. This is 
because the use of nicotine replacement therapies is, mostly, discreet and does not 
threaten the denormalisation policies. Also, it is recognised that many smokers find nicotine 
replacement therapies unsatisfactory as long-term substitutes for smoking (RCP, 2016: 7). 
On the contrary, electronic cigarettes have the potential to permanently replace cigarettes 
(Bell and Keane, 2012: 245). This is because vaping is placed within the discourses of 
recreation and pleasure, as well as within reducing harm (p: 246); also, because the 
electronic cigarette’s ability to imitate features of smoking is making it a popular and 
effective substitute to smoking (RCP, 2016: 70). 
Therefore, electronic cigarettes, it is noted, ‘expose the artificial boundaries placed 
upon “good” and “bad” nicotine’ (Bell and Keane, 2012: 246). Electronic cigarettes may 
produce a new realm where consuming nicotine, in a form that resembles smoking, can 
coexist with the public health agenda, which works against the visibility of any smoking-like 
behaviour and separates addiction and enjoyment (Bell and Keane, 2012: 245, 246; de 




can be an ‘ideal tobacco harm-reduction product’ (2016: 63), and that: ‘Unlike NRT [nicotine 
replacement therapies], e-cigarettes are not medicalised, and their use does not imply 
rejection of smoking or a commitment to quitting’ (p: 101). Until recently, in the UK, all 
electronic cigarettes were sold under the General Products Safety Directive as a less harmful 
substitute for traditional cigarettes (de Andrade and Hastings, 2013). From May 2016, an 
electronic cigarette that contains less than 20 mg/ml of nicotine and that has not sought 
medicinal regulations comes under the European Commission's revised Tobacco Products 
Directive (TPD) and will be regulated as a consumer product. However, an electronic 
cigarette containing more than 20 mg/ml of nicotine, or which makes smoking cessation 
claims, is prohibited unless it has a medicinal license by the MHRA (ASH, 2016a). These 
regulations are important changes in the history of tobacco control in the UK. They imply a 
shift from the historical stance of tobacco harm reduction to eliminating the consumption of 
nicotine, and indicate the acceptance of the electronic cigarette as a harm-reduction 
product by UK regulators. It also indicates a move towards accepting the use of nicotine on 
a non-medical/recreational basis. 
To conclude, electronic cigarettes’ position within harm reduction is controversial. 
Although nicotine replacement therapies claimed their position in the worlds of 
‘good’/medicinal nicotine rather than ‘bad’/recreational nicotine, electronic cigarettes’ 
vague identity places them in both worlds simultaneously. It is this dilemma that I am 
interested in exploring in the context of this thesis. Whilst advocates view an electronic 
cigarette as a good nicotine delivery device and a promising advance in tobacco policies, its 
effects and implications, at the individual and population level, should be evaluated and put 
into perspective. Therefore, it is important to explore electronic cigarette use and efficacy in 
different populations and various settings. My study took place at the time before the 
introduction of the new electronic cigarette regulations in 2016, when controversy and 
confusion about electronic cigarettes were evident among different groups, including stop 
smoking advisors and electronic cigarette users. Exploring the different perceptions in the 
two data sources allows for a deeper understanding of how the phenomenon of electronic 
cigarettes has developed over time. Obviously, these perceptions are influenced by the 
wider economic, cultural and social factors. Hence, first I explore the institutional influences 




debate was still continuing among leading health organisations. Second, I present an 
overview of the influences of the tobacco industry, marketing and the media on electronic 
cigarettes. 
1.4.3. The Position of Electronic Cigarettes in the Stop Smoking Services 
Brief History 
To understand the position of electronic cigarettes in the Stop Smoking Services, it is 
important to provide an overview of the main role of the Stop Smoking Services. These are 
‘a locally managed and co-ordinated service[s] commissioned to provide accessible, 
evidence-based, cost-effective clinical services to support smokers who want to quit’ (DOH, 
2011: 110). 
These services provide their support through trained personnel, such as specialist stop 
smoking advisors, trained nurses and pharmacists, who discuss and agree on the treatment 
option with each client (Bauld et al., 2010; HSCIC, 2015: 4). In 2008, the DOH established the 
National Centre for Smoking Cessation and Training (NCSCT) to provide support for the local 
Stop Smoking Services in delivering smoking cessation programmes, and to deliver training 
and assessments to stop smoking advisors and healthcare professionals (West et al., 2013; 
NCSCT, 2016). All stop smoking advisors are required to be NCSCT certified, have received 
training that meets the NCSCT published standards and are employed by a commissioned 
Stop Smoking Service provider (DOH, 2011: 110). 
Since their inception, the aim of the Stop Smoking Services has been to help smokers 
achieve abrupt quitting with a specific time frame and a controlled supply of medications. 
Once clients consent to treatment and set a quit date – usually in the first session - they 
participate in weekly sessions of structured interventions and receive behavioural support 
and offers of pharmacotherapy (DOH, 2011: 112). The currently available smoking cessation 
medications include: nicotine replacement therapies, Bupropion and Varenicline. Nicotine 
replacement therapies are offered for 8-12 weeks before reducing the dose, then stopping 
their use. Four-week quit-smoking rates are used as the local measure to reflect smoking 
prevalence and the effectiveness of the smoking cessation service (Bauld et al., 2010; DOH, 




Perceptions and Reception of Electronic Cigarettes within the Stop Smoking Services 
The emergence and increased popularity of electronic cigarettes have created a challenge 
for the Stop Smoking Services. This is because the services saw a rise in the number of 
smokers who use electronic cigarettes and clients who enquire about them. At the same 
time, there were no clear guidelines and insufficient conclusive evidence available to the 
advisors to present to their clients. Few studies have addressed the issue of electronic 
cigarettes within the Stop Smoking Services in the UK. For example, Hiscock et al. (2014) 
conducted two online surveys, in 2011 and 2013, of the UK smoking cessation practitioners; 
they found that participants were concerned about electronic cigarettes’ safety, or their 
efficacy for smoking cessation, and were worried that smokers may become dependent on 
electronic cigarettes. Practitioners pointed at the possibility that electronic cigarettes may 
weaken smokers’ willingness to use evidence-based stop smoking methods, and challenged 
denormalising tobacco smoking policies. Respondents were also concerned about marketing 
electronic cigarettes that look like cigarettes. In both surveys, most practitioners were not 
positive about electronic cigarettes. Electronic cigarettes were perceived as promoting the 
continuation of smoking and there were concerns about the impact of electronic cigarettes 
on young people, echoing concerns previously highlighted. 
Beard et al. (2014) conducted an online survey of 58 managers and 1,284 practitioners 
between December 2012 and January 2013. The majority of the practitioners reported that 
their clients were using electronic cigarettes and that they had been asked about them. It 
was found that some practitioners provided non-evidence-based advice. Their advice 
reflected the different risk perceptions of electronic cigarettes that practitioners held. These 
perceptions included: the electronic cigarette is an unsafe product; it maintains addiction; it 
is safer than a cigarette; they don’t know enough about it to give advice; it maintains hand 
to mouth action; it can be used for harm reduction and smoking cessation and it normalises 
smoking. Hence, it was suggested that there was a need to consider further training for 
practitioners on electronic cigarette use and harm reduction, in order to ensure that the 
advice given was consistent and evidence-based. 
The authors also highlighted that, following the regulatory changes to electronic 
cigarettes and the announcement of NICE guidance on harm reduction in 2013, there was a 




need to ensure Stop Smoking Services adhere to the guidelines given. Previous studies 
showed that only 60% of the content of stop smoking manuals, provided to practitioners, 
was communicated with reliability in practice (Lorencatto et al., 2013). One proposed 
reason for this is that healthcare professionals’ personal beliefs might conflict with the 
evidence-based guidelines, and influence the advice they provide to clients. For example, 
previous research showed that some healthcare professionals held inaccurate views about 
nicotine-containing products and harm reduction and that these beliefs were associated 
with the advice they offered to smokers (Beard et al., 2012). Therefore, it is important to 
explore the beliefs and views of stop smoking advisors and to discover the advice they 
provide and the processes of dealing with electronic cigarette users within the service. This 
study took place at a transition period of the history of tobacco control in England, and will 
address the gap in the literature with regards to the perceptions that stop smoking advisors 
held of electronic cigarettes in two Stop Smoking Services in South East England.  
Latest Guidelines to Stop Smoking Advisors 
Recently, NICE provided the following advice to Stop Smoking Services about 
nicotine‑ containing products, including electronic cigarettes: 
Tell people that some nicotine-containing products are not regulated by the Medicines 
and Healthcare products Regulatory Agency (MHRA), and so their effectiveness, safety 
and quality cannot be assured, but that these products are likely to be less harmful than 
cigarettes. (NICE, 2016b) 
PHE stated that ‘stop smoking services should support smokers using electronic cigarettes to 
quit by offering them behavioural support’ (McNeil et al., 2015: 6). In a briefing produced in 
2016, in partnership with PHE, the NCSCT acknowledged that electronic cigarettes: ‘are 
considerably safer than smoking cigarettes, are popular with smokers and that they have a 
role to play in reducing smoking rates’ (NCSCT, 2016: 4). The briefing provided advice on the 
practical elements of dealing with electronic cigarette users who use the services and 
recommended that: 
Stop smoking services should be open to e-cigarette use in people keen to try them to 
help them quit. This is especially so in those who have tried and failed to quit using 




The NCSCT advised the advisors not be ‘alarmed about recreational nicotine’. They asserted 
that it is a choice that some people make, and that it is not ‘the business of stop smoking 
services to make judgements’ about this choice. They also highlighted that the service is not 
a ‘stop nicotine service’ and encouraged the practitioners to listen to electronic cigarette 
users’ experiences and acknowledge the usefulness of electronic cigarettes in helping them 
to stay off tobacco (NCSCT, 2016: 11). The NCSCT, however, emphasised the role of ‘expert 
support from stop smoking services’ for ‘the best chance of quitting’ (NCSCT, 2016: 38). 
To date, the electronic cigarette is not offered as a treatment option similar to other 
available treatments by the Stop Smoking Services. However, some trials have been 
conducted to assess its usefulness within the service. For example, a pilot study, which 
included offering free electronic cigarettes with a 4-week supply of refills, was conducted in 
one routine Stop Smoking Service in the City of London (Hajek et al., 2015). Sixty nine 
smokers accepted using electronic cigarettes, while 31 smoker did not accept. The study 
found that 65% of smokers who accepted using electronic cigarettes achieved abstinence at 
four weeks; of those, smokers who used Vareniciline and electronic cigarettes had a higher 
success rate (85%) than smokers who used electronic cigarettes only (54%). Of smokers not 
accepting the offer of the electronic cigarettes, 45% were abstainers at four weeks. Both 
services included in my study (Hertfordshire Stop Smoking Service and East Sussex Stop 
Smoking Service) follow the recommendations of NICE and NCSCT. Hertfordshire Stop 
Smoking Service announced, on their website, that: ‘The service supports people using e-
cigarettes to help them reduce their smoking, reduce their use of the e-cigarette or to quit’ 
(Hertfordshire County Council, 2016). East Sussex Stop Smoking Service (Quit 51) advertised 
in 2016 for a trial of electronic cigarettes. The study is run by a research group at a 
university in London, with Quit 51 Stop Smoking Service in East Sussex being chosen as one 
of three study sites across the country (Quit 51, 2016). 
To conclude, the institutional stance on electronic cigarettes is changing. I 
demonstrated the existing gap between the recommendations of leading health 
organisations like the RCP and NICE and the policies applied in the Stop Smoking Services. 
However, accepting the use of electronic cigarettes and the prescribing of electronic 
cigarettes by some services are a sign of a transformation of tobacco control management 




cigarettes; they are part of the contextual factors which shape, and are shaped by, the 
diverse perceptions of electronic cigarettes. Next, I will provide an overview of other 
influential social and cultural factors: tobacco industry, marketing and the media. 
1.4.4. The Influences of the Tobacco Industry, Marketing and the Media on Electronic 
Cigarettes 
The social, political and institutional context will inevitably have an influence on the public 
opinion and use of electronic cigarettes. In this section, I shed light on the role of the 
tobacco industry, marketing strategies and the media on electronic cigarettes. This will 
enable me to unravel some of the key contextual trends which have influenced the 
development, discourse and perceptions of electronic cigarettes among my two data 
sources. The emergence of electronic cigarettes, it was argued, has created a “moral 
quandary” (The Lancet, 2013). One reason is the physical and behavioural resemblance to 
smoking a cigarette, as I discussed above. The other reasons are: the use of promotional 
images and messages to advertise for electronic cigarettes, similar to those used in the past 
to promote traditional cigarettes, as well as the growing involvement of the tobacco 
industry in manufacturing and marketing electronic cigarettes. I expand on this next. 
Brief History of the Tobacco Industry 
The history of the tobacco industry in arguably misleading public opinion about the harm 
caused by tobacco use was discussed in the literature (Koop, 2004; Daynard, 2004; Glover, 
2006; Doward, 2013; Godlee et al., 2013; US DHHS, 2014; ASH, 2015d). Many scholars 
believe that Big Tobacco (tobacco industry) was responsible for tobacco addiction and for 
‘decades of deceit and actions that cost millions of lives’ (Brownell and Warner, 2009: 259). 
They were described as: 
notorious masters of deception; they know how to manufacture ignorance 
and rewrite history. They know the power of images and how to twist these to 
violate common sense and pulmonary civility. They also know how to engineer 
desire, and, of course, they’d like us to believe they don’t want youngsters to 
smoke. (Proctor, 2011: prologue) 
The tobacco industry is believed by some scholars to be equipped with persuasive 




this enabled them to manipulate data, falsify facts and mislead the public by creating doubt 
and challenging the scientific evidence that proves the harms of smoking and passive 
smoking (Godlee et al., 2013). Proctor was the first historian to analyse the industry’s 
internal documents extensively. In his book, Golden Holocaust (2011), Proctor examined the 
ways in which the US tobacco industry funded research and drew in big universities and 
experts in different disciplines. He drew attention to the infiltration and manipulation of 
scientific research and concluded that tobacco money had influenced ‘evidence-based 
medicine’ (Proctor, 2011: 459). Moreover, it is argued that tobacco companies are adamant 
in attempting to get people hooked on using any tobacco products, including smokeless 
tobacco, to guarantee a user for life (Glover, 2006). Indeed, the implementation of effective 
policies proved to be a challenging and lengthy process. This is because the tobacco 
industry, it is argued, constantly acted to counteract public health efforts, interfered with 
public health policies and hindered tobacco control work (Doward, 2013; US DHHS, 2014; 
ASH, 2015d). As a consequence, some scholars concluded that it is unlikely to be possible to 
‘negotiate morality with Big Tobacco’, and unrealistic to involve them in public health 
programmes (Koop, 2004: xiv-xv). 
The Tobacco Industry and Electronic Cigarettes 
Although Berridge (2012) suggested that the influence of the tobacco industry in the UK 
differs from that of the US, there is a concern regarding the active interest that the tobacco 
industry has taken in electronic cigarettes (Hastings, de Andrade and Moodie, 2013; de 
Andrade, Hastings and Angus, 2013; Bauld, Angus and de Andrade, 2014). A report by the 
WHO concludes:  
It is unclear yet what this means for the ENDS market. However, if prior interest of the 
tobacco industry in reduced-risk products serves as a precedent, their interest lies in 
maintaining the status quo in favour of cigarettes for as long as possible, while 
simultaneously providing a longer-term source of profit should the cigarette model prove 
unsustainable. In addition, selling these products is intended to bring reputational 
benefits to these companies, as they can pretend to be part of the solution to the smoking 




The WHO and other scholars believe that the industry is promoting electronic cigarettes to 
be used in smoke-free environments, and targeting the young to create a new way of 
consuming tobacco and ‘to ensure that consumers continue to use their products for as long 
as possible’ (Hastings, de Andrade and Moodie, 2013: 18). 
The tobacco industry has been moving to build links with public health and 
policymakers, as they planned to work with the MHRA to produce licensed electronic 
cigarettes to be marketed as an alternative nicotine delivery device (de Andrade, Hastings 
and Angus, 2013). Indeed, in September 2014, Nicovations, a wholly owned subsidiary of 
British American Tobacco plc (BAT), announced the acquisition of a medicinal licence for 
their product Voke, and then their E-Voke electronic inhaler in 2015 (Nicovations, 2014; 
MHRA, 2015). This, according to de Andrade, Hastings and Angus (2013: 3), ‘is jeopardising 
Article 5.3 of the Framework Convention on Tobacco Control, which requires that 
development and implementation of public health policy should be completely protected 
from industry influence’. It was also revealed that several prominent brands of electronic 
cigarettes were purchased by tobacco companies (NCSCT, 2016: 15). As a result, ASH 
introduced new guidelines for health services on the best way to deal with electronic 
cigarette manufacturers who are part of the tobacco industry. ASH stated that the decision 
to prescribe any medicine should be linked to its cost effectiveness, and not to refuse to 
recommend a product because it is manufactured or distributed by a tobacco company 
(ASH, 2015d, e). 
The Media and Marketing Influence 
A positive picture is being painted for electronic cigarettes by the media, supported by 
numerous celebrities using electronic cigarettes as a new, fashionable lifestyle behaviour, 
showing them in movies and on television (Grana, Glantz and Ling, 2011). The public has 
shown great interest in electronic cigarettes and the popular media, such as the BBC and 
the Guardian, has given wide coverage to electronic cigarettes. Between January 2008 and 
February 2010, online searches for information on electronic cigarettes were several 
hundred-fold greater than searches for smoking alternatives in the UK and US (Ayers, Ribisl 
and Brownstein, 2011). The electronic cigarette is extensively marketed online, promoted 
on YouTube videos and advertised on Twitter (Yamin, Bitton and Bates, 2010; Hua, Yip and 




its marketing (Herzog, Metrano and Gerberi, 2012; Kamerow, 2013). It was highlighted 
that some enthusiastic advocates of electronic cigarettes had formed active electronic 
cigarette user groups, where they share information about electronic cigarettes and argue 
against restricting the use of electronic cigarettes (West et al., 2014: 2). The role of the 
Internet in increasing awareness of electronic cigarettes is demonstrated in many surveys. 
For example, in an online survey with 1,347 participating electronic cigarette users from 33 
countries (72% European), 41% of participants said they had become aware of electronic 
cigarettes via the Internet; 35% of participants had first heard of the product from a friend, 
and 8% had seen another person use it (Dawkins et al., 2013). 
Electronic cigarettes have become increasingly available at newsagents and in 
supermarkets (Rooke and Amos, 2014), besides a noticeable growth in the number of 
independent electronic cigarette companies. To explore the influence of marketing 
constructions on people’s perceptions of electronic cigarettes and their use, public health 
researchers at the University of Stirling investigated young people’s exposure to electronic 
cigarette marketing in shops in Scotland (University of Stirling, 2016). The study involved 
3,808 students between 11 and 18 years of age in four high schools. The study found there 
has been an increase in electronic cigarette displays on the high streets. It also found that 
those participants who recalled seeing electronic cigarette displays were twice as likely to 
have tried an electronic cigarette, or were significantly more likely to report their intention 
to try them. However, the study noted that most adolescents in the study who reported 
using electronic cigarettes were not regular users, while no association was established 
between noticing electronic cigarettes at the point of sale and intention to use (Best et al., 
2016). 
The influence of the media on shaping the meanings and use of electronic cigarettes in 
society was highlighted by Rooke and Amos (2014). Both scholars applied thematic analysis 
to twelve national UK and Scottish newspapers and the three most popular online news 
sources between 2007 and 2012. They aimed to explore how the meanings, uses and users 
of electronic cigarettes were presented, and whether and how this had changed. Both 
scholars used the diffusion of innovations theory to explain the use of electronic cigarettes. 
The theory suggests that the mass media plays an important role in creating an awareness 




authors noted that there was a domination of more positive representations of electronic 
cigarettes, which suggests that: ‘the news media coverage has not only paralleled increased 
interest in, and use of ENDS, but may have contributed to it’ (p: 511). 
An experimental study looked at the impact of advertisements promoting candy-like 
flavoured electronic cigarettes on the appeal of tobacco smoking among 598 English school 
children. The authors concluded that exposure to electronic cigarette adverts does not seem 
to increase the appeal of tobacco smoking in their study group. However, adverts of 
flavoured electronic cigarettes, compared with non-flavoured ones, generated greater 
appeal and interest in purchasing and trying electronic cigarettes (Vasiljevic, Petrescu and 
Marteau, 2016). 
Another marketing strategy was investigated in the US. Cobb, Brookover and Cobb 
(2013) analysed the relation between online electronic cigarette affiliates’ advertisements 
and electronic cigarette sellers, and evaluated the descriptive content on advertisements 
and websites. ‘Online affiliate marketing consists of commercial networks where “affiliates” 
run content websites that ultimately direct viewers to vendors (“sellers”), usually resulting 
in a payment from the seller back to the affiliate’ (p: 1). It was suggested that, although this 
marketing strategy is almost invisible to most Internet users, it is growing in use, especially 
in the US and the UK (Prussakov, 2012). Data showed a multilevel relationship between 
consumers who received advertising and the seller. There were unambiguous claims of 
electronic cigarette smoking cessation and health benefits in both electronic cigarette 
advertisements and affiliate websites, but not their linked seller websites. The authors, 
however, concluded that their findings ‘do not indicate that online ENDS affiliate marketing 
is always deceptive, nor do they provide any estimate of how prevalent the use of deceptive 
marketing for ENDS might be’ (p: 3). 
Concerns about media coverage, marketing and the promotion of electronic cigarettes 
have been expressed by institutions and researchers (de Andrade, Hastings and Angus, 
2013; NICE, 2013a; Bauld, Angus and de Andrade, 2014). In a report published by ASH and 
entitled ‘Smoking Still Kills’, it was stated that the government needs to pay attention to the 
impact of electronic cigarettes and their expansion in the market in order to protect the 
long-standing achievements of tobacco control programmes (ASH, 2015c: 37). PHE warned 




‘substantial public health gains’ that electronic cigarettes may bring (de Andrade, Hastings 
and Angus, 2013: 2). Therefore, the importance of monitoring and regulating the electronic 
cigarette market was highlighted, especially to avoid the gateway risk (The Lancet, 2013; de 
Andrade and Hastings, 2013; Grana, 2013; Cobb, Brookover and Cobb, 2013; Rooke and 
Amos, 2014; University of Stirling, 2016). 
On the other hand, PHE suggested that health scare stories in the media may have 
influenced the public perception of electronic cigarette safety and impacted the popularity 
of electronic cigarette use (McNeill et al., 2015: 79). There have been warnings about ‘[t]he 
growth of [...] false perception [about] risks’ and a call for clear communication of the 
‘relative safety’ of electronic cigarettes (ASH, 2015b; West, Beard and Brown, 2016). A study 
from the US in 2010 showed that 82% of responders believed that vaping was safer than 
smoking, but that figure shrunk to 51% in 2014 (Tan and Bigman, 2014). Similarly, according 
to the Smoking Toolkit Study data in 2016, a minority of current smokers believed that 
electronic cigarettes are less harmful than cigarettes; a higher number was documented in 
the previous two years. The same data showed a decrease in the growth of electronic 
cigarettes by current smokers (West, Beard and Brown, 2016). This may be explained by 
changing risk perception, which I will discuss in the next chapter. 
To conclude, the role of the tobacco industry, marketing strategies and the media on 
electronic cigarette use is recognised by researchers and institutions. This thesis explores 
these contextual factors and determines their influence on the construction of different 
circulating perceptions of electronic cigarettes. I also reveal how these perceptions can 
shape some of these factors. 
1.5. The Rationale for Conducting this Research and Research Questions 
The controversial position of electronic cigarettes is continuing among the public, various 
health personnel and in the political sphere (Abrams et al., 2014; O'Connor and Fenton, 
2015; RCP, 2016: 7). Further, there is still a lack of data about why, how, where and with 
whom people use electronic cigarettes. It is suggested that more studies from different 
disciplines, at both individual and population level, are needed to address several 
ambiguous issues about electronic cigarette use (WHO, 2009: 39), with limited involvement 




2005). Similarly, there are still gaps in the research surrounding tobacco harm reduction (de 
Andrade and Hasting, 2013), and uncertainties about the safety of electronic cigarettes, 
their long-term effects and efficacy for smoking cessation (Kmietowicz, 2014). 
Understanding the perceptions and views that different populations hold for electronic 
cigarettes is important in order to form evidence-based knowledge about electronic 
cigarette use and development. While a large body of studies have explored the use of 
electronic cigarettes, as I presented earlier, to date few qualitative studies have investigated 
the use of electronic cigarettes. These studies ranged between health behaviour research, 
public health, health science and health psychology. The findings from these studies will be 
discussed in the next chapter. 
There is a lack of sociological work exploring the use of electronic cigarettes in 
different populations. In order to add to the sparse sociological studies and to address the 
gap in qualitatively studying electronic cigarette perceptions, this qualitative study explores 
the meanings and perceptions of electronic cigarettes among two groups: a group of 
electronic cigarette users and a group of stop smoking advisors in South East England. This 
thesis draws on the Boundary Objects Theory (Star and Griesemer, 1989) and 
Biomedicalization theory (Clarke et al., 2003; Clarke et al., 2010; Clarke, 2010). Firstly, I 
propose the boundary objects theory as an approach for understanding the social 
construction of electronic cigarettes. This concept plays a role in facilitating interactions, 
translations and coherence among different social worlds; hence, it provides a useful 
framework for analysing the interrelated social worlds of electronic cigarette users and stop 
smoking advisors. Secondly, I apply the biomedicalization theory to explain the wider 
contextual influences on the social construction of electronic cigarettes; at the same time, I 
explore the influence of electronic cigarette perceptions on the construction, resistance or 
dominance of biomedicalization processes. I argue that the construction of different 
perceptions of electronic cigarettes is influenced by processes of the biomedicalization 
theory. I also argue that the biomedicalization theory does not explain how biomedical 
processes are constructed and how different human agents influence those processes. I 
argue that electronic cigarettes function as translational boundary objects (Williams et al., 
2008), which bridge different worlds together. I also argue that electronic cigarettes 




and hence may reshape the landscape of public health and the sociological discourse of 
nicotine addiction. 
I was motivated to undertake this study because I have an interest in tobacco control 
and in harm reduction in particular. This emerged from personal experience and my 
educational background. I grew up in an environment where smoking was a popular habit 
and where I saw the devastating effect of smoking related diseases. Later, when I worked as 
a dentist, I saw the adverse influence of smoking on oral health. While studying for my 
Masters in Dental Public Health, I became aware that smoking is one of the main causes of 
oral and general health inequalities and became more knowledgeable about harm reduction 
approaches. I also became interested in understanding smokers’ behaviour and helping 
smokers to stop smoking; hence, I attended ‘stop smoking’ training. The two days training 
introduced the main approaches used at English Stop Smoking Services to help smokers quit 
smoking. When I started my PhD in 2012 in sociology, electronic cigarettes were a new 
phenomenon, but the suggestion that they could be part of a solution to help smokers stop 
smoking attracted me to explore their use further. To fit with my personal interest in 
tobacco control, my ambition to pursue a career in health research and because of my 
ability to gain agreement from Hertfordshire Stop Smoking Service to do my research at 
their site, I decided on the topic of exploring how electronic cigarettes are perceived from 
the point of view of the stop smoking advisors and their clients who use electronic 
cigarettes. In the Methodology chapter, I will explain how the design and focus of this 
project have changed due to the challenges I faced in recruiting participants.  
It has been argued that qualitative data researchers need to show real sensitivity to 
how they interpret a social situation or process. By reporting how and why they did what 
they did from a particular background and set of values, they can help the reader determine 
whether, or how, the researchers’ perspectives influenced their conclusions. (Altheide and 
Johnson, 2011). The authors argue that: 
focusing on the process of investigation and communicating that process, the problems 
and solutions encountered in accessing, collecting, analyzing, and interpreting data-to the 
best of our ability-is quite consistent with analytic realism, or the general notion that the 




I came to research from a positivistic background in Dentistry. But, after studying for my 
Masters in Dental Public Health, I developed an interest in the interpretivist qualitative 
approach. Despite my move to the social sciences discipline to do my PhD, I still felt 
intellectually caught between two paradigms. On the one hand, my explicit theoretical and 
methodological position rejected the adoption of a passive voice and the notions of 
objectivity, where I as a researcher remain detached and neutral in order to produce 
‘objective’ scientific facts. On the other hand, I felt a positivist pressure to detach myself 
from my research and hide my voice. My approach also reflected the epistemological and 
ontological assumptions underpinning the methodological and theoretical tradition I was 
using in analysing my data in which there is a tendency to subjectivities and interpretations 
of meaning. I do, however, realise the importance of being reflective when conducting 
research and I am aware that my biases and preconceived assumptions may have influenced 
my interpretations, as Sword (1999: 277) explains:  
Although some would criticize the subjectivity that is inherent in interpretive work, no 
research is free of the biases, assumptions, and personality of the researcher. We cannot 
separate self from those activities in which we are intimately involved. 
I will address reflexivity in both the Methodology and the Conclusion chapters. Next, I 
present my research questions.  
Research Questions 
The following questions will be addressed: 
1) How are electronic cigarettes perceived by electronic cigarette users and stop 
smoking advisors? 
2) What are the perceived risks associated with electronic cigarettes, as discussed by 
electronic cigarette users and stop smoking advisors? 
3)  What factors have shaped these perceptions of electronic cigarettes? 
The data collection started in 2014 and was completed in 2015, meaning that different 
electronic cigarette users used different electronic cigarette devices which became available 




electronic cigarettes without focusing on a particular brand, design, ‘generation’ or 
particular components, flavours or nicotine concentrations.  
1.6. Structure of the Thesis 
This thesis is based on a methodology that includes qualitative interviews. The following 
Chapter 2, ‘The Debate around Electronic Cigarettes’ Risk’, discusses the risks attributed to 
electronic cigarettes as identified in national and international studies. It provides a partial 
literature review on the sociology of risk by introducing major risk theories relevant to this 
study. It discusses the link between risk perceptions and trust between officials and lay 
people, and explores risk perceptions and stigma. Chapter 3, ‘The Theoretical Framework of 
the Thesis’, discusses the theoretical concepts (Biomedicalization and Boundary Objects) 
and how they formed the basis for the thesis research questions. In Chapter 4, ‘Research 
Methodology’, I describe the range of factors that shaped the overall scope of this study. I 
provide an overview of the methods used to collect and analyse data and justify why they 
were chosen. In Chapter 5, ‘The Individual Choice to Use Electronic Cigarettes as a 
Treatment or Substitute’, I use interview data to elucidate the perceptions of electronic 
cigarettes as described by electronic cigarette users and stop smoking advisors. I present the 
reasons for using electronic cigarettes as revealed by both groups, and discuss two key 
themes: electronic cigarettes’ ambiguity and individualisation. In Chapter 6, ‘The Ambiguity 
of Electronic Cigarettes’ Risk’, I use interview data to discuss the potential physical and 
social risk of electronic cigarettes, as identified by participants, and link the discussion to the 
sociology of risk. In the final chapter (Chapter 7), I consolidate my findings. I discuss the 
commonality and disjuncture between the perceptions of electronic cigarettes drawn on by 
the two datasets. I discuss how the combination of theories enabled me to elucidate the 
different perceptions of electronic cigarettes and understand the contextual factors that 
influenced these perceptions. I conclude the thesis by outlining some opportunities of 
further research. 
1.7. Summary 
This introduction has provided the relevant historical context for this study. It traced the 
history of tobacco use, nicotine addiction, tobacco public health and harm reduction in the 




described the position of electronic cigarettes in harm reduction and in NHS Stop Smoking 
Services, especially in South East England, where the study was conducted. It also shed light 
on the role of the tobacco industry, marketing strategies and the media. In so doing, I began 
to reveal some of the key socio-political trends that influence the perceptions and discourse 
of electronic cigarettes. This chapter revealed the substantial controversy that electronic 
cigarettes have generated and the gap in the research which provided the motivation for 
conducting this study. The next chapter focuses on the risks and benefits of electronic 




Chapter 2. The Debate around Electronic Cigarettes’ Risks 
2.1. Introduction 
As outlined in the previous chapter, the emergence of electronic cigarettes has provoked 
substantial controversy. The controversy over the potential risks attributed to electronic 
cigarettes is at the core of this debate. This chapter explores the risks attributed to 
electronic cigarettes as identified in national and international studies. It discusses the link 
between risk perceptions and trust between officials and lay people, and explores risk 
perceptions and stigma. These issues are important in helping to explain the role of risk 
perceptions of electronic cigarettes, among other social meanings, on the stance that 
different participants take on electronic cigarettes; they also help to understand the relation 
between the experts and the lay electronic cigarette users, and the stigma that may arise 
towards electronic cigarettes. The chapter begins by introducing major risk theories relevant 
to the thesis, followed by the notion of trust between experts and lay people. This is 
followed by focusing on the link between risk perceptions and stigma. I conclude by 
presenting the identified and perceived benefits and risks attributed to electronic cigarettes. 
2.2. Risk Theories 
This section introduces the major sociological risk theories relevant to this study. 
In the literature, there is no widely accepted definition of the term ‘risk’ (Aven and 
Renn, 2009), either in science or in ‘lay’ perception (Renn, 1998; Joffe, 2003). Similarly, 
there has been no broadly accepted model of risk perceptions (Heinßen, Sautter and Zwick, 
2002; Hawkes and Rowe, 2008). Risk has been the subject of numerous studies across many 
disciplines, such as economics and psychology. Renn (1998) pointed at the role of 
sociological and cultural sciences in developing broader risk concepts and helping to 
understand the variability of risk. This is achieved by exploring and analysing the social and 
cultural variances and their influence on risk perception. Numerous social sciences scholars 
have studied risk (e.g. Douglas and Wildavsky, 1982; Clarke, 1989; Giddens, 1990; Luhmann, 
1990; Bauman, 1991; Beck, 1992a, b; Douglas, 1992; Lash, Szerszynski, Wynne, 1996; 
Lupton, 1999; Lash, 2000; Tulloch and Lupton, 2003). Social theorists have highlighted the 




disagreements about the different approaches proposed to study risk (Wildavsky and Dake, 
1990), scholars agree that risk has become an increasingly important phenomenon and a 
pervasive issue in contemporary Western society (Mitchell and McClean, 2014). It has also 
been argued that, in Western societies, risk has become a central part of human existence, 
as well as an integral concept of human experience that is associated with responsibility, 
choice and blame (Lupton, 1999: 26). 
The essence of risk, as Adam and Loon (2000: 2) argue, is not that: ‘it is happening, but 
that it might be happening’. Lupton identified three major theoretical perspectives in 
sociological writings on risk. These are the ‘risk society’, ‘governmentality’ and 
‘cultural/symbolic’. Each of these approaches was based upon the work of different 
influential scholars (Lupton, 1999: 26). Later, Tulloch and Lupton (2003) developed their 
‘socio-cultural’ approach to risk that was interpreted as a descendant of the cultural theory 
(Zinn, 2004: 10). I identified a relevance to my thesis of ‘risk society’ and the ‘sociocultural’ 
approaches; hence, I elaborate on these two approaches next. 
2.2.1. Risk Society 
The risk society approach, according to Lupton, draws upon the writings of Beck (1992a, b; 
1995; 1999) and Giddens (1990; 1991). This approach asserts that risk has changed over the 
years. Whilst risk used to be linked to natural events outside the scope of human 
responsibility, in modern societies risk is increasingly linked to human actions and decision-
making (Giddens, 1990; Beck, 1992 a, b; Ewald, 1993). Giddens explained the transition from 
external risk to what he called ‘manufactured risk’, referring to risk created by human 
development, especially by the progression of science and technology (Giddens, 1999: 4). 
Risk society is believed to be increasingly living ‘on a high technological frontier which 
absolutely no one completely understands and which generates a diversity of possible 
futures’ (Giddens, 1999: 3). Both scholars believe the risk society has produced risks and is 
constantly worrying about the future and safety, and is increasingly preoccupied with 
debating, preventing and managing those risks (Giddens, 1999: 3; Beck, 2006: 2). Indeed, in 
contemporary society, the effects of different risks are deeply debated by politicians, 
scientific experts, the media and the public (Mythen, 2004: 2). Beck and Giddens also 
pointed at the disconnection between lay people and professionals on the risk issue. They 




and individualisation (human responsibility to cause and minimise risk). In world risk society, 
individuals are required to face the ‘ungraspable threats to civilisation’ and cope with 
unexpected uncertainties and the ‘unintended consequences of modernity’ (Beck, 1992a; 
Beck, Bonss and Lau, 2003), and are increasingly described as ‘responsible consumers’. 
Accordingly, individuals bear the responsibility of making health decisions on their own; yet, 
at the same time, they remain under the power of expert systems that fail to control and 
manage the uncertainty of the global world (Beck, 2006: 8). This process of making 
decisions, as a result of anxieties and uncertainties about risk, includes critical reflection, 
self-confrontation and self-transformation, as ‘the self becomes a reflexive project’ (Beck, 
1996; Giddens, 1991: 32; emph. in original). In their paper, Beck, Bonss and Lau (2003: 14) 
discussed ‘meta-change resulting from the unintended consequences of simple 
modernization’. The scholars described the ‘institutional turbulences’ that are caused by 
risks of new technologies, and noted how the public reflection on technologies leads to 
‘meta changes’ (p: 15), as the uncertainty of technology leads to conflicts among different 
actors such as politicians, decision makers, consumers and the mass media. 
The ‘risk society’ approach seems to capture the discourse of electronic cigarettes, as 
the uncertainty that electronic cigarettes have created has led to a widespread debate 
about their risk in society. It has also shown individuals making their decisions amid 
uncertainties. Nevertheless, the risk society approach was criticised for failing to 
demonstrate the role played by several sociocultural factors such as gender, age, social class 
and others in constructing varied risk knowledges and experiences (Lash, 1993; Lupton and 
Tulloch, 2002). The approach was also criticised by Douglas for its focus on the responsibility 
of individuals in making choices. Douglas introduced the cultural theory (1990; 1992) and 
believed that risk perceptions are influenced by culture (Douglas, 1992: 58). Douglas sees 
risk ‘as a socially constructed interpretation and response to a real danger that objectively 
exists, even if knowledge about it can only ever be mediated through sociocultural 
processes’ (Lupton, 1999: 40). Therefore, it is believed that people react to risk according to 
the way they perceive society and the legitimacy that they ascribe to institutions. Thus, they 
adhere to specific social relationships, generating a distinctive perspective of the world, 
referred to as ‘cultural bias’ (Wildavsky and Dake, 1990; Langford et al., 2000: 692). The 




different ‘cultural bias’ in different contexts and in different situations over time (Langford, 
2000: 693; Renn, 2002). Later, Tulloch and Lupton (2003) developed their sociocultural 
approach to risk that was considered a descendant of the cultural theory (Zinn, 2004: 10). 
2.2.2. The Sociocultural Approach 
Tulloch and Lupton interviewed lay people and ‘experts’ in the UK and Australia to explore 
risk as part of everyday life and how people understood risk on a personal, regional and a 
global level. Within the sociocultural approach, individuals are heavily influenced by their 
cultural context; they refer to different sources of information, which can be competing or 
contradictory and, consequently, they form their own knowledge. Risks here are discursively 
constructed in daily life and are influenced by several factors, including: mass media, 
individual experience and life discourse, local memory, moral principles and personal 
judgements (Tulloch and Lupton, 2003; Zinn, 2004). Hawke and Rowe reviewed 67 
qualitative studies on risk perception and concluded that cultural and socio-economic 
factors are important in explaining how and whether people perceive something as ‘risky’ 
(Hawke and Rowe, 2008: 633). The review found that a high perception of risk was 
associated with the following factors: low trust in the appropriate body; high feeling of 
powerlessness or low control over a hazard; low level of voluntary engagement in a 
particular activity; and absence of perceived benefits. Some studies (e.g. Lupton and 
Tulloch, 2002) found that demographic aspects such as age and sex are important for risk 
perception. 
In the same vein, this thesis takes into consideration the different contextual factors 
that have an influence on the perception of risk among the two data sources. It is vital to 
emphasise that my thesis considers risk as something that is socially constructed. It also 
recognises that knowledge about risks is socially constructed, dynamic and historical, as it is 
mediated through social and cultural frameworks of understanding (Lupton, 1999: 22; Zinn, 
2009: 524). This assumption helps to detach this study from the objectivist and reductionist 
understandings of risk, which interpret risk as a risk assessment or statistic-probabilistic 
calculation (Zinn, 2009). In this thesis, I focus particularly on the construction of risks ‘as 




In the next section, I discuss the trust between officials and lay people in view of the 
above sociological risk theories. I discuss briefly policy-making and risk, and how the 
interaction between the lay users and the professionals is influenced by risk perceptions. 
This is an important concept to discuss in this thesis, because the official knowledge has an 
influence on the discourse and perceptions of electronic cigarettes. 
2.3. Risk and Trust between Professionals and Lay People 
This thesis explores the perceptions of both health professionals on the one hand, and the 
lay electronic cigarette users’ perceptions on the other. Hence, examining how electronic 
cigarette users interact with health professional and official knowledge, and the level of 
trust they demonstrate, will increase my understanding of the construction of electronic 
cigarette perceptions. 
A number of empirical studies have confirmed that having trust in expert systems is 
vital in shaping risk perceptions and individual decision-making strategies (Earle and 
Cvetkowich, 1995; Heinßen, Sautter and Zwick, 2002; Green, Draper and Dowler, 2003; 
Raithatha et al., 2003; Brown, 2009). Although, in the past decades, it was believed the 
public had become less confident in state institutions (Kasperson, Golding and Tuler, 1992), 
institution-related trust is recognised as an important filtering function through which to 
perceive and evaluate risks (Heinßen, Sautter and Zwick, 2002: 44). In their review, Hawke 
and Rowe (2008) pointed at several studies that associated low levels of trust in a particular 
body with high levels of perceived risk, and vice versa (e.g. Wakefield and Elliott, 2000; 
Brown and Ping, 2003; Walter et al., 2004; Aldoory and Van Dyke, 2006). Professional or 
‘expert’ knowledge is argued to be vital to the construction and publicising of health risks, 
and to promoting the domination of normalising technologies (Green, Thompson and 
Griffiths, 2002: 277). It has also been suggested that people’s perception of health risk 
changes over time and is usually mediated by politics and policy (Bröer et al., 2014: 525). 
Further, Putnam (2001; 2002) suggested that trust breakdown creates uncertainty, which 
has an acute effect at psychological, social, political and economic levels. Similarly, Lupton 
(1997b: 380) warned that ‘in the face of conflicting options’ and uncertainty, the lack of 
trust in medical expertise may result in ‘paralysis and distress’. In society, managing risks 




the political sphere, they have to be managed by politicians (Giddens, 1999: 5). I will discuss 
this next. 
2.3.1. Policy-Making and Risk 
Several studies have looked at the interconnection between policy-making and risk 
(Alaszewski and Brown, 2012; Aven, 2013; Bröer et al., 2014). Brown and Olofsson (2014: 
426) believed that risk has become ‘potently and insidiously political’. They discussed how 
uncertainty became an important resource for policymakers. They also argued that different 
social problems, which may not have been previously characterised as risk, are prone to be 
framed as risks. Different actors with different agendas may forward certain perceived risks 
to the political arena; consequently, policymakers are required to tackle these risks. Both 
scholars argued that, depending on the interests and legitimacy of policymakers and other 
stakeholders, risks can either be emphasised and problematised, or ignored (p: 428). 
Moreover, the impact of policy interventions and rhetoric have an influence on others, who 
may experience uncertainty and vulnerability in new or different ways. The polarisation of 
opinions in society makes it difficult for policymakers to determine sound health risk policies 
that can compromise or find an acceptable middle ground. In cases of great uncertainties, it 
is argued, the public expects institutions to have risk expertise and communication, to be 
responsible for safety, regulation, control, contingency measures and, if necessary, for 
compensation (Gregory, Slovic and Flynn, 1996). 
Linke and colleagues (2014) traced the relationship between science and policy. They 
emphasised that scientific expert knowledge and advice are considered a basis for political 
decision-making in most domains of industrialised countries. However, the importance of 
science becomes questionable when it conflicts with social or political values (p: 506). 
Giddens pointed at the frequent disagreement between scientists, which results in lay 
people, government authorities and politicians ‘taking a decision in the context of 
conflicting, changeable scientific and technological information’ (1999: 6). 
An increasing aspect of modern risk societies is the simultaneous distrust and reliance 
on expert knowledge (Giddens, 1991; Lupton and Chapman, 1995; Nettleton, Burrows and 
O’Malley, 2005). Zwick (2002a: 45) discussed two dilemmas that face the public in modern 




technologies and hazards; hence, they rely on the information from the technological 
designers and on political regulations to control risks. The second is ‘the asymmetry of 
communication’, as there are different patterns of exchanging information between 
individuals and institutions. Hence, this affects the ‘institution-related trust’ and the 
interaction between professionals and lay people, as I discuss next. 
2.3.2. Interaction between the Professionals and Lay People 
Individuals in Western society, according to many theorists (Giddens, 1991; Beck, 1992a; 
Armstrong, 1995), follow ‘expert’ or professional knowledge as part of risk-avoidance 
practice and self-care. Giddens argued that the relation with science and technology has 
shifted from taking scientific knowledge for granted to a more dialogic and engaged 
relationship with science and technology (1999: 6). Beck (2006: 8), however, pointed to the 
shift of the position of key institutions of modernity in science, business, mass media and 
politics from ‘trustee to suspect’. These are seen as a ‘source of risk’ as well as risk 
management instruments. Beck believes that individualisation is an outcome of ‘a failure of 
expert systems to manage risks’. He explained how individuals became ‘alienated from 
expert systems’, and are forced to mistrust the promises of control and risk rationality by 
these key institutions. Giddens (1990: 35; 1994: 89), on the other hand, argued that 
individuals calculate risk and make cognitive decisions; but, at the same time, they trust the 
expert system based on the ‘assumption of technical competence’. 
Lash and Lupton pointed at the limitations of the reflexivity concept proposed by Beck 
and Giddens and argued against individualisation. Lupton (1997b: 373) explained that, when 
lay people interact with health professionals, they act either as a ‘consumerist’ or as a 
‘passive patient’, depending on the context. Reflexivity, according to Lupton, has failed to 
recognise ‘the complexity and changeable nature of the desires, emotions and needs’, 
which influence the interaction between lay people and health professionals or medical 
knowledge. Lash suggested that people respond ‘aesthetically’ and ‘emotively’ to risk. 
Responses, according to Lash, can be non-reflexive, based on unarticulated assumptions and 
moral values that are developed and shared by members of cultural subgroups. Lash 
asserted that contradictions and contingency are part of the modern self, but are not fully 
acknowledged by Beck and Giddens (Lash, 1993; Lupton and Tulloch, 2002). Also, the 




people follow a rational and logical model of decision-making when dealing with hazards. 
Further, Lupton (1999: 87) argued that, since ‘risk’ has become ‘problematized, rendered 
calculable and governable’, health decision-making has become part of the ‘life-worlds’ of 
individuals. However, rather than passively absorbing health messages and making stand-
alone informed choices, individuals make health decisions based on ‘mediated 
interpretation’. It has been suggested that ‘experts’ and lay people often disagree about the 
meaning of risk (Gregory, Slovic and Flynn, 1996). Lay people’s risk perception processes are 
subjective (Hay et al., 2005); they perceive risk in a more complex and multi-dimensional 
way than do risk assessors, or experts, who base their risk assessment on the possibility of 
human harm (Hawkes and Rowe, 2008: 617). Hence, ‘lay actors often resist or directly 
challenge experts’ judgements on risk’ (Lupton, 1999: 111; Green, Thompson and Griffiths, 
2002: 277). 
In recent years, the notion of an ‘expert’ patient has emerged in UK health policy 
(DOH, 2001) as part of the government’s plans to ‘modernise’ the health service (Wilson, 
2001: 134). Fox, Ward and O’Rourke (2005) noted how the DOH (2001) linked patient 
expertise with ‘“empowerment”, a “better quality of life”, “self-esteem” and a “userled 
NHS”.’ Similar to Giddens and Beck’s arguments earlier, the ‘expert patient’, according to 
the DOH, is expected to take responsibility for researching health conditions and to interact 
with the medical professionals collaboratively. In their study on weight loss, Fox, Ward and 
O’Rourke used Foucault’s (1980) concept of ‘technology of the self’, where a body is being 
disciplined in relation to systems of thought, to describe the ‘expert patient’ relation, which 
they also described as a ‘reflexive project of self-governance’ (2005: 1306). The patient’s 
expertise, it has been proposed, is grounded in ‘subjective experiences of embodiment, 
health and illness’ as opposed to the medical model of assessment of professional expertise 
(Tuckett et al., 1985 in Fox, Ward and O’Rourke, 2005: 1306). 
It is argued that risks created by the momentum of electronic cigarettes innovation 
have created an atmosphere of mistrust between the professional and lay people (Beard, 
2015). Moreover, scholars have argued that poor risk communication on the part of a 
particular institution can lead to a loss of confidence and trust and, hence, facilitate the 
formation of stigma (Zwick, 2002a). However, in contemporary public health discourses, it is 




and follow experts’ advice (Lupton, 1999; Rose, 1990; Rhodes and Cusick, 2002). Those who 
fail to change their behaviour accordingly may be judged irresponsible, blamed for the lack 
of self-care (Petersen, 1997), or even ‘find themselves stigmatized and subject to moral 
judgements’ (Lupton, 2006: 14). Stigma has been a major concept in the field of smoking. 
Similarly, social acceptability, as indicated in the first chapter, plays a key role in the 
increased popularity of electronic cigarettes. For these reasons, it is essential to discuss the 
concept of stigma, which I will turn to next. 
2.4. Risk Perceptions and Stigma 
Risk perception studies showed that fear from possible risk may lead to this risk becoming 
stigmatised. Hence, risks associated with electronic cigarettes may lead to the stigmatising 
of electronic cigarette users. I discuss this in view of the stigma attached to smokers in the 
West. 
Sociologists like Durkheim have emphasised the powerful role of social norms as tools 
of social control. The key idea is that individuals want to follow social norms to avoid social 
exclusion. Those facing stigmatisation change their behaviour and gain direct benefits 
which, in some cases, lead to indirect benefits to society because of a reduction in illness or 
socially disruptive behaviour (Gibbs, 1965). The term ‘stigma’ was initially introduced by 
Erving Goffman in the early 1960s. The concept describes the link between a person and an 
undesirable stereotype, which leads other people in the society to discredit that person 
(Goffman, 1963: 3). Stigma was defined by Gregory, Slovic and Flynn (1996: 216) as: 
something that is to be shunned or avoided not just because it is dangerous but because it 
overturns or destroys a positive condition, signalling that what was or should be 
something good and acceptable is now marked as blemished or tainted. 
Social stigmatisation theory, it was argued, seems to be able to accommodate multiple 
forms and severities of stigma; it involves stereotyping, status loss, experiences of 
discrimination, and the personalisation of negative stereotypes (Stuber, Galea and Link, 
2009). According to scholars, the phenomenon of stigmatisation seems to have increased 
during the late twentieth century, while the social amplification of risk perceptions has been 
a feature of various health and risk events in many nations across the globe (Pidgeon and 




Scambler and Hopkins (1986) conducted a British study on epilepsy and distinguished 
between ‘enacted stigma’ and ‘felt stigma’. Enacted stigma refers to manifest discrimination 
and hostility against a person based on their social unacceptability or perceived stigmatised 
status. Felt stigma signifies both a sense of shame and fear of encountering enacted stigma 
(Scambler, 2009: 445). Moreover, Steward et al. (2008) distinguished between ‘felt 
normative stigma’ and ‘internalized stigma’. ‘Felt normative stigma refers to a subjective 
awareness of stigma which it is expected will motivate individuals to take action to avoid 
enacted stigma’ (Scambler, 2009: 446). Internalised stigma describes when those who are 
subjected to stigma from others accept that their discredited status is valid, and hence the 
consequence is ‘self-stigma’ (Steward et al., 2008: 3). However, some studies that addressed 
stigma pointed at minorities who rejected being victims and resisted being stigmatised 
(Schneider and Conrad, 1980; Scambler and Hopkins, 1986). Also, Scambler and Paoli (2008) 
introduced notions of ‘project’ stigma and deviance, where both notions refer to the 
rejection of shame and blame, respectively. 
It was found from cross-cultural studies that the consequences of stigma are 
‘remarkably similar in different health conditions, cultures and public health programmes’ 
(Van Brakel, 2006: 329). Stigmatisation of risks can influence behaviour and can result in the 
avoidance of products or places (Zwick, 2002b: 28). Garrick (1998: 42) warned that 
‘technological stigmas’ evolve out of considering only the risks and costs of technology 
because only facts about the risk are highlighted, while the total benefits to society are 
hidden. Garrick discussed the hidden agendas for particular risk amplifiers and emphasised 
the role of media in exposing bad news, regardless of the context. Scholars noted that poor 
presentation of technical information to the public by journalists, critics, review groups and 
technologists results in misrepresentation and ambiguity of the impact of technology on 
public safety and the environment (Garrick, 1998; Zwick, 2002a: 38). Hence, the fear of 
possible health, social, economic or environmental consequences may lead to amplifying 
the risk or stigma. This means that judging and reacting to risks and stigmas does not rely on 
the objective risk characteristics, technical or scientific risk studies solely (Kasperson et al., 
1988; Gregory, Slovic and Flynn, 1996; Kasperson et al., 2003). Several biotechnological 
innovations and products were stigmatised due to fear and ambiguity, such as nuclear 




(Gregory, Slovic and Flynn, 1996; Garrick, 1998). Fear has also been linked to stigmatising 
attitudes towards various attributes, health conditions and behaviours such as leprosy, 
HIV/AIDS, mental illness and smoking (Scambler and Hopkins, 1986; Stuber, Galea and Link, 
2008). 
2.4.1. Stigma and Smoking 
Stigma and smoking have been addressed in the literature (Markle and Troyer, 1979; 
Brandt, 1990; 1998; Louka et al., 2006; Bayer and Stuber, 2006; Stuber, Galea and Link, 
2008; Helweg‐Larsen, Tobias and Cerban, 2010). Stuber, Galea and Link (2008) used data 
from a general population survey of New York City residents, including current and former 
smokers. They suggested the following factors contributed to the formation of smoker-
related stigma among their participants: (a) construction of smoking as a voluntary 
behaviour, (b) fear that second-hand smoke harms children, (c) structural forms of 
discrimination against smokers, (d) low levels of education, and (e) social norms specifically, 
disapproval of smoking behaviour expressed by family and peers. Helweg‐Larsen, Tobias and 
Cerban (2010) conducted in-depth qualitative interviews with 15 smokers from each 
Denmark and the US. They found that Danes and Americans had similar experiences with 
disapproval and stigmatisation and described a society that considered smokers as ‘bad, 
low-class, undesirable individuals that are treated as immoral social outcasts’ (p: 883). 
Gough et al. (2009) conducted 22 focus group discussions with young adults from both high 
school and university settings in the UK. They reported a consensus over the claim that 
smokers were over-targeted and treated unfairly compared to other groups. 
Several studies suggested that stigma has played a role in reducing cigarette 
consumption and smoking prevalence (Kim and Shanahan, 2003; Hammond et al., 2006; 
Alamar and Glantz, 2006; Amonini, Pettigrew and Clayforth, 2015). For example, in Louka et 
al.’s (2006) study, smokers were highly motivated to avoid social disapproval, which 
influenced them both emotionally and behaviourally. Exposure to social disapproval was 
found to have an impact on the ways in which smokers felt about their smoking, as well as 
their smoking behaviour (Louka et al., 2006). However, in Helweg-Larsen et al.’s (2010) 
study, some participants said that smoking regulations, but not the stigma, reduced their 
cigarette consumption. Stuber, Galea and Link (2009) provided some evidence that smoker-




withdrawal from non-smokers’ peers, which might reinforce tobacco use. Another 
consequence was keeping the smoking status secret, which might prevent smokers from 
interacting with smoking cessation programmes and benefiting from the available 
treatments. 
The social norms approach, where a social milieu and legal climate are created to 
lessen the desirability, acceptability and accessibility to tobacco, has been applied to change 
behaviour at the individual level through changing population level smoking-related 
behaviours (Zhang, Cowling and Tang, 2010). Kim and Shanahan (2003: 343) expressed their 
concerns about the ‘unfavorable public sentiment’ towards cigarette smoking; where 
unhealthy behaviours, like smoking, are becoming socially unacceptable and, accordingly, 
stigmatised as deviant behaviours. Moreover, it has been argued that the denormalisation 
of tobacco use policies has resulted in the stigmatisation of smokers (Bayer, 2008; Bell et al., 
2010). Over the past decade, the strategy of ‘denormalising’ tobacco use has become an 
important global tobacco control approach (WHO, 2008). Tobacco denormalisation was 
described by Lavack (1999: 82) ‘as all the programs and actions undertaken to reinforce the 
fact that tobacco use is not a mainstream or normal activity in our society’. These, according 
to Hammond et al. (2006: 225), include strategies which target those places where people 
can smoke, the advertising and selling regulations of tobacco products, and providing the 
public with information about the dangers of second-hand smoke through media 
campaigns. 
Moreover, Bell et al. (2010) provided some evidence of widespread discrimination 
against smokers in healthcare systems in the West. Such attitudes and practices, according 
to Bell et al., showed that denormalisation policies succeeded in changing social norms, 
values and attitudes regarding smoking and smokers. Bell et al. linked this transformation to 
the growing emphasis on the individual responsibility for health and illness, a concept that 
was addressed by sociological scholars, as discussed earlier. Most importantly, Bell et al. 
(2010) suggested that there is no strong evidence that denormalisation strategies will serve 
to reduce health-related inequalities. In fact, they believe that these strategies are likely to 
serve to increase health-related inequalities. Stigmatised smokers, they suggested, may not 
disclose their smoking status to health professionals and, hence, reinforce smoking, as 




study in four localities in Scotland (Ritchie, Amos and Martin, 2010) found that smokers 
perceived the Smokefree legislation to have increased their feeling of being stigmatised. The 
separation between smokers and non-smokers had resulted in self-stigmatisation by 
smokers of their own smoking behaviour. Smokers reported feeling the loss of social status 
in public places, not smoking outside, reducing social outings and stigmatising other 
smokers. Thus, the Smokefree legislation, this data suggests, has created an unacceptable 
social attitude towards smokers. 
The ethical justification of denormalisation policies was explored by several scholars 
(Bayer, 2008; Burris, 2008). For example, Bayer suggested that, since stigmatising policies 
have succeeded in reducing smoking, they should be morally acceptable. Burris, however, 
emphasised that public health policies must not act as a social control tool, and should be 
cautious about the potential for public health efforts to further stigmatise minority groups 
or classes. It is in this context that electronic cigarettes have been suggested as being 
attractive to smokers because they can help smokers avoid some of the stigma they come 
across (Voigt, 2015). Voigt discussed the raised concerns about electronic cigarettes 
renormalising smoking and the call to apply similar regulations to restrict their use. Voigt 
argued that the debate about regulating electronic cigarettes should be explored through 
the lens of the ethical complexities of attempting to manipulate social norms to change an 
individual’s behaviour. 
Some evidence has pointed at the electronic cigarette’s social acceptability. For 
example, in ASH surveys, social acceptability was found as a reason for using electronic 
cigarettes (McNeill et al., 2015). However, the latest ASH Smokefree GB surveys on the use 
of electronic cigarettes among adults and young people (ASH, 2016b) showed that 1% of 
users stopped using electronic cigarettes because they were embarrassed to use them in 
public. Other studies showed a small number of electronic cigarette users were concerned 
about the social acceptability of electronic cigarette use, and felt embarrassed about using it 
(Kralikova et al., 2012; Dawkins et al., 2013). In their qualitative study on perceptions of 
electronic cigarettes, Sherrat et al. (2015a: 9) suggested that regulating electronic cigarettes 
may be viewed as a social endorsement of electronic cigarettes for some participants who 
felt uncertain or concerned about electronic cigarettes’ safety. However, the authors also 




electronic cigarettes to stop smoking. The findings, according to the authors, ‘demonstrate 
how social endorsement or even comparison could contribute towards the formation of 
attitudes around social acceptability’. Disapproval for the similarity of electronic cigarettes 
to cigarettes was also reported (Sherratt et al., 2015a; Rooke, Cunningham-Burley and 
Amos, 2015). Similarly, it is argued that the resistance to accepting electronic cigarettes and 
the public performance of vaping may shift the stigma associated with tobacco cigarette use 
to electronic cigarettes (Shickle, 2009: 20). In this thesis, concern of stigma emerged among 
some electronic cigarette users. I will expand on this in Chapter 6. However, next, I will 
discuss the benefits and risks of electronic cigarettes. 
2.5. The Benefits and Risks of Electronic Cigarettes 
Risks and benefits are at the core of the controversy that electronic cigarettes have 
generated. First, I discuss their benefits as an effective smoking cessation aid. Then, I 
present their identified risks as presented in scientific studies and, finally, as perceived by 
smokers, ex-smokers, members of the public and electronic cigarette users. 
2.5.1. The Efficacy of Electronic Cigarettes as a Smoking Cessation Aid 
Data from several studies and a Cochrane review have reported using electronic cigarettes 
successfully to give up traditional cigarette smoking and reduce cigarette consumption (e.g. 
Caponnetto et al., 2013; Bullen et al., 2013; Biener and Hargraves, 2014; Etter, 2014; Etter 
and Bullen, 2014; McRobbie et al., 2014). There is also evidence that electronic cigarettes 
can encourage quitting or cigarette consumption reduction even among those who have no 
intention to quit or refuse other support (McNeill et al., 2015: 51). In a longitudinal survey, 
Etter and Bullen (2014) found that electronic cigarette use may contribute to relapse 
prevention and smoking cessation. A randomised clinical trial investigated the efficacy of 
second-generation electronic cigarettes over eight months. The results showed a reduced 
cigarette craving and withdrawal symptoms immediately and effectively, with almost half of 
the participants achieving eight-month reductions in, or complete abstinence from, tobacco 
smoking (Adriaens et al., 2014). A pilot study from Italy followed 71 vape shop customers 
from seven different shops after their initial visit to the shops. The findings showed 
significant reductions in the amount of cigarettes smoked per day at six and twelve months. 




respectively (Polosa et al., 2015). Another longitudinal Internet survey from GB found that 
using electronic cigarettes daily while smoking appeared to be associated with ‘subsequent 
increases in rates of attempting to stop smoking and reducing smoking, but not with 
smoking cessation’ (Hitchman et al., 2015; Brose et al., 2015b: 1160). 
Some studies compared the effectiveness of electronic cigarettes to other used 
medications. For example, in their survey, Etter and Bullen (2011) reported that around 68% 
of electronic cigarette users have tried and failed to quit previously using nicotine 
replacement therapies, Bupropion and Varenicline. Bullen et al. (2010) compared electronic 
cigarettes with nicotine inhalers and found that electronic cigarettes delivered nicotine 
more rapidly than the inhaler, while they significantly reduced cigarette cravings and the 
number of cigarettes smoked at a level similar to that of nicotine replacement products. 
Moreover, electronic cigarettes were perceived by users to be more satisfying than using an 
inhaler. One population-based survey (Brown et al., 2014a) of 5,863 English smokers found 
that those who used electronic cigarettes on their last quit attempt were more likely to quit 
than those who used over-the-counter nicotine replacement therapies, or no quit aid. In 
2015, it was estimated that more than 1 million smokers used electronic cigarettes 
compared with around 700K, who used licensed nicotine replacement therapies (West and 
Brown, 2016). 
When the efficacy of electronic cigarettes was compared to other nicotine 
replacement therapies, it was suggested that the latter fail to help many smokers to quit, 
because they do not deliver nicotine in the same way as a cigarette (Fagerström and 
Bridgman, 2014), and do not replace the unique sensory cues or rituals associated with 
smoking (Rose, 2006; Fagerström, 2012). Electronic cigarettes, however, are consumed like 
conventional cigarettes, so that the characteristics of the smoking habit (e.g. hand to mouth 
gesture, ‘throat hit’ of the vapour, exhaling visible vapour) are maintained (Cope, 2013). 
Therefore, the possible effectiveness of electronic cigarettes as an aid in smoking cessation 
could be ascribed to these particular features (Farsalinos et al., 2013). It is also argued that 
the behavioural element is deeply embedded in most addictive practices (Buchhalter et al., 
2005). Also, since electronic cigarettes address the behavioural issue of nicotine addiction, 




(Bullen et al., 2010; Etter and Bullen, 2011; Wagener, Siegel and Borrelli, 2012; Dawkins et 
al., 2012; Caponnotte et al., 2013). 
PHE stated that, although the evidence suggests that current electronic cigarettes are 
much more popular than other licensed stop smoking medications, it is still unknown if they 
are more or less effective (McNeill et al., 2015: 51). However, they pointed to emerging 
evidence that electronic cigarettes can be effective as a cessation and reduction aid (McNeill 
et al., 2015: 7). ASH concluded that evidence suggests electronic cigarettes ‘compare 
favourably with other stop smoking aids’ (ASH, 2016a). However, the NCSCT stated that 
‘there are a limited number of good quality and reliable studies, especially on the subject of 
cessation’ (NCSCT, 2016: 4). 
Next, I discuss the available evidence on the risks of electronic cigarettes. Then, I will 
present the perceived risks as discussed by the public, smokers, ex-smokers and electronic 
cigarette users. 
2.5.2. Risks Involved in Electronic Cigarette Use 
Studies have highlighted some health and safety risks associated with electronic cigarettes. 
There are also concerns regarding social risk, which include the risk of the uptake and long-
term use of electronic cigarettes, gateway use and renormalisation of smoking. 
2.5.2.1. Health and Safety Risk 
A key concern is the content of electronic cigarettes. For example, an early laboratory 
analysis had detected nicotine-derived nitrosamine contaminants in some devices (FDA, 
2009a). Concerns were also highlighted that inhalation of the main components, many 
times every day, may cause respiratory irritations (WHO, 2009: 6; German Cancer Research 
Centre, 2013: 7). The component glycerine has been reported to cause lipoid pneumonia in 
one electronic cigarette user (McCauley, Markin and Hosmer, 2012). A negative pulmonary 
effect for second-hand use (passive vaping) has been reported (Flouris et al., 2013). Some 
studies warned of a possibility that the vapour may become contaminated with metals, or 
chemicals from plastics in the device (Williams et al., 2013). Other studies demonstrated 
insufficient information about the liquids, inconsistency of delivering nicotine and incorrect 




Brown and Cheng (2014) conducted a systematic literature search in 10 reference databases 
throughout October 2013. They found that it was difficult to evaluate the impact of 
electronic cigarettes on individual users and public health due to cross-product and within-
product differences in aerosol production, nicotine delivery and potential product use risks. 
Concerns have also been raised about the risk of nicotine intoxication; fatal poisoning 
(especially for children, if a high nicotine content electronic cigarette is swallowed); the 
hazard of leaked cartridges, as well as the disposal issue (Cobb et al., 2010; de Andrade and 
Hastings, 2013; Gupta, Gandhi and Manikonda, 2014; Bartschat et al., 2015; Gill et al., 
2015). Some adverse health effects were reported after using electronic cigarettes such as: 
mouth and throat irritations, dry cough, dizziness and nausea (German Cancer Research 
Center, 2013: 7). A number of accident and emergency cases were also reported after using 
electronic cigarettes, even though a causal relationship was not confirmed (Chen, 2013). 
One systematic review concluded that ‘due to many methodological problems, severe 
conflicts of interest, the relatively few and often small studies, the inconsistencies and 
contradictions in results, and the lack of long-term follow-up, no firm conclusions can be 
drawn on the safety of ECs [electronic cigarettes]. However, they can hardly be considered 
harmless’ (Pisinger and Døssing, 2014). 
These safety concerns have been challenged. For example, it was highlighted that the 
FDA laboratory test found only trace levels of carcinogens of the corresponding levels in 
traditional cigarettes, in only a few samples tested, and were at levels similar to approved 
nicotine-containing products (FDA, 2009b; Cahn and Siegel, 2011). Another study showed 
that the carcinogen compounds in electronic cigarettes are 9-450 times lower than the 
levels found in traditional cigarettes, and are comparable to the levels found in currently 
licensed nicotine-containing products (Goniewicz et al., 2013b). It was also argued that the 
risk of accidental poisoning due to electronic cigarette use is no different from many 
household devices and chemicals (Wagener, Siegel and Borrelli, 2012). Additionally, it was 
argued that the adverse symptoms that were reported after using electronic cigarettes 
improved over time (Etter, 2010; Caponnetto et al., 2011a; Polosa et al., 2011; Dawkins et 
al., 2013). It was also noted that none of the experimental or prospective follow-up studies 
have documented serious adverse events (NCSCT, 2016: 36). For example, Bullen et al.’s 




cigarettes or nicotine replacement therapy patches groups. The findings showed no 
significant differences in occurrence of adverse events between the groups. In another 
study that addressed the impact of using one brand in relation to long-term safety, 
Caponnetto et al. (2013) found evidence of significant progressive health improvements, 
and a decrease of all symptoms throughout the study. One systematic review by Burstyn 
(2014) deemed electronic cigarettes to be very unlikely to pose significant risks to users and 
did not identify harms for bystanders from the vapour. 
Although existing research does not provide a definitive conclusion about electronic 
cigarettes’ safety in absolute terms, there is an indication that they are less harmful than 
tobacco cigarettes, and comparable in toxicity to approved nicotine replacement therapies 
(NICE, 2013a: 11; Farsalinos and Polosa, 2014; PHE, 2015; NCSCT, 2016). A systematic review 
concluded that ‘existing evidence indicates that EC [electronic cigarette] use is by far a less 
harmful alternative to smoking’ (Farsalinos and Polosa, 2014). A report by PHE (McNeill et 
al., 2015: 12) confirmed that the electronic cigarette is around 95% less harmful than 
smoking. The NCSCT (2016: 33) stated that studies have not found any adverse effects of 
short-term electronic cigarette use on haematological or blood chemistry parameters, nor 
cardiovascular function in both smokers and ex-smokers. As for the long-term effect, NCSCT 
(2016: 34) stated that, although they do not know the long-term risk, ‘the magnitude of any 
risks that may emerge from long-term e-cigarette use is likely to be small’. Similarly, 
although the second-hand vapour from electronic cigarettes exposes others to nicotine and 
to other toxicants, the exposure has been found to be much less than those results from 
cigarette smoke (Czogala et al., 2014; Goniewicz, Hajek and McRobbie, 2014; NCSCT, 2016: 
35). 
2.5.2.2. Social Risk: The Uptake of Electronic Cigarettes, Long Term Use, Gateway Use and 
Renormalisation of Smoking 
Concerns were raised that the uptake of electronic cigarettes, by non-smokers, might be a 
gateway to smoking and, hence, lead to re-normalise smoking. Another concern is the long-
term use of electronic cigarettes, which might maintain addiction (Cobb and Abrams, 2011; 




Several studies warned that electronic cigarettes might be used as a gateway to 
smoking, particularly among children and young adults (Henningfield and Zaatari, 2010; Choi 
et al., 2012; Corey et al., 2013; Pepper et al., 2013; Pepper and Brewer, 2013; Goniewicz, 
Lingas and Hajek, 2013; Sutfin et al., 2013; Lee, Grana and Glantz, 2014; Wills et al., 2016). 
For example, in Choi et al.’s (2012) study, some participants stated that electronic cigarettes 
take users one step closer to smoking, so that they would end up smoking cigarettes. Half of 
the participants, even non-smokers, admitted they would try an electronic cigarette if 
offered by a friend. An Internet survey in Poland found that 25 out of a total of 179 
participants were non-smokers when they started using electronic cigarettes; of those, 20% 
reported that they had also started cigarette smoking through the use of electronic 
cigarettes (Goniewicz, Lingas and Hajek, 2013). However, other scholars have contested the 
gateway use concern and have argued that, to date, there are no available longitudinal 
studies that have examined whether electronic cigarettes serve as a gateway to future 
tobacco use (Pepper and Brewer, 2013; Bell and Keane, 2014; Bauld, 2016). PHE stated that, 
thus far, there is no data supporting the claim of gateway use (Britton and Bogdanovica, 
2014: 14). 
Research from different Western countries showed an increased use of electronic 
cigarettes among young people (Goniewicz and Zielinska-Danch, 2012; McMillen, Maduka 
and Winickoff, 2012; Pearson et al., 2012; Corey et al., 2013; Demjén et al., 2013). For 
example, one study from the US found that more than 10% of college students, who 
reported using electronic cigarettes, had never smoked a conventional cigarette (Sutfin et 
al., 2013). In the Global Youth Tobacco Survey conducted in 2012 in Hungary among 
teenagers aged between 13 and 15 years, 6.7% of participants, who had used electronic 
cigarettes within the last 30 days prior to the survey, were non-smokers (Demjén et al., 
2013; German Cancer Research Center, 2013: 19). However, PHE analysed the available 
evidence and concluded that, with the exception of one Polish survey, electronic cigarette 
ever-use was reported in less than one in ten children in these studies. Ever-use, PHE found, 
was concentrated in young people who smoked. PHE could also not identify evidence that 
non-smoking children who tried electronic cigarettes were more likely to try tobacco later 




Moreover, evidence from an ASH annual online survey of young people showed that, 
in 2015, 13% of those surveyed had tried electronic cigarettes at least once, which is up 
from 5% in 2013. However, more young people (21%) had tried cigarettes than electronic 
cigarettes and 64% of those using electronic cigarettes had tried tobacco first. Regular use 
(once a month or more) was rare and mostly among children, who were current smokers at 
the time or had previously smoked. Compared to other surveys from Wales, Scotland and 
England, ASH stated that the patterns of electronic cigarette use were similar among all 
these surveys (ASH, 2015f). ASH confirmed that regular use of electronic cigarettes is limited 
to current and ex-smokers, while use amongst ‘never’ smokers ‘remains negligible’. 
In addition, several studies addressed the long-term use of electronic cigarettes and 
showed varied results (e.g. Polosa et al., 2011; Caponnetto et al., 2011a). According to a US 
survey of 216 first-time electronic cigarette buyers, most of the former smokers (56.7%) 
continued using electronic cigarettes. Of those respondents who were not smoking at the 6-
month point (n67), 34.3% were nicotine-free, which, according to authors, suggests that 
electronic cigarettes can reduce nicotine dependence (Siegel, Tanwar and Wood, 2011). In 
Bullen et al.’s (2013) trial, a third of the participants allocated to electronic cigarette groups 
reported continued product use at six months. Those who had relapsed to smoking but 
continued to use electronic cigarettes at six months, had reduced cigarette consumption. 
Another study found that 26.9% of quitters who used electronic cigarettes to quit still used 
these products by week 52, but the majority of people who quit were free from using 
electronic cigarettes (Capponnetto et al., 2013). 
Further, the concern of renormalisation of smoking, which means making cigarette 
smoking appear to be a normal activity, was highlighted in the literature (Fairchild, Bayer 
and Colgrove, 2014; Voigt, 2015). However, many scholars and public health bodies have 
contested this claim (Dunworth, 2015; NCSCT, 2016). Although the NCSCT (2016: 37) 
acknowledged the validity of these concerns, they stated that there were no data to show 
that this was happening. In fact, they highlighted the available evidence which showed that 
cigarette smoking prevalence among both adults and young people had continued to fall in 
England and the US, while electronic cigarette use increased. 
In view of all the above studies, it was recommended that the unintended 




considered in future research and policymakers should control electronic cigarette 
marketing (de Andrade, Hastings and Angus, 2013). Scholars asserted that long-term use of 
any nicotine-containing product must not be encouraged, although, in certain 
circumstances, electronic cigarettes can be a lower-risk option than smoking (Borland, 
2011). In 2015, the UK government announced that under-18s will be banned from buying 
electronic cigarettes and there will be restricted electronic cigarette advertisements. Next, I 
present electronic cigarettes’ perceived risk as presented by different groups of people. 
2.5.3. Risk Perceptions of Electronic Cigarettes 
Here, I present the perceived risk as presented by smokers, ex-smokers, the public and 
electronic cigarette users. 
Several international surveys have addressed the risk perceptions of electronic 
cigarettes (e.g. Etter and Bullen, 2011; Pearson et al., 2012; Dawkins et al., 2013; Farsalinos 
et al., 2014). In some studies, electronic cigarette users showed little concern about the 
safety of electronic cigarettes. For example, an online survey of 6,607 US adult smokers 
found that participants perceived electronic cigarettes to be less harmful than snus (a 
dissolvable tobacco), and smokeless tobacco, and less likely to cause lung cancer, heart 
disease and oral cancer compared to regular cigarettes (Pepper et al., 2015). Pepper et al. 
suggested that the innovative aspect of electronic cigarettes may have influenced these 
perceptions. Another online survey of US university students reported that participants 
viewed electronic cigarettes to be less harmful than other nicotine-containing products 
(Latimer, Batanova and Loukas, 2013). In a worldwide survey of 19,414 dedicated electronic 
cigarette users, participants reported minor side effects and substantial health benefits. 
Most of them considered electronic cigarettes as less harmful than tobacco cigarettes, while 
11.0% considered them to be absolutely harmless (Farsalinos et al., 2014). Also, Tan and 
Bigman (2014) used data from the Health Information National Trends Survey in the US and 
found that 51% believed electronic cigarettes were less harmful than cigarettes. 
To the contrary, other international studies showed concerns about the safety and 
health influence of electronic cigarettes (e.g. Etter, 2010). In their systematic review, Pepper 
and Brewer (2013) concluded that there were concerns about the safety of electronic 




avoid restrictions on smoking. A survey of 64 ever-users of electronic cigarettes from South 
Spain found that 68% of participants thought that electronic cigarettes were not good for 
their health (Muñoz et al., 2014). Respondents in another US survey were concerned about 
the safety and the long-term effect of electronic cigarettes (Baweja et al., 2016). Sutfin et al. 
(2013) conducted a study reporting on the prevalence and correlations of electronic 
cigarette use among a large, multi-institution, random sample of college students in the US. 
They found that half of their sample did not know how harmful electronic cigarettes were 
when compared to regular cigarettes. Almost a quarter of ever electronic cigarette users 
(23%) reported uncertainty, while 45% of ever electronic cigarette users reported it was 
safer than a traditional cigarette. 
In GB, a number of quantitative studies have also explored the risk perceptions of 
electronic cigarettes. For example, a survey conducted in 2010 suggested that 71% of 
smokers perceived electronic cigarettes to be safer than smoked tobacco (Dockrell et al., 
2013). Another population-based survey in GB conducted by Brown et al. (2014b) found that 
67% of current smokers perceived electronic cigarettes to be less harmful than smoked 
tobacco, whilst 24% felt unsure whether electronic cigarettes were safer. However, the 
perception of harm has changed over the years (O'Connor and Fenton, 2015). A longitudinal 
web-based survey of a general population sample of British smokers and ex-smokers found 
that the proportion who perceived electronic cigarettes to be less harmful than tobacco 
cigarettes decreased from 2013 to 2014. The study found that the perception of electronic 
cigarettes as less harmful was more likely among older participants, those who had 
previously perceived electronic cigarettes to be less harmful than cigarettes, those who had 
tried it and those who stopped smoking during the study. The study also found that 
perceiving electronic cigarettes as less harmful than tobacco cigarettes predicted later use 
of electronic cigarettes among participants who had not previously tried an electronic 
cigarette, especially among smokers (Brose et al., 2015b). It is also reported that more than 
three times as many people in 2016 than in 2013 think electronic cigarettes are as harmful 
as, or more harmful than, smoking. Among electronic cigarette users (smokers and ex-
smokers), 47% identified that electronic cigarettes are a lot less harmful than smoking. (ASH, 
2016b). Sherratt et al. (2015b) conducted a survey of 319 participants recruited from Stop 




participants felt uncertain whether electronic cigarettes were safer than smoked tobacco. 
Sherratt et al. found that risk perception of electronic cigarettes was related to electronic 
cigarette use, as current electronic cigarette users were more likely to view electronic 
cigarettes as less harmful than former or never users. However, never users were more 
uncertain as to whether electronic cigarettes were safer than smoked tobacco. 
Few international qualitative studies have addressed the risk perceptions of electronic 
cigarettes. In their public health study, Barbeau, Burda and Siegel (2013) used focus groups 
with 11 participants from electronic cigarette forums and websites in the US. Their 
participants viewed electronic cigarettes as both a tool for smoking cessation and as a safer 
alternative to cigarettes. Five themes emerged to describe users’ perceptions of the reasons 
for electronic cigarettes’ efficacy in quitting smoking: first, ‘bio-behavioural’ factors; second, 
social benefits for sharing the experience with others; third, hobby aspects and keeping the 
habit; fourth, personal identity as ‘vaper’; and, fifth, the difference between smoking 
cessation and nicotine cessation. Additionally, participants considered electronic cigarettes 
to be capable of facilitating smoking cessation with less harmful effects, without the need to 
give up nicotine. In contrast, they referred to the negative side effects of nicotine 
replacement therapies and their ineffectiveness in avoiding a relapse. 
McQueen, Tower and Sumner (2011) conducted a health behaviour research. They 
interviewed 15 participants who attended a vape group meeting in the US. Their 
participants favoured the unknown risks of electronic cigarettes over the known cigarette 
smoking risks. The participants, however, pointed out their concerns about the long-term 
health effects and quality control for liquids and components. Some of the emerging themes 
were: the culture of ‘vaping’; the social and informational support among the vapers’ 
community; the use of Internet resources; the learning curve to using electronic cigarettes; 
and the different modifications (‘mods’) available for electronic cigarettes. The study 
highlighted the different motives and perceived benefits of using electronic cigarettes 
compared to tobacco cigarettes, including: enjoying the imitation of cigarettes; the 
improved sense of taste and smell; better breathing and the ability to exercise; reduced 
costs; and the rapidly reduced nicotine tolerance and dependence. 
Choi et al. (2012) conducted 11 focus group discussions with 66 young adults (aged 




Participants reported positive perceptions of these products, while reporting few negative 
perceptions. Some participants believed these products were less harmful than cigarettes 
and helpful in quitting smoking, while others thought the opposite, particularly regarding 
electronic cigarettes. 
Peters et al. (2013), from health science, investigated the beliefs and perceived social 
norms relating to electronic cigarettes among 47 teenage boys in the US, who self-identified 
themselves as current electronic cigarette users. The results showed the main reasons for 
using electronic cigarettes were the ‘expeditious consumption and concealment’. According 
to the respondents, the reasons for the increased popularity of the electronic cigarette were 
because it was perceived to be healthier than a tobacco cigarette; it looked good and it was 
easy to access. Participants also self-reported being able to use electronic cigarettes 
everywhere, including school and home. 
Rooke, Cunningham-Burley and Amos (2015) conducted a qualitative of 64 smokers 
and ex-smokers in Central Scotland. About half of the participants had tried an electronic 
cigarette and eight had used them for longer term. The results showed a considerable 
uncertainty around the safety, health effects and regulatory oversight of electronic 
cigarettes. There were conflicting views with regards to the acceptability of continued 
nicotine addiction and the similarity of electronic cigarettes to conventional cigarettes. The 
scholars concluded that: ‘different groups of smokers bring diverse expectations, 
requirements and concerns to their evaluations and therefore to the potential use of 
nicotine-containing products’ (p: 60). 
Another qualitative study from the perspective of health psychology was conducted in 
GB. Sherratt et al. (2015a) undertook semi-structured telephone interviews with 20 
participants engaged in Stop Smoking Services in North West England. Participants were 
concerned about maintaining nicotine addiction through their dependency on electronic 
cigarettes over the long term. The scholars reported that safety appeared to be a key 
concern for all participants. However, participants compared the health risks associated 
with electronic cigarettes against using regular cigarettes and accepted electronic cigarettes’ 





To conclude, the perceived risks of electronic cigarettes vary among different 
populations. In general, there is a conception that electronic cigarettes are less harmful than 
smoking. The studies above identified some social risks such as maintaining addiction, long-
term use and the gateway use, but strong evidence is still lacking. 
2.6. Summary 
This is the second literature review chapter. It discussed risk in sociology, linked risk to trust 
between the professionals and lay people, and then discussed the link between risk and 
stigma. It presented the literature that addresses the risks and benefits of electronic 
cigarettes. It highlighted the risks associated with electronic cigarettes as identified in the 
scientific studies and as perceived by smokers, ex-smokers, members of the public and 
electronic cigarette users. Both physical and social risks were discussed. This overview, in 
both chapters, has revealed some of the key wider contextual trends that have an influence 
on the development and discourse of electronic cigarettes in the UK. The following chapter 




Chapter 3: The Theoretical Framework of the Thesis 
3.1. Introduction 
This chapter sets out the theoretical framework upon which this study is based, and draws 
upon key sociological concepts to explore the use of electronic cigarettes in this South East 
England qualitative study. The theoretical underpinnings of my empirical investigation are 
the boundary objects theory and biomedicalization theory. Here, I want to demonstrate 
how drawing on both concepts enables me to grasp the meanings of electronic cigarettes as 
presented in two data sources (electronic cigarette users and stop smoking advisors) 
through empirical research. I begin by introducing the biomedicalization theory with a 
particular link to addiction. Then, I will introduce the boundary objects theory. Lastly, I 
discuss how the theoretical framework informed the formation of the research questions. 
3.2. Biomedicalization 
Here, I introduce the biomedicalization theory and explain the biomedical processes that I 
will demonstrate, in the data chapters and the conclusion, their influence on the social 
construction of electronic cigarettes’ meanings. First, I introduce the concepts of 
medicalization and biomedicalization. Then, I discuss how electronic cigarettes manifest a 
biomedical era through discussing the processes of biomedicalization. Finally, I provide a 
critique of both concepts, with a particular link to tobacco addiction. This critique forms the 
basis for my argument, which links both biomedicalization and boundary objects. 
3.2.1. The Progress from Medicalization to Biomedicalization 
The concept of biomedicalization is considered to be one of the most powerful ‘social 
transformations’ in the twentieth century in the West (Clarke et al., 2003: 161). 
Biomedicalization, according to Clarke et al. (2003: 161), ‘is a historical shift’ from the 
‘medicalization’ concept which emerged in the 1970s through the work of influential 
scholars such as Michael Foucault, Ivan Illich and Irving Zola (Williams and Calnan, 1996: 4). 
Foucault introduced the concept ‘clinical gaze’ (Foucault, 1975: 120), which is described as 
the process through which a social object (such as a disease) is categorised as a medical 
condition (Armstrong, 2002: 21). Conrad (1992: 209) defined medicalization as ‘a process by 




that used to be considered deviant, such as madness, drunkenness and opiate use, become 
a medical condition, hence shifting such behaviours from ‘badness to sickness’ (Conrad and 
Schneider, 1992; Conrad, 2008: 6). 
Conrad analysed studies between 1970 and 1980 and, as a result, suggested the 
following main contributing factors to medicalization: first, the rise of the power of medical 
authority; second, the growth of social movements and the tendency for individuals to seek 
technological solutions to problems; third, improved organisational or inter- or intra-
professional links; fourth, increased pharmaceutical innovations and marketing of new 
treatments; fifth, the emergence of health insurance, which is more prominent in the US 
(Conrad, 1992; Conrad and Leiter, 2004; Conrad, 2008). Conrad also pointed out several 
changes that affected the organisation of medicine in the 1980s and which, in turn, have 
had an effect on health issues, such as the growing power of buyers, providers and payers, 
as well as the rise of corporate medicine. All these factors have played a role in giving 
authority to other players; hence, affecting the historical dominance of physicians. Also, a 
shift towards consumerism became evidenced, where the pharmaceutical industry viewed 
patients as a potential market and where patients act like consumers (Conrad, 2008). 
Scholars also pointed at the increased focus on risk factors and health promotion and, 
hence, shifted medical and health concerns into every corner of daily life, behaviours and 
social problems (Armstrong, 1995; Lupton, 1999; Nettleton, 2002). As a result, 
medicalization, it is suggested, extended to include more phenomena like childbirth, death, 
menopause and contraception in the 1970s. Then, in the 1980s/1990s, it further extended 
to include conditions including post-traumatic stress disorder (PTSD), premenstrual 
syndrome (PMS) and attention deficit hyperactivity disorder (ADHD) (Clarke et al., 2003). 
Later, the medicalization theory was criticised for its limitation in encompassing the 
advances and the increased importance of pharmaceutical, genomics and biotechnological 
industries. This has prompted some medical sociologists to propose biomedicalization as an 
extension to medicalization. Clarke et al. (2003: 164) argued that: ‘Social and cultural 
aspects and meanings of medicalization were elaborated even further and largely through 
technoscientific innovations.’ They believe that the biomedicalization of health began when 
cases previously understood as ‘undesirable’ or ‘stigmatisable', such as obesity and 




biomedicine concept as a ‘regime of truth’ (Foucault, 1980: 133) to capture some 
sociocultural dimensions and to ‘demonstrate how processes of biomedical knowledge 
production assume a role in wider constructions of social reality’ (Counts, 2011: 10). 
Further, they showed how biomedical development creates new social forms, where 
blurring boundaries emerge between 'public/private, government/corporation, expert/lay, 
patient/consumer, physician/insurer, university/industry/state, among others’ (Clarke et al., 
2003: 184). This is where I see the relevance of this theory to my study, as I argue that the 
ways of thinking about social life and problems increasingly stem from biomedicine. 
Therefore, the construction of different meanings and perceptions of electronic cigarettes is 
influenced by biomedical development. 
3.2.2. The Biomedicalization Processes 
Clarke et al. (2003: 161) proposed five key interactive processes that ‘engender’ 
biomedicalization and are ‘produced through it’: ‘(1) the political economic reconstitution of 
the vast sector of biomedicine; (2) the focus on health itself and the elaboration of risk and 
surveillance biomedicines; (3) the increasingly technological and scientific nature of 
biomedicine; (4) transformations in how biomedical knowledges are produced, distributed, 
and consumed, and in medical information management; and (5) transformations of bodies 
to include new properties and the production of new individual and collective 
technoscientific identities.’ Cipolla (2010) noted that biomedicalization differs from 
medicalization because it involves more aspects of contemporary life, such as increased 
pharmaceutical influence and human enhancement. Biomedicalization, therefore, 
incorporates complex processes of medicalization, which are transformed due to emergent 
technoscientific, biomedicine and social practices. I draw upon the five processes of the 
biomedicalization concept as described by Clarke et al. and discuss how electronic cigarettes 
manifest the biomedical era. There now follows a brief description of each process. 
The first process describes what Clarke et al. called ‘the Biomedical TechnoService 
Complex, Inc.’. They used this term to emphasise the role of technoscientific innovations in 
the growth of privatisation and corporatisation of research, products and services on the 
national and international level, leading to the expansion of the Western biomedical model. 
The scholars argued that this Complex shapes the way of thinking about social life and 




governments and healthcare and the collaboration between the pharmaceutical industry 
and academy, hence furthering biomedicalization (p: 168) and keeping the interests of 
biomedicine. A similar concept was discussed by Abraham, who introduced the 
‘pharmaceuticalization’ concept. Abraham (2008: 872) warned of ‘neo-liberal corporate 
bias’, where pharmaceutical regulations fail to keep public health interest as a main priority 
(2008: 882). Conrad and Leiter (2004: 171) also argued that: a ‘Corporatized medical-
industrial complex’ resulted in medical markets becoming ‘an important conduit to 
medicalization’. In this thesis, I highlight the link between big corporates, the tobacco 
industry and the government and the effect on the electronic cigarette market and 
research. 
The second process captures the role of different kinds of media, advertisement and 
digital information in creating perceptions and influencing decision-making processes. In the 
biomedicalization era, Clarke et al. believed, the proliferation and increase in access to 
knowledge sources might indicate a process of democratising knowledge. They, however, 
highlighted how ‘the interests of corporate biomedicine predominate’ (2003: 178), 
especially because of the direct to consumer relations. They also explained how the division 
between ‘expert’ and ‘lay’ knowledge was interrupted due to the heterogeneity of 
knowledge sources, leading to the formation of a new social link. These new modes of 
proliferating knowledge have resulted in more powerful lay groups (Clarke et al., 2003: 177). 
Giddens (1991) explained how the availability of information has led individuals to a 
reflexive application of knowledge, where they simultaneously contest and adopt expert 
knowledge systems in planning their everyday life. This, according to Lupton (1997b), 
transforms patients into reflexive consumers, making active decisions concerning treatment 
procedures. In the literature review and the data chapters, I show the role of media and 
marketing on electronic cigarette use and the changeable relationship between ‘experts’ 
and ‘lay’ electronic cigarette users. 
The third process describes the core of biomedicalization, which is the ongoing 
‘technoscientization’ of biomedicine. Biomedicalization focuses on risk and health with a 
central mode of action emphasised on drugs and techno-devices (Featherstone and 
Atkinson, 2013: 117). Clarke et al. described the growth of digitisation in medical 




communication and information systems, are considered ‘key technologies’ in this process, 
playing a crucial role in enforcing global medicine (Clarke et al., 2003: 176; Turner and 
Khondker, 2010: 120). In this thesis, I discuss the influence of digital technologies on the 
popularity of electronic cigarettes, and I describe the continuous technical advances of 
electronic cigarettes. 
The fourth process describes how biomedicalization focuses on risk, behavioural and 
lifestyle improvements, and the industries directed to help achieve these improvements. 
The rise of concepts of ‘“health maintenance," "health promotion," and "healthy living"’ 
imply the importance of achieving and maintaining health (Clarke et al., 2003: 172). In 
contemporary public health discourses, individuals are also responsible for the health of 
others (Petersen, 1997). Responsible individuals are expected to identify risk factors, to 
value and join health promotion regimes, engage actively in accessing knowledge, self-
surveillance, prevention, assessing risk and consuming appropriate biomedical goods and 
services (Clarke et al., 2003). This active pursuing of health, illness and disease by 
biomedical means is ‘a hallmark of biomedicalization’ (Clarke et al., 2010: 382). This 
emphasis on empowering individuals reflects the ‘consumerist’ approach, where ‘lay 
people’ act like consumers, refusing the medical dominance and paternalism when dealing 
with healthcare services (Lupton, 1997b: 373). With regards to electronic cigarettes, the 
literature review and my empirical data illustrate how electronic cigarettes were brought 
into the field of harm reduction approach that emphasises personal responsibility. This is an 
important process for my thesis, because the electronic cigarette, I argue, is utilised as an 
empowerment tool; as such, it represents a trajectory for biomedicalization and signifies the 
biomedical model supremacy in Western society. 
The last biomedicalization process I draw upon is ‘transformations of identities, 
through the creation of new identities by using new technology’. Here, there is an emphasis 
on the transformation of body, self and health through customisation and tailor-made 
services. Clarke et al. pointed to the shift to customisation, to differ from medicalization, 
where normalisation is the core. The regulation of bodies in biomedicalization is enforced 
through an increased importance on individuals’ responsibility for transformation to obtain 
new selves and identities. Clarke et al. refer to four ways that biomedical technoscience are 




obtain a special social identity, such as the use of infertility treatments; secondly, through 
creating new ways of life and mandates; thirdly, by redefining the old health-related 
identities and creating new ones, such as characterising people into high risk or low risk 
cases; and, lastly, the utilisation of new technoscientific modes of communication, such as 
telemedicine (Clarke et al., 2003: 182-183). The authors (p: 165) draw on the concept of 
‘"technologies of the self”’ (Foucault, 1988a), where individuals apply methods, tools or 
technologies to themselves. Foucault explains that ‘technologies of self’: 
permit individuals to effect by their own means or with the help of others a certain 
number of operations on their own bodies and souls, thoughts, conduct and way of being, 
so as to transform themselves in order to attain a certain state of happiness, purity, 
wisdom, perfection, or immortality. (1988a: 18) 
This thesis describes the new practice of ‘vaping’, including its related groups, activities, 
feelings and regulations. It demonstrates how electronic cigarette users disassociate 
themselves from smokers. Thus, it illustrates how electronic cigarettes act as ‘technologies 
of the self’ that produce new identities. 
To conclude, I argue that the development of electronic cigarettes represents a 
manifestation of the biomedical era. The literature review and my data show how processes 
of biomedicalization capture these developments, thus providing a contextual explanation 
for the phenomenon of electronic cigarettes. However, I argue that the theory presents the 
development of the biomedical phenomenon as a powerful and dominant fact, and a taken 
for granted progression in Western society, rather than a process occurring within an arena 
of multiple meanings. I wish to highlight the central role of people in allocating meanings to 
ambiguous scientific objects such as electronic cigarettes, which become boundary objects. 
Clarke et al. argue that biomedical development creates new subjectivities and identities, 
simultaneously encompassing concepts of ‘new forms of agency, empowerment, confusion, 
resistance, responsibility, docility, subjugation, citizenship, subjectivity, and morality’ (Clarke 
et al., 2003: 185). The scholars, therefore, acknowledge the role of human factors in the 
formation, progression and resistance of biomedicalization. However, this 
acknowledgement has not been translated, elaborated or given a clear voice within the 
biomedicalization processes. Clarke et al. present the biomedical processes, but do not 




resist and negotiate these processes. The scholars also state that, in the biomedicalization 
era, ‘There are infinite new sites of negotiation, percolations of power, alleviations as well 
as instigations of suffering, and the emergence of heretofore subjugated knowledges and 
new social and cultural forms’ (Clarke et al., 2003: 185). This is an important starting point 
to link biomedicalization with the boundary objects theory. By utilising the boundary objects 
theory to describe how electronic cigarettes become boundary objects, I aim to elaborate 
more on what Clarke et al. describe as ‘confusion’ and ‘infinite new sites of negotiation’. 
Further, in the Conclusion chapter, I reflect on the usefulness of combining both theories by 
allowing me to explain how electronic cigarettes are creating ‘new subjectivities and 
identities’ and ‘new social and cultural forms’; hence, enabling electronic cigarettes to 
become a means for social change. 
Since electronic cigarettes are perceived, among other perceptions, as a tool to help 
smokers overcome their addiction to cigarette smoking, I will discuss the position of 
addiction and tobacco harm reduction strategies within the 
medicalization/biomedicalization concepts. This historical overview allows us to see how 
human factors are the forces behind the formation of biomedicalization and, at the same 
time, are the forces that resist complete biomedicalization. 
3.3. Addiction, Tobacco Harm Reduction and Biomedicalization 
This section begins by discussing the biomedicalization of addiction, then links tobacco harm 
reduction and biomedicalization. 
3.3.1. Addiction and Biomedicalization 
It is argued that the concept of addiction was invented in the late eighteenth and early 
nineteenth century as part of a fundamental social structural transformation, which 
increased the focus on individuals’ control over their own ‘compulsive’ or ‘deviant’ 
behaviours (Levine, 1978: 53). The phenomenon of addiction to drugs was first used to 
describe the habitual drunkenness from alcohol and then extended to include other 
substances (Levine, 1978: 44). During the 1930s, people addicted to drugs were viewed as 
‘morally flawed and lacking in willpower’ rather than having a health problem; thus, there 
was an emphasis on disciplinary measures rather than prevention and therapy (National 




a state of periodic or chronic intoxication produced by repeated consumption of a drug 
(natural or synthetic). Its characteristics include: (1) an overpowering desire or need 
(compulsion) to continue taking the drug and to obtain it by any means; (2) a tendency to 
increase the dose; (3) a psychic (psychological) and generally a physical dependence on 
the effects of the drug; (4) detrimental effect on the individual and society. (Levine, 1978: 
54) 
Later, in 1964, the WHO replaced the term ‘addiction’ with the term ‘dependence’ and 
likened tobacco to alcohol. ‘The dependence syndrome’ is defined as: 
a cluster of physiological, behavioural, and cognitive phenomena in which the use of a 
substance or a class of substances takes on a much higher priority for a given individual 
than other behaviours that once had greater value. A central descriptive characteristic of 
the dependence syndrome is the desire (often strong, sometimes overpowering) to take 
the psychoactive drugs (which may or not have been medically prescribed), alcohol, or 
tobacco. (WHO, 2014a) 
Both terminologies are still used without clear differentiation; they both stress the physical 
and psychological elements of drug use. However, it has been argued that the term 
‘dependence’ has replaced ‘addiction’ to overcome the moralistic and judgemental 
associations with the word addiction (Campbell, 2012: 7). Later, during the 1980s and 1990s, 
the neurobiological discovery of ‘opiate receptors’ in the brain led to the transformation of 
thinking about drug problems from ‘tolerance’ to ‘neuroadaptation’ (Campbell, 2012: 17), 
while the brain disease model increasingly influenced diagnosis and treatment of drug 
problems (Elam, 2012: 56). It was argued that, between 1990 and 2000, the advancement in 
neuroscience played a major role in the field of addiction. It increased the familiarity of 
constructing addiction as a chronic disease of the brain and using pharmaceutical 
medications to treat addictions, and it gained in political and government recognition. These 
advances have re-fashioned addiction as a medical condition that needs medical 
intervention, and has enforced the biomedicalization of addiction (Campbell, 2012: 15-16, 
emphasis in original). Hence, the scientific and cultural understanding of addiction during 
the twentieth century has resulted in the medicalization of tobacco use, paving the way for 




Elam (2015) has linked addiction and the biomedicalization theory. First, he explained 
that the neurobiological explanation of addiction coincides with the biomedicalization 
processes, where biomedical authority is extending to the biological level. Second, since 
biomedicalization is associated with technoscientific medical innovations, the use and 
development of new technologies to explore and analyse addicted brains are considered 
signs of biomedicalization (p: 48). Third, by portraying addiction as a ‘lifestyle disease’, the 
neurobiology explanation of addiction is contributing to the culture of contemporary 
healthcare, where individuals are responsible for their health (p: 49). Next, I discuss tobacco 
harm reduction and biomedicalization. 
3.3.2. Tobacco Harm Reduction and Biomedicalization 
Here, I briefly discuss how tobacco harm reduction is linked to biomedicalization. 
Tobacco use, it was argued, was subjected to medicalization when it shifted from 
being a kind of acceptable social behaviour to becoming an addiction that needed medical 
treatment (Caron et al., 2005; Rooke, 2013: 22). The first ‘doctor-led attempt’ to medicalise 
smoking occurred when scientific evidence proved a connection between smoking and lung 
cancer in the 1950s (Berridge, 1999: 38). Later, the incorporation of harm reduction in 
tobacco control policy was seen as a shift towards medicalization of tobacco use (Berridge, 
1999; Rooke, 2013). However, over the years there has been an increased acceptance of the 
biomedical model in explaining nicotine addiction, which led to characterising nicotine 
addiction as ‘a brain disease’ (Wise, 2000; Glover, 2006; Courtwright, 2010: 137). It also led 
to the increased authority of neurobiological explanations of tobacco dependence, and for 
medicinal nicotine to attain a major role in the everyday practice of quitting, as discussed in 
part 1.3 (Keane, 2013: 192). Also, the contribution of genomics to the understanding of 
nicotine addiction (Caron et al., 2005; Demers, Bogdan and Agrawal, 2014; Loukola et al., 
2014) has enforced the biomedical discourse of nicotine addiction. Furthermore, Elam and 
Gunnarsson (2012) argued that nicotine replacement therapies signify biomedicalization as 
they have been devised to help smokers become more responsible nicotine addicts. Both 
scholars (2012: 149) used the concept ‘civilizing technologies’, proposed by Scott Vrecko 
(2010), and concluded that nicotine replacement therapies are mainly intended to produce 




It is argued that modern medical, public health programmes such as stop smoking 
programmes and harm reduction policies have embraced the ‘medical gaze’, and focused 
the responsibility of health on individuals who, consequently, regulate themselves through 
the medical lens (Petersen and Lupton, 1996: ix; Miller, 2001: 171). As discussed earlier, 
according to the biomedicalization concept, citizens are subjected to a form of social control 
based on self-regulation, self-monitoring and avoiding ‘risk’; they are obliged to 
acknowledge their biological makeup and susceptibilities, and to improve their own health 
and minimise illness, through adopting healthy lifestyles and keeping well (Nettleton, 1996; 
Rose and Novas, 2004: 22). Here, there is an active promotion to consumerism; yet, at the 
same time, the message of ‘self-governance’ requires individuals to balance their 
pleasurable behaviours and addiction in order to maintain their health and the public health 
(Netherland, 2012: xv). This ‘remoralization’ of disease is an important consequence for 
biomedicalizing addiction as health became a ‘moral obligation’, where addicts have a 
responsibility to manage their chronic brain disease (Clarke et al., 2010: 63; Campbell, 2012: 
21; Elam, 2015). The trend of increased individualisation and promotion of patients’ 
responsibility and autonomy in health decision-making has become embedded in NHS 
practices (The Strategy Unit, 2009) and within the tobacco control regimes (Redfield and 
Brodie, 2002; Mars and Ling, 2008). 
Although embracing the ‘brain disease’ concept by new public health programmes has 
paved the way for biomedicalization of addiction, as suggested by some scholars 
(Netherland, 2012; Campbell 2012; Elam, 2015), processes of both medicalization and 
biomedicalization were criticised for failing to accommodate the various dimensions of 
addiction. Hence, this has hindered the complete ‘bio/medicalization’ of addiction. The 
following section sheds light on these critiques. 
3.3.3. Critique of Medicalization/Biomedicalization of Addiction 
This section presents a critique of medicalization and biomedicalization, and highlights some 
arguments that explain how deeper political, economic and social factors work against the 
full ‘bio/medicalization’ in societies. 
First, it has been argued that both concepts failed to address the importance of the 




xvii). One implication for labelling addiction as ‘brain disease’, and accepting the 
neuroscience theory of pleasure, would be the widening acceptance for new pharmaceutical 
treatments for addiction. Placing the responsibility of addiction on the individual’s 
neurobiological and genetics compositions eliminates the role of the environmental and 
social context in influencing the brain function, shaping behaviours and causing diseases 
(Midanik, 2004: 212-13; Maturo, 2012). According to Turner (1995: 5), ‘one major problem 
with technological medicine is the fact that it divorces the patient from his social context’. 
New public health systems, it was argued, agree to harm reduction because they assume it 
reduces the medical and political burden on the government, thus relieving society from 
accepting responsibility for, or acknowledging the wider social, legal and economic causes 
of, different harms (Miller, 2001; Roe, 2005; Berridge, 2011: 200). 
Second, these approaches have raised some ethical issues. Besides the ethical concern 
of focusing the responsibility of health on individuals, rather than the wider social context, 
the emphasis on the superiority of the scientific medical model over other forms of 
knowledge is perceived as another ethical concern (Miller, 2001: 173). 
Third, it has been argued that the influence of social, economic and political 
differences has led to uneven medicalization and/or biomedicalization across societies, as 
well as the lack of a universal approach to addiction (Campbell, 2012: 16). Hansen and 
Roberts (2012: 98) pointed out that the different underlying concepts of addiction, as 
‘social, psychological and physiological’, are utilised in different phases of health services 
policies according to social, economic and political trajectories. For example, it was 
suggested that categorising drugs into legal and illegal is not related to the amount of harm 
they cause, but rather to the level of power for the social group using them and to other 
political and economic factors. This link is believed to still exist in this century, and is 
considered by some scholars to be the key reason for keeping tobacco and alcohol legal, yet 
keeping marijuana illegal in some countries (Mold, 2011: 124- 125; Netherland, 2012: xviii). 
Further, it is believed that persistence of stigma inhibits complete ‘bio/ 
medicalization’, as some scholars have pointed at the cultural significance and the racial 
division attached to substance use (Mold, 2011; Netherland, 2012; Hansen and Roberts, 
2012). For example, Hansen and Roberts (2012) demonstrated that the biomedicalization of 




stigma for the already stigmatised and marginalised users (non-white). The authors also 
argued that methadone maintenance was accepted by health policies in order to solve the 
problems of urban unrest and concluded that: 
In the case of addiction, the very project of destigmatizing treatment for some leads to 
intensified stigma for others, as a feature of the way color caste systems are utilized in 
commodified biomedical economies. (Hansen and Roberts, 2012: 98) 
Similarly, it has been argued that the social, cultural and historical context of drug use is a 
key issue for tobacco control policies. Mold described how the trend in smoking reduction in 
the UK between 1948 and 2008 was mainly among the higher social groups. This made it 
easier to increasingly stigmatise smokers, as the habit continued among the poor. On the 
contrary, tobacco use was glamorised when it was used by elite politicians (Mold, 2011: 
117). 
Fourth, it is argued that biomedicalization works in line with the market interests by 
concentrating on individuals’ extreme behaviours and neglecting preventive population 
approaches (Midanik, 2004: 214). Indeed, Hansen and Roberts revealed the marketing 
strategies of maintenance opioids, where the profitable pharmaceutical industry was 
promoting and leading clinical research for Buprenorphine as part of the neo-liberal 
deregulation. Further, Mold pointed to the significance of the revenue of tobacco taxes to 
governments’ economies, a factor that hinders efforts to illegalise tobacco (Mold, 2011: 
124). Similarly, I discussed in part 1.2.2 how Elam (2012) and Molimard (2013) argued that 
the pharmaceutical developments in the field of nicotine replacement therapies formed the 
basis of the acceptance of neurobiology explanation of nicotine addiction. Chapman and 
MacKenzie (2010) also highlighted that, due to increasingly medicalised smoking cessation 
and the increased influence of the pharmaceutical industry, tobacco control programmes 
neglect the unassisted cessation or stopping smoking by 'cold turkey' approach. This 
approach, the scholars argued, is the most commonly used method by people who have 
successfully stopped smoking. Similarly, Miller (2001: 177) described the practice of harm 
reduction as ‘a safety net, not a strategy, representing a convergence of economic 
rationalism and social policy’. As a result, the rise of tobacco harm reduction and the 





Fifth, the notion of addiction as a chronic relapsing brain disease is considered to be 
problematic. This is because, even though using drugs is a voluntary behaviour, the addict’s 
brain is to be considered different to the non-addict’s brain, and therefore a different set of 
actions and policies will be established to deal with the assumed state of mind of addicts 
(Kaye, 2012: 29). Therefore, the question as Kaye puts it: 
is not so much whether a biological component to a given disease exists or not – though 
this may indeed be an important issue in its own right –but rather how a series of socially 
established meanings and behaviors come to shape the ‘activation’ and significance (or 
non-significance) of this material reality. (Kaye, 2012: 39) 
This statement is important because it sets the scene for my argument in which I suggest 
the role of social meanings in constructing, activating or inhibiting biomedical processes. My 
belief is that biomedicalization theory works differently in different cultures and populations 
(Campbell, 2012: 23). Campbell (2012: 6) states: ‘addictions are hybrid cultural constructs 
that convey embedded sociocultural meanings that persist in ways that work against full 
bio/medicalization’. Similarly, through discussing the use of electronic cigarettes, I argue 
that the different social meanings that different actors hold for electronic cigarettes steer 
biomedical processes, either towards full ‘bio/medicalization’ or against it. While 
biomedicalization processes may seem to be ingrained in Western societies, I want to use 
the boundary objects theory to argue that these processes are the outcome of complex 
social negotiations and cooperation between divergent social meanings occurring within a 
particular social, economic and political context. In her discussion on boundary objects, Star 
(2010: 614) stated that: 
we live in a world where the battles and dramas between the formal and informal, the ill-
structured and the well-structured, the standardized and the wild, are being continuously 
fought. 
Hence, I continue to argue that biomedicalization processes are the outcome of these 
battles and human interpretations. Biomedicalization, I argue, is a dynamic rather than 
static concept as its processes are constructed around a continuous formation of boundary 




3.4. The Boundary Objects Theory 
Here, I introduce the boundary objects theory and demonstrate how the electronic cigarette 
is flexible enough to allow cooperation between different social worlds, but robust enough 
as a unique entity to form a boundary object. 
The boundary objects theory was introduced by Star and Griesemer (1989) as an 
analytical framework to be applied in complex settings where heterogeneity and 
cooperation are vital. Star and Griesemer discussed their case study of Berkeley’s Museum 
of Vertebrate Zoology in the early twentieth century. They described the smooth 
functioning of the museum, which depended on a variety of different groups with diverse 
aims, values, beliefs and abilities. Boundary objects were defined as those objects used 
within multiple social worlds and adapted to many of them ‘simultaneously’; these objects, 
therefore, cross the boundaries between these social worlds (Star and Griesemer, 1989: 
408). Strauss (1978: 121) referred to social worlds as ‘universes of discourse’ with typical 
forms of communication, symbolisation, activities, sites, technologies, and organisations. He 
stated that, among each social world, various issues are debated, negotiated and contested 
(Strauss, 1978: 124). Star and Griesemer described boundary objects to be ‘both adaptable 
to different viewpoints and robust enough to maintain identity across them’ (1989: 387). In 
essence, although boundary objects have a recognisable structure, they have diverse 
meanings in different social groups (p: 393). Mol (2006: 138) stressed that each different 
social world gives a different meaning to an object, but no one emphasises these different 
meanings. Thus, a boundary object remains 'fuzzy enough to absorb the possible tensions' 
and ‘blurs the boundaries’. Hence, boundary objects need to possess enough coherence and 
be recognisable enough to be regarded as an identifiable entity, yet also flexible enough and 
amenable to different interpretations to allow cooperation by different interests (Mol, 
2006). 
Star and Griesemer proposed four forms of boundary objects (1989: 410–11). First, 
‘repositories’, that require a set of assembled things such as a library, where diversification 
and heterogeneity are maintained without confrontation. Second, an ‘ideal type’, an 
abstraction or representation, that can be adaptable but lacks detail, such as an atlas. Third, 




same boundaries but is perceived differently and can achieve different goals. One example, 
from Star and Griesemer’s study, was the creation of the state of California itself as a 
boundary object for workers at the museum. So, although the amateur collectors and the 
conservationists created a different map than the one created by the professional biologists, 
both shared the same outline of the state and the same goals of conserving California and 
its natural variety. The final form of boundary objects is ‘standardised forms’, which are 
viewed as methods of communication between diverse groups. The literature and my data 
showed that electronic cigarettes were perceived and used in different ways, by different 
actors. Hence, I argue that an electronic cigarette is a form of ‘coincident boundary’. 
According to Jasanoff (2005: 27), boundary objects are ‘repositories of multiple 
meanings’, which cannot be easily reduced to a single static form. Fox (2011: 6) defined the 
boundary objects as ‘entities that enhance the capacity of an idea, theory or practice to 
translate across culturally defined boundaries’. Hence, boundary objects focus on the 
entities which are used to create coherency and cooperation between groups with diverse 
interests. This is achieved by the ability of boundary objects to be adapted to the needs of a 
group, while retaining enough congruity to be useful to others. In this way, ‘boundary 
objects mediate boundaries’ (Lee, 2010: 53) and, hence, are described as translational 
boundary objects. Star and Griesemer defined translation in the context of various social 
worlds as ‘the task of reconciling [the] meanings’ of objects, methods, and concepts across 
these multiple social worlds (1989: 388), so that people can ‘work together’ (389). As a 
result, the boundary objects’ structure ‘is common enough to more than one world to make 
them recognizable, a means of translation’ (p: 393). This thesis sees electronic cigarettes as 
a means of translation between various social worlds. 
Star (2010: 601) pointed at three dimensions in the boundary objects theory: First, the 
‘interpretive flexibility’, which describes the different use and interpretation of an object by 
different groups. The second dimension, ‘the structure of informatic and work process 
needs and arrangements; where boundary objects represent a set of work arrangements 
that are coincidentally material and processual, and where the heterogeneity is maintained 
without ruining the cooperative work, thus ‘allowing different groups to work together 
without consensus’ (p: 206). The third dimension, ‘the dynamic between ill-structured and 




the absence or lack of consensus. The scholar argued that most of the studies that applied 
the theory focused on the ‘interpretive flexibility’. She emphasised the importance of the 
other two dimensions. As Star noted (p: 605), objects exist in-between different social 
worlds; they also take either a form of ill-structured with vaguer identity objects, or a more 
specific and tailored to local use objects. Star and Griesemer clarified that ‘problems for 
negotiation’ arise as a result of mismatches between the overlapping meanings and 
representations of particular objects across multiple social worlds; therefore, to maintain 
coherence and successful negotiations, there must be a careful management of the 
boundary objects (Star and Griesemer, 1989: 412). They stated that, ‘The creation and 
management of boundary objects is a key process in developing and maintaining coherence 
across intersecting social worlds’ (p: 393). This does not mean creating a consensus, rather 
‘representations, or inscriptions, contain at every stage the traces of multiple viewpoints, 
translations and incomplete battles’ (p: 413). Groups who are working together without 
consensus move back and forth between both forms. Consequently, Star argued, people, 
generally regulators, try to control this back and forth movement in order to standardise 
boundary objects. An example of this is the increasing standardisation of different territorial 
representations in many geographical information systems (Star, 2010: 614). Star called for 
more analytical use for the theory. She recommended the use of the latter two dimensions 
to study the work arrangement and heterogeneity, and to understand the materiality and 
infrastructure of a boundary object, rather than focusing on the different interpretations. 
This is of particular relevance to my study as I show how, within biomedicalization 
processes, electronic cigarettes, as boundary objects, begin to move and change into 
standards and processes. 
The concept, however, was criticised for placing a greater emphasis upon cooperation 
between groups and underemphasising the levels of difference between groups involved in 
the interpretation of an object (Gomart and Hennion, 1999). The latter scholars suggest that 
groups often cooperate on the basis of precise differences over an object, rather than on 
the basis of an imprecise or blurred artefact. Lee (2007: 313) held that the concept is not 
flexible enough and is ‘incomplete’. Fujimura (1992) criticised the model for having a weak 
structure. Fox (2011: 80) criticised the model for being ‘taxonomic and descriptive’; 




objects. Fox noted that the concept is sociologically under-theorised, as it does not explain 
how boundary objects function and how the roles of different human agents influence that 
function. Similarly, Riesch (2010: 453) argued that the boundary objects theory does not 
explain how the boundaries develop, why and what they are supposed to consist of and 
how they get negotiated. 
Nevertheless, the theory has been used in different disciplines such as computer 
science, management, history and philosophy of science. Similarly, several social scientists 
have applied the boundary objects theory (e.g. Featherstone et al., 2006; Williams et al., 
2008; Fox, 2011). Williams et al. (2008) used boundary objects to understand the social 
construction of human embryos. They analysed the ways in which embryos have similar and 
different meanings in the related social worlds of embryonic stem cells (ESC) and pre-
implantation genetic diagnosis (PGD) labs. Williams et al. argued that embryos function as 
boundary objects, which help to maintain the differences in goals and practices in the two 
worlds of PGD and ESC work. They also argued that embryos function as translational 
boundary objects that unite different actors in a common purpose. They discussed how 
creating human ESC lines began to bring both worlds into alignment, so that both PGD and 
ESC scientists can talk about the potential therapeutic value of spare PGD embryos. 
Fox (2011) studied the analysis of the innovation of both the antiseptic and aseptic 
surgical techniques with the intention of explaining both resistance and support of new 
technologies. Fox suggested that technological objects (in his case, a spray, a gown, a mask 
and so on) can function as boundary objects in relation to knowledge transfer between two 
communities (in his case, nascent microbiologists and the surgical profession). This function, 
he suggested, may be either facilitative or inhibitory, while the mode of function depends 
on the meanings that these objects encapsulate for key actors. So, ‘technological devices or 
processes may themselves act as facilitative or inhibitory boundary objects during 
innovation’ (Fox, 2011: 70). In his case, the technologies of asepsis were adopted by the 
surgical profession; hence, the technological objects became facilitative boundary objects 
for adopting surgical sterility, while the antiseptic technologies were not accepted by the 
profession. Therefore, the technological objects were considered inhibitory boundary 




facilitative or inhibitory boundary objects, depending on the meanings attached to 
electronic cigarettes by different actors. 
Similarly, in her study on the cholesterol controversy, Garrety (1997) considered the 
bundle of knowledge claims that linked cholesterol to heart diseases. Garrety explained how 
boundary objects are used to explain the role of people in ‘allocating meanings to 
ambiguous scientific objects and ‘facts’’ (Garrety, 1997: 755). She also illustrated the role of 
actors in several social worlds, including the ‘lay world’ in the discourse of dietary change, 
despite the lack of scientific-based evidence (p: 757). She stated that, for scientific 
controversies to emerge, ‘different social worlds attempt to draw and redraw boundaries 
between science and non-science’ (Garrety, 1997: 731). Garrety applied the social worlds 
theory as a framework to investigate the controversy and explain how a scientific outcome 
emerged from a struggle between groups with competing interpretations. 
Accordingly, in the case of electronic cigarettes, it is due to the disagreement and 
different social meanings allocated to electronic cigarettes that the boundary objects have 
formed. More specifically, it is the controversy among scientists, public health personnel, 
the public, electronic cigarette users and politicians that present a problem for those trying 
to agree a definition and a category for electronic cigarettes. Therefore, while specific 
scientific terms, e.g. harm reduction, are used, the consequences of their use, and the lack 
of consensus over their meaning, result in the production of electronic cigarettes as 
boundary objects. This thesis illustrates that consensus over electronic cigarettes is not 
necessary for cooperation, as the flexibility of the electronic cigarettes as boundary objects 
allows for divergent interpretations. 
3.5. Discussion 
In this thesis, I propose the boundary objects theory as an approach for understanding the 
social construction of electronic cigarettes. This concept provides a useful framework for 
analysing the interrelated social worlds of electronic cigarette users and stop smoking 
advisors, or the interrelated social worlds of those who represent ‘bad’ nicotine and ‘good’ 
nicotine use, as discussed in (1.4.2). In this thesis, I describe some of the ways in which 
electronic cigarettes act as boundary objects that can help differentiate the worlds of the 




and yet act as a bridge between these different worlds. This, then, reflects Star’s description 
of boundary objects as objects that work to establish a shared context that ‘sits in the 
middle’ (Star, 1989: 47). 
I view electronic cigarettes in the same way as I do any other technological innovation, 
namely as a ‘novel piece of reality’ that comes with both ‘intended and unintended 
consequences for society’ (Bauer and Gaskell, 2002: 383). Electronic cigarettes bring with 
them opportunities and threats and have the ability to structure behaviour, both in 
individuals and groups (Bauer and Gaskell, 2002). Electronic cigarettes as boundary objects 
function as an active vehicle that will enable communication between communities of 
practice or knowledge. They also encapsulate the broader social meaning of harm 
reduction, nicotine addiction, contemporary public health and the underlying social 
relations that surround their development and adoption (Fox, 2011: 82). 
I apply biomedicalization to explore the effect of the processes of biomedicalization 
on the formation of different perceptions of electronic cigarettes, thus forming electronic 
cigarettes as boundary objects. At the same time, I explore the influence of these 
perceptions on the construction, resistance or dominance of biomedicalization processes. 
My choice for this framework is informed by my engagement with the social sciences 
literature and my empirical data. This combination of concepts, I believe, enables me, as a 
social sciences researcher, to add a novel contribution to the literature through illustrating 
how both concepts can be linked to each other, through empirical research, to enhance a 
deeper understanding of an important emerging phenomenon. 
3.6. How Did the Theoretical Framework Inform the Formation of the 
Research Questions? 
Biomedicalization appears to capture the advancement of electronic cigarettes to date. 
Biomedicalization enables me to explore the effect of the processes of biomedicalization on 
the formation of different perceptions of electronic cigarettes and, ultimately, the formation 
of electronic cigarettes as boundary objects. Recognising the significance of electronic 
cigarette meanings is ‘an acknowledgement of the social and power relations’ that 
electronic cigarettes, as technological objects, mediate (Fox, 2011: 82). This context was the 




 What factors have shaped these perceptions of electronic cigarettes? 
The remaining questions are formed to help investigate the divergent perceptions in my 
data sources. They are: 
 How are electronic cigarettes perceived by electronic cigarette users and 
stop smoking advisors? 
 What are the perceived risks associated with electronic cigarettes, as 
discussed by electronic cigarette users and stop smoking advisors? 
It is worth noting that the last question, which elaborates on the perceived risks of 
electronic cigarettes, was formed based on my engagement with the literature and the 
media coverage of electronic cigarettes. It was apparent that risk is at the core of the 
circulating debate. Obviously, the different risk perceptions of electronic cigarettes, by 
different actors, influence the formation of electronic cigarettes as boundary objects. 
Hence, exploring the different perceptions of risk is an important sociological component for 
this thesis; therefore, I examine risk perceptions and link them to the theoretical concepts 
(boundary objects and biomedicalization). I also link them to the sociological literature of 
risk, which I discussed in the literature review. Answering the research questions enables 
me to elucidate the position that electronic cigarettes take in different social worlds, and 
helps clarify the reasons and contextual factors for either adopting, advocating, resisting or 
opposing electronic cigarette use, or taking a stance in the middle. 
3.7. Summary 
This chapter sets out the theoretical framework upon which the research questions are 
formed and on which this study is based. I draw upon two key sociological concepts, namely 
biomedicalization and boundary objects theory. I propose the boundary objects theory as an 
approach for understanding the social construction of electronic cigarettes in the social 
worlds of two different data sources (stop smoking advisors and electronic cigarette users). I 
argue that biomedicalization processes influence the social construction of electronic 
cigarettes’ meanings and the formation of electronic cigarettes as boundary objects. At the 




cooperation between divergent social meanings. The following chapter presents the 




Chapter 4: Research Methodology 
4.1. Introduction 
This chapter discusses the broader epistemological, ontological, ethical and methodological 
considerations that shaped my research strategy and execution. It explains the research 
methodology and data collection methods that were used to collect and analyse the data in 
order to investigate the research questions. I adopted the philosophical paradigm of 
interpretivism. This qualitative, interpretive methodology enabled me to examine the 
different perceptions of electronic cigarettes amongst a group of electronic cigarette users 
and a group of stop smoking advisors. A thematic analysis approach (Braun and Clarke, 
2006) was employed to analyse my data and identify the major thematic patterns through 
which the two data sources portrayed electronic cigarettes. This project has been shaped by 
a range of influences, most notably the process of gaining access to NHS clients at the stop 
smoking clinics, as well as the low participation rates. This led to a series of amendments 
that were made in order to find alternative ways of recruiting more participants for this 
study. Thus, this chapter also describes how these various factors have shaped the design of 
this project. 
The chapter is structured in the following ways. It provides a summary of research 
sites and the process of gaining access; it presents the debates over the choice of research 
methodology; it provides a summary of the research design and discusses the methods used 
in collecting and analysing the data. It concludes by discussing the ethical considerations, 





4.2. The Research Sites and Gaining Access 
In this thesis, I have been studying real-world events and have come to realise that ‘they 
assume their own natural course and may alternatively present unanticipated resistances 
and challenges’ (Yin, 2011: 30). I explain the main challenges I faced throughout this 
research and how I attempted to overcome them. It is important to shed light on these 
issues because they have affected the design and progress of this study. 
Background: 
My first proposal was to study the use of electronic cigarettes in the NHS Stop Smoking 
Service by interviewing electronic cigarette users and stop smoking advisors at the Stop 
Smoking Service in Hertfordshire. The NHS Stop Smoking Service in this county is currently 
managed by Hertfordshire Directorate of Public Health. They run several stop smoking 
clinics, mostly at General Practitioner (GP) practices. This research used some of these 
clinics to identify potential participants. The reasons for choosing this particular area of 
England were, firstly, that Hertfordshire Stop Smoking Service is part of the NHS Stop 
Smoking Services within England and has an established smoking cessation service that 
could be accessed for research purposes. Secondly, I was able to gain the interest and 
support of the Stop Smoking Service team and the Director of Public Health through 
personal correspondence. Thirdly, NHS Stop Smoking Services across England implement the 
Department of Health policies and provide a comparable service. Hence, conducting this 
project in Hertfordshire would provide information which may represent other similar areas 
in England. 
The Process: 
To begin this research, I gained the following approvals: 
 The approval of the Health and Community Services Research Government 
Committee, Hertfordshire Council. 
 The approval of Hertfordshire Directorate of Public Health. 




 The ethical approval of the Social Care Research Ethics Committee (REC)-National 
Research Ethics Service (NRES). This committee can approve ‘qualitative studies in 
NHS settings with service users which do not include changing the course of 
treatment.’ 
 Research Passport to be able to interview participants from the NHS. 
I was also required to obtain the approval from the NHS body that runs the GP practices 
where the Stop Smoking Service used to provide their service. This NHS body used to be the 
local Primary Care Trust (PCT) until April 2013, when PCTs ceased to exist. This led to 
confusion about which NHS body could permit access to GP practices. The regional 
Comprehensive Local Research Networks (CLRN) provided me with the new ‘agenda’ that 
was introduced in June 2013 for conducting research at GP practices. This stated that GP 
practices had become independent contractors and I would, therefore, need to approach 
each GP practice individually to ask for permission to commence the research. I approached 
all the listed GP practices that I had obtained from Hertfordshire Stop Smoking Service. 
Three practices provided me with letters of approval, three approved by email, two declined 
from participating without disclosing their reasons, and six did not respond to my several 
emails and phone calls. 
The approvals were gained in January 2014. The stop smoking advisors’ invitation 
letters and information sheets were sent to all the stop smoking advisors in Hertfordshire 
Stop Smoking Service to ask them to participate in the study. The protocol of the research 
also indicated that the stop smoking advisors would identify electronic cigarette users in 
their service, inform them about my study and provide them with the electronic cigarette 
user’s invitation letter, which contained my contact details. The first interview took place in 
April 2014. Due to a lack of electronic cigarette users’ participation, even after 
corresponding with the tobacco control manager and sending several reminders to the stop 
smoking advisors over a few months, I decided to amend my proposal. Therefore, my 
proposal was amended and approved as follows: 
 Approach stop smoking advisors outside the clinics, such as pharmacies. 
 Distribute a leaflet about my study in the local area, in places like surgeries, 




 Advertise for electronic cigarette users on social media. 
I advertised the research on Facebook, as well as on some electronic cigarette 
websites, Twitter and a local website for Hertfordshire residents. Later, I met a professor at 
a conference and he offered to help me in getting access to another Stop Smoking Service. 
He put me in touch with the Director of Public Health in East Sussex (Quit 51). The service in 
East Sussex had a prior consent from their service users to be contacted on their mobile 
phones for purposes that might include research. So, after gaining a new ethical approval 
from the School of Social Sciences, Sociology and Communications ethics office, I contacted 
the stop smoking advisors at the service to ask for their voluntary participation. The service 
sent a text message to all electronic cigarette users who were registered on the service with 
details about my research. I also enrolled electronic cigarette users who participate in a 
prize draw of £50 and proposed to conduct the interview over the phone to facilitate 
participation. At the same time, I tried to extend my access to Hertfordshire GP practices, as 
the expiry for access was coming to an end. Unfortunately, due to more organisational 
changes, I was directed from one person to another with promises to investigate and get in 
touch, but no one did. Meanwhile, in East Sussex, the Stop Smoking Service’s text messages 
were sent three times over three months. Leaflets were also distributed at different stop 
smoking clinics in East Sussex. In my last amendment, the departmental ethical officer 
approved the advertising of my research on Brunel University’s website. The last interview 
was conducted in July 2015. Despite my intensive efforts at recruiting participants for my 
study, in the end, the total number of electronic cigarette users was 15 and the number of 
stop smoking advisors was 13. The numbers were close to the proposed numbers in the first 
proposal, which was to interview between 15 and 20 electronic cigarette users and 10 
advisors. 
The design and focus of this project, therefore, is the product of multiple influences. 
The above explanation of the challenges I faced in recruiting participants has shaped the 
progress of the study. As a result, the thesis shifted from focusing on electronic cigarette 
use at the Stop Smoking Service in Hertfordshire to focusing on the phenomenon of 
electronic cigarettes among different individuals from different counties and backgrounds. 




invitation letters and information sheets. Appendix 3 presents the consent forms. Appendix 
4 presents the draft interview guide. 
Before I discuss the data collection methods and process, I will discuss the rationale 
for my choice of research methodology. 
4.3. The Choice of the Research Methodology 
4.3.1. Qualitative Research: Interpretivism 
Social research is considered an important source of knowledge that can influence policy 
(Chowdhury, 2014). My choice of qualitative methodology was based on theoretical and 
practical considerations. First, there is very little qualitative research on the use of electronic 
cigarettes. Second, this methodology fits with my aim to understand the perspectives of 
people participating in the study (Bryman, 1988: 60-63) and the meanings and beliefs that 
underlie their behaviour. Qualitative research: 
involves an interpretive, naturalistic approach to the world. This means that qualitative 
researcher study things in their natural settings, attempting to make sense of, or 
interpret, phenomena in terms of the meaning people bring to them. (Denzin and Lincoln, 
2011: 3) 
Hence, my drive to use qualitative research stems from my desire ‘to capture the meaning 
of real-world events’ from the perception of my participants (Yin, 2011: 11). 
The interpretivism paradigm fits well with the research questions of this thesis, as I 
clarify next. Interpretivism emerged in the nineteenth century from the German philosopher 
and historian, Wilhelm Dilthey (1833-1911). Dilthey distinguished between the natural 
sciences (Naturwissenschaften) and the human sciences (Geisteswissenschaften). He argued 
that, while the natural sciences aimed at developing causal explanations (Erklärung) from 
the outside, human sciences aimed at ‘understanding meaning (Verstehen) from the agent's 
or actor's point of view by grasping the subjective consciousness of action from the inside’ 
(Schwandt, 2007: 315). Interpretivism was elaborated, heavily influenced and applied in 
sociology by Max Weber (1864-1920); it gained stronger ground over time as more 
researchers opened to interpretive-based research methods (Hughes, 2012; Chowdhury, 




where the purpose or meaning of human action is immediately observed, and ‘explanatory 
understanding’, where actions are placed in context of meaning in order to grasp the 
motivation for human behaviour. Weber argued that: ‘human action is both open to and 
requires interpretation in terms of the subjective meaning that actors attach to that action’ 
(Schwandt, 2007: 316). In contrast to the positivist approach, whose main focus is to explain 
human behaviours and the external forces that influence human actions, the primary 
objective of the interpretivist approach is to understand human behaviours and grasp the 
subjective meaning of social actions, including an individual’s motivation, values, intentions 
and free will (Corbetta, 2003: 24; Bryman, 2012: 29-30). However, interpretivism aims at 
capturing the diverse individual perspectives and interpretations of a particular social 
phenomenon. 
By capturing these, interpretivists argue that we can enrich our knowledge and 
understanding of a phenomenon, and make sense of how knowledge is produced and 
negotiated between and amongst individuals. (Hughes, 2012: 17) 
Interpretivists believe that people ‘participate in indeterminate life-worlds, often attaching 
different interpretations and meanings to seemingly similar facts and events, thus 
presenting multiple versions of realities’ (King and Harrocks, 2010: 11). The interpretive 
approach, however, has been criticised for its ‘narrowly micro-sociological persuasion’ 
(Cohen, Manion and Morrison, 2000: 27). Therefore, interpretivism, it has been argued, fails 
to recognise the power of external (structural) forces in shaping the behaviour and events of 
participants’ lives. This thesis attempted to address the wider political and cultural context 
that may have influenced the perceptions and discourse of electronic cigarettes. 
In order to study and understand the phenomenon of electronic cigarettes, I used 
thematic analysis as a methodological approach. I applied thematic analysis of interviews 
with electronic cigarette users and stop smoking advisors groups, to illuminate the process 
of electronic cigarettes’ social construction. I expand on this method next. 
4.3.2. The Method of Analysis: Thematic Analysis 
Thematic analysis is considered one of the most commonly used methods to conduct 
qualitative data analysis. Bryman stated that thematic analysis can be, and has been, 




systematic review of qualitative research, grounded theory, critical discourse analysis, 
qualitative content analysis and narrative analysis (Bryman, 2012: 581). However, thematic 
analysis has not always been distinguished or identified as a particular method; it is often 
poorly described, with no clear criteria for identifying themes, and is even ignored as a 
method by many researchers (Bryman and Burgess, 1994: 224; Vaismoradi, Hannele and 
Bondas, 2013). Ryan and Bernard (2003: 87) suggested that anthropologist Morris Opler 
established principles of thematic analysis to analyse cultures in 1945. Opler used the terms 
‘theme’ and ‘expression’ and linked themes to expressions. Later, according to Ryan and 
Bernard, different social researchers applied Opler’s thematic analysis using different 
terminologies to link themes with expressions. Ryan and Bernard (2003: 87) provided 
examples such as the ground theorist, linking expressions to themes using the term 
‘categories’ (Glaser and Strauss, 1967), ‘codes’ (Miles and Huberman, 1994), or ‘labels’ (Dey, 
1993: 96). In recent years, more distinctive techniques were proposed to assist a thematic 
analysis of qualitative data. For example, the National Centre for Social Research in the UK 
developed a framework, which was described as a ‘matrix based method for ordering and 
synthesising data’ (Ritchie, Spencer and O'Connor, 2003: 219). Also, Bryman noted that 
thematic analysis has developed due to the work of some scholars like Ryan and Bernard 
(2003), and Braun and Clarke (2006) (Bryman, 2012: 580). 
Nevertheless, thematic analysis is sometimes criticised for being an undeveloped 
method that lacks its own special techniques and identifiable history (Bryman, 2012). Some 
scholars believe that there is a blurred boundary between different qualitative approaches, 
such as content analysis and thematic analysis. It is suggested that researchers need to 
identify the distinctive elements of different approaches to qualitative research in order to 
avoid overlap in terms of procedures and techniques (Holloway and Todres, 2003; 
Sandelowski, 2010; Vaismoradi, Hannele and Bondas, 2013). Hence, Braun and Clarke (2006) 
proposed their method of thematic analysis to fill such gap and advocated it as a useful and 
flexible method for qualitative research. 
In this thesis, I apply the data-driven inductive approach of thematic analysis, as 




a method for identifying, analysing and reporting patterns (themes) within data. It 
minimally organizes and describes your data set in (rich) detail. (Braun and Clarke, 2006: 
79) 
Thematic analysis involves searching through data to identify recurrent issues, whereby 
themes emerge inductively from the collected data. Thematic analysis: 
…provides a way of linking diverse experiences or ideas together, and of 
juxtaposing and interrelating different examples and features of the data. The 
themes do re-present and re-contextualise the data to which they relate, but 
this can be of value in creating new readings and renderings of the data. 
(Gibson and Brown, 2009: 129) 
It has been argued that an important characteristic of thematic analysis is its flexibility 
(Braun and Clarke, 2006; Bryman, 2012). While some qualitative analytic methods are linked 
to a particular theoretical or epistemological position, such as grounded theory and 
discourse analysis, thematic analysis ‘can be applied across a range of theoretical and 
epistemological approaches’ (Braun and Clarke, 2006: 78). Thematic analysis has been 
usefully applied in sociology (e.g. Crawford and Brown, 2008; McPherson and Armstrong, 
2009; Newman et al., 2010; Ergler, Kearns and Witten, 2013). The thematic analysis 
technique seemed appropriate for my analysis because of the nature of the qualitative data. 
It allows for the identification, analysis, reporting and interpretation of patterns (themes) 
within data, and deconstructing accounts in an ongoing and systematic way (Bauer and 
Gaskell, 2000). This research is not aimed at generating theory; hence, I found this approach 
to be more suitable than other approaches, such as grounded theory. I found thematic 
analysis useful, especially when commonalities and differences became apparent among the 
emerged themes from my data. I attempt to use the latent or interpretative level for 
thematic analysis, rather than the semantic or explicit level (Boyatzis, 1998). The latent level 
goes beyond the content of the data ‘to identify or examine the underlying ideas, 
assumptions, and conceptualisations – and ideologies – that are theorised as shaping or 
informing the semantic content of the data’ (Braun and Clarke, 2006: 84). 
For grounded theory, it is commonly suggested that researchers should not conduct a 




and not prior to the beginning of the research (Corbin and Strauss, 2014). This is because it 
is suggested that early reading can narrow the analytic vision, leading to an unbalanced 
focus on all the aspects of the data. For the thematic analysis approach, it has been 
suggested that there is no right way, so researchers can engage with literature earlier, 
rather than collecting the data first (Braun and Clarke, 2006). I decided to conduct the 
literature review before the data collection. Silverman stated, without a prior conceptual 
orientation, ‘one would not recognize the “field” one was trying to study’ (Silverman, 2001: 
72). Hence, my early engagement with the literature, I believe, provided me with a strong 
starting point in researching the electronic cigarette phenomenon, and enabled me to link 
the emerging themes with the wider literature. 
Boyatzis (1998: vii) defined a theme as: ‘a pattern in the information that at minimum 
describes and organises the possible observations and at maximum interprets aspects of the 
phenomenon.’ In this thesis, I aimed at providing a rich thematic description of my entire 
data, allowing for themes to emerge. Consequently, the emerging themes became the 
categories for analysis (Daly, Kellehear and Gliksman, 1997; Fereday and Muir-Cochrane, 
2006). Before describing the steps of the thematic analysis and the coding process I used, I 
will explain the research design and data collection process. 
4.3.3. Research design: A qualitative study  
The research design is a qualitative study. Based on my understanding that interpretations 
are viewed as ‘a bridge between representations of particular phenomena and the actual 
world’ (King and Harrocks, 2010: 12), I realised that respondents’ perceptions are the 
outcome of their individual mix of knowledge, beliefs and experiences; hence, I understand 
that they produce different versions of reality. In order to capture the elements that my 
participants perceived as contributing factors to electronic cigarette use, and to understand 
the phenomenon of electronic cigarette, my role as a researcher, by applying qualitative, 
interpretive methods, was to explore the broader context within which electronic cigarette 
use took place (Ritchie and Lewis, 2003: 54). I used qualitative interviews (both face to face 
and phone interviews) to enable people in this study to share their understandings and 
experiences from their point of view. In my data analysis, I used inductive thematic analysis, 
as it was my intention to identify commonalities and differences between the various data 





Interviews were an appropriate method of data collection because they elucidated the 
subjective perceptions of participants and the interpretations of electronic cigarettes. 
Although it was suggested that telephone interviews tend to be shorter than face to face 
interviews (Bryman, 2012: 215), my face to face and phone interviews in both groups were 
between 40 to 60 minutes. Bryman pointed at the notion that telephone interviews do not 
provide good data compared to face to face interviews when asking sensitive questions and 
health issues; he, however, confirmed that this is not evidenced. Although some researchers 
argued that the lack of visual connections when conducting phone interviews affects the 
establishment of a rapport between interviewer and participant (Irvine, Drew and 
Sainsbury, 2013), I believe that my phone interviews may have provided more freedom to 
participants to elaborate on their opinions without being influenced by my (the researcher) 
characteristics, such as ethnicity, thus removing this source of bias (Bryman, 2012: 214). 
Phone interviews, also, may have added anonymity to the participants and saved time and 
cost of travel (Bryman, 2012; Sherratt et al., 2015a). 
Here, I adopt the constructionism view, where interviewers and interviewees are 
actively engaging in constructing meaning (Silverman, 2006: 118). Holstein and Gubrium 
(2010: 150) view all kind of interviews as active, animated interviews. Hence, interviews are 
an outcome of an ‘interactional accomplishment rather than neutral communicative 
grounds’. This, they believe, highlights ‘the inherent interpretive activity of the process’. 
Evidently, interviews do not provide a transparent and actual view of reality. Interviews 
introduce the perceptions and opinions of participants about a particular phenomenon; this 
means that the same reality (phenomenon) can produce several realities (perceptions) by 
different individuals. Therefore, interviews as dynamic, meaning-making events imply the 
need to focus on the circumstances of constructing the meanings and responses. The 
constructionism interviewing approach has been criticised for its narrowness and 
inconsistency (Silverman, 2006). Nevertheless, it is argued that this approach produces 
interview talk that is ‘a reflection of the social encounter between the interviewer and the 
interviewee, and reflexively situated in the wider cultural arena’ (Rapley, 2004: 16). 
In my analysis, I attempted to illustrate how perceptions of electronic cigarettes 




were formed over the individual history of my participants. I understood that the interviews 
are active processes, collaboratively produced where both the participants (interviewee) 
and I (the researcher/interviewer) contribute to the production of the interview data 
(Silverman, 2006). This meant that, during the interviews, I attempted to prompt 
participants into articulating their perspectives on various aspects of using electronic 
cigarettes, thus enabling me to address my research questions. I also acknowledge that the 
jointly produced interview data are situated within the wider cultural arena and broader 
social norms (Silverman, 2006). Hence, I attempted to focus on how the accounts of my 
participants emerged and how they were shaped by the broader social context. For 
example, I asked electronic cigarette users about their smoking history and the reasons for 
using electronic cigarettes. I asked about people’s acceptability of electronic cigarette use 
and about their views on the social, political and institutional stance on electronic 
cigarettes. I explored the role of the media. I contrasted between the interviewees’ 
accounts to add more depth to the analysis. Next, I explain the data collection process. 
4.4. Data Collection 
A convenience sampling approach was used; therefore, I continued to collect data until I 
believed that no new themes would emerge from the interview data (Guest et al. 2006). 
Appendix 5 illustrates the number of interviews that were included in the analysis. 
Participants 
Thirteen stop smoking advisors responded to the invitation letters. From Hertfordshire, I 
conducted seven face to face interviews; five were females and two males. From East 
Sussex, I conducted six phone interviews; four were females and two males. The number of 
years of experience in working at the Stop Smoking Service were between seven months to 
fifteen years. Fifteen interviews were conducted with electronic cigarette users; five were 
using the Stop Smoking Service. In Hertfordshire, I conducted one face to face interview 
with a service user and seven face to face interviews with non-service users. In East Sussex, I 
conducted in total four phone interviews with electronic cigarette users who were using the 
Stop Smoking Service at the time of the study. From other areas in South East England, I 




who were all non-service users. Table 1 summarises the electronic cigarette users’ profile. 
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8H Male  51 Surgeon NO 22 No 4 
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12L Male  38 Lecturer NO 18 Yes 2 years Yes 
13M Male  58 Retired NO 15 No 9 
months 
NO 
14N Male  56 Artist/musici
an 
Yes 16 No 2 years Yes  
15O Femal
e 
60 Para legal in 
family work 





















The Process of Interviews 
Based on my literature review, I designed draft semi-structured questions. My prior reading 
and familiarity with the topic matter allowed me to engage with my participants and prompt 
them into articulating their perspectives on various aspects of the electronic cigarette 
phenomenon. Early interviews took place face to face, at a location and time convenient for 
both the participant and me. After later amendments and for the new research sites, I 
conducted 12 interviews over the phone at a pre-arranged time with the participants. All 
participants gave their consent to the audio-recording of the interviews. To ensure 
confidentiality, participants were given an ID and then the interviews were transcribed 
directly by the researcher and a professional transcriber, who was given some interviews 





Gender  Years of 
experience 
H1 Female 10 years 
H2 Female 1 year  
H3 Male 7 months 
H4 Female 4 years 
H5 Female 1 year 
H6 Female 15 years 
H7 Male 5 years 
S1 Male 3 years  
S2 Male 7 years 
S3 Female 3.5 years 
S4 Female 1 year 
S5 Female 16 months 




interviews with electronic cigarette users, no new information was collected and, therefore, 
I tentatively concluded that saturation had been reached. Since this study was interpretative 
from the outset, the questions were developed and amended throughout the study. For 
example, as a result of the themes that emerged from some interviews, and the new studies 
and media stories that came out during the period of doing this study, I expanded on the 
notions of stigma, willpower and social risk. In general, the interview topic guide and 
questions addressed the thesis questions. The draft interview, with the key questions that 
formed the framework for the semi-structured interviews, can be seen in Appendix 4. 
4.4.1. Semi-Structured Interviews with Stop Smoking Advisors 
All stop smoking advisors in both Stop Smoking Services were invited to take part in the 
research by invitation letter that was sent to them via their managers. All the advisors were 
interviewed once. I gave a different ID to the advisors according to their county. Appendix 6 
presents a full list of interviews with the advisors. The advisors from Hertfordshire were 
interviewed face to face. The advisors from East Sussex were interviewed over the phone. 
One pharmacist in Hertfordshire was interviewed face to face. Interviews lasted between 40 
and 60 minutes. 
Each interview was a joint account of the advisors’ perceptions and my interaction 
with them; therefore, the specific interview questions differed for each participant. In 
general, however, the interview topic guide that I prepared addressed the listed issues 
below (the actual draft interview is appended): 
 The specific role and work of the advisor 
 The training and experience required/attained to deliver the work 
 The process of dealing with clients who attend the Stop Smoking Service 
 The challenges of dealing with electronic cigarette users 
 The perception of risk and/or benefit from electronic cigarette use 
 Views on addiction, smoking and electronic cigarettes 




 Views on harm reduction 
 Institutional/professional/political climate influence. 
4.4.2. Semi-Structured Interviews with Electronic Cigarette Users 
A full list of interviews conducted is presented in Appendix 7. I gave each case an ID for 
anonymity. Each interview was a joint account of the electronic cigarette user’s perceptions 
and my interaction with them; therefore, the specific interview questions differed for each 
participant. In general, however, the interview topic guide that I prepared addressed the 
following issues: 
For service users: 
 The decision to use electronic cigarettes 
 The perception of risk and/or benefit from electronic cigarette use 
 Views on addiction, smoking and electronic cigarettes 
 Views on the role of digital information 
 Views on harm reduction 
 The challenges of using electronic cigarettes within the Stop Smoking Service 
 The reasons for using the Stop Smoking Service 
 Smoking history 
 Institutional/professional/political climate influence. 
For non-service users, I omitted the questions that were linked to using the service. Instead, 
respondents were asked the reason for not using the Stop Smoking Service. 
All the data was then analysed using Braun and Clarke's six stages for thematic analysis, as 
described later. 
4.5. Data Analysis 
By means of the analysis, the thesis aims to cast light on how the development of electronic 




collection, all the interview transcripts were entered into the QSR NVivo10 data 
management program. I read each transcript thoroughly while listening to the audio to 
correct mistakes if necessary, with a focus on the research question being explored. Then, I 
started a comprehensive process of coding the data and identifying themes by creating a 
thematic coding framework on NVivo. I will describe a step-by-step process of the analysis in 
the next section. It is worth noting that the research analysis was an iterative and reflexive 
procedure. I undertook the data collection and the analysis concurrently. I continuously 
reflected on the previous stages of the process before undertaking further analysis to 
ensure that the identified themes were grounded in the original data. 
Stages of Data Coding 
Codes refer to ‘the most basic segment, or element, of the raw data or information that can 
be assessed in a meaningful way regarding the phenomenon’ (Boyatzis, 1998: 63). Empirical 
codes follow the inductive process that provides codes to the collected data (Gibson and 
Brown, 2009: 132-133; Harding, 2013). It has been argued that: ‘the gold standard of 
qualitative research is the detailed analysis and presentation of rich in-depth information via 
emerging rather than imposed themes’ (Grbich, 2013: 19). Therefore, I used a data-driven 
inductive approach to identify the emerging themes direct from the data by looking for a 
‘good code’ (Boyatzis, 1998: 1); I then developed codes in a bottom-up manner to capture 
the main features of data representations of the phenomenon of electronic cigarettes. 
Codes reflected both the manifest content of the data (e.g. the perception that electronic 
cigarettes are safer than cigarettes) and meanings present at a more latent level (e.g. 
personal responsibility). I used the following six phases of analysis framework, as proposed 
by Braun and Clarke (2006): 
1. I familiarised myself with the data sources (interview transcripts) by reading and re-
reading them. I listened repeatedly to the interviews while reading their transcripts. I listed 
the ideas from the data and what was interesting about them. 
2. I generated initial codes. Encoding the text enabled me to organise the data in order to 
identify and develop themes (Fereday and Muir-Cochrane, 2006: 4). I generated a coding 
frame that would enable me to answer the research questions in a balanced way (Joffe, 




by matching the codes with sections of data selected as representative of the code. It was 
essential to test the reliability of the code framework for analysis to determine the 
applicability of the code to the raw information (Boyatzis, 1998). Hence, following the 
coding process, I invited my supervisors to code four interviews. The results were compared 
and more inductive codes were suggested. 
3. Identifying initial themes. First, I identified a long list of codes. Then, I started sorting the 
different codes into potential themes, and collating similar coded data extracts into the 
identified themes (Crabtree and Miller, 1999; Braun and Clarke, 2006: 89). Sub-codes 
emerged from the data using the particular meanings and language of the participants. I 
sorted the segments of text across all my data. I connected the codes and identified themes 
across my data, clustered under headings that directly related to the research questions. 
Similarities and differences between separate groups of data were emerging at this stage, 
indicating areas of consensus and areas of potential conflict. Themes within each data group 





















   
 
 
Figure 1: The initial thematic map 
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Phase 4 I reviewed and organised the themes; I re-read the coded text; I refined some 
coding and identified potential new themes. I then started coding for these as well, until I 
was satisfied that the thematic map I devised fitted the data. 
Phase 5 (Major themes): I clustered, defined, named and described the themes that were 
previously identified from the coded text. Here, I determined what aspect of the data each 
theme captured and identified what was interesting about them and why. An explanation of 
the themes and the subthemes will be presented, explained and evidenced by the collected 
data in the data chapters. By the end of this phase, major themes were defined. Appendix 9 
provides an illustration of the phases and some of the resulted themes. 
Phase 6: The interpretation process was achieved after several iterations for the text, codes, 
and themes, in order to be able to establish an explanatory framework that elucidated the 
different meanings of electronic cigarettes across the two data sources. In this final phase of 
the analysis process, the themes were linked to the research questions and theoretical 
framework. 
4.6. Ethical Considerations 
In any given qualitative research, ethical considerations should be inherent in the research 
design and have to be applied at every stage of the research. Here, I address the ethical 
issues I considered in this research. My position was to conduct ethical research which 
avoids unnecessary intrusion and uses methods that are participatory, non‐invasive and 
non‐confrontational (Morrow and Richards, 1996: 100). Murphy and Dingwall suggest that 
ethical research practice: 
.. depends on the conscientious and reflective commitment of individual researchers and 
research teams to identifying and minimizing potential harm to participants, to 
negotiating fully informed consent at the outset and throughout the research process, and 
to treating all those under study with disinterested even-handedness. (2003: 167) 
Hence, Murphy and Dingwall (2003) advised that informed consent must be open ended, 
relational and built on trust. Miller and Boulton also suggested that consent ‘includes 




and demonstrating that this has been done in a systematic and auditable manner’ (2007: 
2208). 
I considered the ethical issues before the start of the study. Data collection did not 
begin until I had an approved proposal to justify conducting my research and show the 
likelihood to produce useful knowledge. In the interview guide, questions addressed the 
history and experience of smoking. I was aware that participants might share negative 
aspects of their experiences and could have chosen not to ask these questions if I had found 
them inappropriate in the context. I conducted the interviews at a time and a place that was 
convenient to my participants. After amending my ethical approval, I offered my 
participants the choice of face to face or phone interviews and I followed their preferred 
choice. I tried to ensure I remained sensitive to my participants, that the atmosphere of the 
interview was relaxed and friendly, and that my questions did not cause any distress to my 
participants. I am aware that with telephone interviews it is more difficult to tell if people 
were feeling uncomfortable because I could not see them, so I tried to ensure the 
interviewees were not disturbed by my questions by emphasising they could refuse to 
answer any question. Throughout the analytic process, I have attempted to consider how 
the findings will be used and how participants in the setting will react.  
Although I took into account all the expert guidance on ethical research, I realised I 
could not always ensure that everything was done correctly and I was sensitive to the fact 
that things could go wrong. To ensure privacy, confidentiality and anonymity, I provided my 
participants with invitation letters and information sheets. I was aware that some 
participants might not read the information sheets fully and carefully, or might not 
understand some of the language used. Therefore, I explained verbally the aim and protocol 
of the research, aiming at informed participation. I also explained the procedures the 
University has in place to store the data and keep the information guarded. The participants 
were approached without any pressure and asked to partake in the study voluntarily. I am 
aware that some advisors might have felt obliged to take part in my study as a result of the 
encouragement they received from their managers. I am also aware that the electronic 
cigarette users who were clients at the Stop Smoking Service that were invited by their 
advisors to participate, or saw my research leaflets at the clinics, or received a text message 




thought that the Service had something to do with the study, so they might have found it 
more difficult to decline to participate. They might also have thought that their treatment 
could be affected or that what they said would be relayed on to the clinic. Hence, I tried to 
clarify all these issues with my participants and emphasised the importance of their 
voluntary participation. I am also aware that the prize draw might have been the reason for 
some participants to take part in the research. Although I was not keen on introducing 
financial incentives at the beginning of the research to ensure voluntary participation, due 
to lack of participation, I and my supervisors felt it necessary to introduce the prize draw. 
However, to the best of my knowledge, I believe that this incentive has only generated extra 
participants, but did not influence the accounts of participants or the outcome of the 
interview.  
A consent form was obtained from all the participants which made it clear that 
participants could withdraw from the study at any time; they could refuse the recording of 
interviews and they could refuse any question if they felt uncomfortable. In spite of my 
attempts to make my participants feel that they had control of the process, I realise that in 
practice some participants might have found this difficult for a variety of reasons. For 
example, with the recording of interviews, it might have been hard for some participants to 
say that they did not wish to be recorded. My position as a researcher coming through 
official channels to conduct research might have put me in a position of 'power' and hence 
might have influenced the participants’ reactions.  
Participants were given an ID to help keep their data anonymised. Every attempt was 
taken to ensure that the quotes used in the thesis would not identify the participant. I 
agreed with my supervisors to highlight any harmful, illegal, or wrongful behaviour on the 
part of others during the study. I have presented a full picture of the circumstances that 
influenced the study from the onset. I met the requirements to gain all the ethical approvals 
needed to conduct the study and I adhered to their rules and timeframes. I have tried to 
ensure that the study adhered to Brunel University London’s Research Integrity Concordat 
Code which supports research integrity. I have explained and adhered to the analysis 
methods in order to produce authentic and valid results. I also acknowledge that 
consideration of ethical issues is an ongoing process. As far as possible I have tried to ensure 




Pollock (2012: 33) argues that the current bioethical framework of ethical regulation 
was primarily designed to protect study participants from the ‘very real harms’, which could 
result from participating in experimental research. Hence, qualitative research, the author 
argues, ‘does not fit’ within the existing regulatory frameworks which force qualitative 
research to adhere to ‘a bureaucratic system of procedural ethics which is ill suited to the 
nature of the research.’ Indeed, I found the process of completing the IRAS application 
daunting and it made me question the rationale of such complex ethical processes for this 
type of research. As Pollock suggested, it appeared that these ethical regulation processes 
prioritise rigid procedures and formulas over the issues that might happen in the real world 
setting when conducting qualitative research, such as the quality of discussions with 
research participants. Therefore, I share Pollock’s call for a different set of criteria to 
evaluate the qualitative research and to ‘value “empirical ethics” as a means of liberating 
qualitative (and other) research from an outmoded and unduly restrictive research 
governance framework.’ (2012: 25). 
 
4.7. Reflexivity 
The importance of being reflexive is acknowledged within the social sciences and it is widely 
recognised that within data analysis the process of interpretation of data is a reflexive 
exercise through which ‘meanings are made rather than found’ (Mauthner, Parry and 
Backett-Milburn, 1998; Mauthner and Doucet, 2003). It is also acknowledged that in 
qualitative analysis: 
the researcher aims to situate themselves in the participant’s world and to understand 
the subjective (personal) experiences of their research participants. In doing so the 
researcher can turn these subjective experiences into representations that allow 
interpretation and reveal insights that apply more generally beyond those individuals 
studied. (Lambert, Jomeen and McSherry, 2010). 
I came to research driven by a mixture of ambivalence and curiosity about electronic 
cigarettes: what makes a smoker decide to use electronic cigarettes; how they are different 
to other nicotine replacement products and how people deal with the uncertainty of their 
risk. By the time data collection started, I had begun the process of reflection that led me to 




had begun to question the extent to which my ambivalence was attributable to me being a 
non-smoker. Also, had my exposure to different sources of media that present inconsistent 
and contradictory information about electronic cigarettes affected my attitudes? 
Furthermore, was my desire to conceal any personal opinions that may have led me to 
judge my research participants’ views on smoking and addiction having an effect? The only 
way I have found to reconcile these tensions is to acknowledge the socially situated nature 
of my project (Kingdon, 2005).  
Although, as a dentist with a public health background, I was interested in electronic 
cigarette use as a stop smoking aid; as a social sciences researcher, I was attempting to 
explore the varied perspectives of my participants and understand the contextual factors 
that might influence the use, or non-use, of electronic cigarettes. By relating my experiences 
to the social sciences literature I was engaging with, and the fast-paced advances in the field 
of electronic cigarettes, I began to develop a coherent perspective of the different 
perceptions my participants hold for electronic cigarettes. My engagement with the 
literature on electronic cigarettes and sociology enhanced my analysis by alerting me to the 
more subtle features of the data (Tuckett, 2005). Also, my dental and public health 
background equipped me with a good understanding of the medical and social issues 
relating to smoking, addiction and harm reduction. It is possible that my preconceived ideas 
about the potential usefulness of electronic cigarettes as a smoking cessation aid and my 
interest in tobacco harm reduction may have biased my interpretations; however, I 
attempted to limit this influence. For example, during the research process I tried to remain 
aware that the fact I was not a smoker or an electronic cigarette user and my dislike for the 
habit of smoking might influence my interpretation of the electronic cigarette users’ 
accounts. I tried to identify where this appeared to be limiting my understanding of aspects 
of their stories and had ongoing discussions about this with my supervisors. However, I hope 
that my ability to be reflexive and articulate the nature of these limitations was enhanced by 
drawing on the insights of other people I knew who had experienced smoking and/or 
electronic cigarette use. For example, I was aware of stories about quit attempts that failed 
due to smokers finding it difficult to stop their smoking addiction. I also saw successful quit 
attempts using electronic cigarettes and listened carefully to the personal experience of 




influences my beliefs may be having on the themes that I identified and I checked the 
research integrity and issues of trustworthiness, as I will explain next.  
4.8. Research Integrity and Issues of Trustworthiness 
Research integrity is of paramount importance in all kinds of research. Interpretivist studies 
must satisfy the criteria set for trustworthiness. These are credibility (validity), 
transferability (generalisability), dependability and confirmability (Lincoln and Guba, 1985; 
Shenton, 2004). Validity is defined as ‘the extent to which conclusions drawn from research 
provide an accurate description of what happened or a correct explanation of what happens 
and why’ (Jupp, 2006: 311). Validity, it was argued, is complicated in social sciences because 
‘the social world is both constructed by and made of people who see, perceive, and 
interpret things differently’ (Diefenbach, 2009: 883). Transferability can be achieved by 
providing sufficient detail of the context of the study for a reader to be able to decide if the 
findings can be applied to other settings. Dependability, although it was argued is difficult to 
achieve in qualitative research, can be achieved through detailed reporting of the study, 
thus enabling a future researcher to repeat the work. Confirmability can be achieved by 
researchers taking the necessary steps to demonstrate that findings emerge from the data, 
thus avoiding bias (Shenton, 2004: 63, 71). 
Ryan and Bernard (2003: 103) stated that, when using thematic analysis, ‘there is no 
ultimate demonstration of validity’, but researchers can increase clarity and agreement. 
Hence, I recorded my interviews and transcribed them. I used my participants’ own words 
and direct quotes (Patton, 2002). I presented the themes with clarifications for my 
judgement. The themes were continuously revised and iterated to ensure their link to the 
text, codes and research questions. Due to the nature of the doctorate degree, there was a 
limited inter-coder reliability, which refers to the agreement between coders about themes. 
This is because the researcher (me) was mainly responsible for coding and generating 
themes. However, I checked validity by randomly selecting a sample of four transcripts to be 
re-coded by my two PhD supervisors, who confirmed that the transcripts were coded 
consistently and that they included data that supported the key findings of the study.  
To address confirmability, I have used the triangulation approach by corroborating a 




different groups to look for corroborating or conflicting data and to understand whether the 
data pointed to the same direction. This triangulation, according to some scholars, provides 
evidence of the data quality (Shenton, 2004; Williams and Morrow, 2009; Yin, 2011). 
Generalisability, in qualitative research, does not depend on statistical criteria, but on 
the quality of the theoretical interpretations (Mitchel, 1983; Bryman, 2012). Also, it is 
argued that sociological qualitative research mainly aims to contribute to the sociological 
literature, rather than generalisability. Bryman (2012: 406) stated that: ‘the findings from 
qualitative research can be generalised to theory rather than to population.’ The lack of 
generalisability of findings to a wider population of electronic cigarette users and stop 
smoking advisors could be construed as a weakness of the research design. However, the 
research was not designed to fulfil the requirement of generalisability; rather, I was 
interested in garnering individual accounts of electronic cigarette use and providing detailed 
information about the study to allow the reader to establish how similar the findings of 
other cases are and to which the findings might be transferred (Schwandt, 2007). A 
theoretical generalisability can be drawn from the study, as other studies can apply both 
boundary objects and biomedicalization to study other ambiguous objects or ideas. 
4.9. Chapter Summary 
Electronic cigarettes represent a modern technology that has instigated concerns among 
different groups, and therefore it is important to explore the construction of electronic 
cigarettes’ meanings and perceptions. Hence, my aim was to explore the perceptions of 
electronic cigarettes among electronic cigarette users and stop smoking advisors. By 
applying the interpretivist approach, my key emphasis was to understand the participants’ 
behaviours, grasp the subjective meanings they had for electronic cigarettes and capture 
the diverse individual perspectives and interpretations of electronic cigarettes. This thesis 
used the methodological approach of thematic analysis, as described by Braun and Clarke 
(2006). It did not seek to focus on motivations or individual psychologies, but instead aimed 
at theorising the sociocultural contexts and structural conditions that influence meaning and 
experience identified in the study (Braun and Clarke, 2006: 85). 
I highlighted some of the many factors that collectively shaped this project. I 




summary of the research design. I also outlined a detailed method of analysis using a 
process of thematic coding that involved an inductive coding (themes emerging from 
participants’ discussions). The next chapter is the first data chapter, where I apply thematic 





Chapter 5: Individual Choice to Use Electronic Cigarettes as a 
Treatment or Smoking Substitute 
5.1. Introduction 
This chapter primarily addresses the question: How are electronic cigarettes perceived by 
electronic cigarette users and stop smoking advisors? It also addresses the question: What 
factors have shaped these perceptions of electronic cigarettes? 
Scholars identified a gap in our knowledge with regards to the meanings electronic 
cigarettes have for smokers and how they understand and negotiate the risks and benefits 
of their use (Rooke, Cunningham-Burley and Amos, 2015: 1). The two interview chapters 
address this gap. I explore several aspects of electronic cigarette use and development with 
both electronic cigarette users and stop smoking advisors. These include: views on addiction 
and treatments, the reasons for people opting to use electronic cigarettes, the potential 
physical and social risks of electronic cigarettes, electronic cigarettes’ status and regulations 
and future implications. This chapter focuses on electronic cigarettes’ perceptions and 
usage, whereas the following chapter focuses on the risk perceptions of electronic 
cigarettes. I describe the similar and different perceptions of electronic cigarettes in the 
social worlds of stop smoking advisors and electronic cigarette users. I argue that electronic 
cigarettes act as boundary and translational boundary objects. This chapter locates the 
perceptions of electronic cigarettes within the contemporary social scientific theory of 
biomedicalization. It also discusses the link between biomedicalization and boundary 
objects theories. To begin with, I highlight and discuss the various perceptions of electronic 
cigarettes that support my argument of electronic cigarettes as boundary objects. Then, I 
discuss the theme of individualisation. I conclude by linking the findings to boundary objects 
theory and biomedicalization. 
Four key themes emerged from the interviews with stop smoking advisors and 
electronic cigarette users. The themes are: first, the reasons for using electronic cigarettes; 
second, the ambiguity of electronic cigarettes’ status and efficacy; third, empowerment and 




will be addressed in the next chapter. First, I will give a detailed breakdown of the 
participants and their backgrounds.  
Participants 
The mean age of my electronic cigarette users was 44y (range 21–67). Nine were males and 
six were females and duration of electronic cigarette use ranged between 4-36 months 
(average 14.6 months). Eight reported that they were ex-smokers and were only using 
electronic cigarettes at the time of the study; the rest reported dual use of both electronic 
cigarettes and cigarettes with different patterns of use. Their occupations included: a 
counsellor, an audit manager, a surgeon, an IT worker, a gym instructor, an artist/musician, 
a para legal in family work, two lecturers, two were unemployed due to disabilities, two 
were unemployed and two were retired. When asked about the number of years they 
smoked, electronic cigarette users reported smoking for an average 27.4 years (a range of 5-
47 years). Fourteen stated that they made previous attempts to stop smoking. Thirteen 
reported previous use of other aids to help them stop smoking, such as NRT, Champix, 
herbal cigarettes, Allen Carr’s method and hypnosis. Three of the current Stop Smoking 
Service users reported currently using other aids besides electronic cigarettes. The majority 
of the users were using electronic cigarettes that looked like cigarettes (first or second 
generation) with few using more advanced generations. The advisors were all trained ‘stop 
smoking’ specialists with experience of working at the Stop Smoking Service for between 
seven months and fifteen years.  
5.2. Theme 1: The Reasons for Using Electronic Cigarettes 
The electronic cigarette users and advisors expressed different perspectives and opinions on 
the discourse and role of electronic cigarettes. The groups were not homogeneous; rather, 
they were heterogeneous in their attitudes, values and beliefs. Both electronic cigarette 
users and the advisors introduced several reasons and motives for using electronic 
cigarettes. Nearly all the electronic cigarette users opted to use them to improve their 
health. Two users mentioned they used them to save money without referring to any health 
concerns. Electronic cigarette users used electronic cigarettes to stop, reduce or substitute 
smoking and pointed to several aspects that attracted them to electronic cigarettes. One 




was much too easy to slip back” (1A). She also pointed to health benefits; the possibility of 
indoor use; the tobacco free smell and the cheaper price of electronic cigarettes compared 
to cigarettes, 
“My lung capacity feels better, I feel better. I thought smoking was giving me headaches, 
actually I noticed those headaches have gone away. Sometimes I felt quite anxious when 
smoking, so actually I don’t get that with e-cigarettes… It appealed to me that I can use 
them inside. I liked the idea that they didn’t smell, because that’s another thing I didn’t like 
about smoking, and they were cheaper.” (1A) 
The following user, who struggled with quitting when using other nicotine products, liked 
the similarity of electronic cigarettes to ‘real’ cigarettes,  
“It makes you reduce the cigarettes in one way or it makes it easier to stop. I think it is a 
better option because it is quite hard to stop when you have nothing. I tried nicotine 
plasters years ago and it wasn’t working. The e- cigarette feels like a real cigarette.” (4D) 
The following user opted to use electronic cigarettes because he needed to stop smoking 
before a surgical operation. When he asked his surgeon about electronic cigarettes, he told 
him: “as far I am concerned, if you are on e-cigarettes - you no longer smoke.”(3C). Some 
users indicated switching to electronic cigarettes as a substitute to smoking, like 2B who 
tried to quit several times using other aids until he discovered electronic cigarettes and 
since then he has been “using it full time” because he liked “the fact that it is simple and 
easy to use. It doesn’t leave a bad odour lingering anywhere and it’s not unhealthy for me or 
for the people around me.” 5E also said:  
“To me it’s a replacement for cigarettes…. So, the patch is dealing with the nicotine and 
the e-cigarette is dealing with the habit of smoking…..It has got a vapour coming out; it’s 
lighter and it just feels like you are actually smoking a cigarette.” 
11K also pointed to the similarity of electronic cigarettes to cigarettes, as well as the other 
health, odour and expense aspects, he said: 
“It feels like you are smoking and it doesn’t make you stink and it doesn’t make you 
cough…..The money came into it a lot because, you know, cigarettes are really expensive.”  




cigarettes. For example, 14N said he switched to electronic cigarettes because he wanted to 
preserve his singing voice on stage and because his dentist warned him about his gum 
disease (risk perceptions are discussed in chapter six). He described electronic cigarettes as 
a “much more pleasant” way to deal with his addiction. Several users spoke about the ability 
of electronic cigarettes to offer enjoyment and relieve stress (see 5.3.2.3) and confirmed 
that electronic cigarettes can replicate the physical behaviour and rituals of smoking (see 
5.3.2.4). Other reasons are the acceptability by significant others who are non-smokers and 
the continuation of the social aspects of smoking. The users seemed to use electronic 
cigarettes flexibly, sometimes joining smokers outdoors and at other times they ‘vaped’ 
indoors. The following are two examples, 
“What I like about e- cigarettes is there was obviously a social aspect to smoking. For me it 
was a way to get away from my desk and I still sometimes go outside and use my e-
cigarette just for social purposes, just to be one of the girls and join in really. It is better 
than before, you know with groups of friends that used to be quite embarrassing when I 
used to go outside when they were not smoking to have cigarette during meals and stuff. 
So, there is a positive impact on that.” (1A) 
 
“when I considered giving up smoking, I just started to use my e-cigarette more, and 
discovered I liked the taste of it more than tobacco…….The friends that I have understand 
that I’ve made a conscious decision to switch from tobacco to vaping and most of my 
friends are intelligent, well in my view they’re intelligent, and they know that it’s better for 
me and for them if I’m vaping, not smoking. It also means often that I can stay with the 
conversation rather than having to go outside and have a cigarette.” (14N) 
Users spoke about the role of flavours and customising nicotine level in attracting them to 
electronic cigarettes. 7G described electronic cigarettes as “far nicer to smoke than a normal 
cigarette because you can pick all your different flavours; you can pick how much nicotine 
you are going to inhale.” She also said she liked “the fact that your hands don’t smell; your 
hair doesn’t smell; you don’t have to brush your teeth all the time because you can taste 
cigarettes.” 9I also spoke about electronic cigarette use turning into “a bit of a hobby” as he 




more fun; it keeps you occupied and it helps you forget about the cigarettes”. Other users, 
however, were not keen on flavours as the following user explained: 
“For me, the whole point of having e-cigarettes is to eventually stop not to think oh I love 
the cherry one, and this is because that will make me do it more…..For me, it’s not about 
pleasure. That way I don’t want to encourage myself to partake more by having cherry or 
chocolate or whatever, it is about maintenance reduction; ultimately finish.” (15O) 
When the advisors were asked about the reasons they believe people use electronic 
cigarettes, they suggested several reasons and factors that might influence the decision to 
use them. For example, one advisor believed that electronic cigarettes made the life of 
smokers “a lot easier to deal with in terms of trying to become a non-smoker.” She also 
highlighted the role of flavours and “the different gimmicks that comes with it” and the 
expense, friends and convenience, stating: “convenience is that they’ve got it in their hand; 
they can charge it; they can fiddle with it; they can walk around with it.” (H1). One advisor 
highlighted several aspects that attract smokers to use electronic cigarettes,  
“There are people who stopped for months and months who would never use the patch 
and never used the patches or the other medications, but they decided to use the e-ciggi 
[sic] because it is available, it is quick, it looks like a ciggi [sic]. People use them to comfort 
themselves.” (H4)  
One advisor believed that people are “substituting in work environment or socially, in homes 
or in the car or different environments.” (S2). Another advisor believed that people use them 
because they have got a replacement as they swap cigarettes with electronic cigarettes, so 
“they’re substituting that behaviour.” He thought that the whole marketing behind 
electronic cigarettes motivates people to use them, so they “look for the cheapest [option]” 
without necessarily thinking about the health issues. He pointed to several reasons that 
attract smokers to use them including the fact that they have no tobacco in them; they can 
save money; they can try a range of flavours; they can share their experience with friends; 
they can use them in public places and workplaces; they satisfy the hand to mouth action 
and they can make them feel “a bit more secure.” For the younger population, he believed 
that “it is a fashionable thing to do”; “a lot more attractive” and socially acceptable (H3). 




cigarettes because they are fashionable and because “they’re there and they want to vape 
all the different flavours.” However, he suggested that “the older generation are coming 
away from smoking and seeing them as a smoking cessation [tool], as a way of stopping 
smoking completely.” (S5). 
There was an emphasis on the role of hand to mouth and the social benefit. For 
example, H2 said: “for people who have hand to mouth habit or they are out with their 
friends, they still want to feel part of the group, so they will use that.” She acknowledged 
that “for some, it’s just to help them reduce their cravings” on their way to giving up 
smoking. H6 also believed that a lot of the users use electronic cigarettes because they want 
to stop smoking. She highlighted aspects of safer alternative to smoking; saving money; 
similarity to real cigarettes and the “sensation and the hit that they will get from the e-
cigarette that they won’t get from the other products.” She also highlighted the role of 
friends and family recommending it and the ability to use electronic cigarettes when 
socialising or to relieve craving symptoms.  
Their use as a treatment was recognised by several advisors. One advisor said: “It is 
treatment if they use it in a positive manner because some people use electronic cigarettes 
and do not go back for the normal cigarette.” (H7). Another said: “they use it as a tool to 
give up smoking…… they are taking control of their health” (H3). One advisor reflected on 
her clients’ experiences who “just wanted to stop smoking by whatever means.” She 
believed that the electronic cigarette attracted them because of its novelty as they wanted 
“something different to try, but might be successful” and because “it replicates that smoking 
action which a lot of people miss” (H5). S4 believed that electronic cigarettes are “attracting 
those who are trying to cut down on smoking or possibly quit”, but again highlighted the 
role of marketing and different flavours in attracting young people to try something new. S6 
also attributed the attraction to electronic cigarettes to the variety of flavours.  
The perception that people use electronic cigarettes because they are seen as less 
harmful than smoking was highlighted by several advisors. One advisor said:  
“Some of them know that the actual nicotine is not that much harmful, the other 
substances in the cigarettes they are harmful …From a health perspective, they think that 




S3 also agreed that one of the reasons people use electronic cigarettes is their belief that 
they are “healthier alternative to smoking.” She discussed how people self-medicate on 
electronic cigarettes to stop smoking, but also acknowledged that they can be used as an 
“alternative to smoking” as they satisfy the “hand mouth specification.” She described how 
people feel that they are in control as they can adjust their nicotine levels and they have the 
freedom to “vape anywhere and everywhere and sit indoors and do it all day long.” She also 
described how they can be used in stressful situations and to avoid relapse, especially when 
socialising with friendship or family groups who are smokers.  
To summarise the theme: the majority from both groups indicated that the electronic 
cigarette was used as an aid to stop smoking, to cut down smoking or as a substitute to 
smoking. Its efficacy in substituting smoking was attributed to the electronic cigarette’s 
ability to replicate the habits and rituals of smoking, the comfort and pleasure it offers and 
its efficacy in delivering nicotine. Electronic cigarettes relieved withdrawal symptoms and 
helped in avoiding a relapse to smoking. Electronic cigarettes were perceived to be less 
harmful than smoking (this will be discussed in the next chapter). Most users liked the 
similarity of electronic cigarettes to traditional cigarettes. The data suggest that electronic 
cigarettes may have attracted users because of their different flavours; their reduced cost 
compared to cigarettes; their tobacco-free smell; social acceptability; the possibility of 
customising them according to the individual’s needs and desires and the possibility to use 
them indoors. The data also suggest that some users used electronic cigarettes as a hobby 
and a social activity. These findings conform to results in the literature which discusses 
motivations for using electronic cigarettes (e.g. Etter and Bullen, 2011; McQueen, Tower 
and Sumner, 2011; Pearson et al., 2012; Dockrell et al., 2013; Barbeau, Burda and Siegel, 
2013; Dawkins et al., 2013; ASH, 2014a,b; Brown et al., 2014b; Rooke, Cunningham-Burley 
and Amos, 2015). One of the reasons reported in this study is the endorsement and 
encouragement to use electronic cigarettes instead of smoking, especially from friends, 
family and, sometimes, from some health personnel. This opposes other findings from other 
studies, where some vapers reported stopping using electronic cigarettes based on advice 
they had received from a health professional (ASH, 2016b).  
Through discussing the reasons for using electronic cigarettes, it was apparent the 




users and the advisors. It was also apparent that the attitudes towards electronic cigarettes 
reflected a focus on individual responsibility and self- regulation. In the rest of this chapter, I 
will be discussing these two major themes: Theme2: the ambiguity of electronic cigarettes’ 
status and efficacy; and Theme 3: the theme of individualisation. 
5.3. Theme 2: The Ambiguity of Electronic Cigarettes’ Status and Efficacy 
First, I will discuss how electronic cigarettes were represented, in both groups, as a 
therapeutic product. Then, I will discuss how electronic cigarettes were represented as a 
substitute for smoking. From there, I will shed light on the aspects that made electronic 
cigarettes good substitutes for smoking. I will then conclude by discussing how electronic 
cigarettes act as translational boundary objects. 
5.3.1. Electronic Cigarettes as Therapeutic Products 
It is important to highlight that electronic cigarettes were not licensed or prescribed as a 
medicine or a treatment at the time of collecting the data. Participants used the words 
(medicine, treatment and aid) to describe the use of electronic cigarettes for smoking 
cessation, similar to other medicinal products, rather than smoking substitution. First, I 
discuss if electronic cigarettes were viewed and used as therapy (a medicine, a treatment or 
an aid), then I present the extracts that discuss their efficacy in comparison to other nicotine 
medicinal products. Finally, I introduce the views on their potential medicinal use within the 
Stop Smoking Service.  
5.3.1.1. Electronic Cigarettes as a Therapy? 
Electronic cigarettes were represented by some stop smoking advisors as a medicine and an 
aid for nicotine addiction: “I would rather view it as a medicine; as an aid to giving up 
smoking” (H1, advisor). One advisor described using electronic cigarettes as a “self-
medication” act, she said: “I think a lot of people self-medicate using the e-cigarette because 
they do not always have the time and motivation and go to see someone routinely every 
week” (S3, advisor). Electronic cigarettes were acknowledged by stop smoking advisors to 
be used as an aid to help smokers quit smoking: “..they use it [electronic cigarette] as a tool 
to give up smoking, I think that’s what it is” (H3, advisor). “They are using it [electronic 




smoking” (H6, advisor). However, the advisors differentiated between two types of 
electronic cigarette users, namely those who want to stop smoking and ultimately stop 
electronic cigarettes, and those who want to replace smoking and use electronic cigarettes 
as an alternative source of nicotine. 
“It’s two different groups, out there is one that uses it for convenience so they can use an 
e-cigarette in places where they are not allowed to smoke because it gets them through 
that day. But I’ve only seen the population who wants to give up smoking and use it as an 
aid.” (H1, advisor) 
In this research, the majority of electronic cigarette users confirmed they used electronic 
cigarettes to help them quit smoking. “I started on e-cigarettes on my own last year and I 
gave up for the longest period that I have ever done” (7G, user). However, some verbalised 
their intention to stop using electronic cigarettes, while others expressed their desire to 
continue their use. Some electronic cigarette users viewed and described electronic 
cigarettes as a treatment: “For me, it’s a treatment. It’s a way to keep me off tobacco” (14N, 
user). Others disagreed with classifying electronic cigarettes as a medicine, as the following 
user said: “It [electronic cigarette] is not a medicine and is certainly not a treatment” (2B, 
user). One user was sceptical about classifying electronic cigarettes, or indeed any other 
nicotine-containing products, as a medicine, as she explained: 
“I wouldn’t see them as a medicine, I see them the same as the gum or the patches, but I 
wouldn’t call them medicine either, it’s language really, I mean I accept smoking is 
addiction but I don’t think you necessarily need medicine to get off addiction... I think 
medicine for me is quite a triggering word with addiction, I don’t think you are sick, there 
is an element of choice involved.” (1A, user) 
5.3.1.2. Electronic Cigarettes Compared to Nicotine Replacement Therapies 
Participants compared the effectiveness of electronic cigarettes with other licensed nicotine 
replacement therapies used by the Stop Smoking Service, and many provided evidence of 
comparable, if not superior, efficacy of electronic cigarettes in helping people to quit 
smoking. One advisor explained how electronic cigarette users who used their Stop Smoking 
Service “often they say it is [electronic cigarette] useful”, and even when the advisor offered 




“they probably choose to continue using e-cigarette because it’s working for them” (S1, 
advisor). The following advisor believed that electronic cigarettes were as effective as other 
available treatments: “They are as effective as NRT [nicotine replacement therapies]” (S2, 
advisor). Electronic cigarette users also saw this similarity in its efficacy, “it’s a bit like 
nicotine gums or mouth sprays or anything in the old days” (3C, user). These findings 
contradict the results of Rooke, Cunningham-Burley and Amos (2015: 61), who found that, 
‘for most participants, nicotine replacement therapies and electronic cigarettes belonged to 
different categories’; their participants viewed the former as medicinal products, while they 
perceived electronic cigarettes as a less obvious means of quitting smoking than nicotine 
replacement therapies. In this thesis, some advisors acknowledged that electronic cigarettes 
can be a valuable method to quit smoking for particular smokers, such as heavily addicted 
smokers or those who need to satisfy the hand to mouth habit. In fact, electronic cigarettes 
were thought to possibly be more effective than other available products, as the following 
advisor stated: 
“For people that really enjoy smoking or have tried to quit before and struggled, I think a 
lot of them do feel the patches and tablets haven't worked and do kind of see the benefits 
of trying to stop and quit using the e-cigarette, and for a lot of people in that situation, it is 
an alternative to smoking. So that is something that fulfils their needs, definitely.” (S3, 
advisor) 
Indeed, some electronic cigarette users in this study explained how the available products 
failed to help them quit smoking, but electronic cigarettes helped, as the following extract 
shows: “the patches and all of the Nicorette stuff, none of which worked for me” (14N, user). 
Other users explained why electronic cigarettes worked better than other therapies: 
“The other thing about stopping smoking is the satisfaction of the activity of smoking… 
other aids, to my mind, my experience, don’t give you that. You chew a piece of gum, 
which you’re not even allowed to chew; you’ve got to keep it in your cheek and it produces 
all this vile stuff and you’ve got to try not to swallow. It’s horrid. It’s disgusting. Nobody 
needs to do that. So that’s a block, I think, it was certainly a block for me to stop me 
smoking… I hated it. Whereas, I liked smoking. Whereas I like using that in a way… it’s a 





“I don’t think I would have given up smoking without this because gums and patches 
wouldn’t have done this for me. There is something about physically holding an e-cigarette 
that was incredibly helpful, probably more because of the psychological addictive 
element.” (1A, user) 
5.3.1.3. Electronic Cigarettes Help to Avoid Relapse 
Some advisors acknowledged that electronic cigarettes help users to avoid going back to 
smoking and, hence, electronic cigarettes provide security to users. One advisor explained 
how keeping electronic cigarettes as a security measure can be useful in difficult situations: 
“I definitely say, look, if you have an e-cigarette, I’d rather you keep it in your bag and if 
you are really stuck and you are socialising and you are drinking alcohol, I’d rather you use 
that than the real cigarette, so in a way that’s a harm reduction.” (H4, advisor) 
One advisor explained how the electronic cigarette “makes them [users] feel a bit more 
secure” (H3, advisor). Several electronic cigarette users explained their use of electronic 
cigarettes as a security measure or safety blanket to protect them from going back to 
smoking cigarettes. For example, one user confirmed his intention to keep using electronic 
cigarettes to avoid a relapse: “I cannot see myself not using them as I fear that leaving the e-
cigarette will draw me back to smoking” (2B, user). Another user (11K) described electronic 
cigarettes as “a crutch”. The following extracts are more examples: 
“My plan will be to stop using them altogether, but I am not going to not have them 
around the house because the danger would be if I get badly triggered I go buy cigarettes 
rather than using e-cigarette.” (1A, user) 
“It was something that was with me for ten years, or more than that. So this is my, if I feel 
that I’m creeping back, this gets me out of that hole. So again I might do this for a little 
while and then I’ll put it in my bag and I’ll forget about it, and then I’ll think, ‘Well, I 
haven’t had my vape for a while,’ which is, you know, a nice feeling. But at the moment it 
seems to be in my pocket with me.” (10J, user) 
This is compatible with findings from other surveys (e.g. ASH, 2015a; 2016b), where smokers 
used electronic cigarettes to deal with certain situations. Other studies have also shown that 
people use electronic cigarettes to avoid a relapse (e.g. Etter, 2010; Etter and Bullen, 2011; 




5.3.1.4. Electronic Cigarettes’ Use within the Stop Smoking Service 
As discussed in Chapter 1, the current tobacco control programmes in England focus on 
abrupt quitting with a view to eliminating nicotine through a time-framed treatment plan. 
The following advisor explained the process: 
“The emphasis on our service is to stop smoking rather than cutting down, it is not a 
cutting down service, the emphasis is on stopping. For us, we are very much driven by the 
government target of around four weeks quitting. Although we offer the support for 
twelve weeks, it is actually to get that client by four weeks to be part of that four weeks 
quit.” (H5, advisor) 
The advisors used the term ‘weaning’ to describe their strategy in helping people to end 
their nicotine use, as the following advisor clarified: 
“If someone comes to the clinic with me and they’re smoking an e-cigarette, I always 
discuss with them what kind of level the nicotine is and then we can look at weaning them 
off the nicotine to low or zero nicotine and products that still use the vape but without the 
nicotine in it, you know. It’s the ultimate goal.” (S3, advisor) 
Adding licensed electronic cigarettes to the other available treatments within the Stop 
Smoking Service was welcomed by nearly all the advisors. However, it was acknowledged 
that electronic cigarettes will not help all smokers to quit smoking, as the following advisor 
explained: “I think they will be another piece in our armoury. I don’t think they will be the 
answer for everybody, I don’t think they will suit everybody to use” (S2, advisor). The 
majority of the advisors saw the electronic cigarette’s potential to be another “weapon in 
their armoury”, with a focus on the importance of regulating electronic cigarettes, as the 
following extract shows: 
“If that has been a licensed product, I would be happy that it is alongside the range 
because it is an individual choice. So it has to be their individual choice and if it supports 
them to stop then, that’s another weapon in the armoury.” (H5, advisor) 
However, one advisor believed that electronic cigarette users will end up going back to 
smoking. He said:  




smoking [i.e. using electronic cigarette] then they, one day, will go back to normal 
smoking” (H7, advisor).  
Some advisors had concerns about the long-term use of electronic cigarettes: 
“Because even with the nicotine in NRT, we wean them off after a set period. After eight 
weeks, we might say to them, ok so cut down on this, we lower the doses, we manage 
that. With an e-cigarette, you can’t do that, you can… but… I suppose we got so used to it, 
we know how the system works, it is much easier this way.” (H3, advisor) 
“I will still have the same argument about the psychological bond people can actually 
create with the e-cigarette and I will never be happy to recommend it.” (H4, advisor) 
The above examples demonstrate how the advisors brought electronic cigarettes into the 
field of the current public health management of smoking, which emphasises the 
elimination of smoking and any source of nicotine use, including electronic cigarettes. 
Similarly, several electronic cigarette users expressed their desire to stop using electronic 
cigarettes in the future; some had their own individual plans to manage their electronic 
cigarette use according to their needs, lifestyle and desires. For example, the following user 
planned to ‘wean’ himself off nicotine with a view to stopping electronic cigarettes in the 
future, although not adhering to the timeline followed in the Stop Smoking Service. He said: 
“I’m still using nicotine. I have got one bottle here with no nicotine and eventually my 
challenge is to get down through the milligrams, down to twelve and then to six and then 
stop. I think that’s the way I go.” (14N, user) 
To conclude, the electronic cigarette was perceived as a form of treatment to help smokers 
quit smoking. It was compared to other medicinal nicotine products and found to be as 
effective as, or more effective than, other nicotine replacement therapies. It was thought to 
be helpful in avoiding a relapse. Although the electronic cigarette’s potential to be ‘another 
weapon in the armoury’ was acknowledged by the advisors, the possibility of going back to 
smoking and the long-term use of electronic cigarettes raised concerns. For the advisors, the 
electronic cigarette should be used as a tool to wean people off nicotine. For the users, the 
electronic cigarette can be a tool to wean them off nicotine or a device to substitute for 




5.3.2. Electronic Cigarettes Use as a Recreational Habit 
First, I describe how electronic cigarettes were perceived as a smoking alternative. Then, I 
present the reasons for their efficacy as a substitute. 
5.3.2.1. Electronic Cigarettes are a Replacement/Alternative for Cigarettes 
Some advisors disagreed with the view that electronic cigarettes can be viewed as a 
medicine or a treatment, as the following advisor said: “to cure the nicotine addiction, no 
way....it is exactly a replacement” (H4, advisor). Some advisors believed that people used 
electronic cigarettes as an alternative to smoking: “at the moment, I cannot see it as a 
medication, because it’s not licensed as a medication and not been promoted as a 
medication, so I think at the moment it is seen as an alternative to smoking” (H6, advisor). 
One advisor (S6) explained why smokers use electronic cigarettes: 
“I think, for a lot of people, they have transferred their cigarette habit to the e-cigarette. 
They weren’t thinking about quitting, they were looking for a safer alternative. And they 
have chosen a product that’s the closest thing to smoking.” 
Others, as I gave one example earlier, acknowledged that there are two types of electronic 
cigarette users; those who want to stop cigarettes and electronic cigarette use, and those 
who want to replace cigarettes with electronic cigarettes, 
“In between the e-cigarette users, some of them are completely quiet and they are serious 
about it and they have the psychological lean as well, so they are ready and they will stop 
it [electronic cigarette]. The other group of people still carry on with exactly the same 
habit, using much more nicotine than they would ever need and they are not willing to 
stop it, either.” (H4, advisor) 
The ability of electronic cigarettes to work as a substitute to smoking was acknowledged 
also by electronic cigarette users, as the following example shows: “I think it is an aid to stop 
smoking because they’re a good substitute. Nothing else that you can use to stop smoking, 
or there’s nothing else that I’ve dealt with that is a worthwhile substitute to smoking” (11K, 
user). Although, for this user, electronic cigarettes did not replicate fully the experience of 
smoking traditional cigarettes, he asserted: “it is certainly a very good substitute” (11K, 




However, another user (8H), who did not gain the same experience of smoking when using 
electronic cigarettes, decided to stop their use and go back to smoking. Others used both 
cigarettes and electronic cigarettes; they, however, used the traditional cigarettes in 
particular situations, such as social gatherings. For example, the following user said: “last 
night, I did have a cigarette when I was out with friends, but I also had my electronic 
cigarette with me, which I use as my main source of nicotine” (14N, user). The next user 
opted for traditional cigarettes in the Islamic fasting month to get the ‘hit’ he longed for 
during his fasting: “during the Ramadhan season, I reverted back to cigarettes as I felt they 
provided the ‘hit’ that I need during that month. However, once Eid [end of fasting month] 
took place, I was back on the e-cigarette without hesitation” (2B, user). The previous 
examples imply that electronic cigarettes were used as a source of nicotine to replace 
cigarettes. 
It is argued that the possible efficacy of electronic cigarettes could be attributed to their 
ability to deliver nicotine effectively and, at the same time, imitate the habit of smoking 
cigarettes (Farsalinos et al., 2013). Data from this study support this argument, as I will show 
next. 
5.3.2.2. Electronic Cigarettes are Effective in Delivering Nicotine 
Some electronic cigarette users, in this study, acknowledged that electronic cigarettes are 
effective in delivering nicotine. For example, one user said: 
“I know that when I’ve got stressed in the past I smoked more and now when I’m stressed, 
I use my vape more, yes, because of the nicotine, it’s still the nicotine addiction.” (14N, 
user) 
The following user also believed that electronic cigarettes provided the nicotine that her 
body craved for when she got ‘badly triggered’, 
“For me, there is an element when the nicotine has been needed at times, because there is 
a physical dependency, and so when I felt a real strong urge for nicotine, the fact I have 
been able to take a quick puff on them, the e-cigarette has been helpful.” (1A, user) 




“I don’t find it gives me the total satisfaction that a normal cigarette gave me. Thus, I 
‘suck’ on it a lot more than I probably should.” (2B, user) 
Another user believed that he is taking more nicotine: 
“I take far more nicotine now, far more. Well, the thing about the electronic cigarette is 
you, it doesn’t stop, right, you can smoke for three hours continuously or something, I 
don’t know exactly how long the battery lasts. But it lasts for hours.” (11K, user) 
Electronic cigarette users described how electronic cigarettes replicated the physical 
behavioural elements of smoking and substituted the psychological feelings associated with 
smoking (e.g. pleasure and stress relief). Next, I will shed light on the psychological and 
physical aspects that participants mentioned to explain their reliance on electronic 
cigarettes to maintain resistance to smoking urges. 
5.3.2.3. Electronic Cigarettes Offer Enjoyment and Relieve Stress 
Stress seems to be a major factor for using cigarettes and electronic cigarettes. They are 
both perceived as a means to reduce stress and offer enjoyment; they present a coping 
mechanism to the stressors of daily life. Several studies showed that smokers smoke 
cigarettes to relieve stress, which was believed to contribute, in part, to why they continue 
the habit of smoking (Bryant et al., 2011; Slopen et al., 2013; Lawless et al., 2015; Rooke, 
Cunningham-Burley and Amos, 2015). Similarly, some studies concluded that electronic 
cigarettes were used to reduce stress (Rutten et al., 2015). However, in Rooke, Cunningham-
Burley and Amos’s study (2015), some participants expressed doubts about electronic 
cigarettes’ ability to substitute the stress relief characteristics of normal cigarettes. Data 
from this study showed electronic cigarettes were used in stressful situations. This was 
acknowledged by the advisors, as the following examples show: “People use them to 
comfort themselves, I must admit they seem to be successful” (H4, advisor); “I’ve got a friend 
who would not smoke because of medical reasons, but when she had a stressful situation 
she took up smoking an e-cigarette, and she smokes that all the time or vapes” (S3, advisor). 
Electronic cigarette users also confirmed using electronic cigarettes to relieve stress. For 
example, 




way to kind of, you know, you try and cut yourself off from it a little bit. And no, I went 
back on it and I just went and bought the liquid.” (10J, user) 
Electronic cigarettes acted as a substitute for the relaxation that traditional cigarettes used 
to offer, as the following example reveals: 
“I think if I am feeling a little bit concerned about something, it’s the anxiety thing, I 
probably reach for a cigarette rather than the e-cigarette. But that said, if I don’t have any 
cigarettes I don’t panic about it… there have been times when it’s been a whole week 
when I haven’t had any cigarette anywhere in the house and I’ve used that [electronic 
cigarette] and it was fine.” (15O, user) 
Electronic cigarettes provided pleasure to users: “I think when they are using an e-cigarette, 
they enjoy it” (H3, advisor). For the next user, electronic cigarettes fully replaced the 
personal rituals and pleasure he associated with smoking a cigarette: 
“It’s mildly relaxing and, as I say, in the contexts in which I tend to use it, close the door… 
it’s that – I’m not sure that I can separate the feeling that actually using it gives… the 
feeling of being ‘I’m alone’ …that feeling has been, just like, ‘Oh, I can now indulge in 
something that I really know I shouldn’t do.’ It’s like letting your hair down sort of feeling.” 
(11K, user) 
The same user explained: 
“It’s something I do when my kids aren’t around and those kind of things are very 
important. It still has that bubble thing for me, where I go into that little bubble and that’s 
important. It’s a satisfying thing to do, a pleasant thing to do.” (11K, user) 
It is not only the psychological aspects of smoking that electronic cigarettes can substitute. 
Rather, it is the behavioural aspects as well. This will be discussed next. 
5.3.2.4. Electronic Cigarettes Replicate the Physical Behaviour and Rituals of Smoking 
The smoking habit has many behavioural elements associated with it and they play a big 
role in the persistence of the habit of smoking. Among these are: the hand to mouth 
movement; the habit of holding the cigarette, with specific characteristics like size and 
texture, in-between fingers; the visual effect of smoke and the inhalation and exhalation 




many smoking cessation products focus on the neuropharmacology of nicotine, but fail to 
address the behavioural element that is deeply embedded in most addictive practices 
(Buchhalter et al., 2005). Both users and advisors spoke about the rituals of smoking 
cigarettes and highlighted that the ability of electronic cigarettes to maintain those rituals 
was a strong factor in the desire to embrace electronic cigarette use. The following are 
examples from some advisors: 
“They have got something there, they have got a replacement, they swap the cigarette 
and they’re substituting that behaviour.” (H3, advisor) 
“They’ve got it in the hand, they can charge it, they can fiddle with it, they can walk 
around with it… something to hold.” (H1, advisor) 
“I think there’s a massive psychological pull in smoking to do with the hand to mouth and, 
with people who smoked, there’s a lot of association with doing that and the process of 
putting something in your mouth and inhaling. So there is that side of it, so the e-cigarette 
really satisfies the hand mouth, where obviously taking a tablet and a lot of the nicotine 
products do not suffice in the same manner, although they can choose the inhalator. I 
think anyone with an e-cigarette tends not to choose an inhalator.” (S3, advisor) 
Several electronic cigarette users acknowledged and mentioned the importance of the 
behavioural elements in their electronic cigarette use, such as something to do with their 
hands. The following users stated: 
“The psychological element has been helpful, I don’t have to feel I am missing out if I want 
to go out and stand with people and talk. I’ve got something I can use, my e-cigarette, yes 
it has been very helpful.” (1A, user) 
 
“I decided that actually I don’t need e-cigarette, only when I have my coffee I need 
something to do with my hand.” (4D, user) 
“It’s something I got in my mouth and I suck on.” (6F, user) 
“It was effective in the sense that it kind of mimicked cigarettes from, you know, from 
everything else – just from the action you take with your hand to your mouth and your 




In this thesis, some electronic cigarette users were not consuming nicotine in their 
electronic cigarettes (9I, 3C), which might indicate that the behavioural rituals of smoking 
were deeply embedded in their characters, as the following example reveals: 
“In some respect, it is the hand to mouth and it is still seeing the smoke vapour comes out 
of the mouth, so it’s like a double trick to the brain, so it’s like I perceive in some respect of 
why I am no longer on any nicotine.” (3C, user) 
Nevertheless, for some electronic cigarette users, electronic cigarettes changed their 
manipulation habits, hence breaking the habit of smoking, but alternatively paving the way 
for new rituals, as the following example shows: 
“The wonderful thing about it is that it’s changed my hands and my fingers because I don’t 
smoke it between my fingers. I hold it in my hand. So, that has helped break the habit of, 
just the habit of holding a cigarette in my fingers.” (14N, user) 
“You could hold it like a cigarette, but it’s not easy so it changes the way that you smoke… 
which I think is quite a good thing for me certainly, it starts to disassociate itself from 
smoking as such. As I said, I still have the occasional cigarette, but a packet of twenty now 
would last me a week, where before it was a day.” (15O, user) 
The data from this study supported other studies that showed the importance of the unique 
sensory cues, mimicking and rituals associated with traditional smoking and their role in the 
growth of electronic cigarette use (Caponnetto et al., 2011a; Polosa et al., 2011; Caponnetto 
et al., 2011b; McQueen, Tower and Sumner, 2011; Fagerström, 2012; Barbeau, Burda and 
Siegel, 2013; Caponnotte et al., 2013). 
To conclude Theme 2, the data here showed that most people used electronic 
cigarettes with the aim to stop or reduce smoking. This conforms to other studies that 
provided evidence that electronic cigarettes have been used, mostly, as an aid to reduce or 
quit smoking (e.g. Adkison et al., 2013; Brown et al., 2014b; Dawkins et al., 2013; Goniewicz, 
Lingas and Hajek, 2013; Pepper and Brewer, 2013; West, 2014; ASH, 2016b). However, 
electronic cigarettes were represented differently by both the users and stop smoking 
advisors. The advisors acknowledged that electronic cigarettes were used both as a 
substitute for smoking and a therapy. However, the advisors wanted electronic cigarettes to 




therapies. The advisors brought, or wanted to shift, electronic cigarettes into the world of a 
nicotine replacement therapy regime to become a piece of their ‘armoury’, in order to avoid 
the long-term use of electronic cigarettes, which would shift electronic cigarettes from the 
medicinal world to the recreational world. Hence, similar to nicotine replacement therapies, 
electronic cigarettes claim their legitimacy as a medicine as long as they treat nicotine 
addiction, rather than maintain it (Bell and Keane, 2012). However, electronic cigarette 
users have placed electronic cigarettes in a smoking quitting continuum, where boundaries 
are blurry and where electronic cigarette users can tailor their use according to their 
lifestyle, needs and desires. Electronic cigarettes had different meanings; they were 
represented as a continuation for the rituals of smoking; a comfort; a safety blanket; a harm 
reduction tool; a nicotine substitute; a lifestyle icon; a treatment; a piece in the armoury; an 
aid to stop smoking; a risk. These different representations of electronic cigarettes show 
that electronic cigarettes function as boundary objects, as I will discuss next. 
Electronic Cigarettes as Boundary Objects 
The data from both groups showed no consensus with regards to the representations of 
electronic cigarettes. The different meanings of electronic cigarettes demonstrate how 
‘different social worlds maintained a good deal of autonomy in parallel work’ (Star and 
Griesemer, 1989: 399). The dual description of electronic cigarettes (as medication or a 
substitute for cigarettes) shows the ability of electronic cigarettes to function differently in 
different settings (Carlile, 2002). Electronic cigarettes can be both a route to the 
continuation of nicotine dependence and a route to cease nicotine dependence. 
For electronic cigarette users, because of the resemblance of electronic cigarettes to 
traditional cigarettes, users anchored electronic cigarettes to their old smoking habit, thus 
preserving their identity as a smoker and attempting to maintain or replicate the experience 
of smoking on a physical, social and psychological level. Their goals differed to those of the 
stop smoking advisors. Electronic cigarette users did not define a specific framework for 
their pattern of using electronic cigarettes, or deadlines for the duration of their use. Users 
had their own individual plans according to their needs, lifestyles and desires. This explains 
the formation of electronic cigarettes as boundary objects, which help to maintain the 




cigarettes act like anchors ‘which help moor participants within different social worlds’ 
(Williams et al., 2008: 16). 
However, both worlds were able to communicate with each other based on the 
common understanding of electronic cigarettes and their multifaceted roles. So, the 
advisors attempted to embed electronic cigarettes within their public health strategies and 
quitting regimes. Although they disapproved of the electronic cigarettes’ resemblance to 
conventional cigarettes, they acknowledged the electronic cigarettes’ effectiveness and 
usefulness for some cohorts and most of them welcomed electronic cigarettes to be 
another tool in their ‘armoury’. Similarly, for electronic cigarette users, there was no 
agreement on the effectiveness, usefulness and representations of electronic cigarettes. 
They were used as a treatment, a substitute, a crutch and a hobby. Users, who used the 
Stop Smoking Service, were able to combine their individual preference for electronic 
cigarettes with the work of the advisors. Those who used electronic cigarettes outside the 
service viewed the benefits of electronic cigarettes as a stop smoking tool and some 
followed the ‘weaning’ regime to eliminate nicotine. As boundary objects, electronic 
cigarettes’ structure ‘is common enough to more than one world to make them 
recognizable, a means of translation’ (Star and Griesemer, 1989: 393). 
Electronic cigarettes were transformed from an anchor of difference into a bridge of 
similarity, allowing the negotiations and cooperation between different and, yet, similar, 
social worlds. Hence, electronic cigarettes, I argue, became a translational boundary object 
(Star and Griesemer, 1989: 392). This meant that electronic cigarettes enabled a shared 
understanding between the stop smoking advisors, who want to use electronic cigarettes as 
a medicine, and electronic cigarette users, who have a multifaceted use for electronic 
cigarettes. However, the resulted coherence does not mean creating consensus; rather, 
‘representations, or inscriptions, contain at every stage the traces of multiple viewpoints, 
translations and incomplete battles’ (Star and Griesemer, 1989: 413). The following quote 
summarises some of the ways in which electronic cigarettes function as translational 
boundary objects, as they enable similar practices, yet different goals, and they shape the 
social practices in the interrelated worlds of the advisors and electronic cigarette users. 
“I think it’s 50 50, I think they [electronic cigarettes] can be used in either way because… I 




nothing and now I just use this, I use it as a hobby. I think if you want to quit and I have 
known somebody who did that actually you could wean yourself off nicotine and then get 
rid of it and if you wanted to continue… the habit you can get an e-cigarette and continue, 
so you can use them in both ways.” (9I, user) 
Next, I discuss Theme 3, where I argue that the goals, reasons and management of using 
electronic cigarettes represent a manifestation of increased individualisation in society. 
5.4. Theme 3: The Focus on Individualisation 
Here, I show how, throughout the discussion of electronic cigarettes discourse, both data 
sources focused on individual responsibility, empowerment and willpower. Here, I 
demonstrate how the theme of individualisation fits with the biomedicalization process of 
‘the focus on health itself and elaboration of risk and surveillance biomedicines’ (Clarke et 
al., 2003: 161). 
5.4.1. Individual responsibility 
The data showed a sense of individual responsibility for improving own health. This personal 
accountability was fostered by the stop smoking advisors’ approach when dealing with 
clients at the service, and by society overall. Personal choice was emphasised and 
empowerment was considered fundamental to achieve successful outcomes. There was a 
reliance on ‘neo-liberal consumer discourse that promotes being "proactive" and "taking 
charge" of one's health’ (Clarke et al., 2003: 181). All the advisors confirmed that they only 
provided advice to their clients, but decisions and choices were the responsibility of 
smokers/clients. The following advisor summarised the process of dealing with clients: 
“If they asked me about the e-cigarettes or if they were already smoking them, I just give 
them guidance and information about that, but I wouldn’t as I am not allowed to 
recommend to someone… if they started and come to the service already using one… if 
they wish to proceed with using the e-cigarette and if they want to add any other products 
so I just give them advice and guidance and do what I can, but not to tell them what to 
do.” (S3, advisor). 




“It is an individual choice. It’s my role to talk through what those choices are, what any of 
the risks might be... so it has to be their individual choice.” (H5, advisor) 
The following example shows how both users and advisors accepted the perception of an 
individual’s personal responsibility and control over their own health: 
“Yes he [the advisor] accepted it [electronic cigarette] but didn’t recommend it. He is gone 
now, there is a new lady there and she is more accepting of the electronic cigarette and 
said that the service doesn’t have to take the responsibility for it, so if it’s found that there 
is something wrong, health wise or something, eventually it’s my own fault. I do 
understand that.” (5E, user) 
In biomedicalization, there is an emphasis on the responsibility of individuals to be healthy 
and to take the necessary steps to become healthy. Some users spoke about family 
members who advised them to switch to electronic cigarettes to improve their health. For 
example, the following electronic cigarette user spoke about her husband’s advice: 
“He’s the most healthiest [sic] guy you’ll ever meet. So for him, this is a very taboo subject 
as well. And he actually recommended, a good few years ago, ‘You need to go and get an 
electric fag’. And that, I guess, is what prompted me to do it as well.” (10J, user) 
As Clarke et al. (2003: 162) explained, an individual’s responsibility includes ‘improve 
access to knowledge, self-surveillance, prevention, risk assessment, the treatment of risk, 
and the consumption of appropriate self-help /biomedical goods and services’. The 
following extract is an example: 
“Nicotine is still an addictive substance, it is not the actual chemical itself as far as I know 
from the Internet. At least from my research, nicotine is not bad for you, but is still a 
stimulant and it is still addictive, but I can get rid of that completely then I am not tied 
down to anything and it means that if I leave my e-cigarette at home for two days I won’t 
mind… I am not going to get a craving for it.” (9I, user) 
The emphasis on lifestyle choices was considered by Lupton (1997a: 107) to be a move 
towards medicalization and ‘a growing penetration of the clinical gaze into everyday lives’. 
In the next chapter, I will discuss how the rationale to use electronic cigarettes was based 






The advisors focused on empowering individuals to properly manage their individual health 
and make healthy choices. This fits with the dominant concepts of ‘“health maintenance," 
"health promotion," and "healthy living"’ (Clarke et al., 2003: 172). Indeed, some advisors 
believed that the process of quitting smoking is part of a whole lifestyle transformation and 
empowerment. Particular norms of behaviour were constructed and individuals were then 
encouraged and empowered to adopt such norms voluntarily, through self-regulation 
(Petersen, 1997; Leventhal, Brissette and Leventhal, 2003). The following are some 
examples: 
“When I deal with my patients I emphasise, we are talking about this smoking addiction, 
but it is exactly the same like any kind of addiction, it could be a gambling addiction, it 
could be any sort of behaviour change. So this is the way how I help them to distract 
themselves, so this isn’t about smoking, this is about whole ‘let’s get your goals and get 
yourself back’. So I try not to stress too much about the nicotine and the brain and it’s just 
smoking, it’s a change of lifestyle, it’s a self-efficacy self-esteem boost and it’s a whole 
well-being approach for me…” (H4, advisor) 
“At the end of the day you want them to stop smoking for the health and you want to 
reduce the harm caused, the whole point is you want them to have a better lifestyle and 
not being controlled and make sure the cigarette is not in control of them and hopefully 
their health benefits and will improve.” (H1, advisor) 
In this study, the acquisition of control over one self’s life was valued. There was an 
increased desire to take responsibility, to be in control and make personal choices for 
improvement. Individuals acted as active citizens who were in control of their own self 
(Nettleton, 2002: 215). As the following user said: 
“I always think if you’ve made a conscious decision and you can’t, you’re not ready to give 
up nicotine, if you switch to a vape, you’re at least improving your health.” (14N, user) 
The ability to overcome the habit of smoking contributed to the rise of self-esteem and self-
confidence, as one electronic cigarette user explained how switching to electronic cigarettes 




electronic cigarettes “liberates me to make further choices about my lifestyle” (14N, user). 
The advisors also saw how the ability to customise electronic cigarettes empowers smokers: 
“I think… they feel they are in control because, instead of buying products and vapes, they 
can adjust their nicotine levels and they can feel like they’re more in control of the nicotine 
they are taking on board.” (S3, advisor) 
Hence, electronic cigarettes can be viewed as ‘technologies of the self’ (Foucault, 1988a; 
Rose 1996 in Clarke et al., 2003: 165). Using electronic cigarettes can create new 
subjectivities, identities, and new social forms constructed around and through these 
emerged identities (Rabinow, 1992 in Clarke et al., 2003: 165). The next advisor explained 
how their approach of empowering individuals emphasises practising control over other 
habits: 
“Our team is getting a lot of health psychology focus so it is to do with behaviour, they are 
moving away from the medicine approach; the medical approach, we are moving away 
from all that to say, look it’s to do with habit, it’s to do with routine, let’s break that up 
and use goal settings, for example. I think when you do that it’s far more effective and the 
individual benefits more because we feel they will have more control over their behaviour.” 
(H3, advisor) 
For the above advisor, this approach was moving away from the medical model. However, 
according to Clarke et al. (2003: 172), in biomedicalization, ‘health becomes something to 
work toward, an ongoing project composed of public and private performances and an 
accomplishment in and of itself’. Hence, these practices are embedded in the bio/medical 
model. 
5.4.3. Willpower 
Several participants emphasised the role of willpower, or ability to discipline and regulate 
themselves, to quit smoking and even to quit electronic cigarettes, as the following 
examples revealed: 
“It’s absolutely willpower. You do the same with alcohol, you do the same with any 




“The trouble is that then you get down to sort of wherever you get down to at the bottom 
where it’s zero… and then you sort of ramp it up again and get stressed. No, I mean 
willpower is not my strong point really.” (11K, user) 
The following participants refused the idea that electronic cigarettes can treat addiction 
without willpower: 
“If someone is serious about the change… it [electronic cigarette] can be effective, but only 
if they decide, mind wise. I don’t think the tool itself is good enough to use it.” (H4, 
advisor) 
“If you have not got the willpower you are not going to stop regardless.” (3C, user) 
However, the next user revealed that, without aid, he would not be able to stop smoking. 
Nicotine addiction was viewed as a weakness and a sign of lack of control, as the user 
explained: 
“Stopping smoking and not being addicted to nicotine are two different things. I would 
need the willpower to get off the nicotine. I have tried before and I think the longest I’ve 
done without it has been like three months, something like that, and then cracked.” (11K, 
user) 
Health, in biomedicalization, is seen as ‘ongoing moral self-transformation’ (Clarke et al., 
2003: 172), as the following user explained his ongoing attempt to battle nicotine addiction: 
“Willpower… was a huge factor… the first time I quit… the switch to electronic cigarettes, I 
didn’t feel like that. I felt like I was kind of giving into my addiction again rather than… a 
thing to celebrate. So I don’t think willpower was involved in the switch to electronic 
cigarettes.” (12L, user) 
A similar finding was noted in a study that looked into fathers’ stories of reducing and 
quitting smoking (Bottorff et al., 2009). In their study, the notion of quitting with the help of 
nicotine replacement therapies, or other cessation aids, was framed in ways suggesting 
weakness and lacking the control to cope with the physical and psychological burdens of 
quitting. Willpower, as shown in the Chapter 1, was identified in several studies as an 
important factor to successfully quit smoking (Wiltshire et al., 2003; Pipe, Sorensen and 




To conclude Theme 3, the above extracts show how electronic cigarettes fit within the 
culture of contemporary public health systems. In general, the advisors directed clients 
towards medications and behavioural changes, and attempted to bring electronic cigarettes 
into the world of medicinal nicotine to be given a central role as an aid to stop smoking. 
Although some advisors attempted to move away from “the medical approach”, their 
empowering strategies, which aimed at ‘behavioural and lifestyle modifications’ (Clarke et 
al., 2003: 182), were embedded in the medical gaze. Individuals were required to govern 
themselves, observe and monitor their own behaviour by using disciplinary power (Foucault, 
1988 a,b; Nettleton, 1996). They were subjected to a form of social control based on self-
regulation, self-monitoring and avoiding ‘risk’, through adopting healthy lifestyles and 
keeping well (Nettleton, 1996). 
The three discussed themes: the reasons for using electronic cigarettes; the ambiguity 
of electronic cigarettes’ status and efficacy; and the theme of individualisation, show how 
electronic cigarettes can be described as boundary objects and, at the same time, are a 
product of the biomedical era. My participants revealed several reasons for using electronic 
cigarettes. They had different goals and use patterns and they expressed varied conceptions 
about the efficacy, status and risks (see next chapter) of electronic cigarettes. Users who 
perceived electronic cigarettes as therapeutic products, used them differently from those 
who perceived them as a substitute for smoking. For example, the former users had a plan 
to ‘wean’ themselves off electronic cigarettes. The latter users, however, expressed 
enjoying their use as a new habit. The perceived benefits that the users had gained as a 
result of switching from smoking traditional cigarettes to using electronic cigarettes, and the 
different elements that attracted them to use electronic cigarettes (as discussed in theme 1) 
have led users to downplay the uncertainty about electronic cigarettes, as the next chapter 
will reveal. The advisors, however, while acknowledging the benefits and different reasons 
for using electronic cigarettes, were more cautious about these products. It is due to this 
ambiguity, disagreement and different social meanings allocated to electronic cigarettes, 
that the boundary objects have formed. It was also apparent how the biomedical knowledge 
of nicotine, smoking and addiction had an effect on the different use patterns and 
conceptions of electronic cigarettes. Individual responsibility for one’s own health and of 




electronic cigarettes for all the advisors and the majority of users was to maintain health 
and reduce the harm to users and the people around them. I will now elaborate on the link 
of both biomedicalization and boundary objects theories to the findings of this chapter. 
5.5. Discussion 
In this section, I link both biomedicalization and boundary objects theories to the findings of 
this chapter. 
Besides the biomedical process of focusing on health, I draw on the process of 
‘Transformations of identities, through the creation of new identities by using new 
technology’ (Clarke et al., 2003: 161). The interview data suggest that most electronic 
cigarette users used electronic cigarettes to reduce or stop smoking. Some users tried to fit 
electronic cigarettes within their past smoking rituals, such as using electronic cigarettes 
outdoors and in social occasions with their friends who smoke cigarettes. However, the 
transition to using electronic cigarettes, instead of traditional cigarettes, created a new 
social world, new categories of health-related identities and re-defined electronic cigarette 
users’ old ones (Clarke et al., 2003: 182). Using electronic cigarettes as a substitute created a 
unique representation for electronic cigarettes and, most importantly, a new meaning for 
nicotine. Electronic cigarettes not only were represented as a temporary substitute, but as a 
new habit with its own rituals and culture. Electronic cigarette users spoke about their own 
experience of using electronic cigarettes; they described the different flavours they used, 
the strength of nicotine and the varied designs and techniques of using electronic cigarettes. 
Some mentioned developing a new hobby and new ways of communicating with other 
vapers, such as online forums. Moreover, within the third theme (individualisation), I 
showed how new subjectivities emerged as a result of using electronic cigarettes, such as 
new liberated and self-disciplined individuals. This shows how ‘biomedicalization imposes 
new mandates and performances that become incorporated into one's sense of self’ (Clarke 
et al., 2003: 182). 
The construction of different meanings for electronic cigarettes by different actors is 
mobilising processes of biomedicalization of smoking, nicotine addiction and electronic 
cigarettes. Clarke et al. (2003: 173) suggested that, due to a shifting responsibility to 




has become ‘paradoxically both more biomedicalized… and seemingly less medicalized’. It is 
due to the diverse meanings and perceptions of electronic cigarettes that the ambiguity 
regarding electronic cigarettes’ status and efficacy existed. Electronic cigarettes were 
brought into the field of the medical gaze. For the advisors, the ultimate goal was always to 
help users stop smoking, eliminate nicotine and to stop using electronic cigarettes. 
Electronic cigarettes were transported into the world of public health to become part of the 
organisational processes of tobacco control. So, electronic cigarettes were moulded to fit 
into their regime; hence, implying the electronic cigarettes’ value as a cure or remedy. The 
advisors brought electronic cigarettes into the world of ‘clean’, safe, regulated and good 
nicotine, and alienated them from the ‘dirty’, unsafe and ‘deviant’ smoking habit. Shifting 
electronic cigarettes to the harm reduction field and creating opportunities to deal with 
electronic cigarette users/‘consumers’ signifies a more medicalised approach to nicotine 
addiction. 
However, the recreational use of electronic cigarettes outside the medical control 
signifies a less medicalised gaze for nicotine addiction. Electronic cigarettes, as a new 
biomedical product, have created new social forms and social realities with blurring 
boundaries between the world of ‘good’ nicotine and ‘bad’ nicotine (Clarke et al., 2003). 
Electronic cigarettes as ‘technologies of the self’ (Foucault, 1988a) were used, perceived and 
understood differently by different groups and, therefore, functioned as boundary objects. 
Although, on the one hand, these blurring boundaries and diverse meanings might 
undermine the dominance of biomedicalization, on the other hand, they represent a strong 
indication of the ability of boundary objects to maintain identity in spite of the ambiguity. 
As translational boundary objects, electronic cigarettes enabled two social 
phenomena to merge, namely the recreational and therapeutic nicotine. Electronic 
cigarettes have reconciled the meanings of methods and concepts across the multiple social 
worlds of electronic cigarette users and the advisors (Star and Griesemer, 1989: 388). 
Electronic cigarettes have the ability to structure behaviour in individuals and groups (Bauer 
and Gaskell, 2002: 383). I demonstrated different ways of dealing with and managing 
electronic cigarette use by different participants. For example, some users followed a 
‘weaning’ regime similar to the use of nicotine replacement therapies. Some advisors 




smoking. The data in this chapter show how electronic cigarettes have created new forms of 
using nicotine, new identities and new links among the social worlds of ‘good’ and ‘bad’ 
nicotine. Electronic cigarettes as boundary objects enabled the parallel existence and 
coexistence of these new subjectivities and links; hence, we can see how processes of 
biomedicalization are influenced by the formation of electronic cigarettes as boundary 
objects. 
5.6. Chapter Summary 
This chapter explored the perceptions of electronic cigarettes through focusing on 
electronic cigarette users and stop smoking advisors’ perceptions. I focused on discussing 
three major themes, the reasons for using electronic cigarettes; the ambiguity of electronic 
cigarettes’ status and efficacy; and the theme of individualisation. The data from both 
groups showed no consensus with regards to the perceptions of electronic cigarettes. I 
argued that electronic cigarettes function as boundary and translational boundary objects. I 
established a link to biomedicalization theory, where the intensifying foci on health itself 
and the move towards individualisation were evidenced within the data. I also used my data 
to show how both boundary objects and biomedicalization theories are interlinked. The next 





Chapter 6: The Ambiguity of Electronic Cigarettes’ Risk 
6.1. Introduction 
This chapter addresses mainly the question: What are the perceived risks associated with 
electronic cigarettes, as discussed by electronic cigarette users and stop smoking advisors? 
To some extent also, it addresses the question: What factors have shaped these perceptions 
of electronic cigarettes? Using interview data, the chapter provides an overall perspective 
on the risk perceptions and meanings of electronic cigarettes as described by both the 
advisors and electronic cigarette users, and explores some of the sociocultural factors that 
might have mediated such perceptions. This chapter links risk perceptions of electronic 
cigarettes and risk assessment with the wider sociology of risk. This will help explain the role 
of risk perceptions of electronic cigarettes among other social meanings, and the stance that 
different participants take on electronic cigarettes. First, I discuss the different identified 
risks by both groups. Following that, I reflect on the electronic cigarette users’ risk 
assessment strategies. I conclude by discussing the link to the theoretical framework 
(boundary objects theory and biomedicalization). 
6.2. The Emerging Themes 
The ambiguity of electronic cigarettes was a prominent theme. There was uncertainty about 
the risk that they may pose. Two types of risk emerged from the transcribed interviews: 
physical and social risk. Within the physical risk, participants identified health and safety 
risk, and nicotine use risk. Social risks can be grouped into four categories, as follows. First, 
developing an addiction to electronic cigarettes and maintaining nicotine addiction. Second, 
the increased uptake of electronic cigarettes, gateway use and renormalisation. Third, the 
risk of stigma. Fourth, risk of the involvement of tobacco companies. Table 2 summarises 









Theme 1: The Ambiguity of 
Physical Risk  
Health & Safety  
Nicotine Use  
Theme 2: The Ambiguity of 
Social Risk 
Developing Addiction to Electronic Cigarettes and 
Maintaining Nicotine Addiction 
 
Increased Uptake of Electronic Cigarettes, Gateway 
Use, and Renormalisation  
 
Stigma 
Involvement of Tobacco Companies  
  
Table 2: The identified risks by interviewees 
 
6.2.1. Theme 1: The Ambiguity of Electronic Cigarettes’ Physical Risk 
The theme is divided into two subthemes: health and safety risk and nicotine use risk. 
6.2.1.1. Health and Safety Risk 
Participants held different opinions about the safety of electronic cigarettes, as the 
following section shows. 
Doubts about Electronic Cigarettes’ Safety 
Both groups expressed doubts with regards to the safety and health implication of using 
electronic cigarettes. There was uncertainty with regards to the content of electronic 
cigarettes and how this may affect the users and others around them. For instance, the 
following users stated: “We don’t know yet what vaping does” (12L, user), “we don’t know 
whether they [electronic cigarettes] are 100% safe at all” (9I, user), and “it’s [electronic 
cigarette] still giving out a certain vapour which isn’t generally known what’s in it” (7G, 
user). Uncertainty was also expressed by all stop smoking advisors. One advisor said: 
“I wish I could tell them with absolute surety what the safety is and I can’t. I wish I can tell 
them with absolute surety how much nicotine they are getting from the product and I 
can’t. So I think there are gaps there that I would like to fill.” (H6) 
The advisors expressed more negative assumptions with regards to electronic 
cigarettes’ safety and health implication than electronic cigarette users. One advisor 




“They [electronic cigarette users] are really convinced that there is nothing wrong with it 
[electronic cigarette], it’s all good, it’s all safe. They only have vapour. I really think that 
there is a lack of information.” (H4) 
Another advisor stated: 
“I still think that what we give out [nicotine replacement therapy], we know is safe, it’s 
been tried and tested and I wouldn’t, you know, I wouldn’t consider giving an electronic 
cigarette to a member of my family knowing that they’re not regulated in any way.” (S5) 
Interviewees, from both groups, expressed their concerns about health risks in the long 
term which may become a public health problem, as one advisor stated: 
“We know that it is effective, but what are the health risks for people inhaling propylene 
glycol over periods of time? I don’t know and that’s the bit that worries me a little bit; are 
we just storing up for other public health issues in years to come?” (S2) 
One user shared his concerns by stating: 
“There’s no long-term studies. That kind of worries me, not just a little bit, it does worry 
me. So it’s kind of experimenting with the first generation of these for the first time, you 
don’t really know what somebody’s lungs look like in their fifties when they’ve been using 
them for a lifetime. So it’s completely new territory and that kind of makes the risk a little 
bit less easy to grasp.” (12L) 
Another advisor’s concern stemmed from the history of cigarettes and the worry of history 
repeating itself with electronic cigarettes: 
“My slight concern is, of course, many decades back it was thought that cigarettes were 
health-enhancing; it was thought there were benefits from smoking, now I know there is a 
lot less. Obviously, there is no tobacco, there are none of the chemicals in electronic 
cigarettes, but I think my slight concern is that, a decade or so on, or two generations on, 
are we going to be looking at vapers and say, “oh, we now know that those vapers are not 
particularly health-enhancing”, and having to backtrack and do something? I don’t know, I 





Other studies showed electronic cigarette users’ and advisors’ concerns about the safety of 
electronic cigarettes and their influence on health (e.g. Etter, 2010; Muñoz et al., 2014; 
Beard et al., 2014; Hiscock et al., 2014; Rooke, Cunningham-Burley and Amos, 2015; 
Sherratt et al., 2015a, b). Similar to my findings, concerns from the long-term effect of using 
electronic cigarettes were particularly expressed in other studies (e.g. McQueen, Tower and 
Sumner 2011; Baweja et al., 2016). However, for some users in McQueen, Tower and 
Sumner’s (2011) study, the immediate benefits and improving the quality of life were 
perceived to outweigh any potential long-term harms. 
The Electronic Cigarette is Not Unsafe 
Some electronic cigarette users, in this study, were not concerned about the safety or 
health issues related to electronic cigarette use. One user explained when asked if he has 
any worries: 
“No, not at all, I know there is a little bit of concern, but compared to cigarettes, I wasn’t 
worried about that at all because… I am a doctor myself, so there is no tar, there is no 
carbon monoxide. I don’t know what is in the vapour, but I wasn’t the least worried.” (8H) 
One user also answered: “I haven’t really thought about it, frankly I am enjoying it” (13M, 
user). Another user, when she was asked about the safety of electronic cigarettes, replied: “I 
don’t know, I welcome reading more research on it” (1A, user). Some users believed 
electronic cigarettes to be safe to use. One user said: “I mean, I don’t see how they would 
ban electronic cigarettes unless they found they were doing some sort of damage and I don’t 
think there is any evidence to prove that” (5E, user). Another user argued: “I don’t think it’s 
particularly dangerous, anything in excess is going to be bad for you, but if you use it 
properly it’s as simple as that, it’s an aid to give up smoking” (7G, user). Other users also 
stated: “It’s not unhealthy for me or for the people around me” (2B, user). “I would say it 
should be allowed, it doesn’t do any harm… the electronic cigarette does nothing actually” 
(4D, user). 
Moreover, users talked about the health benefits of using electronic cigarettes, like 
improving their lung function. For example, 1A said: “My lung capacity feels better.” 3C said: 
“I noticed after the first month with electronic cigarettes that I am hardly out of breath 




massive difference.” Still, one user mentioned the side effect of throat irritation. Participants 
in other studies reported perceiving electronic cigarettes to be safe (e.g. Goniewicz, Lingas 
and Hajek, 2013). Also, an improvement in health was reported (e.g. Heavner et al., 2009; 
Etter, 2010; McQueen, Tower and Sumner, 2011; Dawkins et al., 2013). Side effects 
affecting the throat were reported as well (Etter, 2010; Dawkins et al., 2013; Hajek et al., 
2014). Some participants, in this study, mentioned negative design issues which affected the 
safety of the product, such as leaking bottles and the safety of chargers. Participants in 
other studies also highlighted the manufacturing quality issues (e.g. Etter, 2010; McQueen, 
Tower and Sumner, 2011). 
The Electronic Cigarette is Safer than Smoking 
As seen in some earlier examples, the safety of electronic cigarettes was compared to 
traditional smoking. There was a consensus in both groups that electronic cigarettes were 
less harmful than smoking. It was, therefore, the relative risk that was pointed at rather 
than the absolute safety. One user said: “I think there is nothing wrong with them, if you 
don’t give up smoking you’re done” (6F). Another user stated: 
“Obviously, this is less harmful to you and people around you. Obviously with the smoking 
you’ve got all the extra chemicals they put in there, which is harmful to you and to people 
around you.” (10J) 
However, there was still some uncertainty: “they are safer than cigarettes, but you know 
you can’t say that for certain” (12L, user). Participants in other studies believed the risk of 
electronic cigarettes was less than the risk from smoking (e.g. Etter, 2010; McQueen, Tower 
and Sumner; 2011; Barbeau, Burda and Siegel, 2013; Pepper and Brewer, 2013; Peters et al., 
2013; Sutfin et al., 2013; Goniewicz, Lingas and Hajek, 2013; Dockrell et al., 2013; Dawkins 
et al., 2013; Brown et al., 2014b; Tan and Bigman, 2014; Pepper et al., 2015; Sherratt et al., 
2015.a, b; Rooke, Cunningham-Burley and Amos, 2015). However, in Sherratt et al.’s (2015b) 
study, a significant number of participants felt uncertain whether electronic cigarettes were 
safer than smoked tobacco. But, since their findings reported that current users were more 
likely to view electronic cigarettes as less harmful than former or never users, their results 




(2016b) also reported that some electronic cigarette users stopped using electronic 
cigarettes because of concerns that they were not safe enough. 
Similarly, the advisors compared electronic cigarettes to normal cigarettes and 
considered the potential of electronic cigarettes as a harm reduction tool for some smokers. 
This is because they viewed them as “a less toxic sort of way of stopping smoking” (S3). One 
advisor stated: “I see their place in harm reduction for those heavily addicted to smoking” 
(H5). She explained: 
“…it could be the electronic cigarette is the thing that helps them to stop, or at least the 
thing to taking nicotine at a relatively safe level without all the chemicals from tobacco 
and all the harm from carbon monoxide. You are at least eliminating two of those big 
sources of ill health and how it affects the health detrimentally.” 
Some advisors envisaged the benefits of electronic cigarettes for smokers with health 
problems: 
“For some people, yes, it’s a really good route and a very effective way for them to stop 
smoking and to transfer onto a less toxic sort of way of stopping smoking… these are 
people who have to stop for health reasons and, although it’s not regulated, we don’t 
know what it does to the body, but if they are suffering from emphysema and they are 
waiting for operations and all sorts of… you name it… and this is what comforts them and 
helps them, this is maybe better than having a cigarette.” (S3, advisor) 
Similar views were reported by other health practitioners in both Beard et al.’s (2014) and 
Hiscock et al.’s (2014) studies. 
6.2.1.2. Risk of Nicotine Use 
In sections (1.2.2), I discussed nicotine characteristics and the debate about its safety. 
Participants from both groups emphasised the implications of using electronic cigarettes 
containing nicotine. In general, it was agreed that nicotine is an addictive substance and, 
therefore, several concerns were raised as a result. The first concern was that the 
substitution for traditional cigarettes may create a new addiction to electronic cigarettes. 
Second, a concern that electronic cigarettes could maintain nicotine addiction. Third, the 




specified their concern regarding the negative effect of using nicotine; one user described 
nicotine as a “poison” (3C, user), while another user thought that “nicotine itself isn’t very 
good for you” (11K, user). Similar concerns were expressed by some participants in Rooke, 
Cunningham-Burley and Amos’s study (2015).  
To summarise, there was uncertainty about the potential health risks of electronic 
cigarettes. The advisors expressed more negative assumptions with regards to the electronic 
cigarette’s safety and health implications, yet both groups agreed on its relative safety when 
compared to traditional smoking. The users’ perceptions of safety ranged between 
perceiving electronic cigarettes to be safe, safer than smoking and not knowing if they are 
safe or not. The anxieties that were expressed by some participants resulted from the 
uncertainty of electronic cigarette use outcome and their potential risk. The health benefits 
were described by some users. Overall, uncertainty was evident in both groups, similar to 
findings from other studies (e.g. Etter, 2010; McQueen, Tower and Sumner; Sutfin et al., 
2013; Pepper and Brewer 2013; Rooke, Cunningham-Burley and Amos, 2015; Sherratt et al., 
2015a, b; ASH, 2016b). In spite of the uncertainty, electronic cigarette users in this study 
continued to use electronic cigarettes. Only one user decided to stop electronic cigarette 
use because he “kept wanting to smoke again” (8H). Next, I discuss the identified social 
risks. 
6.2.2. Theme 2: The Ambiguity of Electronic Cigarettes’ Social Risks 
This theme is divided into four subthemes. First, developing an addiction to electronic 
cigarettes and maintaining the addiction to nicotine. Second, increased uptake of electronic 
cigarettes, gateway use and renormalisation of smoking. Third, risk from stigma and, fourth, 
the involvement of tobacco companies. 
6.2.2.1. Developing Addiction to Electronic Cigarettes and Maintaining Nicotine Addiction 
I consider developing addiction to electronic cigarettes and maintaining addiction to 
nicotine a social risk because as I explained in chapter 1, among the main health 
organisations in the UK, including the Stop Smoking Services and stop smoking advisors, it is 
well accepted that nicotine does not cause harm. Hence, I did not include this risk in the 
physical risk section. Further, I have highlighted that nicotine replacement therapies have 




risk of becoming addicted to these products have not generated fierce debate similar to the 
debate that electronic cigarettes have ignited. In chapter 1, I have also highlighted the 
efforts of mainstream tobacco control movements to eradicate the visibility of any smoking 
like behaviour (Bell and Keane, 2012), and the efforts of some tobacco control programmes 
to hinder the progression of practices such as harm reduction approaches to achieve the 
goal of eliminating all kinds of nicotine use (Elam and Gunnarsson, 2012). This has led me to 
conclude that these efforts to eliminate the use of nicotine are based on their stance of 
eliminating nicotine addiction as a social habit rather than a harmful practice. Indeed, my 
findings show how the worry about the similarity of the habit of electronic cigarette use to 
smoking has led most advisors to approve their ban in public places, regardless of the safety 
issue.  
Some advisors showed a concern with regard to people who had decided to start using 
electronic cigarettes and who might then develop a nicotine addiction. One advisor said: 
“I feel like there is a new toy in the market, ‘let’s try this, you know, because it’s supposed 
to be healthy and not cause any health problems’. But it’s a chemical that they don’t need, 
it’s not going to benefit them, so that’s that. The danger may open up a door for an 
addiction they did not have to begin with. Yeah, it’s a double-edge sword.” (H1) 
The following user also explained how experimenting with electronic cigarettes can develop 
an addiction: 
“Unfortunately habits and addiction, it kind of, for me it creeps in. So if ever my boys or 
anyone in my family said, ‘Well, I’m going to...’ even if they’re not a smoker, ‘I’m going to 
try the vape.’ I’d say, ‘No don’t do it,’ because again it’s something that you might really 
enjoy doing and again it’s – you’ve got to put money into it, and in reality, if you’ve lived 
without it, you don’t need it really.” (10J) 
Other advisors highlighted their concerns about developing addiction to electronic 
cigarettes. Some mentioned that some electronic cigarette users approached their Stop 
Smoking Service asking for help to stop using electronic cigarettes: 
“It started to happen not that often, but I know three instances in the last few weeks when 
people were presented to us, stating that they already quit cigarettes but wanted to come 




Both Beard et al.’s (2014) and Hiscock et al.’s (2014) studies pointed at similar concerns by 
the stop smoking advisors and managers in Stop Smoking Services (see 1.4.3). One advisor in 
this study, however, was not worried about developing an addiction to electronic cigarettes, 
based on comparison with traditional cigarettes and cases of people developing addiction to 
other licensed nicotine-containing products: 
“I wouldn’t be worried because it’s still harm reduction, but we’ve had people become 
dependent on the licensed products, and we’ve suggested a patch programme that can 
help them come off the oral stuff. The oral stuff is much more addictive than the patches. 
So I don’t have any big worries because I know that they’re safer with electronic cigarettes 
than normal cigarette.” (S4) 
Similarly, some users acknowledged the addiction they had developed to electronic 
cigarettes, as the following user put it: 
“It’s going to be as big a struggle as giving up normal cigarettes… But then, I suppose…. 
they help you stop smoking, I can see – I think for me they mimic smoking almost perfectly, 
so the addiction is almost as bad to these things as it is to cigarette.” (12L) 
Some users also acknowledged that using electronic cigarettes can maintain nicotine 
addiction, as one user asserted: 
“I mean there are no health warnings on it [electronic cigarette] because no one has 
discovered any health dis-benefits apart from the fact that it will keep you addicted to 
nicotine. And I think most people who smoke electronic cigarettes, I think, know that 
nicotine is highly addictive.” (14N) 
In their study, Sherratt et al. (2015a) found that both ever and never users 
acknowledged that electronic cigarettes were associated with the maintenance of nicotine 
dependence. Their participants disapproved the long-term nicotine dependence, 
independent of tobacco smoking. They also disapproved of the long-term use of electronic 
cigarettes. Dawkins et al. (2013) raised the question that electronic cigarettes themselves 
could possibly be addictive, although their findings suggested a lower dependency on 
electronic cigarettes compared to tobacco smoking. ASH (2016b) reported that some 
electronic cigarette users stopped using it because of a concern of more frequent use of 




reduces or increases nicotine addiction. In their study, McQueen, Tower and Sumner (2011) 
found that many vapers reported using lower nicotine concentrations over time. A 
prospective population study concluded that smokers who have used electronic cigarettes 
may be at increased risk of not being able to quit smoking (Al-Delaimy et al., 2015: 1218). 
The authors asked for further studies to address their findings, but stated that ‘It may be 
that e-cigarette use is increasing the nicotine dose of smokers and their level of 
dependence, making them less capable of quitting.’ Rooks et al.’s study (2015) found that 
the concern of creating another addiction was highlighted by a group of recent ex-smokers, 
who stated that the concern of creating a new addiction can be attributed to increased 
intake of nicotine, when using electronic cigarettes, due to the unique design and 
consumption technique of electronic cigarettes. This is a point of view that was highlighted 
by some electronic cigarette users in this study. The following two examples were also used 
in section 5.3.2.2 when the efficacy of electronic cigarettes to deliver nicotine was 
discussed: 
“I don’t find it gives me the total satisfaction that a normal cigarette gave me. Thus, I 
‘suck’ on it a lot more than I probably should.” (2B) 
“I take far more nicotine now, far more. The thing about the electronic cigarette is… it 
doesn’t stop… you can smoke for three hours continuously or something, I don’t know 
exactly how long the battery lasts. But it lasts for hours.” (11K) 
To the contrary, other users highlighted the ability to reduce nicotine levels in 
electronic cigarettes. Indeed, some users said they were using zero nicotine-strength 
electronic cigarettes, while others verbalised their plan to reduce nicotine intake. The 
concern of an increased consumption of nicotine as a result of using electronic cigarettes 
was also highlighted by some advisors, as the following extract shows: 
“The other problem I have is that I think a lot of these people are having probably more 
nicotine because they’ve got this electronic cigarette in their mouth all the time.” (S6) 
6.2.2.2. The Uptake of Electronic Cigarettes, Gateway Use and Renormalisation 
In the literature review, I showed that concerns from these risks were raised in spite of the 
lack of strong empirical evidence (see 2.5.2.2). The data from this thesis showed a range of 




The Uptake and Gateway Risk 
Electronic cigarette users in this study were either dual users (both smokers and electronic 
cigarette users) or ex-smokers but currently using electronic cigarettes. Although some saw 
the possibility of the young taking up the habit of using electronic cigarettes, others did not 
think that electronic cigarettes would attract non-smokers, as the following user said: “I 
can’t imagine anybody using it if you didn’t use to smoke… maybe some people think it’s 
cool. I find that a bit difficult to imagine, to be honest” (11K, user). Still, it was viewed as a 
better choice than taking up traditional smoking: “I think it’s kind of sad but it can’t be as 
harmful as smoking, starting to smoke” (5E, user). 
Electronic cigarette users were divided in their opinion as to whether electronic cigarettes 
can be a gateway to smoking. Some agreed with such a possibility, as the following user 
explained: 
“I don’t know. But I don’t see why that can’t happen. If you build up a nicotine addiction 
through vaping, and one day you walk past an airport and there’s no other way of getting 
your fix than buying a packet of cigarettes, because no one sells – I can well imagine 
people will try that.” (12L) 
Another user provided a similar opinion: “I think that is quite a good possibility because they 
are getting used to the habit of putting something towards their mouth and it’s got nicotine 
in it” (7G). Others, however, did not agree with the gateway concern, as the following 
example showed: “I don’t really see that, to be honest… The transition from that to a 
cigarette, I don’t buy that. It’s too different” (11K, user). Another user, who disagreed with 
the gateway idea, said: 
“I don’t think that people use it as a gateway to cigarettes, but I am obviously worried 
about it and I don’t want people to do it, but I do think that there are going to be some 
people who start smoking by using electronic cigarettes and get slightly addicted to it. But 
I don’t think anyone will use it to go to cigarettes because cigarettes smell and taste 
disgusting in comparison.” (9I) 
The advisors were also divided in their opinions. Some were concerned about the gateway 




“I don’t think there is any evidence at the moment that children are starting to use an 
electronic cigarette, that it is used as a gateway drug. But I don’t think we have got 
enough evidence, longitudinal evidence.” (H6) 
Some advisors pointed at the role of advertisement, marketing and flavours in attracting 
young people in particular. One advisor described the popularity of using electronic 
cigarettes among the young; yet, he did not relate that to smoking: 
“The evidence to me by talking to members of the family that they do see that the number 
using them is a fact, but I don’t think it will lead them to smoke.” (S2) 
Another advisor (S5) also described how electronic cigarettes had become popular among 
the young people: “My daughter is in the sixth form, she says that in break time now, the 
students are all getting their electronic cigarettes out and vaping.” Another advisor 
emphasised the increased uptake of vaping, but did not agree with the gateway concept: 
“I think if people start smoking or vaping I’m not necessarily sure it will lead to 
conventional smoking, probably more the other way round I guess… but I do think we’ll 
create a generation of people who have maybe never smoked tobacco but are vapours.” 
(S3) 
The same advisor predicted that, once electronic cigarettes become regulated, they are 
going to become the “more cultural norm”. 
Renormalisation Risk and Denormalisation of Electronic Cigarette Use Policies 
The concern that public health efforts to denormalise smoking may be undermined by 
normalising electronic cigarette use in society was highlighted by the advisors. There were 
concerns of the resemblance between electronic cigarettes and traditional cigarettes and 
the difficulty in differentiating between vaping and smoking, especially by children. Some 
advisors did not approve of using electronic cigarettes in public places and called for 
extending Smokefree laws to include electronic cigarettes, even in the absence of evidence 
of harm. In the words of the following advisor answering the question if she accepts using 
electronic cigarettes in public places: 
“If it looks like a cigarette, no, and it’s not necessarily because there are any effects of 




become very difficult to regulate. Is that person smoking or is that person using the 
electronic cigarette?” (H6) 
The same advisor highlighted the undermining of smoking denormalisation efforts, as 
follows: 
“I do have reservations about it in that it’s looking like a cigarette and undoing the work of 
tobacco control we’ve done in terms of de-normalising it, and I do wonder about people 
using it in front of children as well and what the long-term effects of that are.” (H6) 
Other advisors agreed with this argument, as the following extract reveals: 
“About how it looks. I think generally there has been a huge amount of work to achieve 
the stop smoking ban in public places that is: any transport, any restaurant, any sort of 
public place, and I think to allow electronic cigarettes in those places will be a retrograde 
step.” (H5) 
The similarity of electronic cigarettes to traditional cigarettes in the image and the habit was 
unwelcomed by most advisors. It was viewed as an obstacle to break the habit of smoking 
and to disassociate between both products. For example, the following advisor viewed the 
resemblance between electronic cigarettes and cigarettes to be a hindrance to successful 
quitting, rather than an aspect of electronic cigarettes’ efficacy: 
“I am more worried about the habit and the image, yes, but... it will be regulated anyway 
so then they will have to make amendments. ….my concern is the quick hit and the look 
and what people associate, you know, they are fooling themselves that they are making a 
change, but psychologically they are not ready to make a change because, what I say, why 
would you do exactly the same, just have the real one then.” (H4) 
The following advisor also supported a ban on electronic cigarette use in public places to 
avoid the uptake of electronic cigarettes: 
“Because with the cigarette you can say it is harmful; it’s dangerous; it is not good for you. 
But as they get older they question the nicotine products that are safe so the electronic 
cigarette won’t be an issue in using. I’d rather it be limited in where they can use it, so they 
cannot use it on buses or the trains, in schools, and the same with smoking use, the 




Nevertheless, one advisor (S4) recognised that replicating Smokfree regulations to vaping is 
not a straightforward answer as people’s rights need to be considered, both for vapers and 
the people around them. This agrees with Voigt (2015), who calls to explore restricting of 
electronic cigarette use in the lens of the ethical complexities of attempting to manipulate 
social norms to change an individual’s behaviour. Both Beard et al.’s (2014) and Hiscock et 
al.’s (2014) studies showed that health professionals in Stop Smoking Services were 
concerned about the gateway use, nicotine maintenance and renormalisation of smoking. 
However, users in this study stated that, generally, they did not use electronic cigarettes 
around other people, unless they asked for permission. One user said: 
“I personally don’t use them anywhere I don’t normally smoke at all. So I wouldn’t use it in 
a building unless, of course, it is a friend’s house and I know that they are ok with it. If I am 
sitting down at a bus stop or something, I will ask the people around me if they are all 
right with that. I never use it around kids.” (9I) 
Users, generally, acknowledged that the vape might irritate others, even if there was no 
harm. Most of them also stated that they vape outside public buildings, especially 
restaurants. The following extracts are examples: 
“It’s the same principle. I just think its politeness, so even if the second-hand vape is safe.” 
(3C) 
“My view of the electronic cigarettes is it’s, personally anyway, rude to smoke them any 
place where you wouldn’t be allowed to smoke.” (11K) 
“I still feel that I am smoking and if I am smoking I go outside, it’s the price I pay for it. I 
don’t expect other people to sit around and inhale my vapour, the same way I expect them 
to sit around and inhale my smoke. I would go outside if I want to vape.” (15O) 
Nevertheless, one user introduced a contrary argument, defending electronic cigarette use 
in public places: 
“If I am smoking my electronic cigarette in a place and someone comes up and said I find 
that offensive, the problem is with them not with me, because I am not smoking a 
cigarette which is illegal. I am smoking an electronic cigarette which is legal and… I am 




None of the users, in this study, agreed to use electronic cigarettes in front of children, 
either for health and safety concerns or to avoid initiating a new unwanted habit, as the 
following user clarified: “It doesn’t seem like a very good example to set. And I’m not entirely 
certain that the steam is good for them” (11K). Peters et al.’s (2013) results showed that 
users used electronic cigarettes everywhere, including school and home. Another study 
found that many electronic cigarette users reported having used their electronic cigarettes 
in a location they would not normally have smoked tobacco, like pubs/bars, public 
transport, work, shops, cars and in hospitals (Sherratt, 2015b). Moreover, other studies 
identified concerns about banning electronic cigarettes (Etter, 2010; Etter and Bullen, 2011; 
McQueen, Tower and Sumner, 2011). Pepper and Brewer (2013), in their systematic review, 
could not find any argument by users that electronic cigarettes should be exempted from 
Smokefree indoor regulations. Here, one user agreed with the ban on electronic cigarettes: 
“You know if someone is using electronic cigarettes and there is a non-smoker in the 
building they are not going to like that either because of the different flavours. I think it’s 
right the fact that some places ban the electronic cigarette, it’s still giving out a certain 
vapour which isn’t generally known what’s in.” (7G) 
The majority of users, however, did not approve of a ban on electronic cigarette use in 
public places. The rationale was that banning electronic cigarettes should be linked to 
inflicted harm, as the following user said: 
“I mean, I don’t see how they would ban electronic cigarettes unless they found they were 
doing some sort of damage and I don’t think there is any evidence to prove that.” (5E) 
A similar argument was forwarded by another user: 
“I think the justification for banning cigarettes… passive smoking was an issue. I think if 
there is no danger of passive smoking [vaping] which I believe is the case, I don’t see why 
they should be banned from public places.” (1A) 
Other users believed that smoking and vaping should not be restricted, for example: 
“My opinion and that’s with my fellow people who smoke vapes, is we’re quite angry 
about the idea that it’s going to be banned and that legislation is going to be brought in, 
and we’re really quite angry, because those of us who have managed to keep off tobacco 




with our addiction. So if they start banning it, it’s just going to drive it underground, I 
guess.” (14N) 
Again, the following user believed that: “It shouldn’t be banned in public places as I can 
guarantee it will drive people back to smoking.” (2B, user) 
In summary, the social risks of the uptake of electronic cigarettes, gateway and 
renormalisation were still ambiguous. Participants were divided in their views on whether 
there was a cause for concern. In their discussion of an electronic cigarette ban in public 
places, the advisors were worried about the resemblance of electronic cigarettes to 
cigarettes and favoured a ban on their use in public places. On the other hand, electronic 
cigarette users raised issues of their right to use electronic cigarettes, if harmless to others, 
without being discriminated or stigmatised. However, denormalisation of tobacco use 
policies, it was argued, resulted in the stigmatisation of smokers (Bayer, 2008; Bell et al., 
2010). Accordingly, denormalisation of electronic cigarette use policies may result in the 
stigmatisation of vapers. The risk of stigma is discussed next. 
6.2.2.3. The Risk of Stigma 
Some electronic cigarette users in this study expressed their happiness and satisfaction for 
switching from cigarettes to electronic cigarettes. For example, the following users said: 
“I admire the vapers because I think that they are very smart.” (14N) 
“I mean, at the moment I am smoking but next month I will probably be using vapour 
[electronic cigarette] and I will be a lot happier when I am using the vapour because I 
don’t like smoking, it’s just a very difficult habit to quit.” (7G) 
The advisors also recognised that users “mostly they feel positive about using electronic 
cigarettes” (H7). The following advisor also mentioned the new identity that electronic 
cigarette users are developing: 
“The vaping community is getting bigger, they do seem to want to have an identity. A 
couple of facts. From the people I have spoken to, quite a few are quite proud of 
themselves that they don’t smoke, they are seen as doing something new and exciting and 




Certainly, for people they have been on for a longer time, it’s not about the smoking it’s 
about lifestyle, you certainly see that.” (S2) 
Both groups agreed that electronic cigarette use is more acceptable than smoking. 
However, one of the social risks identified by electronic cigarette users was concern about 
stigma. Here, some users felt that electronic cigarette use was not socially acceptable. The 
advisors, in general, viewed electronic cigarettes to be socially acceptable, especially when 
compared to traditional smoking. The rationale for accepting or stigmatising electronic 
cigarette users was linked to the following reasons: vapour, knowledge, media, culture and 
group differences, safety, novelty, appearance and attitudes towards addiction behaviour. 
Vapour 
Vapour was acknowledged, by some users, to be unpleasant to people around electronic 
cigarette users. Vapour was also believed to be a reason for electronic cigarette use to 
either be accepted or stigmatised. For example, the following user believed that vapour 
irritated others and was a cause for an electronic cigarette ban in some places: 
“I don’t think it’s acceptable. I don’t think people are going to accept it, because I know a 
few people already who, you know, when you’re puffing that out, even though it’s not the 
smoke, someone is still having to breathe it in when they shouldn’t have to. Or even just 
that smell of the, you know, the flavour or – and I know some places have banned it now.” 
(10J) 
Another user (9I) expected that the misuse of electronic cigarettes in a way that irritates 
non-users, such as blowing clouds in their faces, would end up in stigmatising electronic 
cigarettes. To the contrary, other users believed that electronic cigarettes have become 
widely acceptable because “it’s a lot more pleasant to people to smell the vapour than 
smoke” (7G). Another user referred to the tobacco-free smell and the absence of second-
hand smoke as the reasons for social acceptance (15O). Similarly, one advisor suggested 
that the vapour would not be a reason for people not to accept electronic cigarettes: 
“Some people who are already strongly anti-smoking probably won’t be happy seeing 
them. But I think the majority will probably accept them and maybe see it as people 
getting their fix of nicotine, there is some vapour but there is no smoke, so most will 




Lack of or Incorrect Information 
Stigma was also related to lack of information or misunderstanding. Participants pointed out 
the role of communicating the right information about electronic cigarettes to avoid 
stigmatising electronic cigarettes. One user (9I) suggested that electronic cigarette users 
would not be subject to stigma, like smokers. He believed that when people understand 
what electronic cigarettes are, they will not look badly at the users. Another user, however, 
asserted that there was a stigma attached to electronic cigarettes; he believed that 
misunderstanding was the reason and highlighted the role of the media in stigmatising 
electronic cigarette use: “the news is giving electronic cigarettes a massively bad press and 
they are not as bad as people are saying” (3C). The above extract reflects the role of the 
media in creating ‘technological stigmas’, as discussed by Garrick (1998: 42). The lack of 
transparent communication of technical or scientific risk studies may lead to amplifying the 
risk of electronic cigarettes and, hence, amplifying the stigma (Kasperson et al., 1988; 
Gregory, Slovic and Flynn, 1996; Zwick, 2002a; Kasperson et al., 2003). A different view on 
the media was forwarded by one advisor, who suggested that promoting electronic 
cigarettes and the media attention have influenced their uptake and made electronic 
cigarettes socially acceptable (S1). 
Stigmatising the Addiction 
Stigmatising the addiction behaviour was believed, by one user (12L), to be a reason for 
stigmatising electronic cigarette use. The user explained that stigma, that is believed to be 
attached to smokers, has shifted to electronic cigarette users. The same user expressed how 
there had been a transition in people’s reactions to electronic cigarettes over time. So, while 
electronic cigarettes were accepted at the beginning as a smoking cessation aid, stigma 
emerged when they became a lifestyle choice. 12L explained: 
“I think the stigma that smokers have has kind of carried on to the electronic cigarette 
users in the sense that the stigma was surrounding the addiction itself. People see you as 
weak because you give in to the addiction because you obviously don’t have willpower 
enough to stop, so it’s kind of the moral judgement…” 
Other studies showed a small number of electronic cigarette users were concerned about 




(Kralikova et al., 2012; Dawkins et al., 2013; ASH, 2016b). Although some of the electronic 
cigarette users in this study were concerned about social acceptability, only one user 
revealed that she wouldn’t use electronic cigarettes in front of people: 
5E: That’s just the personal thing with me, that’s how I feel, I don’t want to be associated 
with smoking I suppose… most people didn’t even know I smoked cigarettes. 
Researcher: So do you feel more comfortable using electronic cigarettes? 
5E: In front of people, no. 
One user, when asked why she did not approach the Stop Smoking Service, she said: 
“Probably shame. It’s always been quite hidden behaviour and that’s quite public and I am 
also very suspicious of the way the NHS use their data of people who smoke. I would be 
anxious that once my name becomes on the list of someone who previously smoked, I 
would be in future refused medical treatment.” (1A) 
Her answer reflects the notion of ‘felt normative stigma’ (Scambler, 2009: 446) as the 
subjective awareness of stigma by the user motivated her to avoid the service so as to avert 
‘enacted stigma’ (Scambler, 2009: 445). This concurs with Stuber and Galea’s (2009) study, 
where smokers concealed their smoking status from health providers. It also concurs with 
Stuber, Galea and Link’s (2009) findings of smokers’ avoiding cessation programmes in order 
to avoid stigma. It also conforms to the evidence Bell et al. (2010) provided of widespread 
discrimination against smokers in healthcare systems in the West. People’s judgemental 
opinions about using electronic cigarettes were reported in Sherratt et al.’s study (2015a: 9). 
Moral judgement and stigma were described by Lupton (2006: 14) as a manifestation of 
increased individualisation and personal responsibility to conform to the social lifestyle 
norms and behaviours. The social norms that disapprove of smoking, especially the 
disapproval of family and friends, was believed to be a factor that contributed to forming 
smoker-related stigma (Stuber, Galea and Link, 2008). However, electronic cigarette users in 
this thesis did not report experiencing stigma personally. This could be because most users 
in this study used electronic cigarettes within an environment that accepted electronic 
cigarettes, as I show next. 




Users acknowledged that the acceptance of electronic cigarettes differs between different 
cultures or subgroups. While electronic cigarette users may experience stigma in one 
environment; they would be accepted in another surrounding. For example, the following 
user stated that vaping was not accepted by her parents, but was accepted by her friends: 
“I think it depends on cultures and background as well because obviously in some cultures, 
a lot of things are accepted and, in some cultures, those things are just a no-go. So with 
my parents, I couldn’t sit there in the lounge and have this with them. They would kick me 
out of the house… they’d say… “It’s a habit, you don’t need it...” That would be their take 
on it. So I think, I don’t know, it all depends on your background and your culture and 
everything.” (10J) 
This, according to Lupton and Tulloch (2002: 331), shows ‘reflexive awareness of how risk is 
understood and perceived in different ways for different people or social groups’. The overt 
discrimination and social unacceptability of vapers also conform to Scambler’s perspective 
of ‘enacted stigma’ (2009: 445). Electronic cigarette users, who were surrounded by people 
and a community that accepted their habits, did not feel stigmatised. For one user (2B), his 
“social life is better” because he no longer needed to leave the room to have a “fag”. 
Another user did not feel stigmatised, even when he used to be a smoker, because he was 
surrounded by smokers (11K). One user explained how being part of a group of friends who 
accepted each other’s habits, like smoking and drinking, meant that he was not excluded for 
any habit, including vaping (14N). The same user reflected on the stigma that he saw 
alcoholics and drug addicts face in his neighbourhood. He concluded that, although he was 
“forced to live by non-smokers’ rules, [because] pretty much the majority of the population 
doesn’t smoke”, he did not feel stigmatised. Another user spoke about people, who saw her 
vaping, being encouraging and curious about her using electronic cigarettes (1A). The same 
user reported the role of family endorsement: “my children don’t like the fact I use them at 
all but they are proud of me giving up smoking, my husband prefers it”. Another user also 
said: “My wife doesn’t have a problem with it as long as it has a nice smell so she doesn’t 
have to spend on air freshener because it does make the room smell nice.” (3C). Similarly, 
one user emphasised the encouragements he received from his family for using electronic 
cigarettes, and how he made his daughter happy for using electronic cigarettes rather than 




cigarettes around others. He described how people’s perceptions of him had improved 
because they assumed he had stopped smoking (13M). The risk was, therefore, influenced 
by the sociocultural environment in which participants were embedded (Douglass, 1992; 
Lupton, 1999; Adam and Loon, 2000; Tulloch and Lupton 2003). 
It was argued that electronic cigarette users exhibited solidarity to each other (Pepper 
and Brewer, 2013). The social benefits of vaping groups and online forums were highlighted 
in the literature (Etter, 2010; McQueen, Tower and Sumner, 2011; Barbeau, Burda and 
Siegel, 2013). Only one user (3C) in this study had a social activity on the Internet, as he was 
the founder of an online group in his county. The role of social connection was also 
acknowledged by the advisors in this study. One advisor noticed that: “there seems to be a 
sub culture of e-ciggi [sic]” (H4). Another advisor pointed at the electronic cigarette active 
vaping community and forums; he described how vapers try to distance themselves from 
their previous identity as smokers and establish a new vaping culture (S2). Another advisor 
pointed at the social element of using an electronic cigarette: “for some, it is just like a social 
thing when they are with their friends and family, they want to feel a part of that group” 
(H1). This could be explained as an attempt to disassociate themselves from the stigma that 
surrounded smokers, as well as to create new social norms to avoid social exclusion (Gibbs, 
1965). 
The Technological Innovation and Fear of Harm 
The advisors highlighted the novelty and innovative elements of the electronic cigarette, 
which made it attractive, pretty and fashionable and, therefore, “it doesn’t seem to be 
frowned upon” (S1). According to one advisor (H3), the electronic cigarette became a 
fashion item, especially for teenagers. The same advisor stated that electronic cigarette 
users reported using electronic cigarettes around people without feeling embarrassed. He 
also pointed at smokers who felt comfortable and positive while using electronic cigarettes, 
as an aid to stop smoking, compared to other licensed nicotine-containing products, which 
smokers did not like to use in public. Another advisor stated: 
“I see it as a trend in human behaviour. Something which is new, and people like to try 
things, there is some curiosity. It’s been heavily advertised and we live in an electronic age, 




The same advisor described electronic cigarettes as a fashion accessory. Similarly, one 
electronic cigarette user said: 
“I like it when people ask me what I’m doing and I show them my machine and they get 
very interested in it because it doesn’t look like a cigarette.” (14N) 
This conforms to Peppers et al.’s (2015: 323) argument that electronic cigarettes’ status as 
an ‘innovative product might reinforce their positive characteristics’. 
However, similar to the stigmatisation of other technological hazards (Slovic, Gregory 
and Flynn, 1995), stigma was related to the safety and health implication that electronic 
cigarettes may inflict on others. One user asserted: “cigarettes were proved to be harmful to 
people in closed places. Unless they can prove that electronic cigarettes are the same, they 
shouldn’t be stigmatised” (13M). Again, one user believed that stigma is less for electronic 
cigarette users than for smokers: 
“I think they will be a little bit stigmatised, but I don’t think they will be stigmatised as 
cigarettes because we know scientifically that there are real dangers from passive smoking 
and, at the moment, we don’t know if there are real dangers from passive smoking; from 
people using electronic cigarettes.” (8H) 
Similarly, one advisor suggested that electronic cigarettes were accepted because of the 
absence of harm (H7). However, one advisor believed that electronic cigarettes were not 
socially acceptable by non-smokers due to the uncertainty about their content and safety. 
She pointed to fear from electronic cigarettes among non-smokers: “We’re all non-smokers 
and actually we’re all very suspicious”. She also mentioned how her daughter “wants them 
banned because she doesn’t know what she is breathing in” (S5). 
So, ambiguity and fear might contribute to the stigmatising of electronic cigarettes, as 
both reasons played a major part in stigmatising other biotechnological innovations and 
products (Gregory, Slovic and Flynn, 1996; Garrick, 1998), including fear of harming children 
by second-hand smoke, which contributed to the formation of a smoker-related stigma 
(Stuber, Galea and Link, 2008). 




Stigma may also arise from the resemblance of electronic cigarettes to traditional cigarettes. 
Earlier in the chapter, I discussed how the advisors disapproved of this resemblance. 
Another example is this statement from an advisor: 
“If they see something which looks like a ciggi [sic] how am I gonna help them to 
completely forget about smoking when it is exactly a replacement?” (H4) 
However, the advisors saw the potential of the electronic cigarette, once regulated as a 
medicine, in helping certain people to quit smoking, as I discussed earlier. Users 
acknowledged the connection that the public establishes between smoking and electronic 
cigarette use (vaping). One user (13M) mentioned how he was approached in a public place 
by an individual who thought he was smoking. Another user said: “there is a very negative 
[opinion], actually took from a non-smoking community who just see it as another potential 
of hazards like smoking” (8H). Similarly, in Sherratt et al.’s (2015a: 11) study, the 
physiological and behavioural similarities to cigarettes were perceived negatively and were 
disapproved, particularly among never users, who expressed no intention to try electronic 
cigarettes. A similar disapproval was also identified in Rooke, Cunningham-Burley and 
Amos’s study (2015). 
The reasons that were suggested above for stigmatising electronic cigarettes conform 
to the argument that people’s responses to risk can be non-reflexive and based on 
unarticulated assumptions and moral values, which are developed and shared by members 
of cultural subgroups (Lash, 1993). Also, that judging and reacting to risks and stigmas do 
not rely on the objective risk characteristics, technical or scientific risk studies solely 
(Kasperson et al., 1988; Gregory, Slovic and Flynn, 1996). 
To summarise, uncertainty existed with regards to the level of electronic cigarettes’ 
acceptance in society. Participants discussed several reasons for accepting electronic 
cigarette use in society: harmless and/or pleasant vapour, a good understanding of 
electronic cigarettes, innovative and fashionable element, good publicity by media and 
cultural acceptance. However, the suggested reasons for not accepting or stigmatising 
electronic cigarettes were: harmful and/or unpleasant vapour, lack of knowledge or 
misunderstanding, bad media coverage, resemblance to cigarette, disapproval of addiction 




6.2.2.4. Risk of the Involvement Tobacco Companies 
When asked about the involvement of the tobacco industry in electronic cigarettes, some 
users expressed concerns about such involvement, while others were not aware of such 
involvement. This might reflect a lack of transparent communication systems on the part of 
the tobacco industry in the electronic cigarette market. However, I believe this is an 
important social risk that requires exploration because it may reveal deeper moralistic and 
cultural issues, such as the link between the government, science and tobacco industry. It 
can also be an important mediating factor in shaping the growth of electronic cigarettes. 
Two users highlighted the role of the tobacco industry in the electronic cigarette 
market, but with two contradicting views. One user (14N) believed that these companies are 
“clinical criminals”; he considered them his “enemies” because these companies “help make 
the nicotine replacement therapy products. They’re putting up levels of nicotine in tobacco.” 
Hence, when it comes to electronic cigarettes, “they want a share of the action; that’s 
business” (14N). Another point of view was forwarded by the following user, who believed 
that electronic cigarettes posed a threat to the popularity of traditional cigarettes and, 
therefore, the tobacco industry is trying to restrict the popularity of electronic cigarettes: 
“The people who are trying to regulate them at the moment are the tobacco industry and 
obviously they are the ones that don’t want people to stop smoking. I think some of the 
regulations they are trying to put down on e-cigarettes is if they are being used as a way 
to kill them, or to make them redundant rather than to actually help them grow.” (9I) 
The same user believed that tobacco companies, and he referred to “Marlboro”, want to 
monopolise the electronic cigarette market: 
“I think my assumption is that the reason why they are trying to add these regulations to 
them is that, if they do add the higher regulations on them, it means that only Marlboro 
can make the devices, which means they can put any price tag on them.” (9I) 
To the contrary, one user felt safer with a product manufactured by tobacco companies: 
“I know a lot of people wouldn’t associate tobacco companies with safety, but at least, like 
the large multinational companies, they will have much more internal testing of these 




tend to trust the tobacco industry electronic cigarettes probably a bit more.” (12L) 
The advisors were more strongly opinionated about the intentions of the tobacco industry 
to gain new smokers. The following advisor wanted electronic cigarettes to be used as a 
short-term treatment because: 
“They made enough money from it. [There] needs to be a limitation and it’s not a way in 
for major cigarette companies to view it as an avenue for them to get new smokers.” (H1) 
For one advisor, this involvement created a “dilemma”, as she questioned: “So you have got 
a bit of a dilemma. Do you want to give out a product that ultimately has been made by a 
tobacco company?” (S6). Another advisor said: “Why is it not regulated just yet and why are 
the British and American tobacco companies having a fight over the licensing? Is it not to 
keep the money in the same pot? So I don’t think people realise” (H4). However, the same 
advisor expected that a link with the tobacco industry can be a possibility in order to “keep 
up with the times, and, you know, probably our clients want, and we’re very client-based, 
you know, we listen to our clients. So we’ll see.” Such statement reflects the rise in 
consumerism, where patients act and are treated like consumers (Conrad, 2008: 15). This 
also signals the biomedicalization process of intensifying the focus on health and growth of 
the industry of health improvement (Clarke et al., 2003). The scepticism shown here about 
the tobacco industry mirrors similar concerns raised by several scholars who questioned the 
morality and intentions of the industry (see 1.4.4.) (Koop, 2004; Glover, 2006; Brownell and 
Warner, 2009; de Andrade et al., 2013; Hastings and de Andrade, 2013). 
To summarise both themes, the perceptions of risk varied among participants. The 
following risks were identified. First, the physical risks included health and safety risk and 
nicotine use risk. Second, the social risks included: increased uptake of electronic cigarettes; 
developing an addiction to electronic cigarettes; maintaining nicotine addiction; gateway 
use; smoking renormalisation; risk of stigma; and risk of the involvement of tobacco 
companies in electronic cigarettes. 
The emergence of electronic cigarettes does appear to have a range of characteristics 
that help to explain why some people are concerned about it: a novel device that may pose 
a health and safety risk; a threat to the young; and tobacco control policies with uncertain 




were not perceived as a hazard, as users were more inclined towards their psychological 
and social benefits. In this study, some users downplayed the health risk of the electronic 
cigarette and considered it a safe product. One advisor, however, augmented the risk and 
described it as “dangerous”. A key pattern in the representation of electronic cigarettes is 
the uncertainty and quandary associated with them. The electronic cigarette was 
represented as a safe product, a safer alternative to smoking, a therapeutic product, a clean 
nicotine delivery device, an innovation with potential long-term threats, and a risky object. 
It was also seen as a device that can create addiction, maintain nicotine addiction, a 
gateway to smoking and a gateway from smoking simultaneously. Hence, I argue that the 
coexistence of these different risk meanings and representations enabled electronic 
cigarettes to act as boundary objects (Star and Griesemer, 1989). 
Following this description of the perceived risks of electronic cigarettes in both 
groups, I will discuss how these perceptions influenced the way electronic cigarette users 
assessed and managed those risks and link the discussion to sociology of risk. 
6.3. Risk Assessment 
This section discusses the ways electronic cigarette users assessed and managed perceived 
risk, linking the findings to sociology of risk. 
Distrust of the Wider Political Climate 
Most users were aware of the political, medical and scientific debate about the 
development, safety, regulations and risks of electronic cigarette use. Users expressed their 
confusion and revealed a level of suspicion of the political and professional climate. For 
example, one user sought information about electronic cigarettes and concluded that 
electronic cigarettes were much safer than tobacco; hence, he questioned the “conspiracy” 
and the negative climate that surrounded electronic cigarettes: 
“I know Wales is starting to bring in bans, and some of the transport systems and some 
pubs. They sometimes say it is because people mistake vaping for smoking and they use 
that as an excuse. With two million people switching to vapes, and not buying tobacco any 




Another user expressed a similar opinion about the possible ban on electronic cigarettes. It 
reflected a deep mistrust in the political system which, the user believed, is concerned with 
financial gain rather than the citizens’ health: 
“I think the government approach to smoking needs to stop and needs to stop now, which 
I agree with but also disagree with. If you are to take every single smoker in this country 
today and get everybody to stop smoking at exactly the same time, the country’s deficit 
will go up to 125 trillion pounds in less than 6 weeks, so they will have to substitute in 
some way the revenue that’s lost from everybody stopping smoking, which is where I think 
these bans comes from.” (3C) 
A similar remark was put by another user, who also believed that the government makes a 
lot of money out of tobacco and that is why, she suggested, tobacco is still legal: 
“Cannabis, why is that not legal, because it’s less harmful than tobacco, you know, that’s 
why the government has made it illegal here, you know, whereas like drinking – they make 
money, tobacco – they make money.” (10J) 
Nevertheless, one user believed that the political stance on electronic cigarettes is caused 
by fear of blame: 
“Because if it turns out that there is bad stuff in the vapour then the politicians are gonna 
look stupid, aren’t they? So they are being conservative, so they say until we know what’s 
in it, we better be cautious about it.” (8H) 
This illustrates how, in a ‘risk society’, managing risks became a key part of the political 
decision-making (Giddens, 1999). Distrust of the pharmaceutical industry was also 
mentioned by one user: 
“At one time margarine was better than butter, now they found out the margarine is 
worse than butter. This is it. A news they seem to come out every single month it seems to 
me these surveys come out solely to make people buy the products they are trying to push 
by telling people ok don’t have electronic cigarettes; have patches. The electronic 
cigarettes are bad for you; patches are not. This comes out from research, from people 




Another user expressed mistrust in the political decisions and the influence of the tobacco 
industry on political decisions: 
“I would say they are [tobacco companies] pushing, they have got very good friends in 
politics and Parliament and would say that it’s surely because the tobacco industry doesn’t 
want them [electronic cigarettes] to live.” (9I) 
This reflects Brown and Olofsson’s (2014: 426, 428) argument about risk being manipulated 
by different actors’ agendas, and how the interests of policymakers lead to risks being 
emphasised and problematised or ignored. It also conforms to Abraham’s (2008: 882) and 
Clarke et al.’s (2003) argument about the failure on the part of the pharmaceutical industry 
and big corporates to keep the interest of public health a priority and about the domination 
of biomedicine’s interests. As discussed in sections (3.3.3), stances on electronic cigarettes 
might reflect the deeper underlying social, economic and political context of drug use 
(Midanik, 2004; Mold, 2011; Campbell, 2012: 16; Hansen and Roberts, 2012). 
Besides the distrust that electronic cigarette users showed towards the wider political 
and industrial climate, they also showed distrust towards the media, medical and scientific 
experts, as I discuss next. 
Trust between Professionals and Electronic Cigarette Users 
In Chapter 5 (see 5.4.), I discussed how users exhibited a sense of individual responsibility 
for improving own health. This personal accountability was fostered by the advisors’ 
approach when dealing with clients using the Stop Smoking Service, and by society overall. 
Personal choice was emphasised and empowerment was considered fundamental to 
achieve successful outcomes. Most electronic cigarette users in this thesis showed practices 
of self-regulation, self-monitoring and avoidance of risk, which many theorists argued have 
become a key feature of life in Western society (Giddens, 1991; Beck, 1992a; Armstrong, 
1995; Nettleton, 1996). Electronic cigarette users, in this study, were not passively 
absorbing health messages about electronic cigarettes; rather, they made their decisions 
based on ‘mediated interpretation’ (Lupton, 1999: 87). They demonstrated their autonomy 
by actively seeking knowledge; engaging selectively with expert scientific knowledge; 
assessing risk and choosing to use electronic cigarettes (Lupton, 1999: 111), sometimes 




boundaries’ between ‘expert’ and ‘lay’ opinions in the biomedical era (Clarke et al., 2003: 
182), pointing to an emerging atmosphere of distrust between ‘expert’ and ‘lay’ due to the 
ambiguity of electronic cigarettes’ risk (Beard, 2015). For example, two users (7G, 3C) 
described how they proved to their stop smoking advisors, who did not approve of them 
using electronic cigarettes, that electronic cigarettes helped them to stop smoking: 
“My pharmacist, who I had done the stop smoking with, was aware of it [electronic 
cigarette] and he said he didn’t think it will work and I keep proving him wrong every time I 
go.” (3C) 
Electronic cigarette users described the division among the medical profession’s stance on 
electronic cigarettes. Some users were encouraged to use electronic cigarettes by doctors. 
For example, the following user said: 
“When I was told that I have to give up by the surgeon, I asked him about it he said ‘yes 
fine as far I am concerned if you are on electronic cigarettes you no longer smoke’.” (3C) 
Another user was recommended electronic cigarettes by his friend, who was a cardiologist. 
However, he commented on the conflicting messages about electronic cigarettes, as 
follows: 
“I tend to read that, but the stories, at least, at the point where I was sort of deciding to 
use it, I looked into it. But the stories were so conflicting. It’s like, you know, one set of 
doctors say it’s perfectly safe, another set of doctors say it might be terribly dangerous.” 
(11K) 
Another user described the confusion that such conflicting messages created for electronic 
cigarette users: 
“I think one doctor will say, you know, rather you smoke them than you smoke cigarettes 
and the other one will say no. My friend, when she went for her regular check-up with the 
nurse for her pill, the nurse stabbed the question: Still smoking? And she said: no I am 
vaping, and this nurse said: Oh brilliant, you know you are not smoking. I told my doctor I 
was vaping instead of smoking and he said: oooh, they are not regulated you know. For 
goodness sake, if I have said it to another doctor in another surgery they might have said: 




In the face of conflicting information, users’ risk assessment involves active choice-making 
by weighing up the desirable outcomes against the negative consequences (Lupton, 1999: 
76). As one user stated: “I noticed differences in my breathing and my coughing so, to me, 
whatever any harm it might be doing, I can’t see. The benefits I can see” (15O). Another user 
expressed confusion from the conflicting messages about electronic cigarettes, and stated 
that, after reading about electronic cigarettes, he believed they were unsafe products. He, 
however, still used electronic cigarettes because he perceived them to be better than 
smoking: 
“I mean it’s a fantastic thing in lots of ways, and it seems to me, or what I found, is that it 
gives you almost all of the benefits with none of the drawbacks, in the sense that, you 
know, it feels like you’re smoking and it doesn’t make you stink and it doesn’t make you 
cough.” (11K) 
This echoes Fox’s (1999: 30) explanation that, in a ‘risky society’, people judge the level of 
threat of an action or situation by evaluating the consequences of these actions or 
situations to themselves and to others. Most interviewees, in both groups, as discussed 
earlier, assessed the risks of electronic cigarettes by comparing those risks to risks of 
smoking cigarettes, focusing mainly on the relative risk rather than the absolute risk. Hence, 
the risk of electronic cigarettes, which is still under public and scientific debate, was faced 
by calculations of their unknown risk in comparison to the well-known risk of smoking. This 
comparison has provided an escape route for using electronic cigarettes and, to some 
extent, it legitimised their use. The extracts here represent the ‘reflexivity’ that electronic 
cigarette users exhibited when assessing the risk of electronic cigarettes (Beck, 1996; 
Giddens, 1992; 1999). Electronic cigarette users used complex and multi-dimensional ways 
to assess risk, which was not based solely on the possibility of causing harm (Hawkes and 
Rowe, 2008: 617). Electronic cigarette users’ lay assessment involved a complex blend of 
both scientific and informal knowledge. For example, the following user assessed and 
managed the risk of his addiction in the lens of deeper religious beliefs: 
“I had Ayurvedic medicine in India, they say that if you overtax any of your body organs, 
they will give up on you, they will stop working. So with alcohol, it’s your liver, with 
smoking, it’s your lungs and maybe developing cancer and stuff. So the end point of all of 




any of these things has a choice to just stop and say, ‘I’m going to let my body win now 
and heal.’ So I’m the same with nicotine, is, yes it’s been a constant friend to me for many, 
many years, but if I have to live without it, I have to live without it.” (14N) 
Electronic cigarette users clarified how they assessed and responded to the conflicting 
communicated risk through the media and the medical profession’s advice. For example, 
when one participant was asked if she would stop using electronic cigarettes, if a news story 
recommended so, she answered: 
“No, of course, I wouldn’t… because I know I could pick up the next newspaper or see the 
next article and it will be... you couldn’t be so bombarded with information.” (15O) 
The previous user responded to the conflicting advice by making her own judgement: 
“It is what I feel like doing, if I want a glass of red wine I will have a glass of red wine, if I 
want a bottle of red wine I will have one, if I want Vimto I will have Vimto… I do what I 
want, I am old enough to make my own decisions now.” (15O) 
Another user described his approach in dealing with conflicting information: “you hear what 
you want to hear”. He explained: 
“…if I like eating white bread and someone said white bread is bad for you, I don’t 
necessarily say I am not going to eat white bread again. I think it is my personal decision 
on all the things I do, so in this particular case an electronic cigarette for me is cheaper 
than smoking.” (13M) 
Such findings conform to other risk studies that discussed how the lay audience responds to 
media in a complex way. So, they might challenge, resist and contest the dominant 
messages in the media (Wilkinson, 2001; Davin, 2003), or be cynical about the way the 
media portrays risk to attract readers (Lupton, 2005; 2006). The distrust that electronic 
cigarette users revealed in this thesis mirrors Beck’s notion of contemporary risk and the 
formation of anxiety. Also, it reflects Giddens and Beck’s work on lay people losing trust in 
experts on the risk issue, and the challenges they face in making decisions amid the 
conflicting technological information and expert disagreement (Lupton, 2006: 12). However, 
electronic cigarette users still acknowledged the effect experts’ opinions had on their 
decision-making. Users showed a sense of self-governance, where there was an ongoing 




lives (Nettleton, 2002: 218). Risk perception was seen as a dynamic process that changes 
over time (Lupton and Tulloch, 2002). One user emphasised: 
“I should keep my knowledge to the medical literature directly rather than relying on 
newspapers, which I probably would recommend that most people should do.” (12L) 
The next user also looked for a kind of consensus among the scientific studies: 
“I don’t have any plans to stop using it and don’t get me wrong, if it said in a study that 
was released in a couple of months’ time with 200 citation quotations that said that they 
have an undeniable proof that it is damaging some part of my body, I probably will stop 
using it.” (9I) 
Conforming to some theorists’ views (Beck, 1992a; Giddens, 1991; Armstrong, 1995), 
reliance on experts and political risk management was still evidenced. Nearly all users 
approved regulating electronic cigarette use, especially in a way that would protect children 
and young people. For both groups, regulations meant ensuring electronic cigarettes’ safety, 
clear labelling and age restriction use. Some users disapproved of the medicinal regulation 
as they believed it may create a barrier to electronic cigarette users. However, all the 
advisors agreed to the introduction of medicinal regulations to guarantee safety and 
efficacy. So, the data demonstrated the lack of knowledge about electronic cigarettes’ 
hazards, the various official and media channels to exchange this knowledge, and the 
reliance on political regulations to control the risk of electronic cigarettes. 
To conclude, in their risk assessment, the participants predominantly compared 
electronic cigarettes to conventional tobacco smoking to justify their use, but uncertainty 
was prevalent. The majority of electronic cigarette users showed knowledge about the 
current scientific and medical debate about electronic cigarettes and weighed the pros and 
cons of electronic cigarette use. Electronic cigarette users incorporated into their decision-
making strategies deeply held values and beliefs in relation to both, a scepticism of ‘expert’ 
knowledge and a belief and trust in their own rational judgement. Even though electronic 
cigarette users in this study did not necessarily accept the professionals’ assessment of 
electronic cigarettes’ risk, they agreed that regulations to guarantee the safety of electronic 





In this chapter, I showed how perceptions of risk associated with electronic cigarettes were 
embedded within a hybrid combination of habit, personal preference, social relations, 
economic constraints, trust and health concerns (Horlick-Jones and Prades, 2009: 409). In 
this section, I discuss how the construction of electronic cigarettes’ meanings and their 
formation as boundary objects are influenced by biomedicalization processes. At the same 
time, these processes, I argue, are formed and steered by the influence of risk perceptions 
of electronic cigarettes. 
The data in this chapter, as well as the previous one, showed that risk perceptions of 
electronic cigarettes and processes of calculating and managing those risks represent the 
increased focus on individualisation in the biomedical era (Lupton, 2006). Electronic 
cigarette users acknowledged their responsibility of improving their health. They sought 
access to knowledge, through different platforms of media and medical expert 
consultations. They monitored their health; were aware of the different risks of nicotine and 
smoking, as information had been provided by the circulated biomedical knowledge; they 
reflected upon those risks and, consequently, they made their active decision to deal with 
their addiction and use electronic cigarettes (Clarke et al., 2003: 162). The biomedical 
model, therefore, influenced the construction of different meanings of electronic cigarettes 
and, hence, influenced the formation of electronic cigarettes as boundary objects. 
The different perceptions, of how risky electronic cigarettes are, have influenced the 
stances, attitudes and risk assessment strategies that different actors exhibited towards 
electronic cigarettes. This, I argue, is where the formation of electronic cigarettes as 
boundary objects influences biomedicalization. According to Lupton (1999: 25), ‘risks are 
constructed and negotiated within the networks of interaction and meanings that people 
hold’. The data show a high level of ambiguity of risks associated with electronic cigarettes. 
The divergent opinions about the nature, level and seriousness of electronic cigarettes’ risk, 
along with the different reasons for using electronic cigarettes and different perceptions of 
electronic cigarettes’ status and efficacy, as discussed in Chapter 5, formed electronic 
cigarettes as boundary objects. Further, electronic cigarettes enabled diverse social worlds, 




communicate without consensus (Star and Griesemer, 1989: 388). For example, the belief 
that electronic cigarettes are safer than smoking was a reason for many participants in both 
groups to accept the use of electronic cigarettes, in spite of inconclusive safety evidence. So, 
electronic cigarettes have transformed from an anchor of difference into a bridge of 
similarity (Star and Griesemer, 1989: 392), and functioned as translational boundary objects. 
The advisors, who perceived that electronic cigarettes might be risky objects, saw their 
potential to be a “piece in their armoury”; they were able to work together with clients who 
used and perceived electronic cigarettes differently. The data showed that electronic 
cigarettes have become popular and accepted by some members of society and health 
personnel, despite the concern about stigma. This, I argue, signifies the linkage between 
processes of biomedicalization and the formation of boundary objects, resulting in creating 
‘new sites of negotiation’ and ‘new social and cultural forms’ (Clarke et al., 2003: 185). Also, 
in this chapter, the new link between the tobacco industry and governmental organisations 
was highlighted as another example of the translational function of electronic cigarettes, 
thus confirming my argument of the boundary objects’ influence on steering biomedical 
processes. 
The different representations that electronic cigarette users hold for the new 
biomedical innovation (i.e. electronic cigarettes) have become a shared understanding, thus 
creating the new ‘vaper’ identity with new forms of ‘empowerment’, ‘confusion’, 
‘resistance’ and ‘responsibility’ (Clarke et al., 2003: 185). Users highlighted the unity of 
“fellow people who smoke vapes” in their reaction to possible restrictions on electronic 
cigarette use and demonstrated ‘the division of "expert" versus "lay" knowledges’ (Clarke et 
al., 2003: 177). At the same time, the new modes of proliferating knowledge have provided 
a platform for different actors to communicate their experience and knowledge about 
electronic cigarettes, and hence contributed to the growth of knowledge and use of 
electronic cigarettes. I demonstrated how users, through the media and the use of 
technoscientific ways of communication, were aware of the current political, medical and 
scientific debate about the development, safety, regulations and risks of electronic 
cigarettes (Clarke et al., 2003: 176; Turner and Khondker, 2010: 120). Hence, 
technoscientific ways of communications facilitated the formation and nurturing of the 




boundary objects. The media and proliferation of knowledge represent the struggle and 
battles between different social worlds; hence, this process is important in the formation of 
electronic cigarettes as translational boundary objects because it allows for different social 
worlds to coexist and negotiate. Yet, at the same time, the process is steered by the power 
of these different social worlds. 
To conclude, this section explained how processes of biomedicalization have mediated 
the meanings and use of electronic cigarettes. Focusing on risk and personal responsibility 
signifies the biomedical era. Biomedical advances facilitated new linkage and forms in the 
field of electronic cigarettes. Also, the proliferation of knowledge channels produced 
different opinions and meanings for electronic cigarettes; hence, facilitating the formation 
of electronic cigarettes as boundary objects. 
6.5. Chapter Summary 
This chapter examined how the novel phenomenon of electronic cigarettes was assimilated 
and represented as a risk - or not - in the accounts of both stop smoking advisors and 
electronic cigarette users. I illustrated how the perceptions of risk varied among 
participants. A key pattern in the perceptions of electronic cigarettes is the uncertainty and 
quandary associated with them. The following risks were discussed. First, the physical risks 
including health and safety risk and nicotine use risk. Second, the social risks including: 
increased uptake of electronic cigarettes; developing an addiction to electronic cigarettes; 
maintaining nicotine addiction; gateway use; smoking renormalisation; risk of stigma; and 
risk of the involvement of tobacco companies in electronic cigarettes. I described how the 
different perceptions of risks enabled the formation of electronic cigarettes as boundary 
objects. I discussed how processes of biomedicalization have mediated the meanings and 
use of electronic cigarettes, and how, at the same time, the formation of electronic 
cigarettes as boundary objects has an influence on these processes. I linked risk perceptions 
of electronic cigarettes and risk assessment with the wider sociology of risk. The narratives 
of the participants demonstrated an individualisation approach to risk, and a political and 
social awareness of the structural underpinnings of electronic cigarettes’ risks that 




data sources (electronic cigarette users and stop smoking advisors) by looking at 




Chapter 7: Conclusion 
7.1. Introduction 
The aim of this chapter is to consolidate the findings and to highlight the disagreements and 
commonalities between the perceptions of electronic cigarettes drawn on by electronic 
cigarette users and stop smoking advisors in a South East England-based qualitative study. I 
discuss how electronic cigarettes as boundary objects can function as translational and 
facilitative objects between different actors who construct different social meanings of 
electronic cigarettes. I reflect on the theoretical underpinnings of my empirical investigation 
(boundary objects theory and biomedicalization), which, taken together, provided a useful 
framework that enhanced my understanding of the electronic cigarette perceptions in my 
sample. I clarify how the different social meanings attached to electronic cigarettes are 
impacted by the wider political, cultural and technological processes of the 
biomedicalization theory. I also argue that biomedicalization processes are the outcome of 
divergent, but coexisting, perceptions and meanings. 
In the two previous chapters I have demonstrated how electronic cigarettes are 
represented as an ambiguous device. In this chapter, I draw on this key theme and the 
various themes that emerged throughout the data analysis. I discuss how electronic 
cigarettes bring with them opportunities and threats; how electronic cigarettes challenge 
the contemporary social meanings of addiction; and how new innovations can prompt wider 
social and political changes. In the first part of this chapter, I discuss the thematic 
framework of the findings with a general link to relevant literature. Second, I examine the 
link of electronic cigarettes to biomedicalization and then explain why I consider electronic 
cigarettes as boundary objects. Third, I discuss how both theories (boundary objects and 
biomedicalization) are interlinked. I conclude this chapter by discussing the strengths and 
limitations of my study and outline some opportunities for further research that could be 
built upon the findings. I suggest recommendations to policy and practice with regard to 
how the findings of this qualitative study could be used to improve services and outcomes 
for smokers and electronic cigarette users. Finally, I highlight the novel contribution of my 




7.2. Research Questions and Findings Overview 
Electronic cigarettes have created a quandary (Cahn and Siegel, 2011; The Lancet, 2013; 
Bialous and Sarma, 2014; Bullen et al., 2014; O'Connor and Fenton, 2015). The following 
questions have been asked: Is the electronic cigarette a recreational or therapeutic product? 
Is it an extension for smoking or nicotine replacement therapies? Is it a consumer product or 
a pharmaceutical product? Is it health-enhancing or health-damaging? Is it a promise or a 
threat? Electronic cigarettes seem to have many identities and possible meanings and, as 
such, have become an issue that attracts controversy among public, scientists and 
politicians (RCP, 2016). In the introduction to this thesis, I proposed the boundary objects 
theory (Star and Griesemer, 1989) as an approach for understanding the social construction 
of electronic cigarettes among two groups of electronic cigarette users and stop smoking 
advisors. I also proposed the use of biomedicalization theory (Clarke et al., 2003) to explain 
how particular advances in relation to electronic cigarettes make the case for electronic 
cigarettes to be considered a manifestation of the biomedicalization era. Further, I proposed 
that the construction of electronic cigarettes’ meanings and their formation as boundary 
objects are influenced by biomedicalization processes. At the same time, these processes, I 
argued, are formed and steered by the influence of electronic cigarettes’ diverse 
perceptions, presenting the role of human behaviours in shaping social reality (Garrety, 
1997; Fox, 2011; Kaye, 2012). 
I found using both underlying theoretical concepts advantageous for two reasons. 
Firstly, they provided a useful starting point to explore the different meanings and 
perceptions in the two data sources. Secondly, they helped to identify several key factors 
that have shaped the construction and development of different meanings and perceptions 
of electronic cigarettes, and to explain the relational, significance and influence of these 
meanings. I have illustrated in the preceding chapters the diversity of perceptions about 
electronic cigarettes among my data. Applying boundary objects theory has enabled me to 
elaborate and explain the commonalities and disjunctures between the two data sources. It 
helped me to identify the role of the human agents on the construction, resistance or 
dominance of biomedicalization processes. Further, the biomedicalization concept helped 
me to explain the wider social, cultural, technological and historical context that has 




framework allowed for a deeper understanding of the phenomenon of electronic cigarettes 
in my sample. 
One of the biggest challenges for me was how to deal with the inherent biases that have 
shaped my research, whether intentional or unintentional. In my role as a researcher, I 
realised the paramount importance of self-awareness and reflexivity. This is because my 
biography as a dentist or a public health advocate has the potential to bias data collection 
and analysis because of my unique social experience. Grosz (1995: 13) argued that no 
matter how aware and reflexive the researcher tries to be, ‘the author’s intentions, 
emotions, psyche, and interiority are not only inaccessible to readers, they are likely to be 
inaccessible to the author herself.’ Hence, I am aware that there may be limits to my 
reflexivity and self-awareness. I am also conscious that subject accounts are not entirely 
transparent. I am not assuming that what my participants said in an interview context gave 
me direct access to their subjectivity and lived experiences, nor am I claiming that I captured 
their voices and stories and produced an accurate account of their experiences (Mauthner 
and Doucet, 2003). However, when I analysed my data my view was that ‘subjects are 
reflexively constituted between the researcher and the researched’ and that by means of 
research, it is possible to gain some knowledge of their articulated experience and 
subjectivity (Doucet and Mauthner, 1999; Mauthner and Doucet, 2003). As far as I was 
aware, my participants seemed happy to share their stories and lived experiences with me. 
For example, one user was extremely keen on showing me his electronic cigarette and 
explaining how it works. I have tried to make my interviews a two-way interaction process 
and not just a process of collecting information from ‘subjects’. 
As this is my first qualitative research project, the enthusiasm I experienced at the 
beginning during my interviews led me to believe that I had captured the voices and may be 
at least a partial subjectivity of my participants. However, with hindsight I am aware that my 
academic and personal biographies might have affected my choice of academic texts and 
the literature that guided my research. I am also mindful of how this combination of 
academic and personal biographies might have led me to particular ways of engaging with 
and interpreting my data during my data analysis process. My personal and clinical 
experiences, in addition to my review of the literature, influenced how I approached this 




participants would be more worried about the lack of safety evidence on electronic 
cigarettes; I thought that the internet and social media platforms would play a major role in 
encouraging the use of electronic cigarettes among my electronic cigarette users; I assumed 
that the users would have a stronger trust in the scientific, medical and official opinions on 
electronic cigarettes. I also assumed that the advisors might be sceptical about the value of 
electronic cigarettes as a stop smoking aid. I expected that the advisors would be less 
transparent in sharing their personal opinions with me due to their official position. Similar 
to the position that the majority of the advisors took, I was keen on the use of electronic 
cigarettes therapeutically rather than recreationally; however, listening to the experiences 
of my participants has altered my views. I hope I am now more considerate to people who 
struggle with their addiction and who substitute their addiction to cigarettes with electronic 
cigarettes.  
It is recognised that it is not only the personal or academic biographies that influence 
the choices and decisions that the researcher makes with regard to ontology, epistemology, 
methodology, theories, and research methods, ‘but the interpersonal, political and 
institutional contexts in which researchers are embedded also play a key role in shaping 
these ‘decisions’’ (Bell and Newby, 1977; Bell and Roberts, 1984 in Mauthner and Doucet, 
2003: 421). Accordingly, my research (as I highlighted in the methodology chapter) was 
shaped by factors such as the lack of participation and the ethical approval processes. 
Throughout the interview process, I was aware that the field of electronic cigarettes is 
developing continuously and quickly. I acknowledge that the field has changed since I 
started my first interview in April 2014 until the time I conducted the last interview in July 
2015. For example, I was aware of the expansion of electronic cigarette marketing and local 
shops, the ongoing debate about electronic cigarettes in the media, the introduction of new 
‘generations’ of electronic cigarettes and the different stances that different organisations 
and countries showed towards electronic cigarette use. The perceptions and experience of 
my participants may have changed due to some of these factors. For example, the new 
regulations that allow electronic cigarettes to be sold as a medicine and a consumer product 
may have reduced the ambiguity associated with electronic cigarettes which I identified in 




Before presenting the juxtaposition of the research findings, I want to emphasise that 
both the electronic cigarette users and the stop smoking advisors groups were not 
homogeneous; rather, they were heterogeneous in their attitudes, values and beliefs. Both 
expressed different perspectives and opinions on the discourse and role of electronic 
cigarettes. My findings suggest that the electronic cigarette users draw on their personal 
experience, smoking history, stories circulated in the media and other cultural factors to 
construct their perceptions and attitudes towards electronic cigarettes. The advisors’ views 
and attitudes are shaped by their personal beliefs, experience and official duties towards 
their clients. Although both groups showed a level of similarity in their perceptions and 
attitudes towards electronic cigarettes, different stances were exhibited by different 
participants. Nearly all my electronic cigarette users’ group expressed a positive experience 
when using electronic cigarettes. Electronic cigarette users varied in their gender, age, job 
status, smoking status, quitting history and their aim of using electronic cigarettes. They 
used different brands, designs, flavours, nicotine concentration and showed different 
reasons for using electronic cigarettes and different use patterns. They seemed to enjoy 
several aspects of electronic cigarettes, some compared them to normal cigarettes and 
others compared them to other nicotine replacement products. The majority had struggled 
with their past quit attempts using other methods and found electronic cigarettes to be 
more helpful. Although those who attended the Stop Smoking Service may have seemed to 
be more committed to quit smoking and eventually to stop using electronic cigarettes, other 
users who were not using the service also expressed a strong desire to stop electronic 
cigarette use at some point in the future. Some even explained their personal plan to stop 
their use. Social acceptance and endorsements seem to be an important aspect in 
encouraging the use of electronic cigarettes besides the cheaper expense; tobacco- free 
odour; the ability to use them indoors; the different flavours and their relative safety 
compared to traditional cigarettes.  
The advisors showed a mix of opinions and attitudes. The majority were more inclined 
towards their traditional regime of stopping smoking and eliminating nicotine use. The 
advisors, who encountered cases of people struggling with their smoking addiction, saw the 
benefits of electronic cigarettes as a harm reduction tool and a substitute to smoking. In 




licensed nicotine replacement therapies, some showed an openness towards electronic 
cigarettes and understanding of the reasons for their popularity. I sensed a dilemma 
between their official stance and their obligation to adhere to their traditional regime in 
treating smoking addiction on the one hand and their acknowledgment of the possibility of 
effective use of electronic cigarettes as a harm reduction tool on the other. A few advisors 
noted that the different age groups might have different goals. They suggested that the 
older age group used electronic cigarettes to stop smoking, whilst the younger users used 
them as a fashion item or to try different flavours. Users in this study used electronic 
cigarettes both recreationally and therapeutically, with some pointing to the roles of 
flavours and designs in attracting them to use electronic cigarettes. Due to the small 
number of participants, I did not differentiate the perceptions, attitudes and reasons for 
using electronic cigarettes by socio economic factors such as age, gender, ethnicity and 
social class. The study was purposely small and aimed to gain an understanding of the 
different perceptions and attitudes that both groups hold of electronic cigarettes.  
Next, I present the research questions and provide a thematic framework (Figure 1), which 
presents the overall findings of my analysis. 
1) How are electronic cigarettes perceived by electronic cigarette users and stop 
smoking advisors? 
2) What are the perceived risks associated with electronic cigarettes, as discussed by 
electronic cigarette users and stop smoking advisors? 
3)  What factors have shaped these perceptions of electronic cigarettes? 
I suggest that the ways in which perceptions are constructed and used can be classified as: i) 
an electronic cigarette as an ambiguous novelty; ii) an electronic cigarette as a means for 
empowerment; and iii) an electronic cigarette as a means for social change. These 
representations are occurring simultaneously, are dependent on one another and are in 
constant negotiation. All my data exhibit a high level of ambiguity regarding electronic 
cigarettes’ status, efficacy and potential risks; however, the data also show different 
perceptions of electronic cigarettes that are related to a biomedical model of understanding 
and managing nicotine addiction, where individualisation and empowerment are at the 




recreational use of nicotine that mimics smoking, in spite of some electronic cigarette users’ 
















Figure 2: A thematic framework of the perceptions of electronic cigarettes. 
In this chapter, I demonstrate that the understanding of electronic cigarettes as an 
ambiguous device is prevalent among the two data sources. I believe that applying 
triangulation by collecting data from two sources has enabled the perceptions of two 
distinct groups to emerge, as my findings below demonstrate. While I do not suggest that 
the interpretations I present are the only elements which make up the representations of 
the electronic cigarette as an ambiguous device, a means for empowerment and a means 
for social change, I argue that these are the key interpretations and meanings that my 
participants draw on to make sense of the phenomenon of electronic cigarettes within their 
social and personal accounts. Hence, they enable electronic cigarettes to become boundary 
objects that act as both translational and facilitative devices by allowing different social 
groups to communicate and act with regard to electronic cigarettes. As we will see below, 
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7.3. An Electronic Cigarette as an Ambiguous Novelty 
In my analysis, the ambiguity of electronic cigarettes is evidenced through highlighting the 
following aspects: i) the ambiguity of electronic cigarettes’ status and efficacy; ii) the 
ambiguity of the physical risk; and iii) the ambiguity of the social risk. I discuss these in turn 
below. 
7.3.1. The Ambiguity of Electronic Cigarettes’ Status and Efficacy 
The data from this thesis show that electronic cigarettes are perceived and used both as 
therapeutic and recreational products. There is no consensus on one classification over 
another, as different actors held different perceptions. My findings suggest that participants 
in this study construct electronic cigarettes as an ambiguous device due to their different 
perceptions and experiences of electronic cigarettes. 
While some electronic cigarette users described electronic cigarettes as a treatment, 
others disagreed with such classification. The majority of electronic cigarette users 
confirmed that they used electronic cigarettes to help them quit smoking. This conforms to 
other studies, which provided evidence that electronic cigarettes have been used, mostly, as 
an aid to quit smoking (e.g. Adkison et al., 2013; Brown et al., 2014b; Dawkins et al., 2013; 
West, 2014; ASH, 2016b). Some users verbalised their intention to stop using electronic 
cigarettes, while others expressed their desire to continue their use, similar to findings from 
other surveys (ASH 2015a, 2016b). Nearly all the electronic cigarette users in this study 
opted to use electronic cigarettes to improve their health. Two users switched to electronic 
cigarettes to save money without referring to any health concerns. 
The majority of electronic cigarette users found electronic cigarettes to be as effective 
as, or more effective than, other available treatments. Electronic cigarettes’ efficacy as a 
substitute to smoking was attributed to the electronic cigarettes’ ability to replicate the 
habits and rituals of smoking, the comfort and enjoyment they offer and their efficacy in 
delivering nicotine. Electronic cigarettes relieved withdrawal symptoms and helped in 
avoiding a relapse to smoking. Most users liked the similarity of electronic cigarettes to 
traditional cigarettes. The data suggest that electronic cigarettes may have attracted users 
because of their innovative modernistic features; flavours; reduced cost compared to 




the possibility of customising them according to an individual’s needs and desires. The data 
also suggest that some users used electronic cigarettes as a hobby and a social activity. 
These findings support the results in the literature, which discussed motivations for using 
electronic cigarettes (e.g. Etter and Bullen, 2011; Pearson et al., 2012; Dawkins et al., 2013; 
ASH, 2014b; 2016b). One of the reasons reported in this study is the endorsement and 
encouragement to use electronic cigarettes instead of smoking, especially by friends, family 
and, sometimes, by health personnel. This opposes other findings, where some vapers 
reported stopping using electronic cigarettes based on the advice of a health professional 
(ASH, 2016b). 
For stop smoking advisors, data from this study show that, while electronic cigarettes 
were represented by some advisors as a treatment for nicotine addiction and a ‘self- 
medication’ tool, others described them as recreational alternatives to smoking. The 
advisors acknowledged that electronic cigarettes were mostly used as an aid to quit smoking 
and some agreed that they could be as effective as, or more effective than, other available 
treatments. Some advisors envisaged electronic cigarettes’ particular benefits for certain 
types of smokers, such as heavily addicted smokers and those with serious health 
conditions. They also acknowledged the physiological and psychological substitution that 
electronic cigarettes provide, but they disapproved with the resemblance of electronic 
cigarettes to conventional cigarettes and found that to be a hindrance to successful quitting. 
It is apparent, however, that the advisors wanted electronic cigarettes to be part of their 
‘armoury’, aiming at stopping nicotine use. Hence, they asserted the importance of 
regulating electronic cigarettes, similar to other pharmacotherapies they prescribe. 
This study adds to the debate about the perceived efficacy of electronic cigarettes 
compared to nicotine replacement therapies. Participants in one study did not link 
electronic cigarettes to quitting as they did with nicotine replacement therapies, and found 
that electronic cigarettes do not substitute the stress relief characteristics of normal 
cigarettes (Rooke, Cunning-Burly and Amos, 2015). To the contrary, in this study, 
participants from both groups found that electronic cigarettes can be as effective as, or 
more effective than, other nicotine replacement therapies. These differences in the findings 
reflect the former study’s conclusion that ‘different groups of smokers bring diverse 




use of nicotine-containing products’. My data showed electronic cigarettes were used in 
stressful situations, as was found by another study (Rutten et al., 2015). The data from this 
study support other studies that showed the importance of the unique sensory cues, 
mimicking the rituals associated with traditional smoking and their role in the growth of 
electronic cigarettes use (e.g. Caponnetto et al., 2011; Polosa et al., 2011; Fagerström, 2012; 
Barbeau, Burda and Siegel, 2013; Caponnetto et al., 2013). 
The findings expose two important issues. First, the lack of consensus on the reasons 
for using electronic cigarettes, and the status and efficacy of electronic cigarettes, among 
the data sources; second, the lack of consensus on accepting harm reduction in nicotine 
addiction. The advisors in this study focused on eliminating nicotine as a major goal. This 
concurs with the disagreements among public health personnel over harm reduction and 
electronic cigarettes, as I discussed in the literature review (RCP, 2007; 2016; Elam and 
Gunnarsson, 2012). Users, however, placed electronic cigarettes in a smoking quitting 
continuum, where electronic cigarettes can have multi-facets of usage, incorporating 
recreational and therapeutic use. 
7.3.2. The Ambiguity of Electronic Cigarettes’ Physical Risk 
Most users acknowledged the addictive nature of nicotine; their views ranged between 
considering nicotine to be ‘not very good’ to being a ‘poison’. They demonstrated different 
levels of nicotine use, from using zero nicotine to consuming extra nicotine. The advisors 
showed concerns about the addictiveness of nicotine and the extra consumption of 
nicotine. My data highlighted concerns about the safety of electronic cigarettes and their 
potential effects on health. There was a concern about the lack of evidence of long-term 
health implications and a concern about the potential health risks on non-users and children 
in particular. However, the advisors tended to express more negative assumptions with 
regards to electronic cigarettes’ safety and health implications. They justified their concerns 
by the fact that electronic cigarettes were not regulated, licensed or recommended by the 
leading health organisations in the UK. Electronic cigarette users’ perceptions of safety 
ranged between perceiving electronic cigarettes to be safe, safer than smoking and not 
knowing if they are safe or not. Some health improvement was described by some users, 
but one user complained about how his electronic cigarette had affected his throat (see 




the outcome of electronic cigarette use. These concerns echoed the uncertainties discussed 
in the literature review and by the advisors. 
Other studies showed participants’ concerns about the safety of electronic cigarettes 
and their influence on health (e.g. Muñoz et al., 2014; Beard et al., 2014; Hiscock et al., 
2014; Sherratt et al., 2015a, b; Rooke, Cunning-Burly and Amos, 2015). Similar to my 
findings, concerns about the long-term effects of using electronic cigarettes were 
particularly expressed (e.g. McQueen, Tower and Sumner 2011; Baweja et al., 2016). 
Participants in other studies reported perceiving electronic cigarettes to be safe (e.g. 
Goniewicz, Lingas and Hajek, 2013). Also, an improvement in health was reported (e.g. 
Heavner et al., 2009; Dawkins et al., 2013). Side effects affecting the throat were reported 
as well (e.g. Etter, 2010; Hajek et al., 2014). Some participants, in this study, mentioned 
negative design issues which affected the safety of the product, such as leaking bottles, 
similar to other studies (Etter, 2010; McQueen, Tower and Sumner, 2011). It is, however, 
evident that the rhetorical argument about the relative safety of electronic cigarettes in 
comparison to traditional cigarettes is prevalent among my data. Participants in other 
studies believed the risk of electronic cigarettes is less than the risk of cigarettes (e.g. 
Pepper and Brewer, 2013; Peters et al., 2013; Sutfin et al., 2013; Brown et al., 2014b; Tan 
and Bigman, 2014; Pepper et al., 2015). Overall, uncertainty was evident in both groups, 
similar to findings from other studies (e.g. Sutfin et al., 2013; Pepper and Brewer, 2013; 
Rooke, Cunningham-Burley and Amos, 2015; Sherratt et al., 2015a, b). 
7.3.3. The Ambiguity of Electronic Cigarettes’ Social Risk 
Some advisors and electronic cigarette users highlighted concerns over maintaining nicotine 
addiction and developing an addiction to electronic cigarettes. Both sides provided evidence 
of this already happening. Both Beard et al.’s (2014) and Hiscock et al.’s (2014) studies 
pointed at similar concerns by the stop smoking advisors and managers in Stop Smoking 
Services. Other studies discussed maintaining the addiction (e.g. McQueen, Tower and 
Sumner, 2011; Al-Delaimy et al., 2015; Rooke et al., 2015). Further, there was a divide in 
opinion as to whether electronic cigarettes can attract new users and be a gateway to 
smoking, reflecting the existing disagreement in the literature (e.g. McMillen et al., 2012; 
Corey et al., 2013; Bell and Keane, 2014; Bauld, 2016). A different position was apparent 




about renormalisation of smoking and they favoured a ban on electronic cigarettes in public 
places. On the other hand, similar to other studies, most users did not agree with banning 
electronic cigarettes (Etter, 2010; Etter and Bullen, 2011; McQueen, Tower and Sumner, 
2011). These results do not agree with Pepper and Brewer’s (2013) systematic review, who 
could not find any argument by users that electronic cigarettes should be exempted from 
Smokefree indoor regulations. Participants in other studies revealed using electronic 
cigarettes everywhere (Peters et al., 2013), and in locations they would not normally have 
smoked tobacco (Sherratt, 2015b). However, the majority of users in this study said that 
they tend not to use electronic cigarettes around others unless they asked for permission, 
and that they mostly use electronic cigarettes outdoors. 
Further, the risk of the tobacco industry’s involvement in the electronic cigarette 
market was highlighted by both groups (see 6.2.2.4). It is worth noting that this concern was 
higher among the advisors than the users, who were not all aware of such involvement. The 
scepticism shown in this thesis about the tobacco industry mirrors similar concerns raised by 
several scholars (see 1.4.4.), who questioned the morality and intentions of the industry 
(e.g. Koop, 2004; Glover, 2006; Brownell and Warner, 2009; de Andrade et al., 2013). 
An important finding of this thesis is the concern about stigma that some electronic 
cigarette users expressed. Some users felt that electronic cigarette use is not socially 
acceptable and were concerned that the stigma attached to smokers might shift to 
electronic cigarette users. However, the advisors, in general, viewed electronic cigarettes to 
be socially acceptable, especially when compared to smoking. Although the stigma concern 
was highlighted in the literature (e.g. Shickle, 2009; Voigt, 2015) (see 2.4.1.), there are no 
studies that have addressed this issue with regards to electronic cigarettes specifically. 
The rationale for accepting or stigmatising electronic cigarette users, in this thesis, was 
linked to the following reasons: vapour, knowledge, media, culture and group differences, 
safety, novelty, appearance and attitudes towards addiction behaviour (see 6.2.2.3). These 
reasons conform to the argument that people’s responses to risk can be non-reflexive and 
based on unarticulated assumptions and moral values that are developed and shared by 
members of cultural subgroups (Lash, 1993). Some of these reasons were linked to 
stigmatising other conditions. For example, ambiguity and fear were linked to stigmatising 




Garrick, 1998; Stuber, Galea and Link, 2008). The lack of transparent communication of 
technical or scientific risk studies about electronic cigarettes in the media may lead to 
creating ‘technological stigmas’ (Garrick, 1998; Zwick, 2002a). Indeed, although both the 
benefits and risks of electronic cigarettes have been heavily communicated in the media, 
there has been a concern about health scare stories (McNeill et al., 2015), warnings about a 
growing ‘false perception [about] risks’ and a call for clear communication of the ‘relative 
safety’ of electronic cigarettes (ASH, 2015b; West, Beard and Brown, 2016). 
When discussing stigma, we need also to consider the cultural significance and the 
racial division attached to substance use (Mold, 2011; Netherland, 2012; Hansen and 
Roberts, 2012). Social unacceptance and denormalisation of tobacco use policies, it was 
argued, resulted in stigmatisation of smokers, created unacceptable social environment 
towards smokers and succeeded in changing social norms, values and attitudes regarding 
smoking and smokers (Kim and Shanahan, 2003; Bayer, 2008; Bell et al., 2010; Ritchie, Amos 
and Martin, 2010). As shown in the literature review, stigma has played a role in reducing 
cigarette consumption and smoking prevalence (e.g. Alamar and Glantz, 2006; Helweg-
Larsen et al., 2010; Amonini, Pettigrew and Clayforth, 2015). Accordingly, denormalisation 
of electronic cigarette use policies may result in the stigmatisation of vapers; and, if the 
stigmatising of electronic cigarettes spreads, smokers who might benefit from electronic 
cigarettes could lose an opportunity that could improve their health and potentially save 
their lives. 
The implication of concern about stigma can be noted in the electronic cigarette users’ 
behaviour and attitudes. According to Lupton and Tulloch (2002: 331), different people and 
social groups understand and perceive risk differently. Hence, electronic cigarette users 
were aware of this ‘reflexive awareness of risk’ among different groups and cultures and, 
therefore, the majority reported using electronic cigarettes within an environment that 
accepted electronic cigarettes. They spoke about the endorsement they received from 
family members, friends and, sometimes, health personnel. This is important because the 
social norm that disapproves of smoking, especially the disapproval of family and friends, 
was believed to be a factor that contributed to forming smoker-related stigma (Stuber, 
Galea and Link, 2008). Similarly, in the field of electronic cigarettes, Sherratt et al. (2015a: 9) 




around social acceptability’. Users in this study attempted to disassociate themselves from 
the stigma that surrounded smokers and to create new social norms to avoid social 
exclusion (Gibbs, 1965). They highlighted the difference between smoking and vaping and 
the relative safety of electronic cigarettes. 
To avoid stigma, one user verbalised not wanting to be associated with smoking by 
keeping her vaping secret, as she also kept her smoking habit a secret. Another user clearly 
explained that she did not approach the Stop Smoking Service to support her in her quit 
attempts because she feared being stigmatised. Such findings conform to other studies that 
addressed stigma and smoking (e.g. Stuber and Galea, 2009; Stuber, Galea and Link, 2009; 
Bell et al., 2010). It was argued that, for some smokers, the ‘felt normative stigma’ was a 
motivation to avoid the service in order to avert ‘enacted stigma’ (Scambler, 2009). In this 
study, electronic cigarette users did not experience ‘enacted stigma’, but they showed a 
concern that it may develop in society. The majority, however, resisted the ‘internalised 
stigma’ and ‘self-stigma’ (Steward et al., 2008: 3) that smokers grew to accept in the West. 
For example, they disapproved a ban on the use of electronic cigarettes in public places and 
highlighted the lack of evidence of causing harm to others. Users spoke about their right to 
use electronic cigarettes without being stigmatised, shamed or blamed (Schneider and 
Conrad, 1980; Scambler and Hopkins, 1986; Scambler and Paoli, 2008). This opens the 
debate into the ethical complexities of attempting to manipulate social norms to change an 
individual’s behaviour through restricting the use of electronic cigarettes without evidence 
of harm to others (Voigt, 2015). Next, I will discuss the risk of electronic cigarettes within 
the wider sociology of risk. 
7.3.3.1. Link to Sociology of Risk 
Risks from electronic cigarettes, I argue, signal the ‘risk society’. This risk is a ‘manmade’ and 
‘manufactured risk’ (Beck, 1992a, 1996; Giddens, 1999: 4; Lupton 1999: 198). Smoking and 
vaping may exemplify a threat caused by the misuse of a natural product (nicotine). The 
emergence of the electronic cigarette does appear to have a range of characteristics that 
help to explain why some people are concerned about it: a novel device that may pose a 
health and safety risk, a threat to the young and tobacco control policies, and uncertain 
long-term effects (NICE, 2013a; McNeill et al., 2015). Risk has been at the core of the 




Western society (Lupton, 1999; Mitchell and McClean, 2014). Generally, my data discussed 
notions of potential risk, or things that might happen, as a result of using electronic 
cigarettes rather than existing or present harm (Adam and Loon, 2000). Representing a ‘risk 
society’, it was mostly electronic cigarettes’ possible long-term effects, their potential future 
risks and measures to preventing and managing those risks that were constantly debated 
within the data (Giddens, 1999; Beck, 2006). The ambiguous electronic cigarettes that ‘no 
one understands completely’ signify ‘a high technological frontier’ with different possible 
futures (Giddens, 1999: 3) and unexpected uncertainties (Beck, 1992a). 
In the literature review, I discussed how trust in the medical, scientific and political 
systems plays a major role on individual risk perception, decision-making strategies and 
normalising technologies (e.g. Kasperson et al., 1992; Hawke and Rowe; 2008; Brown, 2009; 
Bröer et al., 2014). The relation between the advisors and electronic cigarette users in this 
study did not represent an ‘expert’/‘lay’ relation where expert knowledge assumes 
superiority over service users’ knowledge. My data showed the simultaneous distrust and 
reliance on ‘expert’ knowledge (Giddens, 1991; Lupton and Chapman, 1995; Nettleton, 
Burrows and O’Malley, 2005). Some users expressed suspicion instead of trust in the 
‘expert’ systems (Beck, 2006: 8), and showed less confidence in the government and the 
medical profession’s approach towards electronic cigarettes (Kasperson et al., 1992) (see 
6.3). I demonstrated how some users resisted and challenged experts’ judgements on the 
risk of electronic cigarettes (Lupton, 1999: 111; Green, Thompson and Griffiths, 2002: 277). 
Others trusted the ‘experts’ and expected institutions to be responsible for safety, 
regulation and control of electronic cigarettes, while forming their own plans in using 
electronic cigarettes (Giddens, 1990, 1994; Gregory, Slovic and Flynn, 1996; Zwick, 2002a). 
As opposed to other scholars’ arguments, the lack of trust and uncertainty between 
professional systems and electronic cigarette users did not cause ‘paralysis and distress’ 
(Lupton, 1997b: 380), or adverse psychological, social, political or economic effects (Putnam, 
2001, 2002). Instead, the users showed processes of reflexivity and individualisation 
(Giddens, 1992: 30, 1999; Beck, 1996). Although Lash (1993) proposed that people’s 
responses to risk can be non-reflexive, the study demonstrated the notion of ‘expert 
reflexivity’ (Lupton, 1997b; Fox, Ward and O’Rourke, 2005: 1307), where electronic cigarette 




interacted with health professionals around smoking and electronic cigarettes as a 
‘consumerist’ and not as a ‘passive patient’ (Lupton, 1997b: 373). They calculated risks and 
made cognitive decisions where they simultaneously contested and adopted expert 
knowledge systems in planning their electronic cigarette use (Giddens, 1991). They also 
acknowledged ‘the asymmetry of communication’, as there were different channels to 
disseminate information about electronic cigarettes (Zwick, 2002a). They critically reflected 
on the conflicting available information and discussed the benefits of electronic cigarettes 
(e.g. health gains and financial savings), and compared them to the threats from smoking 
(e.g. health implications and social unacceptability). The electronic cigarette users took 
personal responsibility to minimise the risk of smoking for themselves and others and made 
the decision to switch to electronic cigarettes (Beck, 1992; Giddens, 1999; Fox, 1999). 
Because of the small number of participants, this study did not look into how some 
sociocultural factors such as gender, age, social class and ethnicity may have contributed to 
the construction of electronic cigarettes’ risk knowledges and experiences (Lash, 1993; 
Lupton and Tulloch, 2002). However, the data demonstrated the influence of culture on 
constructing various risk perceptions (Douglas, 1992). Users pointed at the differences in 
cultures and groups’ attitudes towards electronic cigarettes. An example is the user who 
was happy to use electronic cigarettes around her friends, but was not welcomed to use 
them around her parents due to cultural views on smoking and addiction, indicating a 
‘cultural bias’ (Langford et al., 2000: 692). Another example is when a user reflected on the 
culture that stigmatises the addiction behaviour per se. 
My data showed how electronic cigarette users were heavily influenced by several 
cultural and socio-economic factors such as mass media, individual experience and life 
discourse, local memory, moral principles and personal judgements (Tulloch and Lupton, 
2003; Zinn, 2004; Hawke and Rowe, 2008). I demonstrated how the shared values, concerns 
and beliefs about smoking within this South East England study led to accepting the risk of 
using electronic cigarettes to avoid the risk of smoking (Lupton, 1999: 40). Also, the cultural 
opposition to the visibility of the habit of smoking has led the advisors to advocate 
restricting electronic cigarette use. Hence, the gateway and renormalisation risks were 
treated as a ‘real’ threat despite the lack of evidence (Zinn, 2009). I also demonstrated how, 




perceived as a hazard, as they were more inclined towards the psychological and social 
benefits of electronic cigarettes. The health risk of electronic cigarettes was downplayed by 
some users, who considered them safe, while others where not sure about their safety 
However, I showed how electronic cigarette users continued using electronic cigarettes in 
spite of their different levels of concerns. This is due to the subjective nature of assessing 
and dealing with risk (Hay et al., 2005). For some, it could be due to the fact that any harm 
electronic cigarettes may cause was unseen and intangible, or because users engaged 
voluntarily in electronic cigarettes use and, therefore, they felt that they were in control 
(Hawkes and Rowe, 2008). 
The advisors’ risk perceptions showed an active integration of their personal individual 
experiences with electronic cigarettes. These personal experiences functioned both as an 
endorsement for electronic cigarette use (e.g. an aid to stop smoking) or a warning (e.g. a 
gateway to smoking). The advisors drew both on positive and negative accounts of working 
with electronic cigarette users. Similar to other studies, the effect of personal beliefs 
influenced the advice offered to clients, which was not always evidence-based (Beard et al., 
2012; Lorencatto et al., 2013; Beard et al., 2014). Because of the ambiguity of electronic 
cigarettes, the advisors were unable to provide conclusive evidence-based information 
about electronic cigarettes to their clients. This, I believe, may have influenced the relation 
and trust between the advisors and electronic cigarette users in the Stop Smoking Services I 
studied. 
The above theme draws from the biomedicalization process where there is a focus on 
risk and a change in the relation between ‘expert’ and ‘lay’ people (Clarke et la., 2003). In 
the next section, I will explain how society’s preoccupation with identifying sources of risks, 
managing those risks and maintaining health have led to electronic cigarettes becoming a 
tool for empowerment to help smokers manage their nicotine addiction and conform to the 
social norm construction of health. 
7.4. An Electronic Cigarette as a Means for Empowerment 
An electronic cigarette, I argue, is a manifestation of the biomedical era which empowers 
people and emphasises the responsibility of individuals to change their behaviours and 




the stop smoking advisors’ routine managements of clients and the electronic cigarette 
users’ decision-making. I will discuss this next. 
First, the advisors provided what they called a ‘client focused’ approach, where they 
felt that their role was to empower smokers to stop smoking and, ultimately, stop nicotine 
use. I demonstrated how some advisors verbalised that their role is to provide advice and 
guidance to users, who hold the ultimate responsibility for their own health. This approach, I 
argue, stemmed from the clinical gaze without extending beyond the biomedical elements 
of the smoker’s body (Gardner, 2014: 215). Although the advisors showed understanding of 
the different personalities, circumstances and wider influences that may hinder smokers’ 
efforts to quit smoking, they followed their target-driven regime (Bauld et al., 2010; DOH, 
2011; NCSCT, 2014). The advisors drew upon different elements when dealing with clients; 
they acknowledged ‘heavily addicted’ smokers, complicated health issues, mental problems, 
stress and peer pressure. Some advisors described the methods of treatment they use as a 
way to empower smokers and incite their willpower as a new skill to acquire and use in 
other aspects of life. However, in general, the advisors welcomed licensing electronic 
cigarettes as a medicine to be used in conjunction with other provided treatments. This, 
therefore, reflects a biomedical model that endorses a reductive clinical gaze, where 
treatment and pharmacology, focused on individuals, are emphasised rather than 
prevention (Chapman and MacKenzie, 2010; Cummings et al. 2006; White, Oliff and 
Bottorff, 2013). 
Second, electronic cigarette users showed a strong sense of control and authority. 
Users spoke about the role of willpower to stop smoking and/or vaping. Electronic cigarette 
users were strongly motivated to self-manage their smoking and vaping habits, and 
achieved this by amalgamating medical discourses on smoking and related treatments with 
their knowledge and experiences of smoking, stop smoking aids and electronic cigarettes. 
Using electronic cigarettes, similar to other medicinal nicotine forms, to reduce the harm 
that tobacco use inflicted on smokers’ bodies, can be considered ‘a struggle for 
empowerment where the smoker is being given every encouragement to conquer and gain 
control over their cravings for nicotine’ (Elam and Gunnarsson, 2012: 149). Electronic 
cigarettes can be described as ‘technologies of the self’ (Foucault, 1988a) to discipline the 




empowerment tool that smokers use to improve their health and conform to the societal 
norms of being a non-smoker. Further, electronic cigarettes, similar to other nicotine 
replacement therapies, can be described as ‘advanced liberal technologies of the nicotine 
addicted self’ that smokers use to transform themselves into ‘more responsible nicotine 
addicts’ (Elam and Gunnarsson, 2012: 149). Electronic cigarettes can also be perceived as 
‘civilizing technologies’ that are used to produce ‘better’ citizens rather than treat 
physiological illnesses (Vrecko, 2010; Elam and Gunnarsson, 2012: 149). 
The representation of electronic cigarettes as a means for empowerment stem from 
what Clarke et al. (2003: 171) described as ‘Health As Moral Obligation’, where health is 
viewed as an ‘ongoing moral health transformation’ (p: 172). Electronic cigarettes, as an 
empowering tool, showed the role of the ‘lay world’ in shaping a scientific or biomedical 
outcome (Garrety, 1997; Fox, 2011). Consumerisms and lay power have been growing 
significantly in Western society; hence, they can be considered a key driver for representing 
electronic cigarettes as a means for empowerment. Electronic cigarette users were 
accommodated within the Stop Smoking Service, even though electronic cigarettes were not 
licensed at the time. This proves the power of lay knowledge in medicalising the use of 
electronic cigarettes, and demonstrates the role of lay people and social movements in 
actively contributing to the medicalization of a particular problem (Conrad, 2008). It is this 
that I turn to in my last theme, where I explain how electronic cigarettes have become a 
means for social change. 
7.5. An Electronic Cigarette as a Means for Social Change 
Three pathways of change can result from the growth of electronic cigarettes. First, the 
creation of new identities as a result of using new technologies. Second, the formation of 
new forms of social links in society. Third, a change of the conception of recreational 
nicotine use, thus creating a new realm in the field of nicotine addiction. These will be 
explained next. 
The first form of social change is the creation of a new identity for electronic cigarette 
users. The data showed that the term ‘vaping’ became a widely accepted term for 
describing the use of electronic cigarettes. The data pointed at the proliferation of vaping 




involved in vapers’ groups, one user was interested in online activities as he formed an 
online forum for vapers. For some users, electronic cigarettes have created new rituals and 
changed the way they use their hands. I demonstrated how most users were proud of 
switching to electronic cigarettes, as it made them feel smarter, happier and in control. 
Hence, electronic cigarettes represent new technologies that have the ability to create new 
‘subjectivities’ (Clarke et al., 2003: 185). However, the data here showed that the vaper 
identity was not embraced by all electronic cigarette users, as some of them used electronic 
cigarettes in a discreet way. 
The second social change is the rapid move by private multinational companies and 
Big Tobacco to acquire, manufacture, market and research electronic cigarettes. This 
created new links that required new guidance. We saw the new guidelines presented to 
health services on the best way to deal with electronic cigarette manufacturers who are part 
of the tobacco industry (ASH, 2015d, e) (see 1.4.4). This development reflects what Clarke et 
al. (2003: 185) described as the creation of ‘complex intersectionalities of culture, political 
economy, organization, and techno-science’, where new actors are created and new 
linkages are produced by government agencies and private industry (Clarke et al., 2003). 
However, the resemblance of electronic cigarettes to cigarettes, their use as an alternative 
to smoking and the history of the tobacco industry in misleading the public opinion about 
the harm of smoking, all played a role in shaping perceptions of the tobacco industry’s 
intentions. So, even though new links with the industry are being formed slowly and 
cautiously, it is still unclear how these links will progress and what will unfold in the future. 
The third, and the most prominent, social change is the acceptance of a new practice 
for consuming nicotine that mimics smoking. In Chapter 1, I introduced the classifications of 
‘good’ nicotine and ‘bad’ nicotine and pointed at the mainstream tobacco control efforts to 
eliminate the visibility of the smoking behaviour (Bell and Keane, 2012) and all kinds of 
nicotine use (Elam and Gunnarsson, 2012). I explained how public health programmes focus 
on abrupt smoking cessation with a view to stopping nicotine use (DOH, 2011). I also 
discussed the moves towards harm reduction measures, such as gradual smoking cessation 
and long-term use of nicotine-containing products (DH, 2011; NICE, 2012a, b; 2013a, b). 
However, these measures are not, yet, translated into practice within Stop Smoking Services 




emergence of the electronic cigarette as a product that mimics smoking, contains 
pharmaceutical-grade nicotine and is used both therapeutically and recreationally (WHO, 
FCTC, 2012b; Bell and Keane, 2012: 245, 246; de Andrade, Hastings and Angus, 2013). Data 
from this research provides some evidence that electronic cigarettes have become a socially 
acceptable habit. Electronic cigarette users revealed using and enjoying electronic cigarettes 
in social occasions. They spoke about the endorsement and encouragement they get from 
others for switching to electronic cigarettes. Some were vocal about their right to vape as 
long as there was no proven harm to others. However, the concern about stigma was also 
demonstrated, as I discussed earlier. The advisors viewed electronic cigarettes as a socially 
acceptable habit, especially when compared to traditional smoking, and they mostly 
approved the use of electronic cigarettes over smoking. However, they disapproved of the 
resemblance of electronic cigarettes to smoking and favoured medicinal regulations to 
electronic cigarettes to avoid recreational use. 
My data support the literature in acknowledging the growth of using electronic 
cigarettes successfully to quit smoking by replacing tobacco cigarettes with electronic 
cigarettes (RCP, 2016). This growth has paved the way for the new regulations in the UK. 
These regulations, which came into effect from May 2016 (ASH, 2016a) (see 1.4.2), allow for 
both recreational and medicinal status of electronic cigarettes to coexist. These regulations 
are important changes in the history of tobacco control in the UK. They indicate the 
acceptance of electronic cigarettes as harm reduction products by UK regulators; they also 
indicate a move towards accepting the non-medical/recreational use of a device that 
resembles smoking and contains nicotine. 
Regulations are considered an important factor in the creation of social acceptability. 
In their study, Sherratt et al. (2015a: 9) suggested that regulating electronic cigarettes may 
be viewed as a social endorsement of electronic cigarettes for some participants, who felt 
uncertain or concerned about electronic cigarettes’ safety. Lessig (1995: 1030) argued that 
the anti-smoking regulations that were introduced after the publishing of the US Surgeon 
General’s Report in 1964 had stemmed from the ‘social meaning of science’, which proved 
that smoking is harmful. These regulations, Lessig believed, had stimulated the ‘cultural 
redefinition of smoking’, so smoking became socially unacceptable. I argue that, half a 




from the social meaning of science, which suggests that nicotine is not harmful. This 
redefinition may create a new social milieu and legal climate in which electronic cigarettes 
become more acceptable and more accessible, hence forming a new social norm (Zhang, 
Cowling and Tang, 2010). 
The electronic cigarette is described as a device that ‘meets many of the criteria for an 
ideal tobacco harm-reduction product’ (RCP: 2016: 63). Hence, electronic cigarettes may 
produce a new realm where consuming nicotine, in a form that resembles smoking, can 
coexist with public health agenda and their historical stance, which has been 
comprehensively against the visibility of any smoking-like behaviour, and is sceptical about 
coinciding pleasure with health (Bell and Keane, 2012: 245, 246; de Andrade, Hastings and 
Angus, 2013). Consequently, this means not only normalising nicotine use, but also 
normalising the act of using nicotine in a smoking-like behaviour. Electronic cigarettes, I 
argue, resulted in problematising cigarettes rather than nicotine. It is no longer nicotine 
addiction that is a cause for concern, but it is the addiction to tobacco smoking. It is within 
this context that I see how electronic cigarettes have transformed our understanding of 
addiction. Electronic cigarettes function as a tool to change the population level nicotine-
related behaviours; thus forming a new social norm towards a recreational use of nicotine. 
7.6. Linking Biomedicalization and Boundary Objects Theories 
7.6.1. Electronic Cigarettes and Biomedicalization 
Here, I examine the emergence of electronic cigarettes within the context of the 
biomedicalization of smoking addiction, which resulted in legitimising the use of medical 
discourses and treatments to treat a lifestyle condition (Elam, 2015). It is important not to 
look at electronic cigarettes as a biomedical invention that appeared like a miracle to treat 
smoking. We need to historically understand electronic cigarettes’ emergence and recognise 
that their growth is a trajectory for biomedicalized developments within the scientific and 
cultural knowledge about smoking and nicotine addiction. 
Both processes, medicalization and biomedicalization, can be detected when 
examining the development of electronic cigarettes. Medicalization worked through the 
professional jurisdiction over smoking, and the pathologisation of what was seen previously 




organisational work that existed before the emergence of this new technology. Hence, the 
electronic cigarette was embraced by leading organisations and scholars who were 
advocating for harm reduction in the decades that preceded the production of electronic 
cigarettes. Perhaps more important than the developments of the scientific evidence of 
nicotine addiction and the biomedicalization of addiction, is the ability to transform the 
biomedical knowledge of harm reduction to a product. 
The efforts of public health personnel, researchers and scientific studies contributed 
to the science of electronic cigarettes. They also contributed to creating new social and 
cultural environments. These developments made the electronic cigarette a legitimate and 
credible consumer and medical product that smokers can use to overcome their smoking 
habit. The promotion of medications to treat smoking, including electronic cigarettes, 
legitimates smoking as a biomedical condition. However, while, with nicotine replacement 
therapies, there is a departure from the psychological and habitual associations with 
smoking, with electronic cigarettes there is a recognition of the importance of these 
associations. The electronic cigarette has played a key role in changing the equation 
between smoking and nicotine. It facilitated the reconstruction of nicotine as not a 
dangerous product. At the same time, it confirmed the importance of psychological, social 
and habitual elements of smoking. Hence, it is a product of the biomedical knowledge of 
addiction, as it confirms that addiction involves physiological, social and psychological 
elements. It is this association, however, that created dilemmatic situations and the concern 
about stigma. Also, what we see here are elements of the demedicalization of nicotine 
addiction (not a disease that needs a treatment in itself), but simultaneously a continuation 
of biomedicalizing smoking. 
Further, the relationship between the electronic cigarette users and ‘expertise’ can be 
understood to be ‘simultaneously empowering and disempowering, embracive of and 
resistant to medicalization’ (Counts, 2011: v). The attitudes of both the electronic cigarette 
users and the advisors towards electronic cigarettes seem to reflect a convergence of 
professional expertise, grounded in the medical model of disease, and a patient/lay/user 
expertise based on subjective experiences of health and illness. On the one hand, electronic 
cigarette users’ perspectives on electronic cigarettes, smoking and nicotine were mediated 




‘expert’ knowledge as part of a risk-avoidance practice and self-care (Beck, 1992a; Giddens, 
1991; Armstrong, 1995). On the other hand, there was a disconnection between ‘lay’ 
electronic cigarette users and the professionals on the risk issue. Most electronic cigarette 
users saw their use of electronic cigarettes as a means to restore their own health to a 
normative construct of health, to ensure the health of others around them is maintained or 
restored, and to conform to the social norm of not being a smoker or a nicotine user. 
Although they sought professional advice, this advice was filtered through the lens of their 
personal experience and own perceptions. 
Electronic cigarettes denote the hybrid generated through science and technology 
(Clarke et al., 2003: 173). Biomedicalization, in the case of electronic cigarettes, orbits 
around the interaction of these biomedicalization processes: the emphasis on improved 
lifestyle by applying biomedical innovations; focus on risk factors rather than on the 
diseases itself; the creation of new subjectivities through electronic cigarette use; the 
creation of a new community through online and face to face groups, shops and cafes; the 
development of a new market for customised products; new techniques for disseminating 
information about electronic cigarettes; and the new links created as a result of accepting 
electronic cigarettes as a tool of harm reduction within the health and political arena. These 
processes interact with and co-constitute each other. However, it has been argued that 
‘Within processes of biomedicalization, social contexts are often obscured in understanding 
of health and illness as technoscientific definitions come to prevail’ (Fosket, 2010: 349). This 
is where I saw the usefulness of combining the theory of boundary objects with 
biomedicalization in studying the phenomenon of electronic cigarettes, as I explain next. 
7.6.2. Electronic Cigarettes as Boundary Objects 
Here, I discuss how electronic cigarettes as boundary objects can function as both 
translational and facilitative objects between different actors, who construct different social 
meanings of electronic cigarettes. 
In Chapter 1, I discussed how the emergence of electronic cigarettes has created 
controversy regarding their role and effect on society (WHO FCTC, 2012b; RCP, 2016), and I 
showed a similar controversy within my data. The ambiguity of electronic cigarettes allowed 




a safe product; a safer alternative to smoking; a therapeutic product; a clean nicotine 
delivery device; an innovation with potential long-term threats; and as a risky object. It was 
also seen as a device that can create addiction, maintain nicotine addiction, a gateway to 
smoking and a gateway from smoking simultaneously. I demonstrated how, within the same 
group, different meanings and perceptions existed; hence, I argue that the coexistence of 
these different risk meanings and perceptions enabled the formation of electronic cigarettes 
as boundary objects (Star and Griesemer, 1989). 
Electronic cigarettes also function as translational boundary objects. This is because 
electronic cigarettes allowed for heterogeneity and cooperation between different actors 
(Star and Griesemer, 1989). The electronic cigarette was adapted to the multiple social 
worlds of the electronic cigarette users, stop smoking advisors, health organisations and the 
tobacco industry. Hence, it created coherency and cooperation between groups with 
diverse interests and goals. We saw how different actors, who held different perceptions of 
electronic cigarettes’ safety, efficacy and status, shared the understanding that electronic 
cigarettes are less harmful than smoking and could replace cigarettes. This shared 
understanding enabled groups to communicate and cooperate together. Electronic 
cigarettes, which exposed the boundaries between ‘good’ and ‘bad’ nicotine (Bell and 
Keane, 2012: 246), act as a bridge between the two worlds of ‘bad’ and ‘good’ nicotine. 
Electronic cigarettes created a new identity for nicotine, where both ‘bad’ and ‘good’ 
nicotine became entangled. 
By seeing electronic cigarettes as boundary objects, the negotiation over the 
possibility of using electronic cigarettes therapeutically and recreationally emerged. By 
negotiating electronic cigarettes as boundary objects, different actors could each retain 
their own interpretation. As a result, a consensus on the role of electronic cigarettes could 
be achieved given that, as boundary objects, electronic cigarettes could be conceptualised 
in multiple ways. The regulatory framework which allows electronic cigarettes to exist, both 
recreationally and therapeutically, represents what Star described as ‘the 
material/organizational structure of different types of boundary objects’ (Star, 2010: 602), 
where the heterogeneity is maintained without ruining the cooperative work. The electronic 
cigarette is shifting from being a vague identity boundary object to becoming a more 




Electronic cigarettes also function as facilitative boundary objects (Fox, 2011). In the 
literature review, I demonstrated the tensions between scientists over the harm reduction 
approach, especially the long-term use of nicotine (RCP, 2007; Elam and Gunnarsson, 2012). 
Contemporary tobacco harm reduction efforts can be traced back to the 1950s (Doll, 2004). 
However, I demonstrated how the disagreement related to tobacco harm reduction still 
exists in the current official domain and among stop smoking advisors. Electronic cigarettes 
have prompted the debate of harm reduction. They brought to the surface the discussions 
of providing an acceptable and effective form of nicotine as a cigarette substitute (RCP, 
2007), which were initiated back in the early 1990s (Russell, 1991). Electronic cigarettes 
have stimulated the debate on the Stop Smoking Services’ agenda and whether they are 
stop smoking or stop nicotine services (NCSCT, 2016: 11). Electronic cigarettes, I argue, 
facilitated the emergence of new UK regulations which accept practices of harm reduction. 
Electronic cigarettes have transformed ‘the nicotine harm-reduction landscape’ (RCP, 2016: 
7), thus paving the way for a change in our society and a new realm in the field of nicotine 
addiction. 
An implication of the production of electronic cigarettes as boundary objects is that, 
while a coexistence for diverse representations is agreed upon, this does not mean that the 
debate has been settled. Conceptualising electronic cigarettes as boundary objects means 
that divergent interpretations are dynamic and changeable. We saw how the dilemma still 
exists with regards to promoting electronic cigarettes to help smokers stop smoking, and 
controlling electronic cigarettes to discourage their increased uptake or renormalisation of 
smoking. Accordingly, further development in the field of electronic cigarettes might create 
new interpretations for electronic cigarettes, change or end some of the meanings and 
perceptions presented in this thesis. 
7.6.3. How Are Both Theories Interlinked? 
I would like to explain how boundary objects theory links to biomedicalization. I describe 
how the ambiguous electronic cigarettes can function as boundary objects and progress into 
a standard, or a process, and facilitate the formation of new social forms. This will 
contribute to the understanding of the construction and development of biomedicalization 




the wider political, cultural and technological contextual influences that can explain the 
formation of boundary objects. 
In section (3.2.2), I introduced Clarke et al.’s (2003: 185) statement, where they 
described the emergence of ‘new forms of agency, empowerment, confusion, resistance, 
responsibility, docility, subjugation, citizenship, subjectivity, and morality’, and where he 
highlighted the ‘infinite new sites of negotiation, percolations of power, alleviations as well 
as instigations of suffering, and the emergence of heretofore subjugated knowledges and 
new social and cultural forms’. This statement highlights the vital role of the social context 
of the development of biomedicalization processes. It identifies the central role of human 
agents in the construction, resistance or dominance of biomedicalization processes and 
describes how new technologies become a means for creating new social and cultural 
forms. The statement describes how different people interact differently with biomedical 
advances. First, biomedical technologies create new social worlds with a new ‘agency, 
empowerment, confusion, resistance, responsibility, docility, subjugation, citizenship, 
subjectivity, and morality’. Second, people start processes of negotiating their conflict, 
stances, and various perspectives. Lastly, new social and cultural forms emerge. The authors 
called for case studies to examine ‘the heterogeneities of biomedicalization practices and 
effects in different lived situations’ (p: 185). This is where boundary objects theory can be 
useful in elucidating the ambiguities, conflicts and processes of negotiations that come with 
biomedicalization. Clarke and Star (2008: 137) stated that: 
the study of boundary objects can be an important pathway into complicated situations, 
allowing the analyst to study the different participants through their distinctive relations 
with and discourses about the specific boundary object in question. This can help frame 
the broader situation of inquiry as well. 
Boundary objects theory can explain how different biomedical processes are the outcome of 
complex social negotiations and cooperation between divergent social meanings occurring 
within a particular social, economic and political context. 
First, my data demonstrated the focus and preoccupation of my participants on risk, 
risk management and individual responsibility to improve health. It is this human force that 




towards customization and individualization’ and consumerisms (Clarke et al., 2003). My 
data showed how representations and discussions of electronic cigarettes stemmed from 
the biomedical model understanding of nicotine and addiction. The engagement with 
scientific information and personal experiences facilitated the rise of the concept and 
practices of nicotine harm reduction. As boundary objects, electronic cigarettes showed the 
role of the ‘lay world’ in shaping a scientific or biomedical outcome (Garrety, 1997; Fox, 
2011). Electronic cigarettes progressed into a process of harm reduction and facilitated the 
formation of new social forms for using nicotine. Electronic cigarettes as boundary objects 
functioned as an entity that enhanced the capacity of harm reduction to translate across 
culturally defined boundaries (Fox, 2011). With the view that harm reduction represents an 
extension for the ‘medical gaze’ (Petersen and Lupton, 1996: ix; Miller, 2001: 171), we can 
see how the formation of electronic cigarettes as boundary objects enhanced 
biomedicalization. 
Second, electronic cigarettes, as ambiguous boundary objects with diverse meanings, 
have created confusion and uncertainty and, consequently, have generated new groups of 
advocates and opponents. These groups initiated processes of debates and negotiations. 
Biomedicalization processes are the outcome of battling different forms and human 
interpretations. These voices, I believe, are the human force that influences processes of 
‘transformations of identities, through the creation of new identities by using new 
technology’, and ‘the transformations of information and the production and distribution of 
knowledges’ (Clarke et al., 2003). Electronic cigarettes allowed for a form of nicotine to exist 
without implying ‘rejection of smoking or a commitment to quitting’ (RCP, 2016: 101). 
Electronic cigarettes, as technological objects, possess the ability to mediate social and 
power relations (Fox 2011: 82), thus creating new social identities with new social links and 
forwarding social transformation, as I explain next. 
Third, the mismatches between the overlapping meanings and perceptions of 
electronic cigarettes across the different groups caused dilemmatic situations and ‘problems 
for negotiation’ (Star and Griesemer, 1989: 412). Hence, the management of electronic 
cigarettes is a key process in developing and maintaining coherence across these 
intersecting social worlds (p: 393). Bauer and Gaskel (2008: 349) argue that the challenge in 




developments in the context of diverse values and differing representations’. The new 
electronic cigarettes regulations and the new management of links with the tobacco 
industry aim to maintain coherence and successful negotiations between the different 
groups, without necessarily creating consensus, and to maintain their sharply different 
organisational missions (Star and Griesemer, 1989: 413). The new regulations, therefore, 
reflect the successful formation of electronic cigarettes as translational boundary objects by 
enabling people from multiple social worlds and different conceptions, of nicotine, smoking 
and electronic cigarettes, to cooperate. Thus, they enforce the process of ‘the political 
economic reconstitution of the vast sector of biomedicine’ (Clarke et al., 2003). 
In this qualitative study, the boundary objects theory presents a useful tool that 
helped me to understand how the different social worlds come together to collaborate, 
despite the differences in their expertise, goals, and interests, with regards to electronic 
cigarette use, hence enforcing processes of biomedicalizing smoking addiction in our 
society. Simultaneously, I believe that the construction of different social meanings is 
influenced by the domination of the biomedical model. Clarke et al. (2003: 171) pointed to 
this simultaneous link when they described the substantial and constant ‘politico-economic 
transformations of the biomedical sector’. These transformations, they argued, are 
happening on a ‘macro structural’ level across organisations and a ‘meso- and micro-level’ in 
health and medicine practices. The scholars saw such transformations as a means ‘to 
produce new and elaborated mechanisms through which biomedicalization can occur’, but 
at the same time, they believed biomedicalization determines and stimulates many of these 
political and economic transformations in our society. 
In this sense, biomedicalization processes can influence the construction of different social 
meanings and formation of boundary objects. They are the engines that can encapsulate the 
different perceptions that different social worlds form of a particular biomedical 
technoscientific object. In the case of electronic cigarettes, for example, the previously 
formed science of nicotine addiction and harm reduction provided the background from 
where the different interpretations of electronic cigarettes stemmed. Also, the advances in 
the transformation of knowledge mechanisms facilitated the formation of shared 
understanding and negotiating boundaries between different actors. Electronic cigarettes, I 




contemporary public health and the underlying social relations that surround their 
development and adoption (Fox, 2011: 82). 
To conclude, the three emerged themes from this study showed that an electronic 
cigarette was viewed as a potential source of different risks, a means to empower smokers, 
a technology that creates new identities, new links in society and a new realm in the field of 
addiction. I demonstrated how the ways in which different actors interpreted, perceived 
and managed electronic cigarettes influenced the development of several biomedicalization 
processes. Biomedicalization, I conclude, is a dynamic rather than static concept, as its 
processes are constructed around a constant (re) formation of boundary objects. Next, I will 
discuss the limitations and strengths of this project. 
7.7. Strengths and Limitations 
My research, similar to any research project, has strengths, weaknesses, constraints and 
opportunities which I could not anticipate at the outset. Below, I demonstrate the particular 
strengths and limitations of my study in terms of the research context and the theoretical 
underpinning of my work. 
Bryman (2012: 405) highlighted some of the criticisms that qualitative studies have 
been subjected to. For example, qualitative research was criticised for being subjective. This 
is because researchers develop a close connection with their participants, and because the 
researcher’s own views, judgement, preferences, characteristics, and background may 
influence the procedures and progressions of the study. I am aware that my own 
background, experience and knowledge shaped my interpretation; however, my intention 
was to make sense of and interpret the meanings participants have about electronic 
cigarettes. Hence, I applied verbatim quotations for interview transcripts to give participants 
a voice and to illustrate and deepen the understanding of the themes I identified (Corden 
and Sainsbury, 2006). 
There are some methodological issues relating to interviews as a data collection 
method. Diefenbach provided a summary of the methodological problems of qualitative 
research that is mainly based on semi-structured interviews. This includes, for example, the 
process of selecting the interviewees; the influence of the interview situation; the possibility 




Further, there are concerns with regard to the quality of the data, their quantity and the 
time frame, which all affect the validity of the data (Diefenbach, 2009). I argue that the 
interview method I used had enabled individuals to have their knowledge and voices heard. 
However, recruiting was challenging because it depended on people’s willingness to take 
part in a project and on the structure of their lives and lifestyles. While, I believe, 
participants were generally comfortable being interviewed by me, the structure and 
formality of an ethically conducted research project may have influenced their active 
participation in the project, and may have contributed to the difficulties encountered in 
generating participations to conduct interviews. 
One possible limitation of this study would be the potential of sampling bias, as only 
people who could be contacted by mobile phone (at the second site of the research), had 
access to the participating Stop Smoking Services, used social media and visited places that 
advertised my leaflets knew about the research. Also, people with a hearing impairment, or 
who might find it difficult to converse in English might have been put off from participating 
in telephone interviews. Nevertheless, the process of recruiting participants offered an 
opportunity for different electronic cigarette users to participate in the research, regardless 
of their gender, job status and age. This, I believe, added more heterogeneity to the debate. 
A further potential limitation is the use of two different interview methods: face to face and 
phone interviews. Since the themes that emerged from both methods were very similar, I 
have some confidence that there was a high degree of thematic commonality provided via 
both approaches. The resultant themes were drawn from the raw data (inductive), thus 
presenting naturalistically occurring themes evident in the data itself. I also offered to do 
interviews at the convenience of the interviewees to achieve a more relaxed atmosphere. 
My research design was purposely a small qualitative study focusing on the 
perceptions of electronic cigarettes in South East England. This design allowed me to gain a 
deep understanding of the perceptions of electronic cigarettes drawn from the two 
datasets. I also want to highlight the benefits of triangulating two data sources to look for 
corroborating or conflicting data and to understand whether the data point to the same 
direction and, hence, to improve the data quality (Williams and Morrow, 2009; Yin, 2011). 
Through triangulation, I was able to grasp the ambiguity of electronic cigarettes and the 




Another limitation is not looking into how different sociocultural factors such as 
gender, age, social class and ethnicity may have contributed to the construction of the 
different perceptions of electronic cigarettes. The study did not look into how the use of 
different ‘generations’ of electronic cigarettes, brands, models, flavours or nicotine 
concentrations might have contributed to the formation of different perceptions that 
electronic cigarettes users or the advisors hold. This qualitative study would have been 
improved by incorporating observations in the data collection in order to ensure a thick 
description of the perceptions elicited. In addition, there is still a scope for further research 
on electronic cigarette users’ concern about stigma, which has been brought up in my 
research. 
7.8. Further Research 
Here, I suggest further research, which partly stems from the limitations of my study, as 
demonstrated above, and partly from the new ideas generated by the empirical, theoretical 
and methodological levels through my research. I suggest that, by using different methods, 
by interviewing a different group of participants, and approaching electronic cigarettes from 
a different perspective may add further insights into the debate on electronic cigarettes. 
In ‘commodified biomedical economies’ (Hansen and Roberts, 2012: 98), we need to 
consider the power of consumerism, big corporates and Big Tobacco in the field of 
electronic cigarettes. Although not extensively debated in this study, my participants 
pointed at the link between the government, science and the pharmaceutical and tobacco 
industries. More studies are needed to reveal these links and their influence on electronic 
cigarette use in societies. 
Based on the difficulties encountered when recruiting electronic cigarette users to 
participate in the research, I suggest applying alternative research methods when 
conducting research with this population. Using social media, such as forums and online 
discussion groups, would be valuable in order to allow views from electronic cigarette users 
with a wider range of experiences than were potentially included in my sample. A further 
qualitative approach, to understanding the construction and effects of different perceptions 
of electronic cigarettes, may benefit from a comparative study of different locations. These 




particular interventions, such as the prescriptions of electronic cigarettes as a treatment in 
some Stop Smoking Services. Different theoretical approaches can be utilised to further 
explore the phenomenon of electronic cigarettes, such as the Social Representations Theory 
(Moscovici and Duveen, 2008 [1961]). The theory has been proposed as a plausible 
mechanism to explain how boundaries develop and are negotiated among groups (Riesch, 
2010). Other studies may apply the same theoretical approach that I applied here, to 
explore other emerging technologies. 
I also suggest studies that look more closely at the construction and influence of 
stigma towards electronic cigarette users. With regard to participants, I argue that it would 
be valuable in future research to compare the views of health and non-health service 
providers in order to gain an understanding of how all services can be more electronic 
cigarette user-friendly. It would be valuable to conduct future research into the different 
perceptions of electronic cigarettes held by family members of electronic cigarette users 
and the general public. A further participant group, which has not received adequate 
attention, include electronic cigarette users who chose to go back to smoking after stopping 
smoking with the help of electronic cigarettes. It would also be useful to focus on special 
cohorts, such as smokers with mental illness or serious health conditions and those from 
disadvantaged groups to establish the usefulness and uniqueness of electronic cigarettes in 
meeting their needs. Other studies could explore the use of different ‘generations’ of 
electronic cigarettes, brands, models, flavours and nicotine concentrations, and how these 
differences might be linked to perceptions and use patterns of electronic cigarettes. I 
suggest conducting further research looking into how different sociocultural factors such as 
gender, age, social class and ethnicity influence the construction of the different 
perceptions of electronic cigarettes. Longitudinally, it would also be valuable to study the 
social outcomes for the long‐term use of electronic cigarettes. Lastly, I suggest studies that 
looks into the implications of the new electronic cigarettes’ regulation, especially addressing 
the uptake, gateway and renormalisation concerns. In general, as discussed earlier, I 
recommend incorporating observation in the research design. Next, I provide some 
recommendations to suggest how my findings can be translated into actionable approaches 





In this section, I discuss the recommendations to policy and practice drawn from the 
findings from this qualitative study in order to achieve positive outcomes for smokers and 
electronic cigarette users. 
First, my findings suggest that concern about stigma exists among some electronic 
cigarette users in my sample. These findings highlight the importance of conducting 
in‐depth case studies, as my research adds to the small body of literature outlining early 
experiences of electronic cigarettes. In the face of stigma, policies, news and messages 
circulating in the public sphere, particularly the media, ought to address the negative 
conceptions of electronic cigarettes. The formulation and communication of electronic 
cigarettes’ discourses must take into account not just the risks, but also the benefits that 
come from electronic cigarettes. This is particularly so with regard to electronic cigarette 
users, who struggle with their tobacco addiction and who may find electronic cigarettes a 
lifesaving opportunity. 
Second, based on interviews with stop smoking advisors, it became apparent that the 
advisors felt under pressure to meet quitting targets. It also became apparent that the 
approaches applied in the Stop Smoking Services do not coincide with the harm reduction 
messages advocated by the leading health organisations like NICE and RCP. The provision of 
supportive services that focus on smokers’ choices and lifestyle, and build trust between lay 
knowledge and professional knowledge, can create a positive environment for smokers who 
need help in their attempts to quit. I emphasise the benefits in addressing (and accepting) 
smokers’ life choices rather than suggesting a normative life trajectory for them. I stress the 
need to take a proper account of both the personal and physical experience of using 
electronic cigarettes and the cultural and social dimensions. I argued that electronic 
cigarettes signify a historical cultural redefinition of addiction, stemming from the social 
meaning of science, where psychological, physical and lifestyle requirements of smokers are 
recognised and acted upon. This social change, however, can be interrupted if stigma 
towards electronic cigarettes was shifted from smoking. However, building on the new 
regulations of electronic cigarettes and the growth of their use as a harm reduction tool, 




come from a positivist background, this study has helped me to understand and value the 
importance of qualitative research in the field of health, science and technology. My view is 
that personal experiences should not be considered anecdotal or unreliable in relation to 
forming a basis for making scientific decisions. On the contrary, these experiences can be so 
powerful and can change clinical practice as well incite social changes. Hence, I am now a 
strong advocate for qualitative research to be part of studying any new scientific, health or 
medical phenomenon. Next, I conclude the thesis by highlighting the novel contribution of 
my qualitative study to the literature. 
7.10. Novel Contribution 
In this section, I discuss the contributions of my qualitative study to the empirical, 
theoretical and methodological literature. I argue that my contribution adds further 
evidence to the limited knowledge of the experiences of electronic cigarette users. In 
addition, I contribute to the evidence of stop smoking advisors’ experiences, their ways of 
making sense of electronic cigarettes, and working with electronic cigarette users before 
electronic cigarettes become a licensed medicinal product. My theoretical and 
methodological contributions are based on my use of a qualitative research design, 
underpinned by the theoretical framework of boundary objects and biomedicalization. 
Finally, my thesis helps to reveal areas in which further research needs to be undertaken, to 
better understand and find ways to address the possible stigmatising of electronic cigarette 
users, and further understand the implication of the social change that electronic cigarettes 
have instigated. 
My empirical contribution lies in the finding that the perception of electronic 
cigarettes as an ambiguous device is shared among my sample of electronic cigarette users 
and stop smoking advisors. Although electronic cigarette users and the advisors shared this 
perception, they all drew on different, older experiences in their social memory to construct 
either a positive or a negative view of electronic cigarettes. These perceptions stemmed 
from a biomedical understanding of nicotine, smoking and addiction. Hence, electronic 
cigarettes are represented as ‘civilised technologies’ to improve health. There is also a 
consensus on the relative safety of electronic cigarettes in comparison with traditional 




reduction approaches paved the way for new regulations which accept the use of nicotine in 
a form that mimics smoking, both recreationally and therapeutically. Electronic cigarettes, I 
conclude, signify a historical cultural redefinition of addiction, stemming from the social 
meaning of science, where the smokers’ psychological, physical and lifestyle requirements 
are recognised and acted upon. However, in spite of the signs of social change and 
acceptance of electronic cigarette use in society, my findings highlight that the concern 
about stigma shifting from smoking to vaping exists. This will have implications on the way 
public health policies are constructed and communicated. 
There has been a call in the academic literature to use ‘a theory of social meanings’ to 
address problems of technology innovation and adoption (Fox, 2011: 82). My theoretical 
and methodological contributions are based on my use of the theoretical framework of 
boundary objects and biomedicalization theories. In my theoretical approach, I used 
boundary objects to understand the boundary struggle and the negotiations over competing 
meanings, which eventually results in the construction of knowledge and policies in relation 
to electronic cigarettes. Although boundary objects theory was combined with other 
theories and analytic frameworks (e.g. Garrety, 1997; Fox, 2011), this is the first study, to 
my knowledge, that combines both boundary objects theory and biomedicalization. I used 
the biomedicalization theory to illustrate how wider political, cultural and technological 
processes have influenced the formation of different and competing interpretations of 
electronic cigarettes and facilitated the construction of electronic cigarettes as boundary 
objects. I also argued that the coexistence of different social worlds, which was enabled by 
the formation of electronic cigarettes as boundary objects, has influenced the formation, 
direction and progression of various biomedical processes. Applying both theories to the 
topic of electronic cigarettes provided a better understanding and a deeper insight into the 
contextual factors which influence the formation of various meanings for a technological 
object among different social worlds; they also provided a better understanding of how 
these social worlds interact and how they form a power, which, in turn, influence these 
contextual factors. These intertwined dynamics were captured by applying both the 
boundary objects and biomedicalization. Hence, I believe, combining both theories was 
useful to gain a deeper understanding of the emergence and development of electronic 




I will bring my conclusions to a close with some final thoughts on how my 
preconceived perceptions about nicotine addiction, smoking and electronic cigarettes, 
which were influenced by a biomedical model of learning have transformed. As the study 
progressed and throughout my interviews and analysis, I developed an understanding of 
these concepts through the eyes of the human actors and their spoken and written 
accounts. I have come to acknowledge the ways in which smokers have a central role in the 
advances in the field of nicotine addiction, but are also obscured. I would like to see a shift 
within the medical field towards a broader understanding of the social context of science. 
In the four years that I have been researching electronic cigarettes there has been a 
flowering of academic studies of this domain. As I write the last few sentences of my thesis 
the world is significantly different. For instance, I now frequently pass adverts for electronic 
cigarettes, a plethora of new Vaping retail outlets has emerged, and I constantly see the 
smoke drifting above the head of this new and growing social group of Vapers. My thesis 
makes an important contribution to understanding this topic, but it is an ever changing field, 
and much social research still needs to be done. 
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x The participant information sheet or leaflet is appropriate. 
x The procedures for recruitment and obtaining informed consent are appropriate. 
Please confirm the professional research ethics code that will guide the research (please circle) 
 BSA (please state) __________________ 
_Hauke Riesch____________________________  7.5.2015_______________________ 
 




Section IV: Research Checklist 
Please answer each question by ticking the appropriate box: 
 YES NO 
3. Does the study involve participants who may be particularly vulnerable and/or 
unable to give informed consent, thus requiring the consent of parents or 
guardians? (e.g. children under the age of 16; people with certain learning 
disabilities)  
 √ 
2a. Will the study require the cooperation of a gatekeeper for initial access to the 
groups or individuals to be recruited?  
√  
2b. If the answer to Question 2a is Yes, then will the study involve people who could be 
deemed in any way to be vulnerable by virtue of their status within particular 
institutional settings? (e.g. students at school; disabled people; members of a 
self-help group; residents of a nursing home, prison, or any other institution 
where individuals cannot come and go freely) 
 √ 
3. Does the research involve observational/ethnographic methods?   √ 
4. Will the study involve discussion by or with respondents or 
 interviewees of their own involvement in activities such as sexual behaviour 
 or drug use, where they have not given prior consent to such discussion?  
 √ 
5. Are drugs, placebos or other substances (e.g. food substances, vitamins) to be 
administered to the study participants or will the study involve invasive, intrusive 
or potentially harmful procedures of any kind?  
 √ 
18. Will blood or tissue samples be obtained from participants?   √ 
19. Is pain or more than mild discomfort likely to result from the study?   √ 
20. Could the study induce psychological stress or anxiety or cause harm or negative 





21. Will the study involve prolonged or repetitive testing?   √ 
22. Will financial inducements (other than reasonable expenses and compensation 
for time) be offered to participants?  
 √ 
23. Will the study involve recruitment of patients or staff through the NHS?   √ 
12a. Have you undertaken this study as part of your work placement?   √ 
12b. If your answer to Question 12a is Yes, then have the employers at your work 
placement conducted their own research ethics review? 
  





Give a brief description of participants and procedure (methods, tests used etc) in up to 150 words 
This research analyses Electronic Cigarettes (EC) use in Hertfordshire (part of it will be at some smoking 
cessation clinics). The aim is to study attitudes, experiences and views of EC users and smoking cessation 
advisors. 
Semi-structured interviews will be carried with15 to 20 EC users and about 10 stop smoking advisors. 
The exclusion criteria are users with severe dementia, learning difficulties, mental illness and those 
unable to conduct an interview in English and /or give informed and written consent. 
The interview protocol will comprise open-ended questions that enable detailed discussion of 
participants' perceptions, views and experience. 
When ethical approval is gained, the researcher will approach some smoking cessation clinics with 
detailed information sheet about the study and ask for voluntary participation. 
Stop smoking advisors at some pharmacies will be approached for voluntary participation. 
Electronic cigarette users will be recruited through the social media, leaflets that is displayed in clinics 
and e-cigarette shops, identifications by the stop smoking advisors. And any e-cigarette user in 
Hertfordshire who voluntarily agree to participate in this research. 
If participants decide to take part, they will be asked to sign a consent form. Interviews will be audio-
recorded and transcribed verbatim. Data will be analysed using thematic analysis approach. 
Also the following method will be used to collect data: An advertisement will be put up on Brunel 
University London website to ask for electronic cigarette users to participate in the research. A snowball 
sampling technique will be utilised to get more participants. Information sheet will be provided to each 
potential participant. If participants decide to take part, they will be asked to sign a consent form. 
Interviews will be audio-recorded and transcribed verbatim. Data will be analysed using thematic 
analysis approach. 
This is the text for the advertisement: 
(I am a PhD student at Brunel University London, and I would like to talk to people about their 
experiences of using e-cigarettes. If you are interested in taking part in this research and for more 
information, please contact me on my email: nancy.tamimi@brunel.ac.uk or phone 07741546059). At 
this point there will be no incentives to encourage participation.  If the participation is low, the 





Name of Principal Investigator at Brunel University (please print): _________Nancy 
Tamimi_________________________ 
Signature of Principal Investigator at Brunel University: ____________________________________ 
Nancy Tamimi 




 May 2015_______________ 
This request for expedited review has been:  (1) Approved (no additional ethics form is necessary) 
      (2) Declined (full University ethics form is necessary) 













Nancy Tamimi  






1 December 2013 
Dear Sir/Madam, 
‘Electronic Cigarettes Use at Smoking Cessation Service in UK: Users and Staff Perspectives’ 
I am a PhD student at the School of Social Science at Brunel University London, interested in studying 
the use of Electronic cigarettes at the Stop Smoking Service in Hertfordshire. I am inviting you to 
take part in a research study titled ‘Electronic Cigarettes Use at Smoking Cessation Service in UK: 
Users and Staff Perspectives’ 
The aim of the research is to analyse Electronic Cigarettes (EC) use at the Stop Smoking clinics in 
Hertfordshire. The information from this research could provide information about the experience of 
electronic cigarettes use and the different perspectives of the staff and the users, which may be of 
benefit to health professionals, scientists, policymakers and regulatory bodies. 
You are an important person who can help me with this research, as a Smoking Cessation advisor at 
the stop smoking clinics in Hertfordshire; I will be interested to listen to your views and experience. 
Attached is a detailed information sheet about the research. If you agree to take part in the project, I 
will contact you during the following week to ask for your consent and arrange an interview at a 
time and location that is convenient. The interview would last one hour. I will ask you about your 
experience with clients who decides to use Electronic Cigarettes, how the treatment goals at the 
clinics are initiated and negotiated; What are the factors that affect the decision to use EC; what is 
the role of digital information-if any- on EC initiation, use and conceptualisation; how do you view 
and conceptualise EC use and how do you think the experience of EC use affects the users compared 
with previous experiences (as similar or different to other smoking cessation treatments). 
Unit 1A, Howard Court 
14 Tewin Road 








If you have any questions please do not hesitate to contact me on my email 

















 UB8 3PH 
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1 December 2013 
Dear Sir/Madam, 
‘Electronic Cigarettes Use at Smoking Cessation Service in UK: Users and Staff Perspectives’ 
I am a PhD student at the School of Social Science at Brunel University London, interested in studying 
the use of Electronic cigarettes at the Stop Smoking Service in Hertfordshire. I am inviting you to 
take part in a research study titled ‘Electronic Cigarettes Use at Smoking Cessation Service in UK: 
Users and Staff Perspectives’ 
The aim of the research is to analyse Electronic Cigarettes use at the Stop Smoking clinics in 
Hertfordshire. The information from this research could provide information about the experience of 
electronic cigarettes use and the different perspectives of the staff and the users, which may be of 
benefit to health professionals, scientists, policymakers and regulatory bodies. 
You are an important person who can help me with this research, as an electronic cigarette user and 
a client at the stop smoking clinics in Hertfordshire; I will be interested to listen to your views and 
experience. 
With your permission, the stop smoking advisor will pass me your contact details. You will be 
provided with a detailed information sheet about the study. I will, then, contact you during the 
following week to ask for your consent and arrange an interview at a time and location that is 
convenient. The interview would last one hour. I will ask you about your experience in using 
electronic Cigarettes, how and why you decided to use them; where do you get the information 
about electronic cigarettes and if you use any electronic cigarettes websites; how do you view 
electronic cigarettes use and how is the experience of their use is compared with previous smoking 
cessation treatments. 
Unit 1A, Howard Court 
14 Tewin Road 







If you have any questions please do not hesitate to contact me on my email nancy.tamimi@brunel 









Interview (Electronic Cigarette user) 
U:\Nancy\IRAS\0051 
22 January 2014 




We would like to invite you to participate in a 
research project. You should only participate if you 
want to; choosing not to take part will not 
disadvantage you in any way. Before you decide 
whether you want to take part, it is important for 
you to understand why the research is being done 
and what your participation will involve.  Please 
take time to read the following information 
carefully and discuss it with others if you wish. 
Contact the researcher if there is anything that is 
not clear or if you would like more information 
What is the purpose of this study? 
The purpose of this study is to analyse Electronic 
Cigarettes (EC) use at smoking cessation clinics in 
Hertfordshire as part of the new harm reduction 
strategy. The aim is to explore the EC users and 
the staff attitudes, experiences and views about EC 
use. What similarities and differences are there 
between the staff’s and the users’ conceptions? 
How do the staff adapt their work to the users’ 
needs and wishes? And how do they conceive EC 
use generally and in comparison with earlier 
treatment experience.  One part of the study 
involves talking to EC users; this will enable the 
researcher, Mrs Nancy Tamimi, to explore the use 
of EC in clinics. You are invited to participate in this 
study by accepting to be interviewed by the 
researcher, Mrs Tamimi. 
Who is conducting the research? 
Nancy Tamimi, will be conducting the interviews.  
Professor Steven Wainwright is the supervisor of 
the PhD Project.  
Who is funding the research? 
The research is being funded by the researcher. 
What will you be invited to do?  
If you are interested in participating, your 
contact details will be passed to the 
researcher. You will be given a minimum of 24 
hours to decide. If you have any question, 
please feel free to contact the researcher Mrs 
Nancy Tamimi. Within a week of passing your 
contact details- but not before you are given 
the 24 hours- Nancy Tamimi will contact you 
to ask you about your decision. If you decide 
to participate, the researcher will arrange 
with you an interview, at a time and location 
convenient for you lasting about one hour 
and you will be asked to sign an “informed 
consent” form. During the interview, I will ask 
you about your experience in using EC, how 
and why you decided to use EC; What are the 
reasons that affect the decision to use EC; 
where you get the information about EC and 
if you use any EC websites; how do you view 
EC use and how is the experience of EC use is 
compared with previous smoking cessation 
treatments. It is your right to refuse to answer 
specific questions, to discontinue your 
participation, or to ask me to explain my 
questions. Interviews will be audio recorded, 
subject to your permission. Recordings of 
interviews will be deleted at the end of the 
project. If you do not wish the interview to be 
recorded, I will take notes as we talk. You are 
also free to have any interview data 
pertaining to you withdrawn from the study 
within three months after the interview. 
Possible risks of participation 
You may feel uncomfortable talking about 
some issues related to EC use or smoking 
experience. Our aim is to provide all 
participants with safe, respectful and 
confidential opportunities to discuss their 








  Possible benefits of participation 
Once the research is finished, it could 
provide information about the different 
concepts, views, experiences of using EC at 
smoking cessation service, which may be of 
benefit to health professionals, scientists, 
policymakers and regulatory bodies. It may 
also help contribute to a more informed 
public perception of using EC. 
 
Will the information you provided be kept 
confidential?  
Everything you say/report is confidential 
unless you tell us something that indicated 
that you or someone else is at risk of harm. 
We would discuss this with you before 
telling anyone else.  All information that is 
collected about you during the course of 
the research will be anonymous and kept 
strictly confidential, in accordance with the 
1998 Data Protection Act.  Any notes we 
make will be given a code number to 
ensure that they are not traceable to an 
individual.  All the notes will be stored 
securely in a research office for 7 years 
from the project completion. Professor 
Steven Wainwright, Professor Clare 
Williams and Mrs Nancy Tamimi will be the 
only people with access to this stored data.   
 
What will happen to the results of the 
research study? 
The data provided by this study will be used 
to write a PhD thesis and a number of 
reports and papers in academic journals. 
Participants and the research site will not 
be identified on any report/publication.  
You will be able to access publications from 
the Brunel University webpage. 
 
What do you do now? 
It is up to you to decide whether or not to 
take part.   
If you are interested in hearing more about 
the study then please contact Nancy Tamimi 
who will be happy to answer any questions 
you may have. If you agree to participate, 
then interviews will be scheduled at a time 
and place convenient for you.  If you do 
decide to take part, you will be asked to sign a 
consent form and be given a copy of this and 
the information sheet to keep. 
 
 
What if you decided not to take part? 
You are free to decide not to take part.  Even 
if you do agree to take part, you are free to 
withdraw from the study at any time without 
giving an explanation; this will have no effect 
on the care you are receiving.  Mrs Tamimi 
will not use your interview data.  Withdrawal 
will not be possible once data has been used 
in publications (3 months after participation). 
 
What if you have any concerns or questions? 
If you have any concerns or questions about 
this study or the way it has been carried out, 
then please contact, in the first instance, the 
researcher. If this does not resolve your 
concerns, please contact Professor Steven 
Wainwright, Head of the Sociology and 
Communication department, Brunel 
University.  You can contact the Ethics Officer 
in Sociology and Communications at Brunel 
University London, Dr Simon Weaver to 
obtain an independent information or advice 
about your rights as research subject or about 
being involved in this particular research 
study or if you wish to make a complaint 
about the research.  All contact details are 
given at the end of this sheet. 
 
Who has approved the study? 
The study has gained the ethical approval of 
the School of Social Science at Brunel 
University London and the Research 
Governance Committee for the Adult Care 
Service in Hertfordshire and the Social Care 































Department of Sociology and 
Communication  
School of Social Sciences 





Professor Steven Wainwright  
Department of Sociology and 
Communication  
School of Social Sciences 




Dr Simon Weaver 
Department of Sociology and 
Communications 
School of Social Sciences 
Brunel University London 







Interview (Smoking Cessation Advisor) 
U:\Nancy\IRAS\0061 
22 January 2014 
ELECTRONIC CIGARETTES USE AT SMOKING CESSATION SERVICE IN UK: USERS 
AND STAFF PERSPECTIVES 
Introduction 
We would like to invite you to participate in 
this original PhD research project. You should 
only participate if you want to; choosing not 
to take part will not disadvantage you in any 
way. Before you decide whether you want to 
take part, it is important for you to 
understand why the research is being done 
and what your participation will involve. 
Please take time to read the following 
information carefully and discuss it with 
others if you wish. Ask the researcher if there 
is anything that is not clear or if you would 
like more information.  
What is the purpose of this study? 
I would like to interview some smoking 
cessation advisors and Electronic Cigarette 
users from the smoking cessation service in 
Hertfordshire. The purpose of this study is to 
analyse Electronic Cigarettes (EC) use at 
smoking cessation clinics in Hertfordshire as 
part of the new harm reduction strategy. The 
aim is to explore the EC users and the staff 
attitudes, experiences and views about EC 
use. What similarities and differences are 
there between the staff’s and the users’ 
conceptions? How do the staff adapt their 
work to the users’ needs and wishes? And 
how do they conceive CE use generally and in 
comparison with earlier treatment 
experience? I wish to gain an in-depth 
understanding of the Smoking Cessation 
Advisors’ perspectives by talking to them 
about their views. 
Who is conducting the research? 
I, Nancy Tamimi, will be conducting the 
interviews. Professor Steven Wainwright is 
the supervisor of the PhD Project.  
What will you be invited to do?  
You can be involved in this research in either or 
both of the following First I would like you to 
provide your clients who use EC with an 
invitation letter and information sheet for my 
research.  And ask them if they agree for you to 
pass their contact details to me to contact them 
and ask about their decision. I will be contacting 
them after they are given a minimum of 24 hours 
to decide whether to take part in the research or 
not, they also can contact me if they wish. 
Second I would like to interview you as a smoking 
cessation advisor.  Should you decide to be 
interviewed, I will contact you to arrange an 
interview lasting about one hour, at a time and 
location convenient for you. During the 
interview, I will ask you about your experience 
with clients who decide to use EC, how the 
treatment goals at the clinics are initiated and 
negotiated; what are the factors that affect the 
decision to use EC; what is the role of digital 
information on EC initiation, use and 
conceptualisation; how do you view and 
conceptualise EC use and how does the 
experience of EC use compare with previous 
experiences (as similar or different to other 
smoking cessation treatments). It is your right to 
refuse to answer specific questions, to 
discontinue your participation, or to ask me to 
explain my questions. Interviews will be audio 
recorded, subject to your permission. Recordings 
of interviews will be deleted at the end of the 
project. If you do not wish the interview to be 
recorded, I will take notes as we talk. You are also 
free to have any interview data pertaining to you 
withdrawn from the study within three months 





Who is funding the research? 
The research is being funded by the researcher. 
Possible risks of participation in the interview 
Most people enjoy talking about their work. However 
some staff may feel less comfortable talking about 
some issues associated with EC use at the Smoking 
Cessation Service. Issues may be raised that the 
interview and/or study cannot resolve. Our aim is to 
provide all participants with safe, respectful and 
confidential opportunities to discuss your beliefs and 
opinions in connection with EC use. 
Possible benefits of participation 
You may find the topic interesting, and relevant to 
your professional work. Once the research is finished, 
it could provide information about the experience of 
EC use and the different perspectives of the staff and 
the users, which may be of benefit to health 
professionals, scientists, policymakers and regulatory 
bodies. 
Will the information you provided be kept 
confidential?  
Everything you say/report is confidential unless you 
tell us something that indicated that you or someone 
else is at risk of harm. We would discuss this with you 
before telling anyone else.  All information that is 
collected about you and about the clients during the 
course of the research will be anonymous and kept 
strictly confidential, in accordance with the 1998 Data 
Protection Act.  Any notes we make will be given a 
code number to ensure that they are not traceable to 
an individual.  All the notes will be stored securely in a 
research office for 7 years from the project 
completion.  Professor Steven Wainwright, Professor 
Clare Williams and I will be the only people with 
access to this stored data.  You should be aware that I 
am obliged to report any instances of professional 
misconduct to the proper authorities. 
What will happen to the results of the research 
study?  
The data provided by this study will be used to write a 
PhD thesis and a number of reports and papers in 
academic journals. Participants and the research site 
will not be identified on any report/publication.  You 
will be able to access publications from the Brunel 
University webpage. 
 
What do you do now? It is up to you to 
decide whether or not to take part in 
either or both of the following: You can 
participate either by identifying EC users, 
provide them with the invitation letter and 
information sheet and pass their contact 
details to me (if they agreed) to contact 
them. You can also participate by agreeing 
to be interviewed by the researcher. 
If you are interested in hearing more about 
the study then please contact me (Nancy 
Tamimi) and I will be happy to answer any 
questions you may have. If you agree to 
participate in the interview, then 
interviews will be scheduled at a time and 
place convenient for you. You will be asked 
to sign a consent form and be given a copy 
of this and the information sheet to keep.  
What if you decided not to take part? You 
are free to decide not to take part.  Even if 
you do agree to take part, you are free to 
withdraw from the study at any time 
without giving an explanation, and I will 
not use your interview data.  Withdrawal 
will not be possible once data has been 
used in publications (3 months after 
participation). 
What if you have any concerns or 
questions? 
If you have any concern or question about 
this study or the way it has been carried 
out, then please contact, in the first 
instance, the researcher. If this does not 
resolve your concerns, please contact 
Professor Steven Wainwright, Head of the 
Sociology and Communication 
department. You can contact the Ethics 
Officer in Sociology and Communications 
at Brunel University London, Dr Simon 
Weaver to obtain an independent 
information or advice about your rights as 
research subject or about being involved in 
this particular research study or if you wish 
to make a complaint about the research. 







Who has approved the study? 
The study has gained the ethical approval of the School of Social Science at Brunel University 
London and the Research Governance Committee for the Adult Care Service in Hertfordshire 























Department of Sociology and 
Communication  
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Brunel University London 
Telephone: 07741546059 (mobile) 
Email: Nancy.tamimi@brunel.ac.uk 
 
Professor Steven Wainwright  
Department of Sociology and Communication  
School of Social Sciences 




Dr Simon Weaver 
Department of Sociology and 
Communications 
School of Social Sciences 
Brunel University London 






Appendix 3: Consent forms  
 
School of Social Sciences 
Brunel University London  
Kingston Lane 
Uxbridge 
Middlesex UB8 3PH 
Tel: +44 (0)1895 274000 





Interview with Electronic Cigarette User 
ELECTRONIC CIGARETTES USE AT SMOKING CESSATION SERVICE IN UK: USERS AND STAFF 
PERSPECTIVES 
Researcher: Nancy Tamimi, Department of Sociology and Communication; First supervisor: Professor 
Steven Wainwright  
 I confirm that I have read and understand the information sheet dated ................ 
for the above study and have had the opportunity to ask questions. Yes/NO 
 I understand that my participation is voluntary and that I am free to withdraw data 
pertaining to my consultation within three months of participating, without giving any 
reason, and without my legal rights being affected. Yes/NO 
 I agree to be interviewed by the researcher Nancy Tamimi for approximately 1 hour. Yes/NO 
 I understand that data from the interview will inform the study and may be used 
anonymously in publications. Yes/NO 
 I agree for the interview to be audio-recorded Yes /NO 
 I agree to take part in this interview subject to the conditions agreed above Yes/NO 
   
Name of Participants Date     Signature 
I confirm that I have explained the proposed study to the participant: 
 







School of Social Sciences 
Brunel University London 
Kingston Lane 
Uxbridge 
Middlesex UB8 3PH 
Tel: +44 (0)1895 274000 





Smoking Cessation Advisor 
ELECTRONIC CIGARETTES USE AT SMOKING CESSATION SERVICE IN UK: USERS 
AND STAFF PERSPECTIVES 
Researcher: Nancy Tamimi, Department of Sociology and Communication; First supervisor: Professor 
Steven Wainwright  
 I confirm that I have read and understand the information sheet dated ................ 
for the above study and have had the opportunity to ask questions. Yes /No 
 I understand that my participation is voluntary and that I am free to withdraw data 
pertaining to my consultation within three months of participating, without giving any 
reason, and without my legal rights being affected. Yes /No 
 I agree to be interviewed by the researcher Nancy Tamimi for approximately 1 hour. Yes /No 
 I understand that data from the interview will inform the study and may be used 
anonymously in publications. Yes /No 
 I agree to provide clients who use e-cigarettes with the invitation letter and information 
sheet and pass their contact details to the researcher if they agreed. Yes /No 
 I agree for the interview to be audio-recorded. Yes /No 
 I agree to take part in the interview subject to the conditions agreed above. Yes /No 
  
Name of Participants Date     Signature 
I confirm that I have explained the proposed study to the participant: 
   
 
Researcher  Date  Signature 






Appendix 4: Draft interview topic guide 
 
 
DRAFT INTERVIEW TOPIC GUIDE – Stop smoking advisors and Electronic Cigarette (EC) 
users 
(as per accepted qualitative methodologies, this is a draft guide, and questions/topics may 
be adapted as interviews get underway) 
A qualitative study of the use of Electronic Cigarettes at Smoking Cessation Service: Users 





(i) I am interested in your views and experiences of using electronic cigarettes. So 
please feel free to elaborate wherever you think it will help. 
 
(ii) The interview is completely anonymous and will be kept confidential (only my 
academic supervisors and I will have access to the audio-recordings and transcripts). 
Interviewees will not be identified in any publications, presentations etc. 
 
(iii) If it is ok with you, I would like to make an audio recording of the interview. We can 
turn the audio recorder off at any time you request. We can also stop the interview 
at any time you wish, and you can decline to answer any question. 
 
For The EC Users: 
 
This section only for service users 
 
EC Use Decision (Only if they are using/ used the Stop Smoking Service) 
 
Do you use the Stop Smoking Service? 
 
How long have you been using the Smoking Cessation Service? 
 
Have you used it before? Tell me about your experience at the service? 
 
Could you tell me why you chose to use the Smoking Cessation service? What is it what you 





Can you tell me how the decision to use EC was made? What role did the advisor have in 
deciding the treatment? How much control did you have in making the decision? Is there 
any negotiation from your side or the advisor side? 
 
Institutional /Professional Influence 
 
In your opinion, is there any favour for a particular treatment at the smoking cessation 
service? Can you elaborate? 
 
The Role of Digital Information 
 
What information is given to you about EC in the clinic? How is this information presented? 
 
 
This section is for both service and non-service users 
 
EC use decision 
 
What are the reasons that made you decide to use EC? 
 
How long have you been using EC? 
 
How often do you use EC? Tell me about the brand and the way you use it and your 
experience in general since you started. 
 
What do you like/dislike about EC? 
 
Are you planning to use them in the long term? 
 
Are you a supporter or against EC use? 
 
Do you think, if you stopped EC, you will go back to smoking? 
 
The Role of Digital Information 
 
Where did you hear about EC? 
 
Whenever you want to know more about EC, where do you get the information about EC 
from? 
 
There is a lot of information about EC on the Internet and websites for EC users; do you use 
any? If yes, can you name some websites? 
 
Do you think the Internet has an influence on your decision to use EC? If yes, can you tell me 





Smoking History/ Service Use History/Smoking Cessation History 
 
How many years did you smoke? How many cigarettes a day did you use to smoke? 
 
Do you still smoke cigarettes? 
 
What do/did you like about smoking? 
 
How many times have you attempted to quit smoking? 
 
What are the treatments you used so far to help you stop smoking? 
 
EC Efficacy and Conceptualisation 
 
Having used other treatments, in what aspects do you consider EC different than other 
treatments? 
 
In your opinion, does EC use have any particular effect on your attitude, personality, 
identity, social life, dealing with craving symptoms, how people see you, or any other aspect 
in your life? 
 
How effective do you think EC is as a smoking cessation treatment? 
 
How do you view EC? Some people view them as a medicine to treat nicotine addiction; 
others view them as a way of smoking to keep the nicotine addiction alive. Do you have a 
different view for EC? Could you explain your view more? 
 
Do you have any views about the debate that is going on about EC? Gateway, use in public 









What is your official position? Tell me a little bit about what tour work involves. What 
expertise and skills does it require? 
 
If applicable. How long have you worked in the smoking cessation service? 
 
How many Electronic Cigarette (CE) users have you worked with? 
 
Do you feel your training has prepared you for working with EC users? 
 
Management of EC Use 
 
When you start with each client, what do you aim to achieve from providing the service? Do 
you have specific goal/goals that you aim to achieve? Is it different from one client to 
another? What is taken into consideration when deciding upon a treatment option? 
 
For those who decide to use EC: In your opinion, what are the reasons for opting to use 
them over the other options? 
 
How is the decision to use EC usually made? What role do you have in deciding the 
treatment? How much control is the client given in making the decision? Is there any 
negotiation from your side or the client side? Could you give me an example? 
 
The Role of Digital Information 
 
What information is given to clients about EC? How is this information presented? What is 
the source of information? 
 
There is a lot of information about EC on the Internet; do you use the Internet to get 
information about EC? If yes, can you name some websites? 
 
From your experience, do you think the Internet has an influence on your clients’ decision to 
use EC? If yes, can you tell me how and give me examples. 
 
EC Efficacy and Conceptualisation 
 
Having seen the client using other treatments, in what aspects do you consider EC different 
than other treatments? 
 
In your experience, does EC use have any particular effect on the client’s attitude, 
personality, identity, social life, dealing with craving symptoms, etc? 
 





Are you with or against the use of EC cigarettes? Why? Tell me more… 
 
How do you view EC? Some people view them as a medicine to cure nicotine addiction; 
others view them as a medium to deliver nicotine to maintain the addiction. Do you have a 




In your opinion, are there aspects of the current political climate which favour one 
treatment over the other? Could you tell me more? 
 




Is there anything we have not covered that you think would help me understand more 
about this area of EC use? 
 
Thanks very much for your participation. If, afterwards, you think of something that was 
mentioned today that you would prefer not to be included in any publications or 
presentations, please let me know within three months and I will have the information 
withdrawn. 
 
Also, resulting publications will be available on the School of Social Science, Brunel 
University website. If you would like, I can send you a report of the findings of this 








1. Interviews with Stop Smoking Advisors. Total: 13 
1.1. Hertfordshire  I conducted 7 face to face interviews. 
1.2. East Sussex  I conducted 6 phone interviews.  
2. Interviews with electronic cigarette users: Total: 15 (5 only are service 
users)  
2.1. Hertfordshire I conducted 1 face to face 
interview with service user. 
Total: 8 
I conducted 7 face to face 
interviews with non-service 
users. 
2.2. East Sussex I conducted 4 phone interviews 
with service users. 
Total: 4 
3. From other areas 
in South East 
England. 
I conducted 2 face to face 
interviews, and only one phone 





























H1 Hertfordshire  Female 10 years 3/6/2014 
H2 Hertfordshire Female 1 year  5/6/2014 
H3 Hertfordshire Male 7 months 4/4/2014 
H4 Hertfordshire Female 4 years 25/6/2014 
H5 Hertfordshire Female 1 year 10/6/2014 
H6 Hertfordshire Female 15 years 10/6/2014 
H7 Hertfordshire Male 5 years 19/11/2014 
S1 East Sussex  Male 3 years  26/2/2015 
S2 East Sussex  Male 7 years 27/2/2015 
S3 East Sussex  Female 3.5 years 5/6/2015 
S4 East Sussex  Female 1 year 11/3/2015 
S5 East Sussex  Female 16 months 11/3/2015 




Appendix 7: A full list of interviews conducted with electronic cigarette users  
 
  electronic 
cigarette users 
County  Interview 
Date  
1A Hertfordshire  13/11/2014 
2B Hertfordshire 12/12/2014 
3C Hertfordshire 18/12/2014 
4D Hertfordshire 20/2/2015 
5E East Sussex 21/4/2015 
6F East Sussex 21/4/2015 
7G East Sussex 30/4/2015 
8H Hertfordshire 9/6/2015 
9I Hertfordshire 9/6/2015 
10J Hertfordshire 22/6/2015 
11K Uxbridge 24/6/2015 
12L Uxbridge  14/7/2015 
13M Hounslow 27/7/2015 
14N East Sussex 19/6/2015 





























































“I think at the moment it is seen as 
an alternative to smoking” (H6, 
Advisor) 
“last night I did have a cigarette 
when I was out with friends, but I 
also had my electronic cigarette with 
me, which I use as my main source of 
nicotine” (14N, user) 
Effective 
like NRT 
“They are effective as Nicotine 




“I think a lot of people self-medicate 
using the e-cigarettes” (S3, Advisor) 
Good 
substitute 




“I don’t find it to give me total 
satisfaction that a normal cigarette 





































“we don’t know whether they 
[electronic cigarettes] are 100% safe 
at all” (9I, user) 
“I wish I could tell them with 
absolute surety what the safety is 
and I can’t. I wish I can tell them with 
absolute surety how much nicotine 
they are getting from the product 
and I can’t. So I think there are gaps 






“There’s no long-term studies. That 
kind of worries” (12L, user) 
“but what are the health risks for 
people inhaling propylene glycol over 
periods of time” (S2, Advisor) e-cig is 
Safe 
 “I would say it should be allowed, it 
doesn’t do any harm… the electronic 
































“Obviously this is less harmful to you 
and people around you” (10J, user) 
Renormal
isation  
“About how it looks. I think generally 
there has been a huge amount of 
work to achieve the stop smoking 
ban in public places that is: any 
transport, any restaurant, any sort of 
public place, and I think to allow 
electronic cigarettes in those places 






“It started to happen not that often 
but I know three instances in the last 
few weeks when people are presented 
to us stated that they already quit 
cigarette but wanted to come off 
electronic cigarettes and that’s brand 





“I mean there are no health 
warnings on it, because no one has 
discovered any health dis-benefits 
apart from the fact that it will keep 
you addicted to nicotine. And I think 
most people who smoke electronic 
cigarettes, I think, know that nicotine 





“I think the stigma that smokers had 
has kind of carried on to the 
electronic cigarette users in the 
sense that the stigma surrounding 
the addiction itself” (12L, user) 
“Some people who are already 
strongly anti-smoking probably 
won’t be happy seeing them. But I 
think the majority will probably 






“I don’t think there is any evidence at 
the moment that children are starting 
to use electronic cigarettes, that it is 
used as a gateway drug. But I don’t 
think we have got enough evidence; 







“I don’t know. But I don’t see why 
they can’t happen. If you build up a 
nicotine addiction through vaping, 
and one day you walk past an airport 
.and there’s no other way of getting 
your fix than buying a packet of 
cigarettes, because no one sells – I can 





















































“the service doesn’t have to take the 
responsibility for it, so if it’s found 
that there is something wrong, 
health wise or something eventually 
it’s my own fault I do understand 
that” (5E, user) 
“I do what I want I am old enough to 




“I just give them advice and guidance 
and do what I can but not to tell 
them what to do” (S3, Advisor)  
User’s 
choice 




“ I would need the willpower to get 




“when I deal with my patients I 
emphasise that ok we are talking 
about this smoking addiction but it 
exactly the same like any kind of 
addiction, it could be a gambling 
addiction it could be any sort of 
behaviour change so this is the way 
how I help them to distract 
themselves so this isn’t about 
smoking this is about whole let’s get 




“the whole point you want them to 
have a better lifestyle and not being 
controlled and make sure the 
cigarettes not in control of them” 
(H1, Advisor) 









































































by others  
“I like it when people ask me what 
I’m doing and I show them my 
machine and they get very interested 
in it” (14N, user) 
“…they are [kids] proud of me giving 
up smoking my husband prefers it” 
(1A, user) 
“I go to my daughter’s house I smoke 
the e-cigarette, she like it and 























“I think it definitely is, the vaping 
community is getting bigger they do 
seem to want to have an identity. A 
couple of facts. From the people I 
spoken to quite few they are quite 
proud of themselves that they don’t 
smoke, they are seen as doing 
something new and exciting and I 
think again on a long term I think 
their perception is they try to 
distance themselves. Certainly for 
people they have been on for a 
longer time It’s not about the 
smoking it’s about lifestyle you 
certainly see that with” (S2, Advisor) 
“It doesn’t look like a cigarette. I 
don’t smoke one that looks like 
cigarettes… I admire the vapers 
because I think that they are very 
smart” (14N, user) 
“Well its turning into a hobby I could 
put it down and not using it at all 
any more but it’s like a big hobby for 
me I got very advanced device and I 
like going to events and things about 




“I know a lot of people wouldn’t 
associate tobacco companies with 
safety, but at least like the large 
multinational company, they will 
have much more internal testing of 
these things than, you know, 
somebody working in their shed in 
Northumberland. So actually I tend 
to trust the tobacco industry 
electronic cigarettes probably a bit 
more” (12L, user). 
“So you have got a bit of a dilemma. 
Do you want to give out a product 
that ultimately has been made by a 
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